data_2rvh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rvh _Structure_validation_residue.Date_analyzed 2016-10-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -119.54 125.44 48.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.556 1.142 . . . . 0.0 110.31 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.09 111.73 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.526 -1.286 . . . . 0.0 107.526 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -120.24 152.12 38.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.26 1.424 . . . . 0.0 110.342 -170.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.48 1.031 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 170.184 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.5 mt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -105.13 118.16 35.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.657 1.583 . . . . 0.0 108.8 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -98.36 126.71 43.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.429 1.492 . . . . 0.0 110.407 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.71 126.55 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.019 1.328 . . . . 0.0 109.485 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -136.66 146.78 46.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.617 1.567 . . . . 0.0 110.329 -169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.03 -6.17 82.03 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.9 p -52.44 133.65 43.79 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -52.94 138.09 61.48 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.802 3.002 . . . . 0.0 113.267 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.04 -16.18 63.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.842 0.857 . . . . 0.0 113.113 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.79 -18.3 64.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.129 0.972 . . . . 0.0 113.34 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -92.85 120.76 33.53 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.687 1.195 . . . . 0.0 110.511 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.51 124.05 22.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.329 0.652 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -60.85 -38.59 86.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.026 0.53 . . . . 0.0 111.266 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.19 -34.46 73.66 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 113.19 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -70.67 -37.76 73.68 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.408 -0.808 . . . . 0.0 111.441 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.3 mt -58.87 -47.87 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mt -54.82 -47.66 73.78 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.963 0.802 . . . . 0.0 111.561 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.26 -42.75 99.16 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 112.33 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.71 -46.42 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.127 0.571 . . . . 0.0 111.184 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.72 -27.71 65.2 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -78.76 -35.18 44.94 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.86 -1.15 . . . . 0.0 113.071 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -77.49 -59.35 2.82 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.988 0.915 . . . . 0.0 113.103 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.45 -39.78 14.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.326 1.051 . . . . 0.0 113.373 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.92 -13.11 34.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.855 0.862 . . . . 0.0 113.198 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.99 28.1 16.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.172 1.789 . . . . 0.0 113.332 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.33 -170.83 3.29 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.621 1.168 . . . . 0.0 111.1 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -144.62 150.9 38.19 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.233 1.013 . . . . 0.0 109.589 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.67 172.02 45.06 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.544 0.977 . . . . 0.0 115.544 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -154.22 158.53 40.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.355 1.862 . . . . 0.0 111.568 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.8 mt -89.49 128.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.7 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 124.877 1.271 . . . . 0.0 109.474 -173.485 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 pt . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.09 132.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.41 132.38 49.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.048 1.339 . . . . 0.0 108.13 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.26 143.02 47.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.926 1.69 . . . . 0.0 108.382 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.4 136.45 46.08 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.195 -0.941 . . . . 0.0 111.523 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.98 48.87 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.666 1.603 . . . . 0.0 113.63 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.93 87.46 4.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.53 1.932 . . . . 0.0 110.969 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -109.86 22.66 15.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.426 1.49 . . . . 0.0 112.985 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -57.37 -46.75 83.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 0.0 114.141 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.67 84.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.8 -47.24 78.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.178 0.991 . . . . 0.0 112.06 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.1 -36.24 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.978 -0.451 . . . . 0.0 111.35 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.45 -50.21 72.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.02 -38.11 81.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.929 . . . . 0.0 112.874 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -60.26 -49.37 77.86 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.003 1.274 . . . . 0.0 111.64 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.83 -38.27 87.55 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.236 1.015 . . . . 0.0 111.23 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.82 -47.11 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.64 0.776 . . . . 0.0 111.574 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -75.38 -48.22 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.198 0.999 . . . . 0.0 113.43 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -97.6 -32.68 11.66 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.93 -18.28 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.774 0.715 . . . . 0.0 112.719 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.54 10.32 85.4 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.618 1.104 . . . . 0.0 114.184 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.02 132.44 45.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.218 1.009 . . . . 0.0 110.014 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -76.23 136.29 39.69 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.477 -0.765 . . . . 0.0 110.95 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -48.99 -37.65 20.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.503 . . . . 0.0 114.841 -169.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -53.62 -23.14 10.2 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.535 1.534 . . . . 0.0 114.886 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -77.43 -14.33 59.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.99 1.316 . . . . 0.0 114.365 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.6 mt -105.58 119.3 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 119.454 1.024 . . . . 0.0 110.407 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -96.05 130.43 43.06 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.143 1.377 . . . . 0.0 109.922 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 108.919 174.549 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -118.47 117.62 29.5 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 109.748 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.6 mt -109.54 103.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -110.98 174.4 5.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.264 2.225 . . . . 0.0 110.594 -169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 124.169 0.988 . . . . 0.0 109.082 169.04 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 m -98.68 123.6 42.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.808 1.643 . . . . 0.0 108.778 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.82 115.81 30.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.289 1.836 . . . . 0.0 110.225 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.44 127.4 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.581 1.152 . . . . 0.0 109.845 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.41 152.5 51.47 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.343 1.857 . . . . 0.0 110.211 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.48 -3.79 71.64 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.61 132.55 71.62 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.676 1.238 . . . . 0.0 110.86 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -54.78 143.22 71.59 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.781 2.987 . . . . 0.0 113.169 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.86 -18.2 64.11 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.47 -19.51 65.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.974 0.91 . . . . 0.0 113.37 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -91.5 109.57 20.86 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.681 1.192 . . . . 0.0 110.285 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.89 118.83 10.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.203 1.001 . . . . 0.0 112.144 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -60.65 -38.2 84.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.462 0.705 . . . . 0.0 111.847 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.61 -38.14 89.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.208 1.003 . . . . 0.0 112.332 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -64.35 -38.06 89.7 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.201 -0.937 . . . . 0.0 111.928 170.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.64 -40.2 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.618 0.767 . . . . 0.0 110.1 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.6 -55.28 37.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.185 0.902 . . . . 0.0 110.749 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.35 -49.27 72.7 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.11 -36.87 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.37 -34.44 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.974 0.806 . . . . 0.0 112.034 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.28 -32.69 74.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.671 -1.268 . . . . 0.0 112.511 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -78.16 -67.63 0.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 112.889 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.22 -34.52 25.86 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -93.68 -4.15 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 112.65 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.43 28.42 16.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.157 1.783 . . . . 0.0 113.158 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.8 m -82.92 -174.9 5.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.551 1.14 . . . . 0.0 112.499 -174.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.41 145.29 35.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.474 1.51 . . . . 0.0 108.712 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.92 172.59 45.54 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.33 163.62 37.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.591 1.556 . . . . 0.0 112.866 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.36 134.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.883 1.273 . . . . 0.0 109.467 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 125.482 1.513 . . . . 0.0 109.463 178.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.198 0.523 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -95.34 133.63 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -104.45 128.07 52.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.15 1.38 . . . . 0.0 107.815 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.73 141.41 48.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.983 1.713 . . . . 0.0 108.483 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -72.75 137.48 45.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.858 1.208 . . . . 0.0 111.799 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.77 -175.78 47.25 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.692 1.615 . . . . 0.0 113.693 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.7 84.53 5.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.355 1.862 . . . . 0.0 111.098 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.79 14.62 26.52 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 112.919 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -59.32 -41.54 89.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.53 63.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.089 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -63.74 -44.81 92.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.936 0.894 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.7 -35.39 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.399 0.68 . . . . 0.0 111.246 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.8 t -56.47 -47.8 78.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.541 1.064 . . . . 0.0 111.156 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.81 -39.74 90.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.576 0.751 . . . . 0.0 112.438 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -60.09 -48.39 81.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.725 1.148 . . . . 0.0 111.792 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mmt -59.57 -43.27 93.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.582 1.153 . . . . 0.0 110.604 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.23 -45.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.693 0.797 . . . . 0.0 111.711 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -75.71 -47.15 27.3 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -102.24 -37.43 8.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.0 mt -89.36 -17.02 29.68 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.894 0.77 . . . . 0.0 112.723 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.97 15.99 80.44 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.461 1.029 . . . . 0.0 113.639 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.64 136.22 52.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.213 1.007 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -76.8 139.09 40.24 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.615 -0.678 . . . . 0.0 109.909 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -53.8 -37.55 63.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -56.69 -24.7 50.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.392 1.477 . . . . 0.0 114.981 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -76.86 -16.09 59.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.32 0.964 . . . . 0.0 113.277 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.86 126.24 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.294 1.407 . . . . 0.0 112.123 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -103.15 134.6 46.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.016 1.726 . . . . 0.0 110.27 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 124.98 1.312 . . . . 0.0 108.428 174.472 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -103.6 121.08 42.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.842 0.857 . . . . 0.0 110.076 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.28 103.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -113.16 171.23 7.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.971 2.108 . . . . 0.0 110.21 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.322 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -89.95 116.98 28.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.614 1.566 . . . . 0.0 108.26 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.57 117.19 32.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.952 1.701 . . . . 0.0 110.005 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.93 126.66 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 108.922 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -138.02 159.11 42.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.871 2.068 . . . . 0.0 109.233 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.23 -14.97 2.74 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.289 -1.507 . . . . 0.0 116.103 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.02 130.57 7.22 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 126.207 1.803 . . . . 0.0 112.151 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.43 139.41 65.23 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.241 3.294 . . . . 0.0 113.413 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.96 -11.14 60.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.15 -18.97 61.84 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.114 0.966 . . . . 0.0 113.018 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -90.8 119.72 31.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.561 1.144 . . . . 0.0 110.961 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.79 119.86 16.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 111.568 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -62.75 -38.39 90.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.297 0.639 . . . . 0.0 111.901 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.93 -39.51 89.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.936 0.895 . . . . 0.0 112.225 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -63.49 -39.62 94.92 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.227 -0.921 . . . . 0.0 111.943 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.48 -47.38 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.919 0.781 . . . . 0.0 109.103 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.72 -48.09 75.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.155 0.889 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -62.38 -39.71 94.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.438 -0.789 . . . . 0.0 112.443 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.97 -46.67 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.869 0.759 . . . . 0.0 111.147 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.42 -30.52 67.4 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.05 -31.86 63.06 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.837 -1.164 . . . . 0.0 112.974 171.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -80.01 -61.93 1.84 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.237 1.015 . . . . 0.0 113.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.14 -37.32 20.35 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -92.98 -13.13 29.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.876 0.871 . . . . 0.0 113.002 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.05 29.47 17.66 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.175 1.79 . . . . 0.0 113.012 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.7 m -82.43 -172.1 3.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.697 1.199 . . . . 0.0 111.284 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -146.34 152.76 39.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 109.944 168.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.9 176.23 47.92 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 115.451 0.94 . . . . 0.0 115.451 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -158.33 162.12 37.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.328 1.851 . . . . 0.0 111.64 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 143.79 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 108.985 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 124.436 1.094 . . . . 0.0 109.259 169.789 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.017 0.437 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.33 134.79 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.05 126.01 51.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.887 1.675 . . . . 0.0 107.491 168.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -113.27 140.46 47.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.231 1.412 . . . . 0.0 108.376 170.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -71.41 135.19 47.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.135 -0.978 . . . . 0.0 111.705 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 -169.86 45.88 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.453 1.501 . . . . 0.0 113.539 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.13 87.54 3.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.706 2.002 . . . . 0.0 111.205 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -112.35 20.25 16.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.584 1.553 . . . . 0.0 112.939 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.75 -42.03 92.3 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.38 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.056 0.942 . . . . 0.0 112.154 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.71 -45.15 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.868 0.867 . . . . 0.0 111.811 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.14 -34.81 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.09 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.0 -49.07 78.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.338 0.972 . . . . 0.0 111.162 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.13 -37.81 78.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.83 0.852 . . . . 0.0 112.652 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.36 -48.54 80.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.867 1.212 . . . . 0.0 111.664 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.6 mmt -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.051 0.94 . . . . 0.0 110.734 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.03 -47.89 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.954 0.902 . . . . 0.0 111.417 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -97.94 -33.21 11.3 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.98 -14.22 39.69 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.83 0.741 . . . . 0.0 112.107 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.81 79.75 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.865 1.221 . . . . 0.0 113.899 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.3 mt -71.41 144.07 49.92 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.434 1.117 . . . . 0.0 111.783 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -75.21 138.25 41.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -54.32 -34.86 61.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -55.65 -21.71 19.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.524 1.93 . . . . 0.0 115.311 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -76.68 -10.56 59.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.1 mt -112.86 133.17 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.049 0.94 . . . . 0.0 111.153 -169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.34 128.25 54.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.535 1.934 . . . . 0.0 110.153 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.4 mt . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 124.83 1.252 . . . . 0.0 109.077 175.75 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -118.12 111.43 18.86 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 111.005 -169.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -104.89 110.28 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -118.06 164.89 14.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.512 1.925 . . . . 0.0 109.696 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.646 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.3 m -93.62 118.02 30.84 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.481 1.513 . . . . 0.0 108.304 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.61 115.36 29.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.646 1.578 . . . . 0.0 110.001 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.66 126.89 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 109.288 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -137.62 161.01 37.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.717 2.007 . . . . 0.0 109.412 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 -13.43 8.14 Favored Glycine 0 N--CA 1.477 1.387 0 O-C-N 120.092 -1.63 . . . . 0.0 116.056 169.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -49.97 132.23 22.41 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.974 1.309 . . . . 0.0 111.061 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.83 136.73 51.62 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.086 3.19 . . . . 0.0 113.001 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.83 -3.04 29.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 -17.2 61.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 167.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.4 126.6 40.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.166 1.386 . . . . 0.0 110.247 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -77.64 131.25 37.68 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.608 -0.682 . . . . 0.0 110.84 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.4 -37.57 83.92 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.336 0.654 . . . . 0.0 111.678 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -61.15 -33.31 73.21 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.868 0.867 . . . . 0.0 112.601 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.6 -39.49 84.77 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.261 0.937 . . . . 0.0 111.516 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.04 -47.02 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 0.0 109.196 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.27 -47.08 76.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.766 0.712 . . . . 0.0 111.872 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -62.48 -39.3 93.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.725 0.693 . . . . 0.0 112.351 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.13 -48.17 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 118.985 0.811 . . . . 0.0 111.13 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.46 -29.76 67.5 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.22 -26.87 56.5 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.691 -1.256 . . . . 0.0 113.56 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.56 -49.58 5.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.96 -40.9 17.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.973 0.909 . . . . 0.0 112.953 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.71 -9.75 36.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.651 1.18 . . . . 0.0 112.606 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.32 30.84 20.12 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.934 1.694 . . . . 0.0 112.659 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.08 -165.07 1.27 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.558 1.143 . . . . 0.0 111.335 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.17 146.42 26.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.78 0.832 . . . . 0.0 110.971 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.47 176.17 46.13 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -155.71 164.46 38.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.131 1.773 . . . . 0.0 111.086 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mt -103.08 139.7 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.39 1.476 . . . . 0.0 110.055 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 125.124 1.37 . . . . 0.0 109.182 173.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.109 0.48 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.15 133.23 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -103.78 117.4 34.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.823 1.649 . . . . 0.0 107.005 167.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.45 145.14 30.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.894 1.278 . . . . 0.0 108.898 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.83 131.0 44.42 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.538 -0.726 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -167.05 47.82 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.707 1.146 . . . . 0.0 113.662 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -97.69 93.0 6.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.585 1.954 . . . . 0.0 111.25 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -116.87 22.4 12.66 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.417 1.487 . . . . 0.0 113.072 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -58.52 -45.47 88.73 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.26 77.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.991 0.916 . . . . 0.0 112.198 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -65.89 -45.59 81.44 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 111.954 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.99 -35.41 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.254 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.3 t -57.37 -48.22 79.61 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.106 0.866 . . . . 0.0 111.09 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.49 -37.86 87.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.475 0.71 . . . . 0.0 112.766 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.49 -49.93 75.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.792 1.178 . . . . 0.0 111.383 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -58.92 -43.89 91.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 110.672 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.42 -44.29 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.578 0.751 . . . . 0.0 111.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.9 t -76.36 -48.09 21.15 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -99.46 -35.48 9.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.44 -14.25 30.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.878 0.763 . . . . 0.0 112.834 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.58 15.16 81.26 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.583 1.087 . . . . 0.0 113.784 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.33 148.64 49.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.316 1.058 . . . . 0.0 110.109 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -86.58 144.83 27.01 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.376 -0.828 . . . . 0.0 110.031 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -52.93 -39.63 62.98 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.653 -0.655 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -59.5 -21.03 59.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.543 1.537 . . . . 0.0 114.983 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -77.46 -14.29 59.72 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.075 0.852 . . . . 0.0 113.204 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.5 mt -108.05 122.67 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 120.317 1.417 . . . . 0.0 111.607 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.94 123.79 43.45 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.374 1.87 . . . . 0.0 109.627 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.808 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -118.53 122.78 43.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.32 1.048 . . . . 0.0 110.494 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -116.58 111.09 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -120.55 174.21 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.411 1.484 . . . . 0.0 110.952 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 168.79 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.402 0.144 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -93.81 119.48 32.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 108.547 169.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -101.43 123.53 45.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.207 1.403 . . . . 0.0 110.608 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.27 123.88 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.584 1.154 . . . . 0.0 109.114 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.61 152.52 48.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.301 1.84 . . . . 0.0 109.33 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 -5.14 63.95 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.914 -1.116 . . . . 0.0 115.879 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.31 129.45 51.36 Favored Pre-proline 0 N--CA 1.477 0.918 0 CA-C-N 119.475 1.638 . . . . 0.0 109.89 170.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -51.32 140.7 42.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.842 3.028 . . . . 0.0 113.679 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.83 -3.47 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.87 -18.41 62.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 0.0 111.912 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -92.41 133.1 36.21 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.048 1.339 . . . . 0.0 111.319 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.79 117.63 17.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.224 1.009 . . . . 0.0 111.192 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.53 -39.99 89.87 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 111.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -56.91 -35.99 69.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 113.812 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -71.51 -35.81 70.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.949 0.9 . . . . 0.0 111.847 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.47 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.796 0.839 . . . . 0.0 109.717 173.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.25 -55.77 30.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.26 0.936 . . . . 0.0 110.443 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -54.15 -48.73 70.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.378 1.071 . . . . 0.0 113.217 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.57 -31.97 65.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.102 0.865 . . . . 0.0 112.261 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.54 -34.85 72.72 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.773 -1.205 . . . . 0.0 112.426 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -75.27 -59.28 2.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.475 1.11 . . . . 0.0 113.34 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.61 -38.83 15.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.192 0.997 . . . . 0.0 113.675 -169.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.4 -4.79 50.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.985 0.914 . . . . 0.0 113.013 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.13 24.5 13.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.087 1.755 . . . . 0.0 113.3 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.2 m -81.96 -171.96 3.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.849 1.26 . . . . 0.0 112.012 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -144.81 153.83 42.04 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.888 1.275 . . . . 0.0 109.256 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.01 176.46 46.85 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 -169.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.14 164.73 30.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.232 1.813 . . . . 0.0 112.067 -171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.15 146.37 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 125.593 1.557 . . . . 0.0 108.704 169.582 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 pt . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.279 0.562 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.9 mt -100.16 134.69 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 166.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -103.84 129.2 51.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.535 1.534 . . . . 0.0 107.501 168.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.24 142.53 46.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.335 1.454 . . . . 0.0 108.29 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -77.99 135.1 37.74 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.036 -1.04 . . . . 0.0 111.296 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.68 -172.1 44.05 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.713 1.625 . . . . 0.0 113.22 -174.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -97.8 88.44 4.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.465 1.906 . . . . 0.0 111.22 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -112.56 17.58 19.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.798 1.639 . . . . 0.0 113.014 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -59.21 -42.94 92.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -169.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.46 -38.59 74.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.964 0.905 . . . . 0.0 112.153 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.9 -44.77 84.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.75 -33.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.235 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -49.47 77.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.402 1.001 . . . . 0.0 111.042 170.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.0 -36.59 75.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.696 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.35 -49.36 75.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.781 1.173 . . . . 0.0 111.854 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.4 mmt -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.241 1.016 . . . . 0.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.53 -49.72 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.305 1.042 . . . . 0.0 111.782 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -75.62 -46.33 32.26 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -101.83 -36.66 8.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 mt -89.55 -18.49 26.51 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.953 0.797 . . . . 0.0 112.915 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.05 14.57 81.75 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.572 1.082 . . . . 0.0 113.618 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.16 134.55 49.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.292 1.046 . . . . 0.0 108.93 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -75.19 148.1 39.85 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.52 -0.738 . . . . 0.0 110.136 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -56.99 -36.63 70.59 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.704 -0.623 . . . . 0.0 112.338 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -64.42 -17.66 63.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.099 1.76 . . . . 0.0 115.199 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -79.69 -10.04 59.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.349 0.977 . . . . 0.0 113.202 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 42.3 mt -113.64 131.74 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.03 -1.044 . . . . 0.0 111.074 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -106.46 135.72 47.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.453 1.501 . . . . 0.0 110.628 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 124.63 1.172 . . . . 0.0 108.851 173.166 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -116.58 119.52 35.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 110.754 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mt -109.39 109.27 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -117.92 176.35 5.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.443 2.297 . . . . 0.0 110.892 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.477 0.897 0 O-C-N 121.126 -0.984 . . . . 0.0 110.117 168.068 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.662 0.267 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.7 m -96.91 130.4 44.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.441 1.497 . . . . 0.0 107.548 168.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.34 122.54 46.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 110.569 -176.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.43 124.16 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.594 1.158 . . . . 0.0 109.525 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -130.22 150.85 51.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.567 1.947 . . . . 0.0 109.673 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.88 58.5 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.53 129.22 69.65 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 119.107 1.454 . . . . 0.0 110.407 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.64 141.84 51.99 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.036 3.157 . . . . 0.0 112.616 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -11.99 60.06 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.72 -22.58 66.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.574 0.75 . . . . 0.0 112.314 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -91.1 104.33 16.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.852 1.261 . . . . 0.0 109.44 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.02 125.32 24.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.73 0.812 . . . . 0.0 112.554 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.9 -40.08 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.428 0.691 . . . . 0.0 112.343 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -63.9 -39.13 93.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.581 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -64.64 -36.45 84.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.041 0.936 . . . . 0.0 112.328 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.8 -48.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.951 0.796 . . . . 0.0 109.326 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.45 -42.63 82.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.2 0.909 . . . . 0.0 112.174 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -58.72 -41.79 87.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.082 0.855 . . . . 0.0 112.255 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.94 -46.27 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.708 0.685 . . . . 0.0 111.534 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.9 -31.62 68.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE2' ' H ' ' A' ' 66' ' ' GLY . 87.5 mttt -75.42 -29.76 59.85 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.952 -1.092 . . . . 0.0 113.117 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -83.35 -61.66 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.11 0.964 . . . . 0.0 113.278 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.83 -39.24 24.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.151 0.98 . . . . 0.0 113.239 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -93.31 -7.8 43.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.565 1.146 . . . . 0.0 113.082 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.21 27.38 15.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.713 . . . . 0.0 113.287 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.4 m -83.86 -174.4 5.26 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.591 1.157 . . . . 0.0 111.736 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -138.85 144.95 39.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.209 1.004 . . . . 0.0 109.439 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' ' HE2' ' A' ' 59' ' ' LYS . . . -169.03 171.57 43.01 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 115.431 0.933 . . . . 0.0 115.431 -169.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -162.73 158.93 23.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.947 1.699 . . . . 0.0 112.128 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.16 137.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.712 1.205 . . . . 0.0 109.556 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.173 1.389 . . . . 0.0 110.199 -178.481 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.81 134.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -101.87 140.67 35.84 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.488 1.515 . . . . 0.0 108.551 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.41 141.94 50.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.97 1.708 . . . . 0.0 108.433 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.41 138.03 44.98 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.016 -1.052 . . . . 0.0 111.923 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.7 -172.47 44.44 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.21 1.386 . . . . 0.0 113.412 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -94.04 99.01 11.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.719 1.207 . . . . 0.0 110.04 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.23 18.54 14.46 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.536 1.534 . . . . 0.0 112.544 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -52.45 -55.23 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.618 1.167 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.01 88.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.264 1.026 . . . . 0.0 112.49 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -66.46 -45.35 80.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.497 0.719 . . . . 0.0 112.041 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.82 -36.14 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.227 0.611 . . . . 0.0 110.961 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.78 -48.47 75.26 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.317 0.962 . . . . 0.0 111.193 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.9 -39.55 89.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.592 0.757 . . . . 0.0 112.767 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -59.91 -49.58 77.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.807 1.185 . . . . 0.0 111.465 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.9 mmt -58.32 -41.32 84.25 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.233 1.013 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.36 -50.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.505 -0.747 . . . . 0.0 111.491 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.2 m -89.46 -14.16 35.96 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.27 -39.94 3.33 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.087 1.312 . . . . 0.0 113.324 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.12 -15.08 39.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.495 1.043 . . . . 0.0 113.09 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.72 14.74 79.26 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.471 1.034 . . . . 0.0 113.709 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 mt -68.94 151.59 46.35 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.541 1.171 . . . . 0.0 109.956 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -88.03 145.28 26.06 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -55.4 -37.64 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -61.28 -18.07 56.68 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.55 -14.22 60.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.403 1.002 . . . . 0.0 112.974 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.2 mt -111.52 128.64 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.218 0.917 . . . . 0.0 111.233 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.2 133.26 48.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.463 1.905 . . . . 0.0 109.79 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 124.074 0.949 . . . . 0.0 108.912 172.915 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -110.36 125.99 53.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.942 0.897 . . . . 0.0 110.981 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.61 117.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 108.258 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 mtt85 -129.59 174.59 9.53 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.79 1.636 . . . . 0.0 110.564 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 mt . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 110.371 175.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.7 m -89.34 115.76 27.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.661 1.184 . . . . 0.0 108.391 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -97.26 126.41 42.45 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.482 1.513 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.77 129.13 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.179 1.392 . . . . 0.0 109.586 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -139.97 157.68 45.29 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.453 1.901 . . . . 0.0 109.723 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.06 62.71 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.89 131.84 66.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 118.663 1.231 . . . . 0.0 110.143 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -53.01 140.75 58.87 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.678 2.919 . . . . 0.0 113.196 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.41 -15.05 62.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.33 -20.21 66.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.937 0.895 . . . . 0.0 113.228 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -90.89 115.78 28.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 110.63 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -68.41 121.17 15.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.071 0.949 . . . . 0.0 111.415 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 mt -59.81 -37.8 80.16 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.18 0.992 . . . . 0.0 111.936 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.36 -31.86 71.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.315 1.046 . . . . 0.0 112.488 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -37.34 69.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.872 0.869 . . . . 0.0 112.311 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.88 -47.26 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.88 -48.3 75.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.845 0.748 . . . . 0.0 111.637 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.28 -45.52 93.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.71 0.804 . . . . 0.0 112.148 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.51 -47.75 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.976 0.51 . . . . 0.0 111.329 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.46 -26.98 65.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.22 -37.1 38.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.616 -1.302 . . . . 0.0 113.308 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.03 -48.46 9.2 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.24 -38.77 12.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.958 0.903 . . . . 0.0 113.148 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -93.07 -8.44 42.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.952 0.901 . . . . 0.0 113.335 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.06 27.83 17.31 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.812 1.645 . . . . 0.0 113.57 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.5 m -87.84 -173.29 4.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.672 1.189 . . . . 0.0 111.282 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.74 145.75 38.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.388 1.075 . . . . 0.0 109.757 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -172.04 173.12 45.1 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.16 163.16 37.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 112.684 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.4 mt -98.4 134.98 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.927 1.291 . . . . 0.0 109.499 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 125.196 1.398 . . . . 0.0 109.278 176.348 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.23 0.538 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.73 136.96 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.93 133.22 51.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.569 . . . . 0.0 107.866 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.81 141.17 48.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 108.283 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.44 134.13 47.51 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.888 -1.133 . . . . 0.0 111.575 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.49 39.32 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.81 1.195 . . . . 0.0 113.621 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -101.8 100.78 11.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.68 1.592 . . . . 0.0 110.378 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -123.37 22.09 9.36 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.304 1.441 . . . . 0.0 113.173 -170.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -60.54 -43.88 96.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.11 89.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.455 0.702 . . . . 0.0 111.847 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.17 -47.28 80.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.05 0.94 . . . . 0.0 111.871 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.99 -34.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.882 -0.511 . . . . 0.0 111.534 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.93 -49.75 75.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.378 0.99 . . . . 0.0 111.083 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.49 -38.64 81.41 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.634 0.774 . . . . 0.0 112.65 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.32 -49.6 76.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.49 1.041 . . . . 0.0 111.633 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.13 -38.97 80.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.024 0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.99 -50.76 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.375 0.67 . . . . 0.0 111.374 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.5 m -84.93 -28.92 25.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -169.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -103.52 -44.0 5.24 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.264 0.938 . . . . 0.0 112.559 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.82 -19.77 28.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.071 0.85 . . . . 0.0 113.178 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.56 14.93 77.21 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.425 1.012 . . . . 0.0 113.727 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.07 145.21 51.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.626 1.213 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -74.28 140.95 45.31 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.506 -0.746 . . . . 0.0 110.819 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -53.29 -44.73 68.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.58 0.752 . . . . 0.0 112.211 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -63.79 -24.52 67.79 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.28 -6.27 54.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.548 1.139 . . . . 0.0 112.459 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.92 131.04 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.88 -1.137 . . . . 0.0 110.344 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -109.33 128.36 55.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 110.277 173.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 169.679 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -100.31 112.32 24.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.94 0.896 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.5 mt -102.3 101.8 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -107.6 174.47 5.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.101 2.16 . . . . 0.0 110.715 -171.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.168 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -89.53 124.41 34.49 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.689 1.596 . . . . 0.0 108.295 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 114.1 27.37 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.456 1.502 . . . . 0.0 110.118 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.76 122.55 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.118 0.967 . . . . 0.0 109.363 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -125.62 151.59 46.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.65 1.98 . . . . 0.0 109.681 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.86 4.45 82.45 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -57.5 131.13 81.64 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.698 1.249 . . . . 0.0 110.456 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.26 139.75 63.03 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.07 3.18 . . . . 0.0 113.149 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.47 -10.29 59.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.95 -19.8 62.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.993 0.917 . . . . 0.0 112.939 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -91.97 121.59 33.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.771 1.228 . . . . 0.0 110.917 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.71 118.16 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.701 0.8 . . . . 0.0 111.146 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.36 -37.15 77.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.686 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -63.17 -37.24 86.44 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.181 0.992 . . . . 0.0 112.121 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -66.69 -37.66 85.18 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.28 -0.887 . . . . 0.0 111.663 171.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.33 -40.96 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.536 0.734 . . . . 0.0 110.097 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.28 -54.26 48.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.302 0.955 . . . . 0.0 110.888 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -55.84 -48.27 75.79 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.942 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.99 -35.82 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.2 -30.72 62.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.025 0.829 . . . . 0.0 112.117 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -71.06 -30.43 66.58 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.768 -1.207 . . . . 0.0 112.769 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.15 -61.68 1.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 113.125 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.51 -40.55 23.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 -169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.87 -7.03 50.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.407 1.083 . . . . 0.0 112.554 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.65 28.98 17.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.11 1.764 . . . . 0.0 112.893 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -91.91 -162.13 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.635 1.174 . . . . 0.0 111.764 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -155.4 152.47 29.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.102 0.961 . . . . 0.0 111.421 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.7 176.4 48.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.03 165.03 36.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.862 1.665 . . . . 0.0 112.738 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -101.78 135.29 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.018 1.327 . . . . 0.0 109.876 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 125.24 1.416 . . . . 0.0 110.029 -178.509 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.01 132.51 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -100.22 133.18 45.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.001 1.32 . . . . 0.0 107.723 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tp -123.35 143.16 50.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.606 1.562 . . . . 0.0 108.756 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.158 -0.964 . . . . 0.0 112.093 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.93 -170.47 39.81 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.215 1.388 . . . . 0.0 113.669 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -97.55 77.56 2.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.895 2.078 . . . . 0.0 111.081 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -100.26 15.34 27.93 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.075 1.75 . . . . 0.0 113.54 -170.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -58.39 -40.18 81.66 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -41.3 64.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.001 0.921 . . . . 0.0 112.123 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -65.77 -41.8 91.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.847 0.859 . . . . 0.0 112.54 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.75 -35.31 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.809 -0.557 . . . . 0.0 111.204 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.56 -48.54 79.07 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.474 1.034 . . . . 0.0 111.014 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.13 -39.7 83.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.813 0.845 . . . . 0.0 112.551 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -60.17 -49.49 77.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.597 1.09 . . . . 0.0 111.778 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.4 mmt -61.02 -38.53 86.44 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.189 0.995 . . . . 0.0 110.893 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -74.02 -46.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.742 0.817 . . . . 0.0 111.002 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -82.4 -37.65 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -103.37 -39.65 6.7 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.472 0.709 . . . . 0.0 112.808 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.5 mt -83.61 -17.77 40.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.729 0.695 . . . . 0.0 112.273 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.65 76.31 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.662 1.125 . . . . 0.0 113.636 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.98 159.05 34.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.564 1.182 . . . . 0.0 111.24 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.2 146.96 25.8 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.608 -0.682 . . . . 0.0 109.435 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -55.95 -36.82 68.22 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.367 -0.833 . . . . 0.0 112.365 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -65.94 -10.47 39.37 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -78.79 -9.59 59.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.86 1.209 . . . . 0.0 113.078 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.7 mt -117.89 136.21 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.207 . . . . 0.0 110.995 -169.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -112.56 135.97 52.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.352 1.861 . . . . 0.0 109.968 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.421 1.089 . . . . 0.0 109.334 177.122 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -103.78 113.32 26.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.195 0.998 . . . . 0.0 109.655 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.72 98.75 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -106.41 174.5 5.86 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.886 2.074 . . . . 0.0 110.683 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 167.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.1 m -93.07 115.5 28.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.813 1.245 . . . . 0.0 108.945 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.49 112.07 24.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.715 1.606 . . . . 0.0 110.001 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.48 125.02 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 109.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -132.79 152.75 51.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.134 1.773 . . . . 0.0 110.186 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.33 77.19 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 168.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.16 131.43 60.16 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 118.717 1.259 . . . . 0.0 111.283 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -51.67 136.73 50.22 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 113.283 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.65 -13.44 62.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 113.906 -171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.69 -19.16 63.59 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.145 . . . . 0.0 113.11 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -94.56 125.34 39.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 111.0 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -74.57 124.75 27.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.504 0.722 . . . . 0.0 111.361 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.42 -38.75 85.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.075 0.55 . . . . 0.0 111.446 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -59.61 -37.18 77.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.497 1.119 . . . . 0.0 112.76 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -66.81 -39.52 87.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.191 0.905 . . . . 0.0 111.538 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.67 -47.26 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.222 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.868 0.758 . . . . 0.0 111.672 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.23 -42.43 99.31 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.428 -0.795 . . . . 0.0 112.512 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.14 -45.51 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.008 0.822 . . . . 0.0 111.346 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.15 -32.94 65.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.631 -1.293 . . . . 0.0 112.751 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -75.68 -63.72 1.23 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.72 1.208 . . . . 0.0 113.235 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -92.54 -32.69 14.74 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -167.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -90.91 -13.94 32.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 112.625 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 61.24 30.53 19.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.241 1.816 . . . . 0.0 112.86 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.32 -170.92 3.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.775 1.23 . . . . 0.0 111.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.94 152.75 36.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.869 1.268 . . . . 0.0 109.255 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.89 45.73 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 115.226 0.851 . . . . 0.0 115.226 -170.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -158.14 163.56 37.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.792 1.637 . . . . 0.0 112.32 -172.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.01 136.15 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.189 1.395 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 125.072 1.349 . . . . 0.0 109.573 177.614 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 121.294 0.568 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.84 134.28 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -105.96 116.8 32.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.643 1.577 . . . . 0.0 107.83 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tp -102.76 146.51 28.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.178 1.391 . . . . 0.0 109.185 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -69.37 133.4 47.76 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.547 0.739 . . . . 0.0 111.693 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 -170.12 54.78 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.11 1.338 . . . . 0.0 113.992 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -94.86 98.28 10.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.092 1.757 . . . . 0.0 111.326 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -120.45 20.75 11.82 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.057 1.743 . . . . 0.0 112.533 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -60.12 -40.91 91.4 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.57 70.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 112.355 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.98 -44.96 83.38 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.936 0.895 . . . . 0.0 111.691 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.61 -35.19 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.104 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.11 -49.54 75.58 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.51 1.05 . . . . 0.0 111.094 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.61 -39.11 79.54 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 0.0 112.68 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -60.43 -47.92 84.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.627 1.103 . . . . 0.0 112.02 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.4 mmt -61.27 -41.1 96.37 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.875 0.87 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.63 -47.97 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.732 0.813 . . . . 0.0 111.296 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -76.44 -48.09 20.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -100.48 -33.14 10.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.46 -15.85 38.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.145 0.884 . . . . 0.0 112.316 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.63 15.55 80.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.84 1.21 . . . . 0.0 113.685 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -71.1 157.89 37.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.547 1.174 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.48 147.14 24.81 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.642 -0.662 . . . . 0.0 109.586 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.56 -36.51 64.42 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.448 -0.782 . . . . 0.0 112.76 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -57.59 -21.7 40.6 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.884 1.674 . . . . 0.0 115.094 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -77.08 -7.69 56.17 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.279 0.945 . . . . 0.0 113.412 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.29 136.05 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.338 1.055 . . . . 0.0 110.791 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.53 134.22 54.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.755 2.022 . . . . 0.0 109.991 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 124.821 1.248 . . . . 0.0 108.996 177.443 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -114.94 120.68 40.76 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.624 1.169 . . . . 0.0 110.182 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.9 mt -114.27 116.37 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -128.99 174.57 9.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.253 1.821 . . . . 0.0 110.202 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.157 0.983 . . . . 0.0 108.483 169.481 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -89.7 132.37 35.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 107.663 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -112.94 124.5 52.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.246 1.419 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.36 126.57 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.973 1.309 . . . . 0.0 108.597 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -135.83 149.87 49.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.201 1.801 . . . . 0.0 109.502 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.12 -2.29 66.17 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 115.817 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.45 130.14 53.11 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.357 1.578 . . . . 0.0 111.08 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -52.29 139.7 53.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.397 3.398 . . . . 0.0 113.48 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.88 -16.19 63.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.85 0.86 . . . . 0.0 113.302 -172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.33 -20.2 66.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.026 0.931 . . . . 0.0 113.088 172.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -93.0 118.09 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.867 1.267 . . . . 0.0 110.693 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.12 120.3 14.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.966 0.906 . . . . 0.0 111.574 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.3 -39.05 89.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.729 0.811 . . . . 0.0 111.914 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.78 -35.59 78.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.001 0.921 . . . . 0.0 112.461 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.51 -40.39 96.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.206 0.912 . . . . 0.0 112.308 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.27 -40.15 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 109.915 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.97 -55.43 35.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.213 0.915 . . . . 0.0 110.848 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 0.0 112.788 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.06 -36.18 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.92 -32.81 65.56 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.974 0.807 . . . . 0.0 112.318 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -70.69 -33.8 71.28 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.082 . . . . 0.0 112.641 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -76.96 -58.6 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.495 1.118 . . . . 0.0 113.259 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.87 -41.32 15.08 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.31 -11.47 35.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.154 0.982 . . . . 0.0 113.127 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.25 26.92 15.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.242 1.817 . . . . 0.0 113.046 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.2 m -80.91 -171.99 3.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.717 1.207 . . . . 0.0 111.709 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -146.83 149.59 33.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.66 1.184 . . . . 0.0 109.83 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.62 46.62 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.436 0.934 . . . . 0.0 115.436 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.61 164.71 33.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.755 1.622 . . . . 0.0 112.872 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.4 mt -98.56 134.89 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.899 1.279 . . . . 0.0 109.663 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 125.167 1.387 . . . . 0.0 109.758 178.302 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.442 0.639 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.94 132.76 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 166.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -99.34 137.07 38.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.515 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tp -125.64 139.93 53.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.547 171.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -70.69 136.89 49.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.067 -1.021 . . . . 0.0 111.834 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.64 -163.09 36.62 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.893 1.235 . . . . 0.0 113.492 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.27 98.19 7.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.663 1.585 . . . . 0.0 110.146 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -120.8 18.23 11.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.146 1.379 . . . . 0.0 113.303 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -61.5 -42.75 99.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.36 82.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.534 0.734 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -66.25 -45.33 80.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.068 0.947 . . . . 0.0 111.958 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.67 -36.46 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.222 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.67 -49.34 75.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.388 0.994 . . . . 0.0 111.208 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.45 -39.8 84.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.928 0.891 . . . . 0.0 112.601 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.02 -49.61 76.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.746 1.157 . . . . 0.0 111.837 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.6 mmt -59.79 -37.22 78.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.23 1.012 . . . . 0.0 110.948 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -76.78 -44.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.911 0.884 . . . . 0.0 111.116 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.8 m -86.12 -21.99 27.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -169.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -119.03 -38.25 3.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 0.0 113.455 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.83 -14.88 50.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.401 1.0 . . . . 0.0 112.437 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.28 14.98 80.97 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.869 1.223 . . . . 0.0 113.798 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -70.94 158.43 36.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.405 1.102 . . . . 0.0 111.211 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -88.45 149.41 23.69 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -53.19 -39.69 63.84 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.501 -0.749 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -60.21 -18.52 49.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.738 1.615 . . . . 0.0 114.947 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -78.84 -8.97 59.3 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.352 0.978 . . . . 0.0 113.424 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.1 mt -118.03 130.34 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 119.353 0.978 . . . . 0.0 111.407 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -104.09 125.81 50.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.336 1.854 . . . . 0.0 110.082 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -112.38 117.14 31.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.302 1.041 . . . . 0.0 110.448 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.24 108.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.3 174.04 6.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.085 2.154 . . . . 0.0 109.949 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.472 0.667 0 O-C-N 120.983 -1.073 . . . . 0.0 108.725 169.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.52 0.2 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.1 m -89.11 118.7 29.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.584 1.954 . . . . 0.0 108.053 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.24 116.32 32.24 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.018 1.727 . . . . 0.0 110.126 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -101.39 126.63 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 109.557 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -135.93 158.21 44.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.741 2.016 . . . . 0.0 109.736 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.87 -6.39 48.32 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 120.438 -1.414 . . . . 0.0 116.183 168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.93 130.97 48.98 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 118.563 1.181 . . . . 0.0 110.529 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.24 137.1 55.43 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.931 3.087 . . . . 0.0 112.938 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.68 -14.33 62.85 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.5 -19.68 64.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.241 1.017 . . . . 0.0 113.165 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -89.86 123.87 34.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.548 1.139 . . . . 0.0 111.054 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -74.83 120.59 20.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.963 0.905 . . . . 0.0 111.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.3 -39.07 89.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.563 0.745 . . . . 0.0 111.765 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -60.22 -36.56 77.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.027 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -69.48 -36.88 76.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.875 0.87 . . . . 0.0 112.027 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.77 -47.67 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.917 0.781 . . . . 0.0 109.24 172.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.2 -46.61 79.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.178 0.899 . . . . 0.0 111.628 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -61.81 -33.76 74.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.135 0.974 . . . . 0.0 112.788 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.9 t -75.38 -50.57 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.064 0.545 . . . . 0.0 111.117 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.88 -33.37 74.59 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -72.28 -25.61 61.66 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.816 -1.178 . . . . 0.0 113.662 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.88 -48.92 5.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.132 0.973 . . . . 0.0 113.625 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -83.78 -38.85 20.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.065 0.946 . . . . 0.0 113.004 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 -10.93 23.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.856 1.263 . . . . 0.0 112.978 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.0 26.56 14.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.406 1.882 . . . . 0.0 113.145 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.39 -174.98 4.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.657 1.183 . . . . 0.0 112.241 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -143.7 150.81 39.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.488 1.115 . . . . 0.0 109.413 169.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.39 173.8 46.44 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.35 166.08 33.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.61 1.564 . . . . 0.0 112.372 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.4 134.98 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.948 1.299 . . . . 0.0 109.678 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.988 1.315 . . . . 0.0 109.533 177.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.397 0.617 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.2 mt -93.68 135.06 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.23 129.96 52.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.444 1.498 . . . . 0.0 107.548 168.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -120.75 140.15 52.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.338 1.455 . . . . 0.0 108.743 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.35 132.57 45.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.964 -1.085 . . . . 0.0 111.524 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.91 -156.12 21.32 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.923 1.725 . . . . 0.0 113.623 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.35 47.94 1.34 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.636 2.374 . . . . 0.0 111.605 -173.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -75.14 25.05 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.024 2.529 . . . . 0.0 116.29 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -57.7 -47.22 82.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.633 1.173 . . . . 0.0 114.082 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.42 74.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.9 0.88 . . . . 0.0 111.932 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -64.52 -46.0 84.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.612 0.765 . . . . 0.0 111.868 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.92 -35.94 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.719 -0.613 . . . . 0.0 111.369 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -56.11 -49.02 75.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.209 0.913 . . . . 0.0 111.197 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.11 -38.36 86.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.788 0.835 . . . . 0.0 112.846 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.3 -48.56 81.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.934 1.243 . . . . 0.0 111.56 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.73 -44.68 93.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 110.581 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.34 -44.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.707 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.6 t -79.16 -49.15 13.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -98.11 -35.77 10.3 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -88.67 -13.88 38.7 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.753 0.706 . . . . 0.0 112.494 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.49 17.31 79.3 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.774 1.178 . . . . 0.0 113.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.7 mt -70.79 153.56 42.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.503 1.151 . . . . 0.0 111.74 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -79.42 137.69 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.675 -0.641 . . . . 0.0 110.39 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -55.23 -38.81 68.95 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 0.0 112.756 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -59.2 -21.16 59.05 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 114.605 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.58 -4.7 58.06 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.314 1.046 . . . . 0.0 112.942 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -112.01 126.59 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.51 -1.369 . . . . 0.0 110.89 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -105.89 120.16 41.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.585 1.954 . . . . 0.0 110.004 172.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 169.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -96.21 116.96 29.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.066 0.946 . . . . 0.0 110.049 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.41 102.52 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -108.09 174.11 6.02 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.92 2.088 . . . . 0.0 110.855 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.691 1.196 . . . . 0.0 108.217 169.15 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.359 0.123 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 m -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.529 1.932 . . . . 0.0 107.681 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.57 120.43 28.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 110.614 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.7 121.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.322 1.049 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -127.93 153.97 46.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.641 1.977 . . . . 0.0 110.02 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.98 -5.2 50.54 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.076 1.19 . . . . 0.0 116.076 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -49.36 129.86 17.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 0.0 111.001 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -52.01 137.45 53.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.944 3.096 . . . . 0.0 113.209 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.05 -8.67 55.01 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.25 -17.81 62.47 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.133 1.373 . . . . 0.0 113.0 169.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -94.13 129.76 40.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.081 1.353 . . . . 0.0 111.41 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.14 118.75 22.12 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.985 0.914 . . . . 0.0 111.936 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.76 -38.48 90.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.23 0.612 . . . . 0.0 112.254 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.43 -36.08 81.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.862 0.865 . . . . 0.0 112.584 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -64.03 -39.27 93.72 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.061 -1.024 . . . . 0.0 111.764 169.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -63.24 -39.71 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.93 0.892 . . . . 0.0 110.068 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.45 -55.83 30.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 110.976 170.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.4 -48.82 73.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.931 0.893 . . . . 0.0 112.8 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.86 -36.73 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.06 -34.68 64.13 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.193 0.906 . . . . 0.0 111.98 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -34.39 77.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.758 -1.214 . . . . 0.0 112.471 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.63 -60.44 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.32 1.048 . . . . 0.0 113.105 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.69 -39.16 18.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.89 -4.42 49.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.464 1.106 . . . . 0.0 112.638 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.39 28.85 18.32 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.161 1.785 . . . . 0.0 113.102 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.48 179.76 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.55 1.14 . . . . 0.0 112.74 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -133.27 140.92 47.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.356 1.462 . . . . 0.0 108.366 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.57 168.86 41.89 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 -169.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -159.41 165.05 34.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.661 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.4 135.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.681 1.192 . . . . 0.0 109.976 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.1 t . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 125.675 1.59 . . . . 0.0 109.052 175.402 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.29 131.92 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 166.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.5 139.11 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.318 1.447 . . . . 0.0 108.245 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.52 136.13 47.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.463 1.505 . . . . 0.0 108.419 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -72.56 138.95 47.21 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.102 -0.999 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.17 -174.95 39.2 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.985 1.755 . . . . 0.0 113.361 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.54 77.59 2.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.882 2.073 . . . . 0.0 110.828 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.65 15.52 27.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 113.652 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -58.6 -41.64 86.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.23 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.132 0.973 . . . . 0.0 112.279 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.03 -44.34 84.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 111.75 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.49 -33.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.173 0.589 . . . . 0.0 111.092 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 111.085 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.04 -39.65 78.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.52 0.728 . . . . 0.0 112.626 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.92 -49.78 76.36 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.425 1.011 . . . . 0.0 111.733 175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.0 mmt -59.76 -39.69 85.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 110.882 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.01 -52.7 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.611 0.765 . . . . 0.0 111.034 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -83.03 -31.18 27.55 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -103.58 -42.18 5.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.226 0.921 . . . . 0.0 112.938 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -82.39 -20.35 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.155 0.889 . . . . 0.0 112.577 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.19 18.7 66.39 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.318 0.961 . . . . 0.0 113.592 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.5 mt -69.59 157.05 37.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.642 1.221 . . . . 0.0 110.464 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -87.74 146.34 25.71 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.45 -0.781 . . . . 0.0 109.299 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -55.13 -36.69 66.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.317 -0.864 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.91 -19.54 43.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.892 1.677 . . . . 0.0 115.035 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -79.29 -9.46 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.05 132.3 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 120.957 -1.089 . . . . 0.0 110.926 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -106.31 124.87 50.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.548 1.539 . . . . 0.0 109.544 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 124.199 1.0 . . . . 0.0 108.415 174.102 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -118.67 120.18 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.222 1.009 . . . . 0.0 110.389 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.83 104.48 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -109.79 169.79 8.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.87 1.668 . . . . 0.0 110.568 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.462 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.0 m -89.18 138.93 30.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.595 1.558 . . . . 0.0 107.618 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -127.46 120.99 29.61 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.845 1.258 . . . . 0.0 110.335 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.84 126.52 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.671 1.188 . . . . 0.0 109.519 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.09 151.51 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.457 1.903 . . . . 0.0 109.751 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.91 -1.45 79.07 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.08 133.3 59.4 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.654 1.227 . . . . 0.0 111.101 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.52 144.19 64.08 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.039 3.159 . . . . 0.0 113.452 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.37 -16.66 63.57 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.053 0.941 . . . . 0.0 113.329 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.67 -17.8 63.52 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 113.481 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -93.23 122.12 35.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.666 1.187 . . . . 0.0 111.313 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -73.1 117.39 14.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.853 0.861 . . . . 0.0 111.331 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.2 mt -60.23 -36.5 77.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.598 0.759 . . . . 0.0 111.819 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -62.88 -38.46 90.97 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.325 1.05 . . . . 0.0 112.027 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -65.38 -37.43 86.98 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.431 -0.793 . . . . 0.0 111.697 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.28 -41.05 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 110.124 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.87 -53.24 60.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.262 0.937 . . . . 0.0 111.013 170.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -56.87 -50.06 73.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.554 0.742 . . . . 0.0 112.873 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.82 -37.43 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' C ' ' HG ' ' A' ' 64' ' ' CYS . 96.5 mt -72.97 -38.33 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.569 0.622 . . . . 0.0 111.712 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.23 -31.87 72.96 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.244 -1.535 . . . . 0.0 112.329 173.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -73.99 -65.43 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.142 1.377 . . . . 0.0 112.933 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -91.69 -29.32 16.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -167.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -93.98 -7.75 41.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.842 0.857 . . . . 0.0 112.488 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.38 26.05 15.59 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.402 1.881 . . . . 0.0 113.236 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HG ' ' C ' ' A' ' 58' ' ' LEU . 7.7 p -82.58 -169.24 2.36 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.558 1.143 . . . . 0.0 112.631 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -141.18 151.78 44.11 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.045 1.338 . . . . 0.0 109.339 167.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.61 172.32 44.09 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -158.01 162.03 38.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.717 1.607 . . . . 0.0 111.904 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.48 129.56 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.111 1.364 . . . . 0.0 108.329 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.601 1.16 . . . . 0.0 109.516 -178.083 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.398 0.618 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.7 mt -90.97 127.97 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -94.43 130.64 40.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.229 1.412 . . . . 0.0 107.713 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -119.09 136.21 54.26 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.655 1.582 . . . . 0.0 107.89 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -76.92 128.17 34.06 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.308 -0.87 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.56 -170.23 28.08 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.237 1.399 . . . . 0.0 113.363 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -97.76 83.95 3.28 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.68 1.992 . . . . 0.0 111.335 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -110.08 15.13 22.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.223 -169.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -59.18 -46.28 88.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.62 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.854 0.861 . . . . 0.0 111.912 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.25 -45.9 89.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.296 1.039 . . . . 0.0 111.913 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.52 -36.12 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.236 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.95 -47.36 80.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.521 1.055 . . . . 0.0 110.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.08 -39.14 91.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.456 0.702 . . . . 0.0 112.641 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -59.66 -49.13 78.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.65 1.114 . . . . 0.0 111.602 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.5 mmt -59.06 -44.34 91.83 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.625 1.17 . . . . 0.0 110.522 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt -72.18 -44.14 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.635 0.774 . . . . 0.0 111.68 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 t -75.3 -48.05 25.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -100.96 -37.09 8.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.0 mt -90.83 -13.39 33.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.723 0.692 . . . . 0.0 112.84 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.57 15.54 81.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.726 1.155 . . . . 0.0 113.687 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.2 145.01 53.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.239 1.019 . . . . 0.0 110.626 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -82.16 134.66 35.32 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.714 -0.617 . . . . 0.0 110.388 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -51.97 -44.43 63.99 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.75 0.82 . . . . 0.0 112.392 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -22.2 63.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -81.73 -10.96 59.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 112.982 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -106.73 124.55 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.644 1.111 . . . . 0.0 110.617 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -101.26 135.11 43.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.806 1.642 . . . . 0.0 110.457 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 108.845 173.888 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -96.53 118.82 33.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.62 0.768 . . . . 0.0 110.32 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mt -108.53 109.39 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -121.26 174.43 6.71 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.503 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 120.613 0.244 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -91.41 125.05 36.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.339 1.855 . . . . 0.0 108.441 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -106.69 128.9 54.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.539 1.536 . . . . 0.0 110.827 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.0 124.09 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.851 1.26 . . . . 0.0 109.734 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -127.67 155.21 44.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.452 1.901 . . . . 0.0 109.501 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 1.25 90.61 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 168.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -61.13 131.45 92.04 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 118.678 1.239 . . . . 0.0 110.661 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.49 142.36 59.44 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 124.124 3.216 . . . . 0.0 113.267 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.28 -17.25 62.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.164 0.985 . . . . 0.0 113.096 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.03 -18.64 65.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.876 0.87 . . . . 0.0 113.159 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.99 116.86 29.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.856 1.262 . . . . 0.0 110.79 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -69.79 120.78 16.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.074 0.95 . . . . 0.0 111.588 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.91 -39.27 88.74 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.208 1.003 . . . . 0.0 111.974 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.0 -31.38 71.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.926 0.891 . . . . 0.0 112.538 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -40.7 79.32 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 111.836 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.07 -47.65 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.654 0.782 . . . . 0.0 109.057 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.3 mt -55.65 -48.58 74.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.718 0.69 . . . . 0.0 111.674 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.58 -43.29 97.42 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.445 -0.785 . . . . 0.0 112.452 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.15 -46.61 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.118 0.872 . . . . 0.0 111.16 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.06 -27.65 64.81 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -76.81 -35.86 57.3 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.659 -1.276 . . . . 0.0 113.254 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -77.91 -62.32 1.71 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.95 -32.03 20.33 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.221 1.409 . . . . 0.0 113.988 -166.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.7 -8.88 27.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.13 0.972 . . . . 0.0 113.162 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.62 28.25 16.89 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.831 1.652 . . . . 0.0 113.444 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 92.9 m -87.32 -169.85 2.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.921 1.289 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -148.58 149.87 32.31 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.913 0.885 . . . . 0.0 110.082 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.14 177.38 47.15 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.7 161.41 29.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.912 1.685 . . . . 0.0 111.942 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.13 141.37 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.688 1.195 . . . . 0.0 109.226 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 124.971 1.308 . . . . 0.0 109.411 173.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.347 0.594 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.27 136.52 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.38 135.04 47.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.186 1.795 . . . . 0.0 108.212 168.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.93 140.62 52.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.749 1.62 . . . . 0.0 108.946 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -72.64 138.51 46.77 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.281 -0.887 . . . . 0.0 111.991 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.72 -169.69 43.1 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.558 1.551 . . . . 0.0 112.895 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.47 97.75 7.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.053 1.341 . . . . 0.0 109.998 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -115.07 27.45 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.885 1.274 . . . . 0.0 113.702 -167.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -51.94 -59.02 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.537 1.535 . . . . 0.0 112.639 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.46 -38.91 91.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.786 1.235 . . . . 0.0 112.195 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.72 -48.41 79.36 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 111.731 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.21 -34.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.828 -0.545 . . . . 0.0 111.344 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.95 -50.03 73.88 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.212 0.915 . . . . 0.0 111.182 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.79 -38.2 81.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.094 0.958 . . . . 0.0 112.647 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.68 -48.12 83.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.67 1.123 . . . . 0.0 111.791 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.5 mmt -61.86 -41.73 98.2 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 110.591 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.25 -48.18 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.049 0.94 . . . . 0.0 111.535 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -80.95 -48.34 12.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -98.51 -34.06 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -85.75 -15.61 41.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.897 0.771 . . . . 0.0 112.035 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.37 79.64 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.017 1.294 . . . . 0.0 113.777 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.48 151.71 42.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.562 1.181 . . . . 0.0 112.141 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -74.15 141.31 45.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.022 0.529 . . . . 0.0 109.929 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -57.36 -36.66 71.48 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.25 -21.1 47.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.961 . . . . 0.0 114.87 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.15 -9.76 58.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.105 0.962 . . . . 0.0 113.127 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.9 133.78 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.384 1.074 . . . . 0.0 110.692 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -110.65 133.84 52.96 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.148 1.779 . . . . 0.0 110.188 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 124.141 0.976 . . . . 0.0 109.346 173.158 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -107.45 115.08 29.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.559 1.144 . . . . 0.0 109.344 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.28 108.5 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -116.97 173.57 6.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.524 1.929 . . . . 0.0 110.865 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.755 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 m -89.43 132.37 35.03 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.878 1.671 . . . . 0.0 107.828 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -117.43 126.77 53.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 110.925 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.48 123.57 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.544 1.138 . . . . 0.0 108.943 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -129.9 149.51 51.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 109.388 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 4.85 89.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.58 131.71 64.01 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 118.567 1.184 . . . . 0.0 111.319 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.25 143.19 53.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.383 3.389 . . . . 0.0 113.615 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -67.49 -18.94 65.25 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 113.37 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.5 -16.91 62.95 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -96.23 124.27 40.17 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.718 1.207 . . . . 0.0 111.799 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.11 121.55 23.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.166 0.986 . . . . 0.0 111.852 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.24 -39.25 92.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.534 0.733 . . . . 0.0 112.395 -174.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -62.86 -34.71 77.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.285 -0.884 . . . . 0.0 112.172 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 tpt85 -64.95 -37.55 88.04 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.15 0.886 . . . . 0.0 111.929 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.9 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.373 1.069 . . . . 0.0 110.164 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.94 -52.78 64.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.199 0.909 . . . . 0.0 110.914 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -54.89 -50.52 68.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 112.638 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.11 -36.1 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -34.9 65.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.651 0.66 . . . . 0.0 112.145 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.45 -33.28 73.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.756 -1.215 . . . . 0.0 112.425 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -74.87 -66.23 0.78 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.122 1.369 . . . . 0.0 113.153 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -91.2 -29.82 17.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -167.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.33 -4.93 47.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.878 0.871 . . . . 0.0 112.561 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.34 28.1 16.26 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.193 1.797 . . . . 0.0 113.246 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.1 m -83.06 177.8 8.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.491 1.116 . . . . 0.0 112.771 -173.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -126.21 141.7 51.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.462 1.505 . . . . 0.0 107.93 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.26 166.96 39.57 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.84 158.34 40.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.236 1.815 . . . . 0.0 111.821 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.7 mt -93.69 136.24 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.741 1.216 . . . . 0.0 108.991 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.972 1.309 . . . . 0.0 109.448 177.249 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 121.338 0.589 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.0 mt -99.73 132.08 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 165.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -99.34 139.41 35.03 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.569 1.548 . . . . 0.0 108.682 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tp -129.02 138.44 51.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.783 1.633 . . . . 0.0 108.229 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -72.38 139.69 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.126 -0.984 . . . . 0.0 111.477 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.19 -172.39 43.42 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.419 1.485 . . . . 0.0 113.379 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -98.88 85.67 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.754 2.021 . . . . 0.0 110.954 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -109.45 16.21 22.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.596 1.559 . . . . 0.0 113.258 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -58.34 -42.96 88.03 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -39.31 66.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 112.089 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -63.81 -45.22 90.59 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.025 0.93 . . . . 0.0 111.826 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.44 -35.46 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.162 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.75 -48.81 76.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.494 1.043 . . . . 0.0 111.164 170.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.93 -40.15 83.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.784 0.834 . . . . 0.0 112.678 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -59.75 -49.94 75.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.767 1.167 . . . . 0.0 111.869 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.0 mmt -59.67 -37.82 79.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 110.903 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.52 -45.05 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.998 0.919 . . . . 0.0 111.084 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -85.42 -22.14 28.47 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.12 -38.0 2.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.386 0.993 . . . . 0.0 113.601 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.7 mt -82.74 -14.94 53.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.505 1.048 . . . . 0.0 112.48 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.81 14.95 80.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.841 1.21 . . . . 0.0 113.609 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.54 159.51 34.19 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.543 1.171 . . . . 0.0 111.514 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.13 151.29 22.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.378 0.671 . . . . 0.0 110.05 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -55.91 -38.92 70.88 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.255 -0.903 . . . . 0.0 111.657 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.19 -0.11 3.14 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.05 -1.86 56.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.967 1.258 . . . . 0.0 113.033 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt -128.06 132.44 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 120.738 -1.226 . . . . 0.0 111.597 -169.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.69 126.98 51.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.572 1.549 . . . . 0.0 109.829 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.058 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.1 127.62 55.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.919 . . . . 0.0 110.883 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mt -117.71 99.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -103.53 174.61 5.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.715 2.406 . . . . 0.0 110.214 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.3 mt . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.058 0.943 . . . . 0.0 108.771 169.36 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -82.69 116.14 21.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.952 1.301 . . . . 0.0 107.919 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 113.31 24.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.502 1.521 . . . . 0.0 110.004 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.02 129.33 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.668 1.187 . . . . 0.0 108.479 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -144.75 161.45 39.2 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.992 1.717 . . . . 0.0 110.152 -167.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.62 -14.2 4.53 Favored Glycine 0 N--CA 1.475 1.251 0 O-C-N 120.463 -1.398 . . . . 0.0 116.541 168.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -47.99 130.93 12.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.224 1.41 . . . . 0.0 111.55 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -53.5 140.81 63.9 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.954 3.103 . . . . 0.0 113.112 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.76 -10.58 59.78 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.86 -19.57 63.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.85 0.86 . . . . 0.0 112.742 170.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.71 114.13 26.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.048 1.339 . . . . 0.0 110.394 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -66.99 123.15 19.39 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.32 -38.63 80.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.553 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.58 -32.9 74.51 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.118 0.967 . . . . 0.0 112.567 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -69.5 -38.4 77.61 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.277 -0.889 . . . . 0.0 111.517 171.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.2 mt -57.95 -47.05 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.041 0.837 . . . . 0.0 108.964 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.18 -48.73 73.37 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.005 0.82 . . . . 0.0 111.743 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -61.57 -43.67 98.44 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.665 -0.647 . . . . 0.0 112.301 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.23 -46.86 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.651 0.659 . . . . 0.0 111.137 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.63 -32.16 70.69 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.92 -34.36 64.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.674 -1.266 . . . . 0.0 113.208 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.83 -48.46 9.34 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.38 -41.36 12.88 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.704 0.802 . . . . 0.0 113.135 -171.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -94.38 -12.53 27.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.336 1.054 . . . . 0.0 113.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.82 31.17 16.56 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.146 1.778 . . . . 0.0 112.858 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.0 m -80.96 -177.67 6.52 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.476 1.11 . . . . 0.0 111.636 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -138.25 145.92 41.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.374 1.07 . . . . 0.0 109.332 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.63 172.09 45.13 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 116.158 1.223 . . . . 0.0 116.158 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.91 161.87 38.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.538 1.535 . . . . 0.0 112.583 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.0 mt -97.73 134.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.928 1.291 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t . . . . . 0 N--CA 1.477 0.884 0 C-N-CA 125.285 1.434 . . . . 0.0 109.773 179.095 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 121.345 0.593 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.91 133.47 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.17 123.2 45.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tp -108.97 136.36 48.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.174 1.39 . . . . 0.0 108.209 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.48 134.99 48.27 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.208 -0.933 . . . . 0.0 111.673 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.39 -168.95 40.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.378 1.466 . . . . 0.0 113.436 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -98.55 99.74 10.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.811 1.644 . . . . 0.0 109.899 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -122.0 20.72 10.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.863 1.265 . . . . 0.0 113.226 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -62.16 -44.28 96.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.07 -39.62 90.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.458 0.703 . . . . 0.0 111.772 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -64.76 -46.15 83.41 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.141 0.977 . . . . 0.0 111.988 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.47 -36.37 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.857 -0.527 . . . . 0.0 111.352 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.02 -48.24 82.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.313 0.96 . . . . 0.0 111.199 171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.38 -37.72 78.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.817 0.847 . . . . 0.0 112.671 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.57 -48.72 79.69 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 111.693 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.7 mmt -59.99 -42.99 95.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.205 1.002 . . . . 0.0 110.578 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.75 -48.62 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.081 0.952 . . . . 0.0 111.608 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -79.17 -47.84 15.31 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -98.97 -35.82 9.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.21 -17.58 25.82 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.632 0.651 . . . . 0.0 112.728 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.84 17.29 80.0 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.372 0.987 . . . . 0.0 113.623 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.0 145.86 51.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.31 1.055 . . . . 0.0 110.785 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -74.29 143.85 44.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.725 0.774 . . . . 0.0 111.664 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 9.1 mptt -62.31 -42.07 99.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.509 0.724 . . . . 0.0 112.166 -168.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.04 -21.48 63.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.975 1.31 . . . . 0.0 113.999 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -82.3 -4.12 56.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.665 1.186 . . . . 0.0 112.326 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.32 136.12 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.669 1.588 . . . . 0.0 108.838 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.12 116.73 25.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.729 1.612 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.21 121.47 35.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.785 0.834 . . . . 0.0 110.098 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 104.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -111.89 166.0 11.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.267 1.827 . . . . 0.0 109.363 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.476 0.826 0 O-C-N 120.799 -1.188 . . . . 0.0 109.833 169.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.75 0.309 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.8 m -89.84 121.73 32.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.131 1.772 . . . . 0.0 107.999 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 p -106.64 121.42 44.3 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.451 1.5 . . . . 0.0 110.347 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.45 129.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.884 1.273 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.35 152.51 49.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.554 1.941 . . . . 0.0 109.878 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.34 2.31 78.83 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.12 132.76 68.61 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.234 1.413 . . . . 0.0 111.575 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.08 140.04 41.23 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.445 3.43 . . . . 0.0 113.664 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.48 -22.59 67.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.308 1.043 . . . . 0.0 113.564 -172.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.49 -19.08 65.7 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.21 103.95 15.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.042 1.337 . . . . 0.0 110.557 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.5 126.76 28.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.615 1.166 . . . . 0.0 112.2 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 mt -61.97 -40.04 94.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.24 0.616 . . . . 0.0 111.953 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.82 -36.37 83.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.809 0.844 . . . . 0.0 112.217 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -63.83 -38.9 92.8 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.044 -1.035 . . . . 0.0 111.936 169.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.88 -42.33 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.884 0.874 . . . . 0.0 109.931 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mt -58.12 -52.92 63.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.107 0.867 . . . . 0.0 111.025 171.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.56 -50.71 71.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.822 0.849 . . . . 0.0 112.975 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.66 -39.26 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' C ' ' HG ' ' A' ' 64' ' ' CYS . 96.6 mt -71.56 -37.43 71.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.727 0.694 . . . . 0.0 111.996 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -66.94 -29.67 69.6 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.101 -1.624 . . . . 0.0 112.729 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.19 -63.22 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.152 0.981 . . . . 0.0 113.094 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.06 -33.94 29.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.32 -8.31 36.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 112.8 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.41 26.82 16.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.219 1.807 . . . . 0.0 113.275 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.418 ' HG ' ' C ' ' A' ' 58' ' ' LEU . 8.2 p -81.9 -169.93 2.6 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 112.851 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -139.48 149.22 43.71 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.931 1.292 . . . . 0.0 109.382 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -178.98 173.25 45.49 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -163.91 164.11 23.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.358 1.863 . . . . 0.0 111.717 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -100.06 140.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.554 1.141 . . . . 0.0 109.563 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.481 1.109 0 C-N-CA 125.259 1.423 . . . . 0.0 109.626 176.165 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.8 pt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.436 0.636 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.43 133.11 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -101.2 132.99 46.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.77 1.628 . . . . 0.0 107.987 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -122.6 135.14 54.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.935 1.694 . . . . 0.0 107.769 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -73.68 134.25 43.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.314 -0.866 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.54 -169.12 25.73 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.813 1.673 . . . . 0.0 113.279 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -105.09 52.37 0.74 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.015 2.126 . . . . 0.0 111.601 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -75.54 21.47 0.14 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.742 2.417 . . . . 0.0 116.267 -167.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -57.62 -47.55 81.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.5 74.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.872 0.869 . . . . 0.0 111.782 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -64.24 -45.34 88.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.29 -36.32 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.721 -0.612 . . . . 0.0 111.391 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.3 t -57.18 -48.6 78.33 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.34 0.973 . . . . 0.0 111.014 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.23 -39.0 85.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.095 0.958 . . . . 0.0 112.637 175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.37 -49.61 77.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.938 1.245 . . . . 0.0 111.632 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 mmt -62.97 -40.49 97.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.008 0.923 . . . . 0.0 110.734 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.02 -49.74 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.887 0.875 . . . . 0.0 111.605 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.8 t -79.47 -48.23 14.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -97.08 -33.31 11.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.35 -18.13 29.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.793 0.724 . . . . 0.0 112.369 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.91 17.22 77.57 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.546 1.07 . . . . 0.0 113.802 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.97 155.45 40.56 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.635 1.218 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.85 148.13 30.09 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.798 -0.564 . . . . 0.0 109.581 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -57.67 -35.75 70.99 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.466 -0.771 . . . . 0.0 112.212 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -63.86 -17.27 62.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.979 1.712 . . . . 0.0 115.131 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -73.66 -11.54 60.45 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.455 1.025 . . . . 0.0 113.132 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -117.34 138.97 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.975 1.31 . . . . 0.0 110.566 -169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -120.25 115.58 23.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.51 1.924 . . . . 0.0 109.938 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.92 115.84 31.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.124 0.969 . . . . 0.0 109.887 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.56 104.52 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -110.22 173.93 6.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.163 2.185 . . . . 0.0 110.871 -170.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.747 1.219 . . . . 0.0 108.516 169.081 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -93.91 140.3 29.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.613 1.965 . . . . 0.0 108.027 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.33 119.02 24.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.75 1.22 . . . . 0.0 110.83 -174.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.6 121.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 109.611 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.75 152.76 46.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.351 1.86 . . . . 0.0 109.622 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.03 -3.13 62.45 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -55.52 130.6 70.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 118.714 1.257 . . . . 0.0 110.276 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.41 138.4 65.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.792 2.995 . . . . 0.0 113.194 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.15 -6.88 50.34 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.936 0.894 . . . . 0.0 113.234 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.48 -18.82 62.28 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.569 -0.707 . . . . 0.0 112.473 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -90.69 129.94 36.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.634 1.174 . . . . 0.0 110.915 170.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.6 117.47 14.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.351 0.66 . . . . 0.0 110.891 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.05 -37.94 84.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.122 0.569 . . . . 0.0 111.382 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.4 -32.67 72.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.59 1.156 . . . . 0.0 113.202 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -71.0 -38.1 72.67 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.07 0.85 . . . . 0.0 111.402 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.951 0.796 . . . . 0.0 109.086 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.94 -49.6 70.94 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.929 0.786 . . . . 0.0 111.55 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -61.13 -43.66 98.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 112.576 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.66 -44.2 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.494 0.588 . . . . 0.0 111.371 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.0 mt -70.77 -31.49 68.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.79 -33.64 66.38 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.836 -1.165 . . . . 0.0 112.894 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.68 -58.53 3.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.24 1.016 . . . . 0.0 113.292 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.18 -42.38 13.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 0.0 113.449 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -90.31 -12.37 37.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.185 0.994 . . . . 0.0 112.818 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.49 30.14 17.16 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.226 1.81 . . . . 0.0 112.912 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.7 m -81.29 -172.2 3.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 111.442 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -147.47 150.64 34.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.731 1.212 . . . . 0.0 109.241 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.0 172.52 44.72 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 115.836 1.095 . . . . 0.0 115.836 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -153.39 158.13 41.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.425 1.89 . . . . 0.0 111.83 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.4 mt -91.86 130.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.676 1.19 . . . . 0.0 108.452 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.762 1.225 . . . . 0.0 109.399 -176.894 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -92.68 129.98 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 166.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -97.56 130.79 44.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.073 1.349 . . . . 0.0 107.532 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -122.01 139.66 53.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.523 1.529 . . . . 0.0 108.578 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -78.12 136.14 37.81 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.339 -0.85 . . . . 0.0 111.17 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.54 -174.05 42.75 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.828 1.68 . . . . 0.0 113.27 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -97.83 88.69 4.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.42 1.888 . . . . 0.0 110.923 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -112.12 16.42 20.17 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.414 1.485 . . . . 0.0 113.358 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -58.89 -41.3 86.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.36 65.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.126 0.97 . . . . 0.0 112.319 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -66.07 -43.6 86.95 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.992 0.917 . . . . 0.0 111.911 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.47 -35.51 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.186 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.0 t -56.89 -48.85 77.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.454 1.024 . . . . 0.0 111.12 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.34 -38.78 81.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.708 0.803 . . . . 0.0 112.726 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.29 -47.3 86.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.713 1.142 . . . . 0.0 111.864 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.5 -42.33 96.12 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.117 0.967 . . . . 0.0 110.606 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.69 -47.33 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 111.471 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -77.48 -48.94 15.85 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -98.79 -34.53 10.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.4 -14.28 43.84 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.891 0.769 . . . . 0.0 112.24 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.86 15.72 80.87 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.957 1.265 . . . . 0.0 113.88 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.47 153.44 42.24 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.399 1.1 . . . . 0.0 111.805 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -82.72 140.39 33.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.759 -0.588 . . . . 0.0 110.004 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -54.5 -35.62 63.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.875 0.87 . . . . 0.0 113.275 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -56.65 -23.85 44.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.406 1.482 . . . . 0.0 114.323 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.64 -10.04 59.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.796 1.238 . . . . 0.0 113.031 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.2 mt -114.7 134.15 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.443 1.097 . . . . 0.0 110.76 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -110.75 126.94 55.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.574 1.949 . . . . 0.0 109.984 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.1 mt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 124.464 1.105 . . . . 0.0 108.469 173.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.32 126.12 37.27 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.561 0.745 . . . . 0.0 110.17 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.4 115.56 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -128.48 165.14 21.28 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.592 1.557 . . . . 0.0 110.575 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mt . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 124.258 1.023 . . . . 0.0 108.805 169.154 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.501 0.191 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.2 m -95.05 120.14 34.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.718 1.607 . . . . 0.0 108.11 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -99.09 123.91 43.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 110.499 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.21 128.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.957 1.303 . . . . 0.0 108.672 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -142.94 161.26 38.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.788 1.635 . . . . 0.0 110.9 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.48 -16.37 3.07 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 168.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -45.32 133.3 5.82 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 126.253 1.821 . . . . 0.0 112.777 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.15 142.44 55.26 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.982 3.122 . . . . 0.0 113.446 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.6 -13.87 62.54 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.09 -18.65 63.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.722 0.809 . . . . 0.0 113.098 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -93.59 112.64 24.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.846 1.258 . . . . 0.0 110.792 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -69.28 122.25 18.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.294 1.038 . . . . 0.0 112.002 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.42 -35.5 81.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.179 0.592 . . . . 0.0 112.116 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -63.07 -39.16 93.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 112.16 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.09 89.86 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.43 1.092 . . . . 0.0 111.099 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.11 -40.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.178 0.991 . . . . 0.0 110.395 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.32 -54.94 41.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.555 1.07 . . . . 0.0 110.84 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -56.9 -48.35 78.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.765 0.826 . . . . 0.0 112.623 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.47 -37.24 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.38 -33.62 65.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.141 0.882 . . . . 0.0 111.87 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.32 -33.3 74.07 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.908 -1.12 . . . . 0.0 112.572 170.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -79.39 -58.81 3.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.388 1.075 . . . . 0.0 113.314 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -85.1 -41.19 15.96 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.18 -12.64 32.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.938 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.15 31.59 17.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.165 1.786 . . . . 0.0 112.635 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.2 m -80.42 -172.8 3.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.615 1.166 . . . . 0.0 111.521 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -148.11 150.92 34.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.696 1.198 . . . . 0.0 109.266 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.57 171.19 42.29 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 115.642 1.017 . . . . 0.0 115.642 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -150.83 156.27 40.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.127 1.771 . . . . 0.0 111.627 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.34 131.53 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.669 1.188 . . . . 0.0 108.627 171.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 124.899 1.28 . . . . 0.0 109.396 179.334 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.197 0.522 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.3 mt -93.02 130.6 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -101.69 122.76 44.51 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -110.14 140.7 43.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.366 1.466 . . . . 0.0 108.733 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -69.21 135.66 50.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.42 0.688 . . . . 0.0 111.457 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.62 -164.4 41.39 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.08 1.324 . . . . 0.0 114.03 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -100.85 99.54 10.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.18 1.792 . . . . 0.0 109.918 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -121.76 18.09 11.08 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 113.081 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -63.03 -41.78 99.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -168.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.24 73.84 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 172.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -64.92 -45.2 86.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.693 0.797 . . . . 0.0 111.728 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.39 -36.77 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.477 0.711 . . . . 0.0 111.208 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -56.57 -49.41 74.95 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.719 1.145 . . . . 0.0 111.481 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.45 -39.62 84.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.532 0.733 . . . . 0.0 112.413 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.49 -48.11 83.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.099 0.863 . . . . 0.0 112.017 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.81 -42.94 94.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.441 1.096 . . . . 0.0 110.668 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.78 -47.1 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.1 t -75.79 -48.34 22.06 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -103.52 -29.73 10.96 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -168.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.25 -16.3 27.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.273 0.942 . . . . 0.0 112.416 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.38 19.02 75.0 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.41 1.005 . . . . 0.0 113.613 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.54 155.37 40.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.411 1.105 . . . . 0.0 110.716 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -83.38 148.74 27.14 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -53.98 -41.16 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.557 -0.714 . . . . 0.0 111.581 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -64.55 -14.08 55.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -75.93 -9.35 58.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 112.868 172.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.6 mt -115.91 136.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.115 . . . . 0.0 110.338 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -116.94 114.66 24.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.978 1.711 . . . . 0.0 109.96 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.753 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -112.47 114.63 27.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.452 1.101 . . . . 0.0 109.267 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.78 99.65 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -106.49 174.49 5.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.998 2.519 . . . . 0.0 110.72 -171.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 124.09 0.956 . . . . 0.0 108.868 169.62 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.98 131.32 38.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.575 1.55 . . . . 0.0 107.494 167.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -115.14 123.4 48.85 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.057 1.343 . . . . 0.0 110.548 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.58 123.64 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -131.49 143.96 50.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.038 1.735 . . . . 0.0 109.005 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.15 -0.44 83.72 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.27 130.56 51.85 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 118.905 1.352 . . . . 0.0 110.956 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -52.94 139.42 60.63 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.069 3.18 . . . . 0.0 113.324 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -74.32 -7.61 53.4 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.752 0.821 . . . . 0.0 112.652 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.86 126.25 35.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.646 1.178 . . . . 0.0 111.005 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.45 115.49 12.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.442 0.697 . . . . 0.0 111.157 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.58 -36.57 76.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.731 0.812 . . . . 0.0 111.624 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -63.65 -35.56 80.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.651 1.181 . . . . 0.0 112.421 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -67.93 -37.61 81.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 111.573 171.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.61 -40.86 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 0.0 110.023 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.94 -54.45 46.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.261 0.937 . . . . 0.0 110.714 169.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -57.43 -46.39 83.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 113.026 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.02 -36.88 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.43 -34.47 67.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.094 0.861 . . . . 0.0 111.751 176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.25 -34.11 76.75 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.986 -1.071 . . . . 0.0 112.554 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.8 -63.25 1.43 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.245 1.018 . . . . 0.0 113.119 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -81.9 -39.14 24.25 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.87 -3.41 51.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 112.767 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.12 27.99 17.13 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.17 1.788 . . . . 0.0 113.142 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -83.14 -179.94 7.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.524 1.13 . . . . 0.0 112.776 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -129.58 144.58 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.723 1.609 . . . . 0.0 107.898 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.71 171.24 44.33 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -158.4 161.68 37.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.464 1.506 . . . . 0.0 112.48 -174.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mt -94.93 129.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 108.219 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.071 0.948 . . . . 0.0 110.811 -176.001 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.76 129.82 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 165.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -100.27 138.86 36.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.369 1.467 . . . . 0.0 108.801 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -128.96 142.7 50.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.23 1.812 . . . . 0.0 108.355 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -73.25 136.9 44.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.969 1.259 . . . . 0.0 112.027 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.33 -174.87 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.27 1.414 . . . . 0.0 113.702 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.82 73.73 3.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.719 2.007 . . . . 0.0 111.412 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -97.29 16.98 18.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.331 1.852 . . . . 0.0 113.526 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -58.22 -41.54 84.31 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.06 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.068 0.947 . . . . 0.0 112.105 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.57 -44.69 93.36 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.253 1.021 . . . . 0.0 111.853 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.77 -34.8 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.176 0.59 . . . . 0.0 111.199 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.0 t -58.44 -46.91 85.58 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.614 1.097 . . . . 0.0 111.243 171.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.46 -39.06 86.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.63 0.772 . . . . 0.0 112.39 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -60.12 -48.83 80.09 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.639 1.109 . . . . 0.0 111.753 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.4 mmt -60.63 -42.01 96.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.67 -45.92 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.677 0.791 . . . . 0.0 111.548 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -76.91 -47.81 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -101.13 -34.87 9.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -168.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.99 -14.2 48.2 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.166 0.894 . . . . 0.0 112.228 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.63 80.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.076 1.322 . . . . 0.0 113.757 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.83 144.48 52.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.539 1.169 . . . . 0.0 111.302 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -80.2 135.2 36.22 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.691 -0.631 . . . . 0.0 109.636 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -51.79 -34.43 39.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.964 1.305 . . . . 0.0 113.987 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.89 -22.25 9.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.838 1.655 . . . . 0.0 115.134 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -82.35 -9.23 59.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.684 1.194 . . . . 0.0 113.932 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 mt -116.99 128.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.61 1.095 . . . . 0.0 111.26 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.23 134.08 47.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.441 1.496 . . . . 0.0 110.682 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 124.983 1.313 . . . . 0.0 108.153 171.466 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.504 2.273 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -163.65 -174.86 3.87 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.726 1.61 . . . . 0.0 110.871 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -154.67 146.87 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.786 1.634 . . . . 0.0 111.261 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.42 145.02 27.65 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.705 1.202 . . . . 0.0 111.683 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -153.26 146.43 24.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.298 1.439 . . . . 0.0 111.331 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.66 122.47 19.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.393 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -80.44 -36.95 32.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.9 t -173.31 177.73 2.57 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.002 2.121 . . . . 0.0 110.39 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.45 153.49 27.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.711 1.604 . . . . 0.0 111.834 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -79.91 147.76 66.86 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -89.26 -144.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 124.37 3.38 . . . . 0.0 110.152 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -104.05 -4.03 23.79 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.116 1.766 . . . . 0.0 114.071 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.05 144.4 56.74 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.626 1.17 . . . . 0.0 113.532 -171.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -165.2 162.17 19.82 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.768 2.027 . . . . 0.0 110.703 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.7 p -77.24 157.37 30.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.808 1.243 . . . . 0.0 112.374 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.88 154.41 26.7 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.839 1.209 . . . . 0.0 113.224 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -138.96 8.57 2.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.632 1.573 . . . . 0.0 113.889 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.92 158.0 36.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.47 1.508 . . . . 0.0 113.847 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.4 146.58 16.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.826 1.65 . . . . 0.0 110.276 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.3 m -61.88 132.0 51.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.732 1.613 . . . . 0.0 112.022 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.12 158.51 17.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.358 1.463 . . . . 0.0 112.5 171.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -65.37 141.5 58.54 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.482 1.913 . . . . 0.0 112.237 -172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.2 m -68.78 148.62 50.05 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 t30 174.49 126.45 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 130.21 3.404 . . . . 0.0 108.092 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -72.68 136.81 45.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.68 140.4 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.089 2.155 . . . . 0.0 108.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -119.54 125.44 48.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.556 1.142 . . . . 0.0 110.31 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.09 111.73 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.526 -1.286 . . . . 0.0 107.526 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -120.24 152.12 38.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.26 1.424 . . . . 0.0 110.342 -170.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.6 143.26 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -108.02 150.39 27.2 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.84 1.656 . . . . 0.0 112.087 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.36 125.6 41.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.921 1.688 . . . . 0.0 107.852 168.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -140.82 158.23 44.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.547 1.139 . . . . 0.0 111.391 -171.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -63.44 -16.84 61.77 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.36 0.87 78.89 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.008 1.29 . . . . 0.0 114.613 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 78.54 -16.91 0.62 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.879 2.871 . . . . 0.0 114.356 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.37 142.01 55.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.232 0.924 . . . . 0.0 112.79 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.0 m -89.78 131.37 35.77 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 167.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.5 mt -128.94 152.31 48.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.989 0.916 . . . . 0.0 110.414 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -105.13 118.16 35.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.657 1.583 . . . . 0.0 108.8 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -98.36 126.71 43.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.429 1.492 . . . . 0.0 110.407 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.71 126.55 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.019 1.328 . . . . 0.0 109.485 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -136.66 146.78 46.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.617 1.567 . . . . 0.0 110.329 -169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.03 -6.17 82.03 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.9 p -52.44 133.65 43.79 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -52.94 138.09 61.48 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.802 3.002 . . . . 0.0 113.267 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.04 -16.18 63.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.842 0.857 . . . . 0.0 113.113 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.79 -18.3 64.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.129 0.972 . . . . 0.0 113.34 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -92.85 120.76 33.53 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.687 1.195 . . . . 0.0 110.511 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.51 124.05 22.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.329 0.652 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -60.85 -38.59 86.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.026 0.53 . . . . 0.0 111.266 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.19 -34.46 73.66 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 113.19 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -70.67 -37.76 73.68 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.408 -0.808 . . . . 0.0 111.441 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.3 mt -58.87 -47.87 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mt -54.82 -47.66 73.78 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.963 0.802 . . . . 0.0 111.561 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.26 -42.75 99.16 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 112.33 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.71 -46.42 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.127 0.571 . . . . 0.0 111.184 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.72 -27.71 65.2 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -78.76 -35.18 44.94 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.86 -1.15 . . . . 0.0 113.071 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -77.49 -59.35 2.82 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.988 0.915 . . . . 0.0 113.103 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.45 -39.78 14.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.326 1.051 . . . . 0.0 113.373 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.92 -13.11 34.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.855 0.862 . . . . 0.0 113.198 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.99 28.1 16.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.172 1.789 . . . . 0.0 113.332 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.33 -170.83 3.29 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.621 1.168 . . . . 0.0 111.1 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -144.62 150.9 38.19 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.233 1.013 . . . . 0.0 109.589 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.67 172.02 45.06 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.544 0.977 . . . . 0.0 115.544 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -154.22 158.53 40.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.355 1.862 . . . . 0.0 111.568 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.8 mt -89.49 128.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.7 t -140.41 142.09 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.877 1.271 . . . . 0.0 109.474 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -100.81 110.39 22.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.446 0.699 . . . . 0.0 111.187 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.98 143.81 46.57 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.981 1.312 . . . . 0.0 111.354 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -56.93 -33.51 95.32 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.537 2.825 . . . . 0.0 114.656 176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -106.96 -47.18 3.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.617 1.167 . . . . 0.0 112.019 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 57.9 mtt -84.17 -12.46 54.85 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.01 -159.96 47.86 Favored Glycine 0 N--CA 1.469 0.893 0 C-N-CA 124.45 1.024 . . . . 0.0 113.119 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -72.72 117.79 14.84 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.173 0.989 . . . . 0.0 111.258 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 pt -145.72 157.12 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.397 1.879 . . . . 0.0 111.668 -169.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.09 132.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.41 132.38 49.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.048 1.339 . . . . 0.0 108.13 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.26 143.02 47.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.926 1.69 . . . . 0.0 108.382 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.4 136.45 46.08 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.195 -0.941 . . . . 0.0 111.523 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.98 48.87 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.666 1.603 . . . . 0.0 113.63 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.93 87.46 4.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.53 1.932 . . . . 0.0 110.969 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -109.86 22.66 15.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.426 1.49 . . . . 0.0 112.985 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -57.37 -46.75 83.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 0.0 114.141 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.67 84.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.8 -47.24 78.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.178 0.991 . . . . 0.0 112.06 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.1 -36.24 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.978 -0.451 . . . . 0.0 111.35 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.45 -50.21 72.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.02 -38.11 81.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.929 . . . . 0.0 112.874 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -60.26 -49.37 77.86 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.003 1.274 . . . . 0.0 111.64 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.83 -38.27 87.55 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.236 1.015 . . . . 0.0 111.23 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.82 -47.11 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.64 0.776 . . . . 0.0 111.574 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -75.38 -48.22 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.198 0.999 . . . . 0.0 113.43 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -97.6 -32.68 11.66 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.93 -18.28 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.774 0.715 . . . . 0.0 112.719 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.54 10.32 85.4 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.618 1.104 . . . . 0.0 114.184 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.02 132.44 45.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.218 1.009 . . . . 0.0 110.014 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -76.23 136.29 39.69 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.477 -0.765 . . . . 0.0 110.95 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -48.99 -37.65 20.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.503 . . . . 0.0 114.841 -169.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -53.62 -23.14 10.2 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.535 1.534 . . . . 0.0 114.886 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -77.43 -14.33 59.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.99 1.316 . . . . 0.0 114.365 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.6 mt -105.58 119.3 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 119.454 1.024 . . . . 0.0 110.407 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -96.05 130.43 43.06 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.143 1.377 . . . . 0.0 109.922 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.17 129.35 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 108.919 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -125.31 141.9 51.81 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.151 1.38 . . . . 0.0 111.525 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.14 -144.29 6.94 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.807 1.194 . . . . 0.0 112.857 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 p90 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.588 1.955 . . . . 0.0 112.739 178.864 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 tpp . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 t 70.28 -171.57 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.234 1.813 . . . . 0.0 113.144 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.47 161.31 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.881 2.072 . . . . 0.0 111.427 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -75.41 131.16 40.0 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.436 0.694 . . . . 0.0 110.948 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.97 53.6 1.72 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.294 1.438 . . . . 0.0 113.238 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.87 -42.47 84.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.346 1.458 . . . . 0.0 113.335 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -168.67 151.96 5.4 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.97 1.708 . . . . 0.0 112.728 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 p -78.83 -52.49 8.26 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.673 1.189 . . . . 0.0 111.211 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 t80 74.09 164.52 0.28 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.421 2.688 . . . . 0.0 113.773 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -82.41 129.96 61.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.619 1.168 . . . . 0.0 111.801 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -86.14 -135.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.267 3.311 . . . . 0.0 109.638 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.95 -141.11 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.686 1.594 . . . . 0.0 111.732 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.99 -163.77 0.2 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.597 1.559 . . . . 0.0 112.941 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -148.0 48.82 1.06 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.394 1.478 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -71.96 168.24 18.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.203 1.801 . . . . 0.0 112.813 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.78 155.22 51.87 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.09 0.853 . . . . 0.0 113.587 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.55 150.65 48.04 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.157 1.383 . . . . 0.0 112.783 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -149.31 153.17 37.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.623 1.169 . . . . 0.0 112.138 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.61 125.09 28.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.369 1.068 . . . . 0.0 111.17 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.2 m 72.34 -39.33 0.44 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.194 2.598 . . . . 0.0 113.376 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.65 31.05 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.964 2.106 . . . . 0.0 115.538 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m 76.8 -34.42 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 128.116 2.566 . . . . 0.0 113.833 169.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 m -58.14 114.81 2.55 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.898 1.279 . . . . 0.0 113.303 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -177.16 141.58 0.33 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.54 2.336 . . . . 0.0 109.585 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -128.63 134.41 48.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.203 1.002 . . . . 0.0 113.012 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.3 mt -108.77 130.35 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 127.631 2.372 . . . . 0.0 106.827 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -118.47 117.62 29.5 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 109.748 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.6 mt -109.54 103.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -110.98 174.4 5.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.264 2.225 . . . . 0.0 110.594 -169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.84 147.84 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.169 0.988 . . . . 0.0 109.082 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -87.93 133.26 33.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.792 1.237 . . . . 0.0 109.079 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.05 152.21 41.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.961 0.904 . . . . 0.0 112.304 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -78.91 132.26 36.69 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.144 0.977 . . . . 0.0 111.899 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -168.02 69.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.043 2.137 . . . . 0.0 109.388 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.83 -37.32 2.31 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.571 1.558 . . . . 0.0 113.329 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -61.78 154.57 25.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 112.594 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.37 177.85 8.54 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.006 0.923 . . . . 0.0 110.29 166.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.6 m -68.78 129.99 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.233 -0.917 . . . . 0.0 109.182 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 mt -128.27 147.2 50.59 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.751 1.221 . . . . 0.0 109.856 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 m -98.68 123.6 42.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.808 1.643 . . . . 0.0 108.778 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.82 115.81 30.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.289 1.836 . . . . 0.0 110.225 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.44 127.4 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.581 1.152 . . . . 0.0 109.845 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.41 152.5 51.47 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.343 1.857 . . . . 0.0 110.211 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.48 -3.79 71.64 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.61 132.55 71.62 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.676 1.238 . . . . 0.0 110.86 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -54.78 143.22 71.59 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.781 2.987 . . . . 0.0 113.169 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.86 -18.2 64.11 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.47 -19.51 65.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.974 0.91 . . . . 0.0 113.37 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -91.5 109.57 20.86 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.681 1.192 . . . . 0.0 110.285 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.89 118.83 10.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.203 1.001 . . . . 0.0 112.144 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -60.65 -38.2 84.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.462 0.705 . . . . 0.0 111.847 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.61 -38.14 89.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.208 1.003 . . . . 0.0 112.332 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -64.35 -38.06 89.7 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.201 -0.937 . . . . 0.0 111.928 170.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.64 -40.2 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.618 0.767 . . . . 0.0 110.1 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.6 -55.28 37.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.185 0.902 . . . . 0.0 110.749 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.35 -49.27 72.7 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.8 p -70.11 -36.87 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.37 -34.44 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.974 0.806 . . . . 0.0 112.034 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.28 -32.69 74.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.671 -1.268 . . . . 0.0 112.511 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -78.16 -67.63 0.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 112.889 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.22 -34.52 25.86 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -93.68 -4.15 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 112.65 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.43 28.42 16.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.157 1.783 . . . . 0.0 113.158 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.8 m -82.92 -174.9 5.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.551 1.14 . . . . 0.0 112.499 -174.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.41 145.29 35.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.474 1.51 . . . . 0.0 108.712 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.92 172.59 45.54 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.33 163.62 37.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.591 1.556 . . . . 0.0 112.866 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.36 134.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.883 1.273 . . . . 0.0 109.467 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -132.95 140.64 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.482 1.513 . . . . 0.0 109.463 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -100.43 105.2 16.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.518 0.727 . . . . 0.0 109.241 169.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.16 144.78 39.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.993 1.317 . . . . 0.0 111.545 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.45 -33.92 98.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.373 2.715 . . . . 0.0 114.552 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -107.24 -48.22 3.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.873 1.269 . . . . 0.0 112.014 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.7 mtt -78.05 -19.05 55.02 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.09 -157.74 45.31 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.177 0.894 . . . . 0.0 112.522 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -70.67 118.72 13.83 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.75 0.82 . . . . 0.0 111.274 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt -139.74 151.39 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.457 1.903 . . . . 0.0 112.101 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -95.34 133.63 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -104.45 128.07 52.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.15 1.38 . . . . 0.0 107.815 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.73 141.41 48.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.983 1.713 . . . . 0.0 108.483 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -72.75 137.48 45.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.858 1.208 . . . . 0.0 111.799 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.77 -175.78 47.25 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.692 1.615 . . . . 0.0 113.693 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.7 84.53 5.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.355 1.862 . . . . 0.0 111.098 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.79 14.62 26.52 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 112.919 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -59.32 -41.54 89.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.53 63.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.089 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -63.74 -44.81 92.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.936 0.894 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.7 -35.39 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.399 0.68 . . . . 0.0 111.246 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.8 t -56.47 -47.8 78.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.541 1.064 . . . . 0.0 111.156 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.81 -39.74 90.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.576 0.751 . . . . 0.0 112.438 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -60.09 -48.39 81.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.725 1.148 . . . . 0.0 111.792 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mmt -59.57 -43.27 93.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.582 1.153 . . . . 0.0 110.604 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.23 -45.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.693 0.797 . . . . 0.0 111.711 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -75.71 -47.15 27.3 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -102.24 -37.43 8.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.0 mt -89.36 -17.02 29.68 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.894 0.77 . . . . 0.0 112.723 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.97 15.99 80.44 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.461 1.029 . . . . 0.0 113.639 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.64 136.22 52.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.213 1.007 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -76.8 139.09 40.24 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.615 -0.678 . . . . 0.0 109.909 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -53.8 -37.55 63.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -56.69 -24.7 50.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.392 1.477 . . . . 0.0 114.981 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -76.86 -16.09 59.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.32 0.964 . . . . 0.0 113.277 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.86 126.24 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.294 1.407 . . . . 0.0 112.123 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -103.15 134.6 46.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.016 1.726 . . . . 0.0 110.27 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.41 128.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.98 1.312 . . . . 0.0 108.428 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -125.06 169.57 12.02 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.763 1.225 . . . . 0.0 113.151 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.39 -139.33 9.8 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.543 1.544 . . . . 0.0 111.863 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 126.466 1.906 . . . . 0.0 113.283 177.619 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.502 2.175 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 p -160.07 -67.45 0.07 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.581 1.152 . . . . 0.0 111.066 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 tt -163.39 162.46 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 127.055 2.142 . . . . 0.0 110.024 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -63.78 123.36 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.466 0.706 . . . . 0.0 110.448 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -64.8 -16.58 63.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.78 -7.26 59.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.505 1.522 . . . . 0.0 113.551 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -59.25 138.06 57.75 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.457 1.026 . . . . 0.0 112.593 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.9 p -111.81 162.05 15.68 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.093 1.357 . . . . 0.0 113.374 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -164.12 151.78 12.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.657 1.983 . . . . 0.0 110.283 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -164.34 163.05 15.34 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.035 1.734 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.15 -14.72 35.3 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.736 2.957 . . . . 0.0 116.338 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -106.76 6.3 29.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.676 1.591 . . . . 0.0 112.01 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.57 -11.51 60.98 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.361 1.464 . . . . 0.0 114.131 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.35 140.29 58.86 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.073 1.349 . . . . 0.0 112.251 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.0 p -73.88 143.76 45.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.798 1.239 . . . . 0.0 112.84 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.41 -159.93 34.95 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.244 1.402 . . . . 0.0 113.018 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -71.26 -19.22 62.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.513 1.125 . . . . 0.0 113.437 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -153.81 154.57 34.21 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.428 1.891 . . . . 0.0 110.875 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -87.97 115.74 25.65 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 0.0 110.927 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.5 p -91.18 -18.78 23.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.394 1.478 . . . . 0.0 113.758 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.98 141.16 47.74 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.41 1.084 . . . . 0.0 112.93 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -81.49 -29.77 33.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.467 1.507 . . . . 0.0 112.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -63.46 140.73 58.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.936 1.294 . . . . 0.0 114.318 -172.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.92 144.54 48.93 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.897 0.879 . . . . 0.0 112.001 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -137.61 148.95 46.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.422 1.489 . . . . 0.0 110.95 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.98 119.54 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -103.6 121.08 42.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.842 0.857 . . . . 0.0 110.076 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.28 103.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -113.16 171.23 7.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.971 2.108 . . . . 0.0 110.21 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.58 145.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -80.25 152.99 28.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.816 0.846 . . . . 0.0 111.539 -177.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.51 154.92 40.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.278 1.431 . . . . 0.0 112.345 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -80.06 110.26 15.29 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.857 0.863 . . . . 0.0 110.729 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -136.52 25.75 3.14 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.832 1.653 . . . . 0.0 112.034 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.91 -4.99 83.53 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.613 1.578 . . . . 0.0 114.555 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -90.19 165.49 13.92 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.652 1.581 . . . . 0.0 111.46 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -65.86 161.42 21.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.913 0.885 . . . . 0.0 112.345 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.8 m -68.3 133.83 49.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.81 1.244 . . . . 0.0 109.85 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.8 mt -133.47 134.98 44.2 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.82 1.248 . . . . 0.0 110.234 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -89.95 116.98 28.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.614 1.566 . . . . 0.0 108.26 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.57 117.19 32.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.952 1.701 . . . . 0.0 110.005 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.93 126.66 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 108.922 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -138.02 159.11 42.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.871 2.068 . . . . 0.0 109.233 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.23 -14.97 2.74 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.289 -1.507 . . . . 0.0 116.103 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.02 130.57 7.22 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 126.207 1.803 . . . . 0.0 112.151 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.43 139.41 65.23 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.241 3.294 . . . . 0.0 113.413 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.96 -11.14 60.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.15 -18.97 61.84 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.114 0.966 . . . . 0.0 113.018 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -90.8 119.72 31.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.561 1.144 . . . . 0.0 110.961 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.79 119.86 16.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 111.568 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -62.75 -38.39 90.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.297 0.639 . . . . 0.0 111.901 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.93 -39.51 89.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.936 0.895 . . . . 0.0 112.225 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -63.49 -39.62 94.92 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.227 -0.921 . . . . 0.0 111.943 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.48 -47.38 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.919 0.781 . . . . 0.0 109.103 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.72 -48.09 75.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.155 0.889 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -62.38 -39.71 94.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.438 -0.789 . . . . 0.0 112.443 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.97 -46.67 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.869 0.759 . . . . 0.0 111.147 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.42 -30.52 67.4 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.05 -31.86 63.06 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.837 -1.164 . . . . 0.0 112.974 171.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -80.01 -61.93 1.84 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.237 1.015 . . . . 0.0 113.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.14 -37.32 20.35 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -92.98 -13.13 29.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.876 0.871 . . . . 0.0 113.002 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.05 29.47 17.66 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.175 1.79 . . . . 0.0 113.012 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.7 m -82.43 -172.1 3.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.697 1.199 . . . . 0.0 111.284 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -146.34 152.76 39.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 109.944 168.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.9 176.23 47.92 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 115.451 0.94 . . . . 0.0 115.451 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -158.33 162.12 37.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.328 1.851 . . . . 0.0 111.64 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 143.79 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 108.985 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.44 132.53 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.436 1.094 . . . . 0.0 109.259 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -94.07 89.31 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.725 1.21 . . . . 0.0 109.273 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.06 142.41 64.21 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.91 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -57.8 -33.03 96.35 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.496 2.797 . . . . 0.0 114.67 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -107.76 -47.63 3.56 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 112.042 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.6 mtt -80.26 -17.82 51.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.56 -158.81 52.77 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.25 0.932 . . . . 0.0 112.289 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -77.17 116.77 18.08 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.691 0.796 . . . . 0.0 112.317 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -134.92 151.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.985 2.114 . . . . 0.0 111.642 -174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.33 134.79 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.05 126.01 51.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.887 1.675 . . . . 0.0 107.491 168.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -113.27 140.46 47.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.231 1.412 . . . . 0.0 108.376 170.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -71.41 135.19 47.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.135 -0.978 . . . . 0.0 111.705 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 -169.86 45.88 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.453 1.501 . . . . 0.0 113.539 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.13 87.54 3.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.706 2.002 . . . . 0.0 111.205 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -112.35 20.25 16.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.584 1.553 . . . . 0.0 112.939 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.75 -42.03 92.3 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.38 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.056 0.942 . . . . 0.0 112.154 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.71 -45.15 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.868 0.867 . . . . 0.0 111.811 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.14 -34.81 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.09 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.0 -49.07 78.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.338 0.972 . . . . 0.0 111.162 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.13 -37.81 78.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.83 0.852 . . . . 0.0 112.652 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.36 -48.54 80.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.867 1.212 . . . . 0.0 111.664 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.6 mmt -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.051 0.94 . . . . 0.0 110.734 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.03 -47.89 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.954 0.902 . . . . 0.0 111.417 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -97.94 -33.21 11.3 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.98 -14.22 39.69 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.83 0.741 . . . . 0.0 112.107 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.81 79.75 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.865 1.221 . . . . 0.0 113.899 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.3 mt -71.41 144.07 49.92 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.434 1.117 . . . . 0.0 111.783 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -75.21 138.25 41.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -54.32 -34.86 61.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -55.65 -21.71 19.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.524 1.93 . . . . 0.0 115.311 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -76.68 -10.56 59.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.1 mt -112.86 133.17 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.049 0.94 . . . . 0.0 111.153 -169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.34 128.25 54.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.535 1.934 . . . . 0.0 110.153 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.81 129.65 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.83 1.252 . . . . 0.0 109.077 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -126.36 173.9 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.893 1.277 . . . . 0.0 113.138 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.41 -141.25 12.02 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.481 1.515 . . . . 0.0 112.115 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.931 2.092 . . . . 0.0 112.891 175.659 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -76.17 -38.37 56.73 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.231 -0.918 . . . . 0.0 112.761 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm -81.01 77.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -158.08 -18.56 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.737 1.215 . . . . 0.0 114.024 -168.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.163 -0.961 . . . . 0.0 112.137 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 pp -100.94 163.86 12.1 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.121 1.368 . . . . 0.0 112.952 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -165.4 149.36 8.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.847 2.059 . . . . 0.0 110.119 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -60.06 153.59 21.26 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.334 1.054 . . . . 0.0 113.763 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.645 1.578 . . . . 0.0 111.504 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.39 136.14 96.2 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.999 0.92 . . . . 0.0 112.547 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.18 -12.05 33.07 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.581 2.854 . . . . 0.0 115.128 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -135.36 -155.63 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.548 1.539 . . . . 0.0 110.695 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.89 -176.01 4.7 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.925 2.09 . . . . 0.0 111.185 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -143.27 146.95 34.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.408 1.483 . . . . 0.0 111.417 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -152.53 141.06 20.75 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.5 -145.86 18.42 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.41 1.481 . . . . 0.0 113.52 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -131.59 160.82 34.21 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.217 1.807 . . . . 0.0 110.852 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 152.56 45.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.877 0.871 . . . . 0.0 113.326 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -154.32 149.28 26.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.96 1.304 . . . . 0.0 111.025 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.9 m -76.26 78.44 3.04 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.789 1.236 . . . . 0.0 110.772 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.68 161.73 37.15 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.704 2.001 . . . . 0.0 111.311 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -151.82 170.6 19.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.885 1.274 . . . . 0.0 112.565 -169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.3 m -139.93 143.13 36.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.747 2.019 . . . . 0.0 110.244 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -68.93 -32.75 72.58 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 61.4 m-85 -120.53 139.73 52.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.543 1.137 . . . . 0.0 113.724 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mt -113.98 134.36 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 128.084 2.554 . . . . 0.0 107.122 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -118.12 111.43 18.86 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 111.005 -169.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -104.89 110.28 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -118.06 164.89 14.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.512 1.925 . . . . 0.0 109.696 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -116.94 143.19 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -101.01 155.16 18.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.886 1.274 . . . . 0.0 110.769 -171.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -68.04 142.47 55.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.355 0.662 . . . . 0.0 109.691 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -80.04 80.26 6.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.733 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -82.39 -31.14 29.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.469 1.107 . . . . 0.0 111.959 171.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.9 -165.62 41.5 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.008 1.29 . . . . 0.0 111.924 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -67.5 -29.08 68.4 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -141.41 154.89 45.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.242 1.417 . . . . 0.0 112.245 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.3 m -68.19 147.56 52.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 110.782 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.26 147.28 50.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.653 1.181 . . . . 0.0 111.729 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.3 m -93.62 118.02 30.84 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.481 1.513 . . . . 0.0 108.304 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.61 115.36 29.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.646 1.578 . . . . 0.0 110.001 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.66 126.89 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 109.288 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -137.62 161.01 37.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.717 2.007 . . . . 0.0 109.412 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 -13.43 8.14 Favored Glycine 0 N--CA 1.477 1.387 0 O-C-N 120.092 -1.63 . . . . 0.0 116.056 169.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -49.97 132.23 22.41 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.974 1.309 . . . . 0.0 111.061 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.83 136.73 51.62 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.086 3.19 . . . . 0.0 113.001 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.83 -3.04 29.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 -17.2 61.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 167.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.4 126.6 40.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.166 1.386 . . . . 0.0 110.247 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -77.64 131.25 37.68 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.608 -0.682 . . . . 0.0 110.84 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.4 -37.57 83.92 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.336 0.654 . . . . 0.0 111.678 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -61.15 -33.31 73.21 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.868 0.867 . . . . 0.0 112.601 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.6 -39.49 84.77 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.261 0.937 . . . . 0.0 111.516 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.04 -47.02 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 0.0 109.196 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.27 -47.08 76.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.766 0.712 . . . . 0.0 111.872 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -62.48 -39.3 93.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.725 0.693 . . . . 0.0 112.351 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.13 -48.17 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 118.985 0.811 . . . . 0.0 111.13 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.46 -29.76 67.5 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.22 -26.87 56.5 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.691 -1.256 . . . . 0.0 113.56 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.56 -49.58 5.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.96 -40.9 17.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.973 0.909 . . . . 0.0 112.953 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.71 -9.75 36.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.651 1.18 . . . . 0.0 112.606 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.32 30.84 20.12 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.934 1.694 . . . . 0.0 112.659 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.08 -165.07 1.27 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.558 1.143 . . . . 0.0 111.335 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.17 146.42 26.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.78 0.832 . . . . 0.0 110.971 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.47 176.17 46.13 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -155.71 164.46 38.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.131 1.773 . . . . 0.0 111.086 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mt -103.08 139.7 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.39 1.476 . . . . 0.0 110.055 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -136.22 143.05 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.124 1.37 . . . . 0.0 109.182 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.59 103.49 15.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.022 0.929 . . . . 0.0 110.618 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -86.14 144.66 39.03 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.203 1.401 . . . . 0.0 111.487 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.77 -31.37 92.08 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.536 2.824 . . . . 0.0 114.711 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -111.17 -46.37 3.32 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.706 1.202 . . . . 0.0 112.437 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.5 mtt -78.02 -18.21 56.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.53 -157.3 47.56 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.77 1.176 . . . . 0.0 112.746 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.76 109.25 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.859 0.864 . . . . 0.0 110.322 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.64 148.84 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.547 1.939 . . . . 0.0 111.829 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.15 133.23 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -103.78 117.4 34.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.823 1.649 . . . . 0.0 107.005 167.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.45 145.14 30.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.894 1.278 . . . . 0.0 108.898 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.83 131.0 44.42 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.538 -0.726 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -167.05 47.82 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.707 1.146 . . . . 0.0 113.662 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -97.69 93.0 6.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.585 1.954 . . . . 0.0 111.25 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -116.87 22.4 12.66 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.417 1.487 . . . . 0.0 113.072 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -58.52 -45.47 88.73 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.26 77.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.991 0.916 . . . . 0.0 112.198 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -65.89 -45.59 81.44 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 111.954 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.99 -35.41 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.254 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.3 t -57.37 -48.22 79.61 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.106 0.866 . . . . 0.0 111.09 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.49 -37.86 87.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.475 0.71 . . . . 0.0 112.766 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.49 -49.93 75.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.792 1.178 . . . . 0.0 111.383 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -58.92 -43.89 91.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 110.672 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.42 -44.29 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.578 0.751 . . . . 0.0 111.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.9 t -76.36 -48.09 21.15 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -99.46 -35.48 9.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.44 -14.25 30.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.878 0.763 . . . . 0.0 112.834 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.58 15.16 81.26 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.583 1.087 . . . . 0.0 113.784 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.33 148.64 49.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.316 1.058 . . . . 0.0 110.109 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -86.58 144.83 27.01 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.376 -0.828 . . . . 0.0 110.031 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -52.93 -39.63 62.98 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.653 -0.655 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -59.5 -21.03 59.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.543 1.537 . . . . 0.0 114.983 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -77.46 -14.29 59.72 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.075 0.852 . . . . 0.0 113.204 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.5 mt -108.05 122.67 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 120.317 1.417 . . . . 0.0 111.607 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 73.0 mmtt -98.94 123.79 43.45 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.374 1.87 . . . . 0.0 109.627 169.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -101.99 120.92 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -103.96 -32.49 9.22 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.31 -139.21 35.32 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 p90 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.078 1.751 . . . . 0.0 113.234 176.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -68.8 148.83 49.73 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.118 0.967 . . . . 0.0 112.514 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 mt -86.69 85.93 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.355 -0.841 . . . . 0.0 109.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -161.42 134.35 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.779 1.632 . . . . 0.0 110.068 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -164.28 132.8 3.57 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.375 1.47 . . . . 0.0 111.231 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -119.03 137.54 53.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.241 1.416 . . . . 0.0 109.644 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -170.82 166.06 7.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.576 1.951 . . . . 0.0 112.048 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -86.66 136.09 33.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.874 0.87 . . . . 0.0 111.201 171.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -165.37 171.63 13.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.99 1.716 . . . . 0.0 111.472 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.48 151.91 19.05 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.524 1.529 . . . . 0.0 111.783 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.481 2.787 . . . . 0.0 112.662 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -171.42 145.09 2.05 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.423 2.289 . . . . 0.0 110.008 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.89 -20.96 29.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.081 0.952 . . . . 0.0 113.428 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -162.75 156.61 20.56 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.516 1.926 . . . . 0.0 111.023 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -106.98 163.36 13.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.746 1.618 . . . . 0.0 112.525 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.31 179.71 51.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.844 1.211 . . . . 0.0 114.779 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -160.65 -153.33 0.32 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.996 2.119 . . . . 0.0 110.421 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.15 147.82 46.27 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.679 -1.263 . . . . 0.0 113.386 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.23 -10.46 42.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.571 1.548 . . . . 0.0 114.539 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 t -56.42 -25.42 50.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.28 1.432 . . . . 0.0 113.695 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.29 83.38 1.89 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 110.903 170.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.4 t -157.62 172.28 18.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.084 2.153 . . . . 0.0 110.904 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m 69.74 -11.32 0.53 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.892 2.477 . . . . 0.0 114.66 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.34 174.23 9.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.211 1.804 . . . . 0.0 113.356 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -72.38 141.1 48.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.62 133.57 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.632 1.573 . . . . 0.0 107.63 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -118.53 122.78 43.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.32 1.048 . . . . 0.0 110.494 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -116.58 111.09 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -120.55 174.21 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.411 1.484 . . . . 0.0 110.952 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -113.01 133.59 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -108.14 128.96 55.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.634 1.974 . . . . 0.0 108.683 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -74.91 153.25 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.655 0.782 . . . . 0.0 111.735 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 121.0 13.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.535 1.134 . . . . 0.0 109.924 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -63.82 109.43 1.74 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.619 0.767 . . . . 0.0 112.201 -172.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 15.55 70.41 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.606 1.098 . . . . 0.0 114.794 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -136.96 178.2 7.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.799 1.639 . . . . 0.0 112.002 -169.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -53.9 140.05 31.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 114.118 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -68.53 142.01 55.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.487 1.515 . . . . 0.0 108.908 168.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.6 mt -127.07 138.4 53.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.874 0.87 . . . . 0.0 111.087 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -93.81 119.48 32.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 108.547 169.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -101.43 123.53 45.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.207 1.403 . . . . 0.0 110.608 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.27 123.88 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.584 1.154 . . . . 0.0 109.114 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.61 152.52 48.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.301 1.84 . . . . 0.0 109.33 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 -5.14 63.95 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.914 -1.116 . . . . 0.0 115.879 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.31 129.45 51.36 Favored Pre-proline 0 N--CA 1.477 0.918 0 CA-C-N 119.475 1.638 . . . . 0.0 109.89 170.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -51.32 140.7 42.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.842 3.028 . . . . 0.0 113.679 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.83 -3.47 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.87 -18.41 62.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 0.0 111.912 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -92.41 133.1 36.21 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.048 1.339 . . . . 0.0 111.319 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.79 117.63 17.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.224 1.009 . . . . 0.0 111.192 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.53 -39.99 89.87 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 111.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -56.91 -35.99 69.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 113.812 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -71.51 -35.81 70.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.949 0.9 . . . . 0.0 111.847 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.47 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.796 0.839 . . . . 0.0 109.717 173.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.25 -55.77 30.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.26 0.936 . . . . 0.0 110.443 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -54.15 -48.73 70.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.378 1.071 . . . . 0.0 113.217 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.57 -31.97 65.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.102 0.865 . . . . 0.0 112.261 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.54 -34.85 72.72 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.773 -1.205 . . . . 0.0 112.426 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -75.27 -59.28 2.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.475 1.11 . . . . 0.0 113.34 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.61 -38.83 15.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.192 0.997 . . . . 0.0 113.675 -169.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.4 -4.79 50.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.985 0.914 . . . . 0.0 113.013 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.13 24.5 13.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.087 1.755 . . . . 0.0 113.3 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.2 m -81.96 -171.96 3.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.849 1.26 . . . . 0.0 112.012 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -144.81 153.83 42.04 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.888 1.275 . . . . 0.0 109.256 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.01 176.46 46.85 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 -169.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.14 164.73 30.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.232 1.813 . . . . 0.0 112.067 -171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.15 146.37 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -136.17 142.19 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.593 1.557 . . . . 0.0 108.704 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -110.74 93.62 4.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.77 0.828 . . . . 0.0 110.008 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.02 145.87 37.29 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.452 1.501 . . . . 0.0 112.153 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.77 -33.83 97.39 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.501 2.801 . . . . 0.0 114.633 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -106.9 -47.4 3.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.777 1.231 . . . . 0.0 111.95 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.5 mtt -79.69 -16.5 55.58 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.97 -161.1 51.98 Favored Glycine 0 N--CA 1.47 0.958 0 C-N-CA 124.531 1.062 . . . . 0.0 113.219 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.43 112.18 8.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.447 1.099 . . . . 0.0 110.213 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 pt -136.63 153.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.669 1.988 . . . . 0.0 112.227 -171.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.9 mt -100.16 134.69 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 166.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -103.84 129.2 51.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.535 1.534 . . . . 0.0 107.501 168.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.24 142.53 46.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.335 1.454 . . . . 0.0 108.29 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -77.99 135.1 37.74 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.036 -1.04 . . . . 0.0 111.296 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.68 -172.1 44.05 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.713 1.625 . . . . 0.0 113.22 -174.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -97.8 88.44 4.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.465 1.906 . . . . 0.0 111.22 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -112.56 17.58 19.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.798 1.639 . . . . 0.0 113.014 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -59.21 -42.94 92.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -169.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.46 -38.59 74.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.964 0.905 . . . . 0.0 112.153 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.9 -44.77 84.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.75 -33.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.235 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -49.47 77.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.402 1.001 . . . . 0.0 111.042 170.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.0 -36.59 75.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.696 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.35 -49.36 75.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.781 1.173 . . . . 0.0 111.854 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.4 mmt -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.241 1.016 . . . . 0.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.53 -49.72 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.305 1.042 . . . . 0.0 111.782 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -75.62 -46.33 32.26 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -101.83 -36.66 8.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 mt -89.55 -18.49 26.51 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.953 0.797 . . . . 0.0 112.915 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.05 14.57 81.75 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.572 1.082 . . . . 0.0 113.618 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.16 134.55 49.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.292 1.046 . . . . 0.0 108.93 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -75.19 148.1 39.85 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.52 -0.738 . . . . 0.0 110.136 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -56.99 -36.63 70.59 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.704 -0.623 . . . . 0.0 112.338 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -64.42 -17.66 63.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.099 1.76 . . . . 0.0 115.199 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -79.69 -10.04 59.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.349 0.977 . . . . 0.0 113.202 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 42.3 mt -113.64 131.74 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.03 -1.044 . . . . 0.0 111.074 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -106.46 135.72 47.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.453 1.501 . . . . 0.0 110.628 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.05 126.94 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.63 1.172 . . . . 0.0 108.851 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -126.45 -161.54 1.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.583 1.553 . . . . 0.0 111.753 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.73 -151.12 18.91 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 125.182 1.372 . . . . 0.0 113.418 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.376 1.47 . . . . 0.0 114.151 -173.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 p -86.77 162.5 17.8 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.058 1.343 . . . . 0.0 113.085 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.288 39.6 pt 46.84 -142.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.92 2.088 . . . . 0.0 113.843 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.09 162.19 25.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.444 1.898 . . . . 0.0 111.216 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -74.18 156.41 37.34 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.189 0.995 . . . . 0.0 112.074 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -144.21 134.05 23.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.224 1.41 . . . . 0.0 110.795 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -79.17 153.73 29.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.831 1.252 . . . . 0.0 112.656 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -145.0 159.27 43.2 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.417 1.487 . . . . 0.0 110.68 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.91 132.58 49.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.212 1.005 . . . . 0.0 110.702 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -64.71 123.44 83.35 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.863 0.865 . . . . 0.0 111.598 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.96 46.86 2.33 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.957 3.105 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -169.99 140.82 2.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.705 2.402 . . . . 0.0 109.742 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -172.64 161.28 4.83 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.564 1.945 . . . . 0.0 111.157 -171.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -78.34 137.58 38.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.184 0.994 . . . . 0.0 112.065 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.2 p -147.97 155.25 41.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.304 1.841 . . . . 0.0 110.86 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.37 147.61 23.44 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.444 1.021 . . . . 0.0 112.551 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -85.18 125.36 32.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.542 1.137 . . . . 0.0 111.685 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -168.87 166.45 11.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.571 1.948 . . . . 0.0 111.01 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.27 133.11 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.736 1.614 . . . . 0.0 111.524 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.2 m -98.66 120.47 39.15 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.932 1.293 . . . . 0.0 109.383 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.74 -25.0 44.48 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -77.27 135.03 38.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 110.673 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -71.31 150.26 45.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.807 0.843 . . . . 0.0 113.061 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -158.04 163.26 37.88 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.045 1.338 . . . . 0.0 112.129 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.426 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 63.4 m-85 -75.53 142.32 42.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.43 131.49 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.141 1.776 . . . . 0.0 107.147 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -116.58 119.52 35.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 110.754 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mt -109.39 109.27 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -117.92 176.35 5.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.443 2.297 . . . . 0.0 110.892 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.91 147.63 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.126 -0.984 . . . . 0.0 110.117 168.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -126.88 143.13 51.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.707 2.003 . . . . 0.0 108.753 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -94.55 152.18 18.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.99 0.916 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -137.61 167.21 22.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.417 1.887 . . . . 0.0 110.235 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.68 143.32 42.04 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.982 0.913 . . . . 0.0 112.889 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -139.75 27.48 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.11 0.862 . . . . 0.0 112.042 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -83.59 -0.85 52.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.927 1.291 . . . . 0.0 113.681 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.36 131.26 43.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.415 1.086 . . . . 0.0 113.223 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 m -129.72 141.04 50.96 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.402 1.881 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt -123.48 148.73 45.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.875 1.27 . . . . 0.0 111.245 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.7 m -96.91 130.4 44.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.441 1.497 . . . . 0.0 107.548 168.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.34 122.54 46.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 110.569 -176.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.43 124.16 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.594 1.158 . . . . 0.0 109.525 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -130.22 150.85 51.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.567 1.947 . . . . 0.0 109.673 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.88 58.5 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.53 129.22 69.65 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 119.107 1.454 . . . . 0.0 110.407 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.64 141.84 51.99 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.036 3.157 . . . . 0.0 112.616 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -11.99 60.06 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.72 -22.58 66.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.574 0.75 . . . . 0.0 112.314 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -91.1 104.33 16.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.852 1.261 . . . . 0.0 109.44 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.02 125.32 24.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.73 0.812 . . . . 0.0 112.554 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.9 -40.08 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.428 0.691 . . . . 0.0 112.343 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -63.9 -39.13 93.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.581 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -64.64 -36.45 84.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.041 0.936 . . . . 0.0 112.328 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.8 -48.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.951 0.796 . . . . 0.0 109.326 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.45 -42.63 82.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.2 0.909 . . . . 0.0 112.174 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -58.72 -41.79 87.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.082 0.855 . . . . 0.0 112.255 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.94 -46.27 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.708 0.685 . . . . 0.0 111.534 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.9 -31.62 68.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE2' ' H ' ' A' ' 66' ' ' GLY . 87.5 mttt -75.42 -29.76 59.85 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.952 -1.092 . . . . 0.0 113.117 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -83.35 -61.66 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.11 0.964 . . . . 0.0 113.278 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.83 -39.24 24.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.151 0.98 . . . . 0.0 113.239 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -93.31 -7.8 43.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.565 1.146 . . . . 0.0 113.082 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.21 27.38 15.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.713 . . . . 0.0 113.287 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.4 m -83.86 -174.4 5.26 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.591 1.157 . . . . 0.0 111.736 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -138.85 144.95 39.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.209 1.004 . . . . 0.0 109.439 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' ' HE2' ' A' ' 59' ' ' LYS . . . -169.03 171.57 43.01 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 115.431 0.933 . . . . 0.0 115.431 -169.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -162.73 158.93 23.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.947 1.699 . . . . 0.0 112.128 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.16 137.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.712 1.205 . . . . 0.0 109.556 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.91 143.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.173 1.389 . . . . 0.0 110.199 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -102.94 104.28 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.46 146.16 41.32 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.37 1.468 . . . . 0.0 111.696 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.03 -32.17 97.01 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.395 2.73 . . . . 0.0 114.718 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.25 -47.64 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.712 1.205 . . . . 0.0 112.291 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -77.29 -18.23 57.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.95 -158.24 46.17 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.774 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.05 118.58 13.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.934 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt -144.87 154.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.947 1.699 . . . . 0.0 113.075 -169.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.81 134.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -101.87 140.67 35.84 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.488 1.515 . . . . 0.0 108.551 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.41 141.94 50.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.97 1.708 . . . . 0.0 108.433 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.41 138.03 44.98 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.016 -1.052 . . . . 0.0 111.923 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.7 -172.47 44.44 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.21 1.386 . . . . 0.0 113.412 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -94.04 99.01 11.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.719 1.207 . . . . 0.0 110.04 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.23 18.54 14.46 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.536 1.534 . . . . 0.0 112.544 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -52.45 -55.23 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.618 1.167 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.01 88.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.264 1.026 . . . . 0.0 112.49 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -66.46 -45.35 80.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.497 0.719 . . . . 0.0 112.041 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.82 -36.14 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.227 0.611 . . . . 0.0 110.961 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.78 -48.47 75.26 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.317 0.962 . . . . 0.0 111.193 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.9 -39.55 89.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.592 0.757 . . . . 0.0 112.767 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -59.91 -49.58 77.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.807 1.185 . . . . 0.0 111.465 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.9 mmt -58.32 -41.32 84.25 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.233 1.013 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.36 -50.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.505 -0.747 . . . . 0.0 111.491 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.2 m -89.46 -14.16 35.96 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.27 -39.94 3.33 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.087 1.312 . . . . 0.0 113.324 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.12 -15.08 39.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.495 1.043 . . . . 0.0 113.09 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.72 14.74 79.26 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.471 1.034 . . . . 0.0 113.709 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 mt -68.94 151.59 46.35 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.541 1.171 . . . . 0.0 109.956 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -88.03 145.28 26.06 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -55.4 -37.64 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -61.28 -18.07 56.68 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.55 -14.22 60.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.403 1.002 . . . . 0.0 112.974 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.2 mt -111.52 128.64 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.218 0.917 . . . . 0.0 111.233 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 71.5 mmtt -103.2 133.26 48.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.463 1.905 . . . . 0.0 109.79 169.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.55 129.89 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.074 0.949 . . . . 0.0 108.912 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -120.51 177.93 4.86 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.253 1.421 . . . . 0.0 112.246 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.84 -153.84 28.47 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.686 1.136 . . . . 0.0 113.628 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.988 2.115 . . . . 0.0 113.606 177.612 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.0 m -139.95 154.81 47.3 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.954 1.302 . . . . 0.0 111.767 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -86.22 151.67 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.465 1.106 . . . . 0.0 111.54 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.76 155.37 27.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.739 1.616 . . . . 0.0 110.844 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -76.1 155.9 34.32 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.95 171.53 14.98 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.552 1.141 . . . . 0.0 111.824 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -76.62 -176.0 3.6 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.9 p -69.53 155.6 40.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.723 1.209 . . . . 0.0 113.476 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -72.11 156.62 38.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.766 1.226 . . . . 0.0 112.56 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -112.23 85.68 7.11 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.571 1.548 . . . . 0.0 110.874 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.75 -25.35 39.86 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.202 2.601 . . . . 0.0 113.391 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -94.21 4.92 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.015 0.926 . . . . 0.0 113.066 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.2 -18.43 60.76 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.646 1.178 . . . . 0.0 113.529 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -69.18 128.92 38.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.497 1.119 . . . . 0.0 111.836 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 p -85.52 -17.0 37.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.494 1.518 . . . . 0.0 113.318 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -146.44 36.63 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.556 1.074 . . . . 0.0 113.191 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -139.43 156.21 47.11 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.001 1.72 . . . . 0.0 111.277 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.66 -17.35 61.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.367 1.067 . . . . 0.0 113.594 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.86 156.99 23.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.599 1.96 . . . . 0.0 110.915 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.4 p -77.77 133.72 38.19 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.58 1.152 . . . . 0.0 110.999 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.82 -20.42 60.46 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -138.54 160.15 40.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.117 2.167 . . . . 0.0 110.462 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.2 p -74.08 91.32 2.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.125 0.97 . . . . 0.0 111.526 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -66.64 136.77 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.76 0.824 . . . . 0.0 112.336 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 81.1 m-85 -80.42 140.88 35.78 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.77 124.98 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -110.36 125.99 53.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.942 0.897 . . . . 0.0 110.981 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.61 117.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 108.258 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 mtt85 -129.59 174.59 9.53 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.79 1.636 . . . . 0.0 110.564 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.76 137.91 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 110.371 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -89.42 128.94 35.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.627 1.971 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -72.89 136.21 45.23 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.195 0.998 . . . . 0.0 111.683 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -82.98 153.35 25.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -167.95 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.066 2.546 . . . . 0.0 107.141 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.15 -28.91 55.24 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -84.71 155.8 21.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.568 1.947 . . . . 0.0 111.759 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -74.78 170.59 15.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.173 1.389 . . . . 0.0 113.034 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 m -79.62 119.13 22.15 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 167.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.8 mt -131.39 146.68 52.38 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.821 1.248 . . . . 0.0 110.26 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.7 m -89.34 115.76 27.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.661 1.184 . . . . 0.0 108.391 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -97.26 126.41 42.45 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.482 1.513 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.77 129.13 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.179 1.392 . . . . 0.0 109.586 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -139.97 157.68 45.29 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.453 1.901 . . . . 0.0 109.723 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.06 62.71 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.89 131.84 66.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 118.663 1.231 . . . . 0.0 110.143 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -53.01 140.75 58.87 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.678 2.919 . . . . 0.0 113.196 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.41 -15.05 62.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.33 -20.21 66.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.937 0.895 . . . . 0.0 113.228 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -90.89 115.78 28.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 110.63 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -68.41 121.17 15.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.071 0.949 . . . . 0.0 111.415 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 mt -59.81 -37.8 80.16 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.18 0.992 . . . . 0.0 111.936 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.36 -31.86 71.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.315 1.046 . . . . 0.0 112.488 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -37.34 69.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.872 0.869 . . . . 0.0 112.311 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.88 -47.26 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.88 -48.3 75.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.845 0.748 . . . . 0.0 111.637 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.28 -45.52 93.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.71 0.804 . . . . 0.0 112.148 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.51 -47.75 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.976 0.51 . . . . 0.0 111.329 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.46 -26.98 65.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.22 -37.1 38.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.616 -1.302 . . . . 0.0 113.308 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.03 -48.46 9.2 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.24 -38.77 12.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.958 0.903 . . . . 0.0 113.148 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -93.07 -8.44 42.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.952 0.901 . . . . 0.0 113.335 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.06 27.83 17.31 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.812 1.645 . . . . 0.0 113.57 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.5 m -87.84 -173.29 4.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.672 1.189 . . . . 0.0 111.282 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.74 145.75 38.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.388 1.075 . . . . 0.0 109.757 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -172.04 173.12 45.1 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.16 163.16 37.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 112.684 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.4 mt -98.4 134.98 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.927 1.291 . . . . 0.0 109.499 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.0 t -131.29 139.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.196 1.398 . . . . 0.0 109.278 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -103.89 99.24 9.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.865 0.866 . . . . 0.0 109.937 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.41 145.68 40.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.341 1.457 . . . . 0.0 111.784 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.0 -31.63 93.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.575 2.85 . . . . 0.0 114.735 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.34 -46.99 3.23 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.735 1.214 . . . . 0.0 112.426 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.2 mtt -78.68 -15.35 58.59 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.96 -158.62 52.26 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 124.37 0.986 . . . . 0.0 112.559 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -72.33 116.58 12.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.906 0.883 . . . . 0.0 110.893 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 pt -139.51 151.37 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.473 1.909 . . . . 0.0 112.173 -172.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.73 136.96 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.93 133.22 51.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.569 . . . . 0.0 107.866 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.81 141.17 48.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 108.283 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.44 134.13 47.51 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.888 -1.133 . . . . 0.0 111.575 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.49 39.32 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.81 1.195 . . . . 0.0 113.621 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -101.8 100.78 11.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.68 1.592 . . . . 0.0 110.378 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -123.37 22.09 9.36 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.304 1.441 . . . . 0.0 113.173 -170.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -60.54 -43.88 96.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.11 89.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.455 0.702 . . . . 0.0 111.847 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.17 -47.28 80.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.05 0.94 . . . . 0.0 111.871 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.99 -34.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.882 -0.511 . . . . 0.0 111.534 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.93 -49.75 75.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.378 0.99 . . . . 0.0 111.083 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.49 -38.64 81.41 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.634 0.774 . . . . 0.0 112.65 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.32 -49.6 76.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.49 1.041 . . . . 0.0 111.633 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.13 -38.97 80.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.024 0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.99 -50.76 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.375 0.67 . . . . 0.0 111.374 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.5 m -84.93 -28.92 25.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -169.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -103.52 -44.0 5.24 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.264 0.938 . . . . 0.0 112.559 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.82 -19.77 28.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.071 0.85 . . . . 0.0 113.178 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.56 14.93 77.21 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.425 1.012 . . . . 0.0 113.727 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.07 145.21 51.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.626 1.213 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -74.28 140.95 45.31 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.506 -0.746 . . . . 0.0 110.819 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -53.29 -44.73 68.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.58 0.752 . . . . 0.0 112.211 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -63.79 -24.52 67.79 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.28 -6.27 54.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.548 1.139 . . . . 0.0 112.459 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.92 131.04 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.88 -1.137 . . . . 0.0 110.344 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.2 mmtt -109.33 128.36 55.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 110.277 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 77.0 mt -107.49 119.53 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -104.59 -26.53 12.3 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.19 -150.46 43.96 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 123.783 0.833 . . . . 0.0 113.074 170.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 tpp . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -79.18 177.55 8.74 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 112.864 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.38 159.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.406 1.882 . . . . 0.0 111.967 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.47 163.03 27.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.283 1.033 . . . . 0.0 112.397 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -61.28 138.25 58.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.783 0.833 . . . . 0.0 112.544 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.7 tp -155.72 150.15 25.93 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.519 1.528 . . . . 0.0 110.708 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -155.37 167.09 31.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 0.0 112.24 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 t -161.91 170.96 18.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.777 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -85.91 174.66 9.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.869 1.668 . . . . 0.0 112.602 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.83 145.09 96.35 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.649 1.18 . . . . 0.0 113.316 -176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.06 -21.97 17.57 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.4 2.733 . . . . 0.0 113.631 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -173.34 163.27 4.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.526 2.331 . . . . 0.0 109.928 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.28 155.61 35.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.535 1.934 . . . . 0.0 111.176 175.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.0 170.99 11.53 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.173 1.789 . . . . 0.0 112.041 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.4 t -160.09 158.44 30.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.905 1.682 . . . . 0.0 111.068 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.21 -172.07 22.37 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.702 1.62 . . . . 0.0 113.895 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -157.55 131.61 8.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.779 1.632 . . . . 0.0 110.896 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.61 165.39 10.21 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.646 1.978 . . . . 0.0 110.551 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.22 -26.48 58.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.7 p 65.37 -19.48 0.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 129.395 3.078 . . . . 0.0 116.973 170.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.89 6.47 2.58 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.56 1.544 . . . . 0.0 114.744 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -75.43 -11.11 59.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.922 2.089 . . . . 0.0 114.923 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 m -56.49 138.82 51.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.708 1.203 . . . . 0.0 114.108 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -74.31 -17.85 60.79 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -118.56 152.23 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.637 1.575 . . . . 0.0 112.44 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.4 mt -86.55 116.23 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 167.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -100.31 112.32 24.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.94 0.896 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.5 mt -102.3 101.8 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -107.6 174.47 5.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.101 2.16 . . . . 0.0 110.715 -171.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.7 mt -122.17 138.67 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.9 143.22 37.9 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.417 1.487 . . . . 0.0 110.02 -172.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -73.39 103.19 3.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.774 0.83 . . . . 0.0 110.035 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.68 126.71 31.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.739 0.816 . . . . 0.0 111.486 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -106.66 63.03 0.64 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.376 1.47 . . . . 0.0 109.816 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.27 7.43 88.48 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.82 1.2 . . . . 0.0 114.202 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -98.1 171.46 8.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.17 1.788 . . . . 0.0 111.963 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.59 153.0 44.18 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.553 0.741 . . . . 0.0 111.921 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -68.66 138.9 55.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.26 1.424 . . . . 0.0 110.791 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -128.62 135.42 49.29 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.604 1.162 . . . . 0.0 110.36 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -89.53 124.41 34.49 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.689 1.596 . . . . 0.0 108.295 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 114.1 27.37 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.456 1.502 . . . . 0.0 110.118 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.76 122.55 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.118 0.967 . . . . 0.0 109.363 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -125.62 151.59 46.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.65 1.98 . . . . 0.0 109.681 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.86 4.45 82.45 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -57.5 131.13 81.64 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.698 1.249 . . . . 0.0 110.456 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.26 139.75 63.03 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.07 3.18 . . . . 0.0 113.149 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.47 -10.29 59.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.95 -19.8 62.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.993 0.917 . . . . 0.0 112.939 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -91.97 121.59 33.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.771 1.228 . . . . 0.0 110.917 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.71 118.16 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.701 0.8 . . . . 0.0 111.146 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.36 -37.15 77.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.686 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -63.17 -37.24 86.44 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.181 0.992 . . . . 0.0 112.121 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -66.69 -37.66 85.18 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.28 -0.887 . . . . 0.0 111.663 171.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.33 -40.96 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.536 0.734 . . . . 0.0 110.097 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.28 -54.26 48.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.302 0.955 . . . . 0.0 110.888 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -55.84 -48.27 75.79 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.942 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.99 -35.82 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.2 -30.72 62.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.025 0.829 . . . . 0.0 112.117 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -71.06 -30.43 66.58 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.768 -1.207 . . . . 0.0 112.769 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.15 -61.68 1.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 113.125 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.51 -40.55 23.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 -169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.87 -7.03 50.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.407 1.083 . . . . 0.0 112.554 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.65 28.98 17.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.11 1.764 . . . . 0.0 112.893 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -91.91 -162.13 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.635 1.174 . . . . 0.0 111.764 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -155.4 152.47 29.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.102 0.961 . . . . 0.0 111.421 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.7 176.4 48.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.03 165.03 36.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.862 1.665 . . . . 0.0 112.738 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -101.78 135.29 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.018 1.327 . . . . 0.0 109.876 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.44 143.76 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.24 1.416 . . . . 0.0 110.029 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -105.75 100.6 10.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.548 0.739 . . . . 0.0 109.511 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -84.58 144.67 43.18 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.452 1.501 . . . . 0.0 111.781 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.52 -32.25 93.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.611 2.874 . . . . 0.0 114.871 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.76 -47.42 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.616 1.166 . . . . 0.0 112.19 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.1 mtm -80.26 -17.24 52.76 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 -157.55 44.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.221 0.915 . . . . 0.0 113.201 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -70.12 114.53 8.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.827 1.251 . . . . 0.0 110.634 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -142.4 152.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.714 1.606 . . . . 0.0 113.093 -169.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.01 132.51 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -100.22 133.18 45.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.001 1.32 . . . . 0.0 107.723 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tp -123.35 143.16 50.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.606 1.562 . . . . 0.0 108.756 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.158 -0.964 . . . . 0.0 112.093 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.93 -170.47 39.81 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.215 1.388 . . . . 0.0 113.669 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -97.55 77.56 2.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.895 2.078 . . . . 0.0 111.081 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -100.26 15.34 27.93 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.075 1.75 . . . . 0.0 113.54 -170.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -58.39 -40.18 81.66 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -41.3 64.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.001 0.921 . . . . 0.0 112.123 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -65.77 -41.8 91.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.847 0.859 . . . . 0.0 112.54 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.75 -35.31 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.809 -0.557 . . . . 0.0 111.204 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.56 -48.54 79.07 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.474 1.034 . . . . 0.0 111.014 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.13 -39.7 83.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.813 0.845 . . . . 0.0 112.551 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -60.17 -49.49 77.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.597 1.09 . . . . 0.0 111.778 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.4 mmt -61.02 -38.53 86.44 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.189 0.995 . . . . 0.0 110.893 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -74.02 -46.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.742 0.817 . . . . 0.0 111.002 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -82.4 -37.65 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -103.37 -39.65 6.7 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.472 0.709 . . . . 0.0 112.808 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.5 mt -83.61 -17.77 40.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.729 0.695 . . . . 0.0 112.273 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.65 76.31 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.662 1.125 . . . . 0.0 113.636 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.98 159.05 34.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.564 1.182 . . . . 0.0 111.24 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.2 146.96 25.8 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.608 -0.682 . . . . 0.0 109.435 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -55.95 -36.82 68.22 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.367 -0.833 . . . . 0.0 112.365 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -65.94 -10.47 39.37 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -78.79 -9.59 59.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.86 1.209 . . . . 0.0 113.078 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.7 mt -117.89 136.21 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.207 . . . . 0.0 110.995 -169.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -112.56 135.97 52.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.352 1.861 . . . . 0.0 109.968 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.3 127.08 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.421 1.089 . . . . 0.0 109.334 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -126.84 -157.71 0.82 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.583 1.553 . . . . 0.0 111.714 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.45 -151.54 19.37 Favored Glycine 0 N--CA 1.472 1.067 0 C-N-CA 125.03 1.3 . . . . 0.0 113.579 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.635 1.574 . . . . 0.0 114.299 -174.13 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p -78.9 -34.7 44.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.456 1.102 . . . . 0.0 113.056 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 3' ' ' ILE . 3.8 mp -65.5 135.56 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.446 1.099 . . . . 0.0 109.649 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 76.55 -8.4 1.67 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 128.036 2.535 . . . . 0.0 114.116 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -70.03 139.89 52.76 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.912 -1.118 . . . . 0.0 112.372 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 pp -162.19 170.46 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.204 1.802 . . . . 0.0 111.784 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -100.89 133.1 45.86 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.704 1.202 . . . . 0.0 111.368 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -105.56 9.99 33.22 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 114.197 -173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -0.95 9.51 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -146.12 145.2 23.64 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.289 1.435 . . . . 0.0 111.582 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.26 -34.37 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.138 2.559 . . . . 0.0 112.685 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.6 p90 177.87 168.9 0.72 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.23 3.012 . . . . 0.0 109.337 -174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.8 150.88 39.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.945 1.698 . . . . 0.0 111.319 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.21 29.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.023 1.329 . . . . 0.0 113.199 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.3 p -96.06 149.53 21.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 111.611 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.35 -4.13 59.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.754 1.169 . . . . 0.0 114.777 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -164.25 153.89 14.1 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.265 1.826 . . . . 0.0 111.278 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -158.34 158.09 33.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.902 1.681 . . . . 0.0 111.265 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.3 138.56 43.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.452 1.101 . . . . 0.0 112.137 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.2 p -100.45 -27.66 13.33 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.591 1.557 . . . . 0.0 113.602 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.1 59.08 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.5 p -84.09 172.97 11.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.157 1.783 . . . . 0.0 111.939 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.8 p -149.85 155.92 40.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.748 1.219 . . . . 0.0 111.938 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -77.52 150.21 34.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.974 0.91 . . . . 0.0 112.582 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -72.16 137.79 47.21 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.69 -0.631 . . . . 0.0 112.411 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mt -89.89 119.69 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -103.78 113.32 26.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.195 0.998 . . . . 0.0 109.655 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.72 98.75 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -106.41 174.5 5.86 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.886 2.074 . . . . 0.0 110.683 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -116.1 146.78 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -92.82 139.17 30.82 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.036 0.934 . . . . 0.0 109.596 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -70.33 147.49 49.56 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.212 1.005 . . . . 0.0 112.964 -172.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -79.41 138.58 37.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.536 1.134 . . . . 0.0 111.7 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -162.37 -127.72 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.138 1.775 . . . . 0.0 108.841 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.98 -22.64 78.72 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 119.863 1.21 . . . . 0.0 112.642 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -88.14 152.46 21.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.389 1.476 . . . . 0.0 111.155 170.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -72.79 -175.9 1.85 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.163 1.385 . . . . 0.0 112.688 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 m -67.96 129.93 41.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.279 1.032 . . . . 0.0 108.288 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.8 mt -136.4 141.37 43.64 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.671 1.188 . . . . 0.0 109.986 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.1 m -93.07 115.5 28.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.813 1.245 . . . . 0.0 108.945 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.49 112.07 24.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.715 1.606 . . . . 0.0 110.001 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.48 125.02 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 109.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -132.79 152.75 51.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.134 1.773 . . . . 0.0 110.186 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.33 77.19 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 168.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.16 131.43 60.16 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 118.717 1.259 . . . . 0.0 111.283 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -51.67 136.73 50.22 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 113.283 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.65 -13.44 62.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 113.906 -171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.69 -19.16 63.59 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.145 . . . . 0.0 113.11 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -94.56 125.34 39.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 111.0 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -74.57 124.75 27.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.504 0.722 . . . . 0.0 111.361 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.42 -38.75 85.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.075 0.55 . . . . 0.0 111.446 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -59.61 -37.18 77.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.497 1.119 . . . . 0.0 112.76 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -66.81 -39.52 87.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.191 0.905 . . . . 0.0 111.538 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.67 -47.26 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.222 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.868 0.758 . . . . 0.0 111.672 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.23 -42.43 99.31 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.428 -0.795 . . . . 0.0 112.512 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.14 -45.51 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.008 0.822 . . . . 0.0 111.346 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.15 -32.94 65.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.631 -1.293 . . . . 0.0 112.751 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -75.68 -63.72 1.23 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.72 1.208 . . . . 0.0 113.235 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -92.54 -32.69 14.74 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -167.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -90.91 -13.94 32.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 112.625 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 61.24 30.53 19.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.241 1.816 . . . . 0.0 112.86 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.32 -170.92 3.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.775 1.23 . . . . 0.0 111.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.94 152.75 36.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.869 1.268 . . . . 0.0 109.255 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.89 45.73 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 115.226 0.851 . . . . 0.0 115.226 -170.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -158.14 163.56 37.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.792 1.637 . . . . 0.0 112.32 -172.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.01 136.15 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.189 1.395 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.5 t -137.21 140.59 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.072 1.349 . . . . 0.0 109.573 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -100.47 105.27 16.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.436 0.694 . . . . 0.0 110.068 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -87.84 144.54 35.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 111.684 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.24 -31.49 93.71 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 114.803 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -110.65 -47.23 3.28 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.773 1.229 . . . . 0.0 112.377 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.5 mtt -78.47 -17.77 55.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.02 -159.88 47.78 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.541 1.067 . . . . 0.0 112.69 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -71.98 118.88 15.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.779 0.832 . . . . 0.0 111.134 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -142.0 152.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.122 1.769 . . . . 0.0 112.309 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.84 134.28 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -105.96 116.8 32.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.643 1.577 . . . . 0.0 107.83 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tp -102.76 146.51 28.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.178 1.391 . . . . 0.0 109.185 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -69.37 133.4 47.76 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.547 0.739 . . . . 0.0 111.693 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 -170.12 54.78 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.11 1.338 . . . . 0.0 113.992 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -94.86 98.28 10.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.092 1.757 . . . . 0.0 111.326 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -120.45 20.75 11.82 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.057 1.743 . . . . 0.0 112.533 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -60.12 -40.91 91.4 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.57 70.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 112.355 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.98 -44.96 83.38 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.936 0.895 . . . . 0.0 111.691 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.61 -35.19 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.104 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.11 -49.54 75.58 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.51 1.05 . . . . 0.0 111.094 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.61 -39.11 79.54 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 0.0 112.68 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -60.43 -47.92 84.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.627 1.103 . . . . 0.0 112.02 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.4 mmt -61.27 -41.1 96.37 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.875 0.87 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.63 -47.97 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.732 0.813 . . . . 0.0 111.296 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -76.44 -48.09 20.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -100.48 -33.14 10.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.46 -15.85 38.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.145 0.884 . . . . 0.0 112.316 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.63 15.55 80.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.84 1.21 . . . . 0.0 113.685 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -71.1 157.89 37.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.547 1.174 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.48 147.14 24.81 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.642 -0.662 . . . . 0.0 109.586 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.56 -36.51 64.42 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.448 -0.782 . . . . 0.0 112.76 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -57.59 -21.7 40.6 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.884 1.674 . . . . 0.0 115.094 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -77.08 -7.69 56.17 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.279 0.945 . . . . 0.0 113.412 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.29 136.05 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.338 1.055 . . . . 0.0 110.791 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.53 134.22 54.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.755 2.022 . . . . 0.0 109.991 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt -110.91 127.76 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.821 1.248 . . . . 0.0 108.996 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.56 171.36 11.16 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.863 1.265 . . . . 0.0 113.153 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.01 -140.52 11.51 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.615 1.579 . . . . 0.0 112.098 173.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.5 p90 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 126.483 1.913 . . . . 0.0 113.173 174.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 tpp . . . . . 0 N--CA 1.501 2.082 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 p -102.62 -16.29 16.1 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.83 -29.02 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -165.89 137.58 3.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.372 1.869 . . . . 0.0 109.843 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -91.13 112.03 23.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.043 0.937 . . . . 0.0 110.752 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.1 144.38 31.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 110.786 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -102.16 172.33 6.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.897 1.279 . . . . 0.0 112.322 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -76.32 136.63 39.58 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.185 -0.947 . . . . 0.0 111.501 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -144.19 166.29 25.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.358 1.463 . . . . 0.0 111.649 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -151.69 145.02 17.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.86 1.664 . . . . 0.0 111.215 174.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -93.66 -145.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.104 3.203 . . . . 0.0 110.437 -173.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.34 27.24 2.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.583 1.953 . . . . 0.0 111.662 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.69 153.57 41.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.168 1.387 . . . . 0.0 113.661 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.02 152.23 16.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.421 1.888 . . . . 0.0 110.791 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 t -161.97 165.72 27.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.459 1.503 . . . . 0.0 111.543 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.86 163.75 45.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.348 1.452 . . . . 0.0 114.006 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.08 163.15 26.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.43 1.492 . . . . 0.0 113.447 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -158.59 159.82 35.9 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.112 1.765 . . . . 0.0 111.037 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.77 144.53 45.85 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.197 1.399 . . . . 0.0 111.579 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 t -169.22 159.63 9.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.718 2.007 . . . . 0.0 110.639 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.75 -16.87 58.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.682 1.193 . . . . 0.0 113.172 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 m -72.01 145.12 48.54 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.728 1.611 . . . . 0.0 110.769 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.8 p -149.31 153.87 38.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.28 1.032 . . . . 0.0 112.647 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.91 171.92 8.8 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 112.898 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.42 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 72.5 m-85 -72.46 143.09 48.56 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 mt -94.02 132.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -114.94 120.68 40.76 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.624 1.169 . . . . 0.0 110.182 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.9 mt -114.27 116.37 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -128.99 174.57 9.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.253 1.821 . . . . 0.0 110.202 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -115.47 142.06 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.157 0.983 . . . . 0.0 108.483 169.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -87.29 135.76 33.19 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.454 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.96 124.57 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.24 0.616 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -141.16 146.32 36.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.726 1.61 . . . . 0.0 111.115 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -77.06 -27.84 54.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 113.22 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.24 162.14 26.94 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.516 1.532 . . . . 0.0 112.638 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.81 -6.21 30.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -74.33 55.82 0.62 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 113.591 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.1 m -68.66 143.19 54.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.919 2.088 . . . . 0.0 111.399 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -128.35 145.69 51.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.16 1.384 . . . . 0.0 111.945 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -89.7 132.37 35.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 107.663 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -112.94 124.5 52.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.246 1.419 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.36 126.57 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.973 1.309 . . . . 0.0 108.597 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -135.83 149.87 49.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.201 1.801 . . . . 0.0 109.502 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.12 -2.29 66.17 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 115.817 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.45 130.14 53.11 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.357 1.578 . . . . 0.0 111.08 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -52.29 139.7 53.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.397 3.398 . . . . 0.0 113.48 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.88 -16.19 63.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.85 0.86 . . . . 0.0 113.302 -172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.33 -20.2 66.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.026 0.931 . . . . 0.0 113.088 172.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -93.0 118.09 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.867 1.267 . . . . 0.0 110.693 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.12 120.3 14.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.966 0.906 . . . . 0.0 111.574 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.3 -39.05 89.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.729 0.811 . . . . 0.0 111.914 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.78 -35.59 78.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.001 0.921 . . . . 0.0 112.461 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.51 -40.39 96.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.206 0.912 . . . . 0.0 112.308 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.27 -40.15 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 109.915 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.97 -55.43 35.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.213 0.915 . . . . 0.0 110.848 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 0.0 112.788 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.06 -36.18 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.92 -32.81 65.56 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.974 0.807 . . . . 0.0 112.318 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -70.69 -33.8 71.28 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.082 . . . . 0.0 112.641 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -76.96 -58.6 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.495 1.118 . . . . 0.0 113.259 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.87 -41.32 15.08 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.31 -11.47 35.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.154 0.982 . . . . 0.0 113.127 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.25 26.92 15.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.242 1.817 . . . . 0.0 113.046 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.2 m -80.91 -171.99 3.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.717 1.207 . . . . 0.0 111.709 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -146.83 149.59 33.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.66 1.184 . . . . 0.0 109.83 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.62 46.62 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.436 0.934 . . . . 0.0 115.436 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.61 164.71 33.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.755 1.622 . . . . 0.0 112.872 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.4 mt -98.56 134.89 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.899 1.279 . . . . 0.0 109.663 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.0 t -136.22 141.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.167 1.387 . . . . 0.0 109.758 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -102.31 107.72 18.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.692 0.797 . . . . 0.0 109.201 168.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -88.57 145.49 35.41 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.987 1.315 . . . . 0.0 111.635 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.3 -32.4 95.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.495 2.797 . . . . 0.0 114.614 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -111.46 -46.75 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.429 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.4 mtt -77.58 -16.74 58.43 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.23 -161.19 48.62 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.623 1.106 . . . . 0.0 112.982 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.65 119.52 14.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.931 0.892 . . . . 0.0 110.941 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -141.4 150.23 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.281 1.832 . . . . 0.0 112.251 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.94 132.76 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 166.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -99.34 137.07 38.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.515 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tp -125.64 139.93 53.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.547 171.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -70.69 136.89 49.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.067 -1.021 . . . . 0.0 111.834 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.64 -163.09 36.62 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.893 1.235 . . . . 0.0 113.492 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.27 98.19 7.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.663 1.585 . . . . 0.0 110.146 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -120.8 18.23 11.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.146 1.379 . . . . 0.0 113.303 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -61.5 -42.75 99.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.36 82.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.534 0.734 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -66.25 -45.33 80.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.068 0.947 . . . . 0.0 111.958 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.67 -36.46 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.222 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.67 -49.34 75.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.388 0.994 . . . . 0.0 111.208 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.45 -39.8 84.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.928 0.891 . . . . 0.0 112.601 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.02 -49.61 76.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.746 1.157 . . . . 0.0 111.837 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.6 mmt -59.79 -37.22 78.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.23 1.012 . . . . 0.0 110.948 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -76.78 -44.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.911 0.884 . . . . 0.0 111.116 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.8 m -86.12 -21.99 27.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -169.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -119.03 -38.25 3.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 0.0 113.455 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.83 -14.88 50.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.401 1.0 . . . . 0.0 112.437 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.28 14.98 80.97 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.869 1.223 . . . . 0.0 113.798 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -70.94 158.43 36.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.405 1.102 . . . . 0.0 111.211 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -88.45 149.41 23.69 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -53.19 -39.69 63.84 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.501 -0.749 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -60.21 -18.52 49.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.738 1.615 . . . . 0.0 114.947 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -78.84 -8.97 59.3 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.352 0.978 . . . . 0.0 113.424 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.1 mt -118.03 130.34 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 119.353 0.978 . . . . 0.0 111.407 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.6 mmtt -104.09 125.81 50.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.336 1.854 . . . . 0.0 110.082 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.0 120.9 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -104.75 -33.98 8.26 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.74 -136.19 38.5 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -170.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 127.043 2.137 . . . . 0.0 113.438 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.502 2.158 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.9 m -126.96 148.94 50.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.97 1.308 . . . . 0.0 110.851 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -138.65 162.5 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.441 1.497 . . . . 0.0 111.678 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.49 158.72 26.99 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.953 1.701 . . . . 0.0 110.769 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.07 156.58 12.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.587 1.555 . . . . 0.0 112.25 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.3 mt 72.23 -52.78 0.7 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 129.034 2.934 . . . . 0.0 113.537 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -70.6 152.7 43.64 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.277 1.031 . . . . 0.0 113.305 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -169.44 170.65 8.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.207 1.803 . . . . 0.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -80.53 152.28 28.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.541 1.136 . . . . 0.0 112.075 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.13 145.96 16.94 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.736 1.614 . . . . 0.0 110.879 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.09 3.84 7.5 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.599 2.866 . . . . 0.0 115.18 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.25 66.72 9.34 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.98 1.312 . . . . 0.0 111.027 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 160.2 14.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.246 1.418 . . . . 0.0 113.028 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -62.65 136.61 57.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.637 1.175 . . . . 0.0 112.601 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 p -72.39 -39.01 68.31 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 175.17 45.15 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.787 1.661 . . . . 0.0 114.262 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.33 165.3 27.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.645 1.978 . . . . 0.0 110.787 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -147.25 147.91 30.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.837 1.255 . . . . 0.0 111.901 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.19 -41.25 0.15 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.122 1.769 . . . . 0.0 111.738 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 t -168.52 174.93 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.99 2.116 . . . . 0.0 110.336 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.54 171.85 16.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.111 1.764 . . . . 0.0 111.837 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 t -153.89 172.54 17.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.335 1.454 . . . . 0.0 111.946 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t 88.68 134.14 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 130.229 3.412 . . . . 0.0 111.648 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -94.14 -10.02 34.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.048 0.939 . . . . 0.0 113.485 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.502 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 32.5 m-85 -123.12 131.85 53.85 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt -100.28 128.1 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.051 2.14 . . . . 0.0 106.912 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -112.38 117.14 31.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.302 1.041 . . . . 0.0 110.448 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.5 mt -108.24 108.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.3 174.04 6.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.085 2.154 . . . . 0.0 109.949 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.9 mt -125.92 142.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 120.983 -1.073 . . . . 0.0 108.725 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -88.31 130.48 35.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.143 1.377 . . . . 0.0 109.766 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 pm0 -72.56 145.39 47.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.907 0.883 . . . . 0.0 111.153 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.86 163.62 34.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -155.17 139.16 16.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.955 2.102 . . . . 0.0 109.58 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.98 14.65 80.11 Favored Glycine 0 CA--C 1.538 1.509 0 N-CA-C 115.266 0.867 . . . . 0.0 115.266 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.4 ptm85 -158.39 168.49 26.85 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.977 1.711 . . . . 0.0 112.087 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.07 148.72 51.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.158 0.983 . . . . 0.0 113.466 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.8 m -69.1 143.36 54.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.147 1.779 . . . . 0.0 110.027 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.08 133.93 47.02 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.244 1.018 . . . . 0.0 111.28 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.1 m -89.11 118.7 29.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.584 1.954 . . . . 0.0 108.053 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.24 116.32 32.24 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.018 1.727 . . . . 0.0 110.126 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -101.39 126.63 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 109.557 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -135.93 158.21 44.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.741 2.016 . . . . 0.0 109.736 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.87 -6.39 48.32 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 120.438 -1.414 . . . . 0.0 116.183 168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.93 130.97 48.98 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 118.563 1.181 . . . . 0.0 110.529 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.24 137.1 55.43 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.931 3.087 . . . . 0.0 112.938 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.68 -14.33 62.85 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.5 -19.68 64.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.241 1.017 . . . . 0.0 113.165 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -89.86 123.87 34.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.548 1.139 . . . . 0.0 111.054 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -74.83 120.59 20.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.963 0.905 . . . . 0.0 111.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.3 -39.07 89.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.563 0.745 . . . . 0.0 111.765 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -60.22 -36.56 77.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.027 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -69.48 -36.88 76.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.875 0.87 . . . . 0.0 112.027 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.77 -47.67 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.917 0.781 . . . . 0.0 109.24 172.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.2 -46.61 79.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.178 0.899 . . . . 0.0 111.628 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -61.81 -33.76 74.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.135 0.974 . . . . 0.0 112.788 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.9 t -75.38 -50.57 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.064 0.545 . . . . 0.0 111.117 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.88 -33.37 74.59 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -72.28 -25.61 61.66 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.816 -1.178 . . . . 0.0 113.662 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.88 -48.92 5.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.132 0.973 . . . . 0.0 113.625 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -83.78 -38.85 20.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.065 0.946 . . . . 0.0 113.004 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 -10.93 23.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.856 1.263 . . . . 0.0 112.978 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.0 26.56 14.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.406 1.882 . . . . 0.0 113.145 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.39 -174.98 4.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.657 1.183 . . . . 0.0 112.241 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -143.7 150.81 39.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.488 1.115 . . . . 0.0 109.413 169.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.39 173.8 46.44 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.35 166.08 33.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.61 1.564 . . . . 0.0 112.372 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.4 134.98 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.948 1.299 . . . . 0.0 109.678 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t -133.41 140.17 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.988 1.315 . . . . 0.0 109.533 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -99.8 102.6 14.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.582 0.753 . . . . 0.0 110.079 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -86.16 143.89 37.8 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.053 1.341 . . . . 0.0 111.666 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.36 -31.18 93.33 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.506 2.804 . . . . 0.0 114.776 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -110.4 -47.49 3.28 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.664 1.186 . . . . 0.0 112.323 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.5 mtt -78.52 -18.3 54.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.92 -158.88 46.99 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.308 0.956 . . . . 0.0 112.478 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -71.53 118.22 14.08 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.876 -0.779 . . . . 0.0 111.223 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.78 149.57 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.373 1.869 . . . . 0.0 112.202 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.2 mt -93.68 135.06 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.23 129.96 52.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.444 1.498 . . . . 0.0 107.548 168.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -120.75 140.15 52.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.338 1.455 . . . . 0.0 108.743 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.35 132.57 45.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.964 -1.085 . . . . 0.0 111.524 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.91 -156.12 21.32 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.923 1.725 . . . . 0.0 113.623 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.35 47.94 1.34 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.636 2.374 . . . . 0.0 111.605 -173.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -75.14 25.05 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.024 2.529 . . . . 0.0 116.29 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -57.7 -47.22 82.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.633 1.173 . . . . 0.0 114.082 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.42 74.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.9 0.88 . . . . 0.0 111.932 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -64.52 -46.0 84.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.612 0.765 . . . . 0.0 111.868 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.92 -35.94 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.719 -0.613 . . . . 0.0 111.369 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -56.11 -49.02 75.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.209 0.913 . . . . 0.0 111.197 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.11 -38.36 86.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.788 0.835 . . . . 0.0 112.846 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.3 -48.56 81.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.934 1.243 . . . . 0.0 111.56 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.73 -44.68 93.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 110.581 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.34 -44.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.707 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.6 t -79.16 -49.15 13.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -98.11 -35.77 10.3 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -88.67 -13.88 38.7 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.753 0.706 . . . . 0.0 112.494 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.49 17.31 79.3 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.774 1.178 . . . . 0.0 113.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.7 mt -70.79 153.56 42.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.503 1.151 . . . . 0.0 111.74 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -79.42 137.69 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.675 -0.641 . . . . 0.0 110.39 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -55.23 -38.81 68.95 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 0.0 112.756 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -59.2 -21.16 59.05 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 114.605 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.58 -4.7 58.06 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.314 1.046 . . . . 0.0 112.942 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -112.01 126.59 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.51 -1.369 . . . . 0.0 110.89 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.6 mmtt -105.89 120.16 41.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.585 1.954 . . . . 0.0 110.004 172.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 73.8 mt -96.48 122.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -106.13 -35.08 7.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.117 0.967 . . . . 0.0 113.207 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -137.38 39.3 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.817 0.722 . . . . 0.0 111.593 -174.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.291 2.236 . . . . 0.0 113.46 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.3 p -75.72 161.55 28.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.367 1.067 . . . . 0.0 112.694 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.44 124.49 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.207 1.003 . . . . 0.0 109.814 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.26 162.97 16.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.802 1.241 . . . . 0.0 112.619 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -151.81 143.48 23.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.491 1.116 . . . . 0.0 112.007 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.2 tp -116.86 -17.56 10.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.814 1.646 . . . . 0.0 113.378 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -158.22 138.77 12.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.897 1.679 . . . . 0.0 111.188 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 t -123.93 151.31 43.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.021 0.928 . . . . 0.0 110.797 170.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -163.05 166.43 23.63 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.415 -173.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -101.64 113.32 65.86 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.894 0.878 . . . . 0.0 110.981 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.67 -35.37 3.54 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.594 2.196 . . . . 0.0 111.207 170.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -162.79 3.16 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.428 1.891 . . . . 0.0 113.564 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.54 147.39 37.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 113.563 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -161.27 -171.8 3.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.13 2.172 . . . . 0.0 109.962 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.1 m -65.15 129.22 38.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.742 1.217 . . . . 0.0 110.912 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.74 164.92 16.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.805 1.669 . . . . 0.0 113.227 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.82 -22.92 39.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.435 1.094 . . . . 0.0 113.279 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.98 159.98 24.73 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.191 1.396 . . . . 0.0 113.132 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.67 147.22 50.89 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 t -148.08 153.8 39.37 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.039 1.336 . . . . 0.0 111.804 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.69 151.68 1.92 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.433 2.693 . . . . 0.0 110.028 -175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -166.74 154.95 10.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.951 0.901 . . . . 0.0 113.284 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -94.08 7.57 44.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.734 1.614 . . . . 0.0 112.84 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -54.86 147.64 14.77 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.018 1.327 . . . . 0.0 114.238 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.01 139.7 57.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.63 113.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.513 1.125 . . . . 0.0 108.282 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -96.21 116.96 29.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.066 0.946 . . . . 0.0 110.049 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.41 102.52 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -108.09 174.11 6.02 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.92 2.088 . . . . 0.0 110.855 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -126.77 146.56 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.691 1.196 . . . . 0.0 108.217 169.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -93.53 167.74 11.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.519 1.128 . . . . 0.0 111.36 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -65.77 130.25 42.61 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.177 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -74.21 141.08 45.46 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -90.9 68.49 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.49 1.516 . . . . 0.0 109.284 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.6 -119.24 10.9 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -172.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -21.8 60.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 113.484 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -80.44 137.18 36.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.112 0.869 . . . . 0.0 112.381 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.8 m -129.14 150.36 50.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.191 2.196 . . . . 0.0 108.758 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.65 129.24 45.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.783 0.833 . . . . 0.0 111.129 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 m -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.529 1.932 . . . . 0.0 107.681 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.57 120.43 28.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 110.614 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.7 121.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.322 1.049 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -127.93 153.97 46.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.641 1.977 . . . . 0.0 110.02 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.98 -5.2 50.54 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.076 1.19 . . . . 0.0 116.076 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -49.36 129.86 17.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 0.0 111.001 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -52.01 137.45 53.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.944 3.096 . . . . 0.0 113.209 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.05 -8.67 55.01 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.25 -17.81 62.47 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.133 1.373 . . . . 0.0 113.0 169.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -94.13 129.76 40.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.081 1.353 . . . . 0.0 111.41 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.14 118.75 22.12 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.985 0.914 . . . . 0.0 111.936 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.76 -38.48 90.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.23 0.612 . . . . 0.0 112.254 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.43 -36.08 81.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.862 0.865 . . . . 0.0 112.584 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -64.03 -39.27 93.72 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.061 -1.024 . . . . 0.0 111.764 169.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -63.24 -39.71 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.93 0.892 . . . . 0.0 110.068 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.45 -55.83 30.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 110.976 170.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.4 -48.82 73.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.931 0.893 . . . . 0.0 112.8 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.86 -36.73 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.06 -34.68 64.13 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.193 0.906 . . . . 0.0 111.98 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -34.39 77.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.758 -1.214 . . . . 0.0 112.471 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.63 -60.44 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.32 1.048 . . . . 0.0 113.105 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.69 -39.16 18.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.89 -4.42 49.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.464 1.106 . . . . 0.0 112.638 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.39 28.85 18.32 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.161 1.785 . . . . 0.0 113.102 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.48 179.76 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.55 1.14 . . . . 0.0 112.74 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -133.27 140.92 47.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.356 1.462 . . . . 0.0 108.366 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.57 168.86 41.89 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 -169.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -159.41 165.05 34.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.661 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.4 135.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.681 1.192 . . . . 0.0 109.976 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.1 t -130.45 142.7 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.675 1.59 . . . . 0.0 109.052 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -111.49 103.36 11.7 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 0.0 110.979 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -98.36 144.77 28.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.417 1.487 . . . . 0.0 112.287 -171.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.85 -32.81 95.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.495 2.796 . . . . 0.0 114.897 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -106.51 -44.98 4.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.019 1.328 . . . . 0.0 112.511 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.7 mtt -82.86 -14.58 54.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.83 -167.16 54.36 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.133 1.349 . . . . 0.0 113.077 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.32 114.27 5.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt -134.64 151.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.108 1.763 . . . . 0.0 112.726 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.29 131.92 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 166.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.5 139.11 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.318 1.447 . . . . 0.0 108.245 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.52 136.13 47.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.463 1.505 . . . . 0.0 108.419 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -72.56 138.95 47.21 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.102 -0.999 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.17 -174.95 39.2 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.985 1.755 . . . . 0.0 113.361 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.54 77.59 2.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.882 2.073 . . . . 0.0 110.828 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.65 15.52 27.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 113.652 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -58.6 -41.64 86.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.23 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.132 0.973 . . . . 0.0 112.279 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.03 -44.34 84.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 111.75 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.49 -33.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.173 0.589 . . . . 0.0 111.092 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 111.085 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.04 -39.65 78.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.52 0.728 . . . . 0.0 112.626 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.92 -49.78 76.36 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.425 1.011 . . . . 0.0 111.733 175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.0 mmt -59.76 -39.69 85.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 110.882 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.01 -52.7 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.611 0.765 . . . . 0.0 111.034 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -83.03 -31.18 27.55 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -103.58 -42.18 5.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.226 0.921 . . . . 0.0 112.938 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -82.39 -20.35 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.155 0.889 . . . . 0.0 112.577 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.19 18.7 66.39 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.318 0.961 . . . . 0.0 113.592 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.5 mt -69.59 157.05 37.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.642 1.221 . . . . 0.0 110.464 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -87.74 146.34 25.71 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.45 -0.781 . . . . 0.0 109.299 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -55.13 -36.69 66.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.317 -0.864 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.91 -19.54 43.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.892 1.677 . . . . 0.0 115.035 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -79.29 -9.46 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.05 132.3 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 120.957 -1.089 . . . . 0.0 110.926 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -106.31 124.87 50.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.548 1.539 . . . . 0.0 109.544 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.8 mt -100.95 124.13 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.199 1.0 . . . . 0.0 108.415 174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.38 171.33 8.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.954 1.302 . . . . 0.0 112.15 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.46 -144.65 14.71 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.114 1.34 . . . . 0.0 112.435 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.841 2.056 . . . . 0.0 113.313 175.739 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -137.92 154.63 49.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.011 1.324 . . . . 0.0 111.31 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 tt -158.81 149.77 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.589 1.555 . . . . 0.0 110.48 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -133.17 161.59 34.02 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.547 1.539 . . . . 0.0 111.291 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -156.48 154.63 30.69 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.779 1.632 . . . . 0.0 111.281 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -147.47 169.75 18.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.208 1.403 . . . . 0.0 112.478 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.88 97.9 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.049 0.94 . . . . 0.0 111.131 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 p -85.54 -16.2 40.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.699 1.2 . . . . 0.0 113.772 176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -90.74 153.34 20.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.892 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -143.12 146.98 39.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.103 1.761 . . . . 0.0 110.101 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.92 -28.36 5.11 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.193 2.595 . . . . 0.0 112.842 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -178.81 167.88 1.68 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.724 2.81 . . . . 0.0 109.293 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 146.79 27.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 111.157 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.69 -27.24 37.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.199 1.0 . . . . 0.0 113.068 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 p -86.71 150.48 24.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.827 1.651 . . . . 0.0 112.32 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.23 -161.08 37.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.998 1.285 . . . . 0.0 112.802 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.01 137.18 54.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.08 0.952 . . . . 0.0 111.901 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -80.49 135.38 36.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.036 . . . . 0.0 112.103 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -144.18 150.24 37.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.066 1.347 . . . . 0.0 111.197 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -148.0 12.75 0.98 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.089 1.356 . . . . 0.0 113.394 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.01 8.65 5.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.078 2.151 . . . . 0.0 115.55 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 152.5 41.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 112.147 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 p -79.1 -6.91 57.59 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.031 1.332 . . . . 0.0 113.358 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -74.94 -5.66 45.03 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 50.8 m-85 -72.88 134.63 44.9 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.067 -1.021 . . . . 0.0 112.554 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.9 mt -99.69 132.77 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.16 1.784 . . . . 0.0 107.425 170.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -118.67 120.18 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.222 1.009 . . . . 0.0 110.389 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.83 104.48 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -109.79 169.79 8.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.87 1.668 . . . . 0.0 110.568 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mt -126.11 140.4 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -74.84 156.77 36.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.892 0.877 . . . . 0.0 111.62 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -72.66 130.43 40.54 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.624 -0.673 . . . . 0.0 112.019 -169.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -80.05 100.8 8.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.33 1.052 . . . . 0.0 110.664 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -119.32 13.58 12.78 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.736 2.014 . . . . 0.0 113.212 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.21 53.13 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.506 1.527 . . . . 0.0 114.2 -172.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.96 171.6 7.31 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.016 1.727 . . . . 0.0 111.538 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -55.9 140.91 41.21 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.981 1.712 . . . . 0.0 113.857 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.4 m -70.71 124.55 24.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.463 1.105 . . . . 0.0 109.342 169.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.0 mt -129.58 136.35 49.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.48 1.512 . . . . 0.0 110.17 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.0 m -89.18 138.93 30.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.595 1.558 . . . . 0.0 107.618 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -127.46 120.99 29.61 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.845 1.258 . . . . 0.0 110.335 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.84 126.52 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.671 1.188 . . . . 0.0 109.519 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.09 151.51 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.457 1.903 . . . . 0.0 109.751 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.91 -1.45 79.07 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.08 133.3 59.4 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.654 1.227 . . . . 0.0 111.101 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.52 144.19 64.08 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.039 3.159 . . . . 0.0 113.452 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.37 -16.66 63.57 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.053 0.941 . . . . 0.0 113.329 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.67 -17.8 63.52 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 113.481 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -93.23 122.12 35.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.666 1.187 . . . . 0.0 111.313 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -73.1 117.39 14.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.853 0.861 . . . . 0.0 111.331 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.2 mt -60.23 -36.5 77.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.598 0.759 . . . . 0.0 111.819 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -62.88 -38.46 90.97 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.325 1.05 . . . . 0.0 112.027 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -65.38 -37.43 86.98 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.431 -0.793 . . . . 0.0 111.697 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.28 -41.05 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 110.124 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.87 -53.24 60.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.262 0.937 . . . . 0.0 111.013 170.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -56.87 -50.06 73.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.554 0.742 . . . . 0.0 112.873 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.82 -37.43 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' C ' ' HG ' ' A' ' 64' ' ' CYS . 96.5 mt -72.97 -38.33 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.569 0.622 . . . . 0.0 111.712 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.23 -31.87 72.96 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.244 -1.535 . . . . 0.0 112.329 173.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -73.99 -65.43 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.142 1.377 . . . . 0.0 112.933 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -91.69 -29.32 16.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -167.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -93.98 -7.75 41.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.842 0.857 . . . . 0.0 112.488 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.38 26.05 15.59 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.402 1.881 . . . . 0.0 113.236 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HG ' ' C ' ' A' ' 58' ' ' LEU . 7.7 p -82.58 -169.24 2.36 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.558 1.143 . . . . 0.0 112.631 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -141.18 151.78 44.11 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.045 1.338 . . . . 0.0 109.339 167.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.61 172.32 44.09 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -158.01 162.03 38.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.717 1.607 . . . . 0.0 111.904 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.48 129.56 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.111 1.364 . . . . 0.0 108.329 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.4 t -138.53 140.96 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.601 1.16 . . . . 0.0 109.516 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -101.93 111.64 23.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.671 0.788 . . . . 0.0 111.061 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.42 144.53 34.0 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.428 1.491 . . . . 0.0 111.234 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.11 -31.01 92.19 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.423 2.749 . . . . 0.0 114.775 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -111.64 -47.1 3.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.641 1.176 . . . . 0.0 112.348 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.6 mtt -78.04 -16.34 58.14 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.3 -160.71 48.05 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.599 1.095 . . . . 0.0 112.871 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -71.65 118.53 14.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.02 0.928 . . . . 0.0 111.015 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.51 152.22 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.304 1.841 . . . . 0.0 111.813 -170.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.7 mt -90.97 127.97 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -94.43 130.64 40.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.229 1.412 . . . . 0.0 107.713 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -119.09 136.21 54.26 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.655 1.582 . . . . 0.0 107.89 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -76.92 128.17 34.06 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.308 -0.87 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.56 -170.23 28.08 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.237 1.399 . . . . 0.0 113.363 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -97.76 83.95 3.28 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.68 1.992 . . . . 0.0 111.335 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -110.08 15.13 22.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.223 -169.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -59.18 -46.28 88.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.62 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.854 0.861 . . . . 0.0 111.912 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.25 -45.9 89.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.296 1.039 . . . . 0.0 111.913 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.52 -36.12 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.236 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.95 -47.36 80.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.521 1.055 . . . . 0.0 110.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.08 -39.14 91.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.456 0.702 . . . . 0.0 112.641 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -59.66 -49.13 78.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.65 1.114 . . . . 0.0 111.602 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.5 mmt -59.06 -44.34 91.83 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.625 1.17 . . . . 0.0 110.522 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt -72.18 -44.14 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.635 0.774 . . . . 0.0 111.68 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 t -75.3 -48.05 25.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -100.96 -37.09 8.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.0 mt -90.83 -13.39 33.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.723 0.692 . . . . 0.0 112.84 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.57 15.54 81.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.726 1.155 . . . . 0.0 113.687 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.2 145.01 53.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.239 1.019 . . . . 0.0 110.626 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -82.16 134.66 35.32 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.714 -0.617 . . . . 0.0 110.388 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -51.97 -44.43 63.99 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.75 0.82 . . . . 0.0 112.392 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -22.2 63.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -81.73 -10.96 59.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 112.982 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -106.73 124.55 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.644 1.111 . . . . 0.0 110.617 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 68.6 mmtt -101.26 135.11 43.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.806 1.642 . . . . 0.0 110.457 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.49 128.14 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 108.845 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -126.07 -159.24 0.9 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 111.296 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 -152.15 18.73 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.989 1.28 . . . . 0.0 113.079 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.384 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 N--CA 1.504 2.231 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -83.84 -9.83 58.47 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.6 pt -71.58 156.56 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.785 1.234 . . . . 0.0 113.168 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.06 157.23 31.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.97 1.308 . . . . 0.0 112.414 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.34 30.04 0.69 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.794 1.237 . . . . 0.0 112.412 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.74 118.56 10.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.312 1.445 . . . . 0.0 110.14 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -72.52 125.49 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.381 1.072 . . . . 0.0 112.497 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -84.06 147.34 27.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.892 0.877 . . . . 0.0 111.116 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.55 158.86 35.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.787 1.235 . . . . 0.0 112.078 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -158.31 143.6 12.1 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.326 1.85 . . . . 0.0 110.132 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.41 -47.31 26.54 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.608 2.872 . . . . 0.0 114.95 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -176.78 142.25 0.4 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.546 1.939 . . . . 0.0 111.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.83 27.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.186 1.394 . . . . 0.0 111.538 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.11 154.94 20.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.952 1.301 . . . . 0.0 112.974 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.2 m -136.23 135.9 39.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.81 1.644 . . . . 0.0 109.451 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 122.83 6.39 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.308 0.956 . . . . 0.0 111.466 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -165.73 159.48 16.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.398 1.879 . . . . 0.0 110.918 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.57 162.79 35.43 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.531 1.532 . . . . 0.0 112.605 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -155.15 150.76 27.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.063 1.345 . . . . 0.0 111.162 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 t -162.66 159.36 24.35 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.593 1.557 . . . . 0.0 111.427 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.68 64.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.62 1.168 . . . . 0.0 113.892 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -106.97 -100.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.38 1.472 . . . . 0.0 111.176 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 m -87.47 107.93 18.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 112.828 -169.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -154.76 160.69 41.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.559 1.543 . . . . 0.0 110.588 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -70.68 139.23 51.19 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.522 -0.736 . . . . 0.0 110.589 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mt -84.52 111.8 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -96.53 118.82 33.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.62 0.768 . . . . 0.0 110.32 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mt -108.53 109.39 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -121.26 174.43 6.71 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.7 mt -109.78 139.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -85.4 152.82 22.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.855 0.862 . . . . 0.0 111.042 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.49 150.06 49.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.774 1.229 . . . . 0.0 113.009 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -72.45 125.5 27.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.458 0.703 . . . . 0.0 110.931 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -168.27 -44.29 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.085 1.754 . . . . 0.0 111.514 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.79 173.83 55.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.664 1.126 . . . . 0.0 112.896 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -70.04 -22.21 63.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -132.67 158.32 42.61 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.898 1.679 . . . . 0.0 112.13 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 m -68.53 146.18 53.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.48 134.48 47.82 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.396 1.078 . . . . 0.0 111.252 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -91.41 125.05 36.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.339 1.855 . . . . 0.0 108.441 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -106.69 128.9 54.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.539 1.536 . . . . 0.0 110.827 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.0 124.09 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.851 1.26 . . . . 0.0 109.734 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -127.67 155.21 44.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.452 1.901 . . . . 0.0 109.501 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 1.25 90.61 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 168.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -61.13 131.45 92.04 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 118.678 1.239 . . . . 0.0 110.661 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.49 142.36 59.44 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 124.124 3.216 . . . . 0.0 113.267 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.28 -17.25 62.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.164 0.985 . . . . 0.0 113.096 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.03 -18.64 65.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.876 0.87 . . . . 0.0 113.159 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.99 116.86 29.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.856 1.262 . . . . 0.0 110.79 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -69.79 120.78 16.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.074 0.95 . . . . 0.0 111.588 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.91 -39.27 88.74 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.208 1.003 . . . . 0.0 111.974 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.0 -31.38 71.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.926 0.891 . . . . 0.0 112.538 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -40.7 79.32 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 111.836 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.07 -47.65 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.654 0.782 . . . . 0.0 109.057 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.3 mt -55.65 -48.58 74.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.718 0.69 . . . . 0.0 111.674 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.58 -43.29 97.42 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.445 -0.785 . . . . 0.0 112.452 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.15 -46.61 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.118 0.872 . . . . 0.0 111.16 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.06 -27.65 64.81 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -76.81 -35.86 57.3 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.659 -1.276 . . . . 0.0 113.254 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -77.91 -62.32 1.71 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.95 -32.03 20.33 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.221 1.409 . . . . 0.0 113.988 -166.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.7 -8.88 27.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.13 0.972 . . . . 0.0 113.162 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.62 28.25 16.89 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.831 1.652 . . . . 0.0 113.444 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 92.9 m -87.32 -169.85 2.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.921 1.289 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -148.58 149.87 32.31 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.913 0.885 . . . . 0.0 110.082 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.14 177.38 47.15 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.7 161.41 29.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.912 1.685 . . . . 0.0 111.942 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.13 141.37 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.688 1.195 . . . . 0.0 109.226 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.79 138.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.971 1.308 . . . . 0.0 109.411 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -100.14 97.97 8.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 109.579 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.49 146.3 50.02 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.42 1.488 . . . . 0.0 112.002 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.97 -32.84 87.35 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.793 2.995 . . . . 0.0 115.33 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -121.64 -36.68 3.0 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 mtt -77.52 -18.54 56.91 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.24 -157.76 50.13 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.264 0.935 . . . . 0.0 112.433 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.19 115.68 11.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.615 0.766 . . . . 0.0 111.004 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 pt -137.04 151.75 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.479 1.911 . . . . 0.0 112.173 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.27 136.52 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.38 135.04 47.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.186 1.795 . . . . 0.0 108.212 168.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.93 140.62 52.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.749 1.62 . . . . 0.0 108.946 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -72.64 138.51 46.77 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.281 -0.887 . . . . 0.0 111.991 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.72 -169.69 43.1 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.558 1.551 . . . . 0.0 112.895 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.47 97.75 7.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.053 1.341 . . . . 0.0 109.998 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -115.07 27.45 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.885 1.274 . . . . 0.0 113.702 -167.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -51.94 -59.02 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.537 1.535 . . . . 0.0 112.639 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.46 -38.91 91.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.786 1.235 . . . . 0.0 112.195 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.72 -48.41 79.36 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 111.731 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.21 -34.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.828 -0.545 . . . . 0.0 111.344 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.95 -50.03 73.88 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.212 0.915 . . . . 0.0 111.182 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.79 -38.2 81.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.094 0.958 . . . . 0.0 112.647 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.68 -48.12 83.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.67 1.123 . . . . 0.0 111.791 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.5 mmt -61.86 -41.73 98.2 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 110.591 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.25 -48.18 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.049 0.94 . . . . 0.0 111.535 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -80.95 -48.34 12.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -98.51 -34.06 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -85.75 -15.61 41.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.897 0.771 . . . . 0.0 112.035 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.37 79.64 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.017 1.294 . . . . 0.0 113.777 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.48 151.71 42.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.562 1.181 . . . . 0.0 112.141 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -74.15 141.31 45.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.022 0.529 . . . . 0.0 109.929 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -57.36 -36.66 71.48 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.25 -21.1 47.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.961 . . . . 0.0 114.87 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.15 -9.76 58.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.105 0.962 . . . . 0.0 113.127 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.9 133.78 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.384 1.074 . . . . 0.0 110.692 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -110.65 133.84 52.96 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.148 1.779 . . . . 0.0 110.188 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.6 mt -108.94 128.99 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.141 0.976 . . . . 0.0 109.346 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -126.74 161.37 28.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.647 1.579 . . . . 0.0 111.673 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.99 -143.19 7.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.406 1.003 . . . . 0.0 111.959 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 124.86 1.264 . . . . 0.0 112.886 169.828 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mtp . . . . . 0 N--CA 1.505 2.283 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -67.5 151.42 47.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 112.904 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp -160.06 151.56 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.501 1.52 . . . . 0.0 110.579 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -160.64 154.78 23.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.616 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -155.28 155.55 33.97 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.079 1.351 . . . . 0.0 111.639 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.31 135.23 53.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.256 1.422 . . . . 0.0 111.729 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -159.12 156.51 29.22 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.585 1.554 . . . . 0.0 112.394 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 t -167.82 152.14 6.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 110.036 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -143.28 139.99 30.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.683 1.193 . . . . 0.0 111.53 -171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.08 146.15 47.87 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.963 1.305 . . . . 0.0 112.302 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.73 -37.96 64.15 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.392 2.728 . . . . 0.0 112.813 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -177.24 152.28 0.86 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.218 2.607 . . . . 0.0 109.913 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.65 53.53 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.196 0.998 . . . . 0.0 113.54 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -163.02 155.15 18.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.707 2.003 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -88.32 132.22 34.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.134 0.973 . . . . 0.0 109.943 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.8 7.64 76.23 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.825 1.202 . . . . 0.0 115.531 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -160.34 157.66 28.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.092 1.757 . . . . 0.0 111.527 -175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -144.45 6.49 1.28 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.322 1.849 . . . . 0.0 113.694 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.27 131.54 46.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.952 0.901 . . . . 0.0 111.78 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -84.76 131.81 34.51 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.375 1.47 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.26 144.32 28.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.097 0.959 . . . . 0.0 111.486 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -60.76 -42.74 98.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.099 1.36 . . . . 0.0 112.296 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -69.22 -16.3 63.57 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.61 1.164 . . . . 0.0 114.086 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -88.94 -15.71 33.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.263 1.025 . . . . 0.0 113.297 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -72.17 138.06 47.37 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.077 -1.014 . . . . 0.0 113.219 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.13 126.65 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.846 1.258 . . . . 0.0 107.943 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -107.45 115.08 29.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.559 1.144 . . . . 0.0 109.344 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.28 108.5 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -116.97 173.57 6.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.524 1.929 . . . . 0.0 110.865 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.0 141.64 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -84.17 162.3 20.27 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.455 0.645 . . . . 0.0 111.719 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -80.46 103.82 10.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -132.32 143.44 49.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.273 1.429 . . . . 0.0 111.317 -170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -85.22 130.96 34.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.285 1.034 . . . . 0.0 111.095 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.78 -147.18 50.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.86 0.743 . . . . 0.0 112.56 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.86 12.79 6.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.61 1.164 . . . . 0.0 113.715 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -73.47 32.12 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.097 -1.627 . . . . 0.0 113.133 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 m -68.34 142.94 55.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.988 2.915 . . . . 0.0 111.554 -168.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.97 128.86 39.31 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.762 1.225 . . . . 0.0 110.302 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 m -89.43 132.37 35.03 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.878 1.671 . . . . 0.0 107.828 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -117.43 126.77 53.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 110.925 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.48 123.57 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.544 1.138 . . . . 0.0 108.943 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -129.9 149.51 51.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 109.388 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 4.85 89.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.58 131.71 64.01 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 118.567 1.184 . . . . 0.0 111.319 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.25 143.19 53.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.383 3.389 . . . . 0.0 113.615 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -67.49 -18.94 65.25 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 113.37 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.5 -16.91 62.95 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -96.23 124.27 40.17 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.718 1.207 . . . . 0.0 111.799 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.11 121.55 23.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.166 0.986 . . . . 0.0 111.852 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.24 -39.25 92.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.534 0.733 . . . . 0.0 112.395 -174.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -62.86 -34.71 77.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.285 -0.884 . . . . 0.0 112.172 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 tpt85 -64.95 -37.55 88.04 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.15 0.886 . . . . 0.0 111.929 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.9 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.373 1.069 . . . . 0.0 110.164 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.94 -52.78 64.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.199 0.909 . . . . 0.0 110.914 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -54.89 -50.52 68.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 112.638 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.11 -36.1 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -34.9 65.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.651 0.66 . . . . 0.0 112.145 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.45 -33.28 73.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.756 -1.215 . . . . 0.0 112.425 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -74.87 -66.23 0.78 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.122 1.369 . . . . 0.0 113.153 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -91.2 -29.82 17.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -167.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.33 -4.93 47.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.878 0.871 . . . . 0.0 112.561 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.34 28.1 16.26 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.193 1.797 . . . . 0.0 113.246 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.1 m -83.06 177.8 8.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.491 1.116 . . . . 0.0 112.771 -173.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -126.21 141.7 51.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.462 1.505 . . . . 0.0 107.93 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.26 166.96 39.57 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.84 158.34 40.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.236 1.815 . . . . 0.0 111.821 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.7 mt -93.69 136.24 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.741 1.216 . . . . 0.0 108.991 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.36 142.25 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.972 1.309 . . . . 0.0 109.448 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.61 101.36 10.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.049 0.939 . . . . 0.0 109.844 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.52 144.96 32.82 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.154 1.382 . . . . 0.0 111.742 -172.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.43 -31.17 93.53 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.481 2.788 . . . . 0.0 114.744 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -111.15 -47.25 3.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.709 1.204 . . . . 0.0 112.4 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.4 mtt -77.76 -17.63 57.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.43 -161.02 49.87 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 124.599 1.095 . . . . 0.0 112.66 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.02 120.45 17.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.787 0.835 . . . . 0.0 111.023 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 pt -144.14 153.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.172 1.789 . . . . 0.0 112.557 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.0 mt -99.73 132.08 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 165.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -99.34 139.41 35.03 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.569 1.548 . . . . 0.0 108.682 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tp -129.02 138.44 51.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.783 1.633 . . . . 0.0 108.229 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -72.38 139.69 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.126 -0.984 . . . . 0.0 111.477 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.19 -172.39 43.42 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.419 1.485 . . . . 0.0 113.379 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -98.88 85.67 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.754 2.021 . . . . 0.0 110.954 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -109.45 16.21 22.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.596 1.559 . . . . 0.0 113.258 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -58.34 -42.96 88.03 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -39.31 66.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 112.089 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -63.81 -45.22 90.59 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.025 0.93 . . . . 0.0 111.826 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.44 -35.46 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.162 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.75 -48.81 76.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.494 1.043 . . . . 0.0 111.164 170.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.93 -40.15 83.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.784 0.834 . . . . 0.0 112.678 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -59.75 -49.94 75.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.767 1.167 . . . . 0.0 111.869 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.0 mmt -59.67 -37.82 79.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 110.903 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.52 -45.05 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.998 0.919 . . . . 0.0 111.084 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -85.42 -22.14 28.47 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.12 -38.0 2.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.386 0.993 . . . . 0.0 113.601 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.7 mt -82.74 -14.94 53.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.505 1.048 . . . . 0.0 112.48 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.81 14.95 80.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.841 1.21 . . . . 0.0 113.609 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.54 159.51 34.19 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.543 1.171 . . . . 0.0 111.514 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.13 151.29 22.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.378 0.671 . . . . 0.0 110.05 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -55.91 -38.92 70.88 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.255 -0.903 . . . . 0.0 111.657 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.19 -0.11 3.14 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.05 -1.86 56.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.967 1.258 . . . . 0.0 113.033 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt -128.06 132.44 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 120.738 -1.226 . . . . 0.0 111.597 -169.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.69 126.98 51.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.572 1.549 . . . . 0.0 109.829 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.87 122.73 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.78 172.24 7.16 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.242 1.417 . . . . 0.0 111.956 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.9 -154.38 27.77 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 124.819 1.199 . . . . 0.0 113.294 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.848 1.659 . . . . 0.0 112.888 169.716 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -75.04 35.33 0.11 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.419 1.887 . . . . 0.0 115.038 -171.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.25 159.7 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.272 1.429 . . . . 0.0 112.241 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -132.31 144.75 50.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.609 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -75.08 -21.02 59.22 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.946 0.899 . . . . 0.0 113.401 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.91 63.98 7.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.867 1.667 . . . . 0.0 110.381 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.9 -39.37 87.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.455 1.102 . . . . 0.0 113.37 -174.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.8 p -173.81 164.37 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.791 1.636 . . . . 0.0 112.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.45 162.79 34.86 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.108 1.763 . . . . 0.0 110.97 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -132.78 142.52 45.07 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.283 1.433 . . . . 0.0 111.085 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.62 -23.27 5.99 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.46 2.773 . . . . 0.0 113.261 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -176.47 157.23 1.64 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.629 2.372 . . . . 0.0 109.898 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.87 153.76 39.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.903 1.281 . . . . 0.0 112.621 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.92 142.63 47.87 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.571 1.148 . . . . 0.0 112.291 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.9 p -138.31 165.49 26.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.693 1.597 . . . . 0.0 111.865 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.52 141.6 5.88 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.822 1.677 . . . . 0.0 112.922 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -168.06 164.88 13.63 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.073 2.149 . . . . 0.0 110.528 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -153.48 139.61 18.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 112.622 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -170.51 169.94 7.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.468 2.307 . . . . 0.0 110.579 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 p -80.98 -71.69 0.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.94 1.296 . . . . 0.0 110.125 170.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.04 162.7 4.63 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.76 2.424 . . . . 0.0 111.303 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -164.38 161.85 21.86 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.223 1.809 . . . . 0.0 111.026 173.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -70.2 142.85 52.39 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.089 0.956 . . . . 0.0 112.118 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.52 159.84 25.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 112.91 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -136.77 163.5 30.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.755 1.622 . . . . 0.0 112.618 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mp -83.49 127.48 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.1 127.62 55.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.919 . . . . 0.0 110.883 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mt -117.71 99.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -103.53 174.61 5.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.715 2.406 . . . . 0.0 110.214 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.3 mt -127.74 137.85 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.058 0.943 . . . . 0.0 108.771 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -95.88 126.87 41.44 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.63 1.172 . . . . 0.0 108.697 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -80.68 138.61 36.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.917 1.287 . . . . 0.0 108.961 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -155.46 144.88 21.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.486 0.715 . . . . 0.0 112.255 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -59.24 150.65 25.12 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.828 1.251 . . . . 0.0 112.582 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.28 13.55 79.65 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.471 1.034 . . . . 0.0 114.45 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 65.06 27.31 12.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.324 1.85 . . . . 0.0 112.457 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -79.06 62.3 3.44 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -65.7 137.17 57.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.124 1.77 . . . . 0.0 110.915 -171.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.6 mt -130.64 126.52 36.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.174 . . . . 0.0 110.202 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -82.69 116.14 21.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.952 1.301 . . . . 0.0 107.919 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 113.31 24.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.502 1.521 . . . . 0.0 110.004 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.02 129.33 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.668 1.187 . . . . 0.0 108.479 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -144.75 161.45 39.2 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.992 1.717 . . . . 0.0 110.152 -167.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.62 -14.2 4.53 Favored Glycine 0 N--CA 1.475 1.251 0 O-C-N 120.463 -1.398 . . . . 0.0 116.541 168.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -47.99 130.93 12.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.224 1.41 . . . . 0.0 111.55 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -53.5 140.81 63.9 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.954 3.103 . . . . 0.0 113.112 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.76 -10.58 59.78 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.86 -19.57 63.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.85 0.86 . . . . 0.0 112.742 170.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.71 114.13 26.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.048 1.339 . . . . 0.0 110.394 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -66.99 123.15 19.39 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.32 -38.63 80.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.553 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.58 -32.9 74.51 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.118 0.967 . . . . 0.0 112.567 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -69.5 -38.4 77.61 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.277 -0.889 . . . . 0.0 111.517 171.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.2 mt -57.95 -47.05 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.041 0.837 . . . . 0.0 108.964 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.18 -48.73 73.37 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.005 0.82 . . . . 0.0 111.743 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -61.57 -43.67 98.44 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.665 -0.647 . . . . 0.0 112.301 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.23 -46.86 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.651 0.659 . . . . 0.0 111.137 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.63 -32.16 70.69 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.92 -34.36 64.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.674 -1.266 . . . . 0.0 113.208 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.83 -48.46 9.34 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.38 -41.36 12.88 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.704 0.802 . . . . 0.0 113.135 -171.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -94.38 -12.53 27.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.336 1.054 . . . . 0.0 113.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.82 31.17 16.56 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.146 1.778 . . . . 0.0 112.858 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.0 m -80.96 -177.67 6.52 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.476 1.11 . . . . 0.0 111.636 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -138.25 145.92 41.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.374 1.07 . . . . 0.0 109.332 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.63 172.09 45.13 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 116.158 1.223 . . . . 0.0 116.158 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.91 161.87 38.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.538 1.535 . . . . 0.0 112.583 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.0 mt -97.73 134.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.928 1.291 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.35 140.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.285 1.434 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -95.54 103.97 15.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.27 143.8 39.84 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.942 1.297 . . . . 0.0 111.681 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.27 -31.38 93.52 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.541 2.827 . . . . 0.0 114.859 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -110.57 -47.13 3.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.583 1.153 . . . . 0.0 112.304 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 61.4 mtt -78.92 -18.88 53.09 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.88 -157.62 45.55 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.372 0.987 . . . . 0.0 112.476 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.83 117.79 11.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.814 -0.815 . . . . 0.0 111.322 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -140.62 152.93 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.26 1.824 . . . . 0.0 112.141 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.91 133.47 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.17 123.2 45.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tp -108.97 136.36 48.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.174 1.39 . . . . 0.0 108.209 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.48 134.99 48.27 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.208 -0.933 . . . . 0.0 111.673 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.39 -168.95 40.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.378 1.466 . . . . 0.0 113.436 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -98.55 99.74 10.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.811 1.644 . . . . 0.0 109.899 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -122.0 20.72 10.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.863 1.265 . . . . 0.0 113.226 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -62.16 -44.28 96.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.07 -39.62 90.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.458 0.703 . . . . 0.0 111.772 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -64.76 -46.15 83.41 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.141 0.977 . . . . 0.0 111.988 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.47 -36.37 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.857 -0.527 . . . . 0.0 111.352 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.02 -48.24 82.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.313 0.96 . . . . 0.0 111.199 171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.38 -37.72 78.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.817 0.847 . . . . 0.0 112.671 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.57 -48.72 79.69 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 111.693 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.7 mmt -59.99 -42.99 95.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.205 1.002 . . . . 0.0 110.578 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.75 -48.62 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.081 0.952 . . . . 0.0 111.608 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -79.17 -47.84 15.31 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -98.97 -35.82 9.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.21 -17.58 25.82 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.632 0.651 . . . . 0.0 112.728 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.84 17.29 80.0 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.372 0.987 . . . . 0.0 113.623 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.0 145.86 51.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.31 1.055 . . . . 0.0 110.785 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -74.29 143.85 44.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.725 0.774 . . . . 0.0 111.664 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 9.1 mptt -62.31 -42.07 99.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.509 0.724 . . . . 0.0 112.166 -168.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.04 -21.48 63.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.975 1.31 . . . . 0.0 113.999 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -82.3 -4.12 56.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.665 1.186 . . . . 0.0 112.326 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.32 136.12 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.669 1.588 . . . . 0.0 108.838 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.12 116.73 25.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.729 1.612 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.97 124.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -111.28 -30.07 7.58 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.66 -155.41 49.79 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.328 0.966 . . . . 0.0 113.883 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.026 1.731 . . . . 0.0 114.59 179.176 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -71.96 -5.47 35.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pp -70.5 -3.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -153.75 139.45 17.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.51 1.524 . . . . 0.0 110.488 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.52 155.64 22.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.644 1.578 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.28 148.42 39.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 110.961 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -139.13 165.77 26.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.664 1.586 . . . . 0.0 111.819 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.1 p -161.16 162.82 31.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.178 1.391 . . . . 0.0 111.944 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -85.63 157.03 20.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 0.0 112.526 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.33 148.35 90.88 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.287 1.035 . . . . 0.0 112.07 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.06 -37.48 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.067 2.511 . . . . 0.0 112.142 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -159.6 152.29 21.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.457 2.303 . . . . 0.0 109.256 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.67 148.29 35.55 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.861 1.664 . . . . 0.0 111.405 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -88.14 169.37 11.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.321 1.448 . . . . 0.0 113.64 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -160.45 158.6 29.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.421 1.889 . . . . 0.0 110.509 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.92 -160.07 33.26 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.142 1.353 . . . . 0.0 113.452 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.49 167.94 20.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.236 1.415 . . . . 0.0 113.328 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -151.84 157.14 41.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.701 1.601 . . . . 0.0 111.524 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -29.21 69.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.457 1.103 . . . . 0.0 113.544 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.4 m 78.24 147.48 0.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.399 2.68 . . . . 0.0 111.83 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.48 152.91 43.18 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.584 1.554 . . . . 0.0 111.331 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -83.51 -63.25 1.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.427 1.491 . . . . 0.0 111.692 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -175.27 170.66 3.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.713 1.605 . . . . 0.0 112.923 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -159.6 -47.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.544 1.937 . . . . 0.0 109.497 169.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -147.79 148.03 30.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.715 2.406 . . . . 0.0 109.03 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.27 108.74 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.21 121.47 35.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.785 0.834 . . . . 0.0 110.098 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 104.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -111.89 166.0 11.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.267 1.827 . . . . 0.0 109.363 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -122.03 143.36 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.799 -1.188 . . . . 0.0 109.833 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -93.07 133.51 36.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.775 1.23 . . . . 0.0 108.864 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -73.86 143.78 45.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.826 0.85 . . . . 0.0 109.847 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -67.48 145.98 54.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.537 1.16 . . . . 0.0 114.126 -169.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -149.15 -41.58 0.15 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.331 2.252 . . . . 0.0 109.609 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.98 -172.87 48.59 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.393 1.473 . . . . 0.0 112.266 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -72.97 -13.03 61.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.16 157.73 45.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.018 1.327 . . . . 0.0 113.316 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.5 m -75.98 149.34 37.63 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.113 1.765 . . . . 0.0 108.974 169.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.2 127.36 44.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.435 0.694 . . . . 0.0 111.323 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.8 m -89.84 121.73 32.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.131 1.772 . . . . 0.0 107.999 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 p -106.64 121.42 44.3 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.451 1.5 . . . . 0.0 110.347 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.45 129.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.884 1.273 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.35 152.51 49.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.554 1.941 . . . . 0.0 109.878 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.34 2.31 78.83 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.12 132.76 68.61 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.234 1.413 . . . . 0.0 111.575 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.08 140.04 41.23 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.445 3.43 . . . . 0.0 113.664 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.48 -22.59 67.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.308 1.043 . . . . 0.0 113.564 -172.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.49 -19.08 65.7 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.21 103.95 15.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.042 1.337 . . . . 0.0 110.557 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.5 126.76 28.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.615 1.166 . . . . 0.0 112.2 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 mt -61.97 -40.04 94.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.24 0.616 . . . . 0.0 111.953 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.82 -36.37 83.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.809 0.844 . . . . 0.0 112.217 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -63.83 -38.9 92.8 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.044 -1.035 . . . . 0.0 111.936 169.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.88 -42.33 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.884 0.874 . . . . 0.0 109.931 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mt -58.12 -52.92 63.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.107 0.867 . . . . 0.0 111.025 171.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.56 -50.71 71.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.822 0.849 . . . . 0.0 112.975 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.66 -39.26 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' C ' ' HG ' ' A' ' 64' ' ' CYS . 96.6 mt -71.56 -37.43 71.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.727 0.694 . . . . 0.0 111.996 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -66.94 -29.67 69.6 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.101 -1.624 . . . . 0.0 112.729 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.19 -63.22 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.152 0.981 . . . . 0.0 113.094 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.06 -33.94 29.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.32 -8.31 36.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 112.8 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.41 26.82 16.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.219 1.807 . . . . 0.0 113.275 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.418 ' HG ' ' C ' ' A' ' 58' ' ' LEU . 8.2 p -81.9 -169.93 2.6 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 112.851 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -139.48 149.22 43.71 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.931 1.292 . . . . 0.0 109.382 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -178.98 173.25 45.49 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -163.91 164.11 23.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.358 1.863 . . . . 0.0 111.717 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -100.06 140.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.554 1.141 . . . . 0.0 109.563 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -138.68 144.19 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.259 1.423 . . . . 0.0 109.626 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -102.98 103.36 13.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.806 0.842 . . . . 0.0 110.065 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.85 143.34 43.19 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.22 1.408 . . . . 0.0 111.687 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.49 -31.32 91.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.634 2.889 . . . . 0.0 114.78 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -109.63 -48.05 3.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.667 1.187 . . . . 0.0 112.301 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -80.5 -14.86 57.9 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.9 -159.09 49.13 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.288 0.946 . . . . 0.0 112.713 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.68 118.69 14.82 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.628 0.771 . . . . 0.0 111.245 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.8 pt -141.04 151.15 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.483 1.913 . . . . 0.0 112.172 -169.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.43 133.11 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -101.2 132.99 46.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.77 1.628 . . . . 0.0 107.987 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -122.6 135.14 54.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.935 1.694 . . . . 0.0 107.769 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -73.68 134.25 43.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.314 -0.866 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.54 -169.12 25.73 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.813 1.673 . . . . 0.0 113.279 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -105.09 52.37 0.74 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.015 2.126 . . . . 0.0 111.601 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -75.54 21.47 0.14 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.742 2.417 . . . . 0.0 116.267 -167.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -57.62 -47.55 81.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.5 74.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.872 0.869 . . . . 0.0 111.782 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -64.24 -45.34 88.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.29 -36.32 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.721 -0.612 . . . . 0.0 111.391 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.3 t -57.18 -48.6 78.33 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.34 0.973 . . . . 0.0 111.014 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.23 -39.0 85.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.095 0.958 . . . . 0.0 112.637 175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.37 -49.61 77.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.938 1.245 . . . . 0.0 111.632 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 mmt -62.97 -40.49 97.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.008 0.923 . . . . 0.0 110.734 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.02 -49.74 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.887 0.875 . . . . 0.0 111.605 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.8 t -79.47 -48.23 14.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -97.08 -33.31 11.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.35 -18.13 29.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.793 0.724 . . . . 0.0 112.369 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.91 17.22 77.57 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.546 1.07 . . . . 0.0 113.802 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.97 155.45 40.56 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.635 1.218 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.85 148.13 30.09 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.798 -0.564 . . . . 0.0 109.581 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -57.67 -35.75 70.99 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.466 -0.771 . . . . 0.0 112.212 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -63.86 -17.27 62.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.979 1.712 . . . . 0.0 115.131 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -73.66 -11.54 60.45 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.455 1.025 . . . . 0.0 113.132 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -117.34 138.97 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.975 1.31 . . . . 0.0 110.566 -169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -120.25 115.58 23.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.51 1.924 . . . . 0.0 109.938 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.7 mt -90.61 123.25 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -106.06 -29.74 9.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.298 1.039 . . . . 0.0 112.951 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.05 -154.62 52.81 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.541 1.067 . . . . 0.0 113.462 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.909 1.684 . . . . 0.0 114.188 179.088 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -67.98 151.36 47.22 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.143 0.977 . . . . 0.0 112.75 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 70.5 mt -131.67 138.84 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.33 1.452 . . . . 0.0 109.003 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.88 141.3 49.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.182 1.393 . . . . 0.0 110.064 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -80.12 152.03 29.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.985 0.914 . . . . 0.0 112.658 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -78.01 60.86 2.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.852 1.261 . . . . 0.0 111.124 170.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -77.86 -22.95 49.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.867 1.267 . . . . 0.0 113.131 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 p -74.73 171.52 13.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.495 1.518 . . . . 0.0 113.193 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -149.8 163.64 37.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.268 1.427 . . . . 0.0 111.232 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -97.91 118.56 63.74 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.339 1.055 . . . . 0.0 111.122 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.83 -30.0 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.145 2.563 . . . . 0.0 112.677 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.9 p90 179.97 151.48 0.42 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.197 2.999 . . . . 0.0 108.866 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.77 12.26 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.38 170.63 15.25 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.673 2.389 . . . . 0.0 114.024 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -145.7 161.53 39.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.055 1.742 . . . . 0.0 110.562 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.13 136.01 16.61 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.577 1.084 . . . . 0.0 113.09 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.93 -23.87 24.99 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.764 1.226 . . . . 0.0 113.065 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.96 159.43 23.58 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.636 1.574 . . . . 0.0 113.679 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.54 14.02 16.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.419 1.488 . . . . 0.0 112.629 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -66.82 139.05 57.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.668 1.587 . . . . 0.0 111.276 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.62 57.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.239 1.016 . . . . 0.0 112.811 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.36 152.8 18.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.065 1.746 . . . . 0.0 112.385 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.2 p -159.3 128.73 5.44 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.611 1.165 . . . . 0.0 111.477 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -174.21 178.23 2.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.624 1.97 . . . . 0.0 110.862 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -72.6 145.96 46.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.304 -0.872 . . . . 0.0 110.889 168.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.61 118.33 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.92 115.84 31.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.124 0.969 . . . . 0.0 109.887 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.56 104.52 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -110.22 173.93 6.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.163 2.185 . . . . 0.0 110.871 -170.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt -121.95 148.19 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.747 1.219 . . . . 0.0 108.516 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -89.65 139.73 30.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.731 0.812 . . . . 0.0 110.948 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.62 127.28 43.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.291 1.437 . . . . 0.0 108.973 173.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -162.8 158.31 22.61 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.392 1.077 . . . . 0.0 112.698 -171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -79.73 -15.96 56.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.26 151.56 43.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.59 1.091 . . . . 0.0 112.605 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.6 -33.57 75.27 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -82.79 135.15 35.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.928 0.891 . . . . 0.0 112.309 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -82.46 151.02 26.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.028 1.731 . . . . 0.0 110.238 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt -127.8 135.41 50.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.412 1.085 . . . . 0.0 110.38 169.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -93.91 140.3 29.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.613 1.965 . . . . 0.0 108.027 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.33 119.02 24.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.75 1.22 . . . . 0.0 110.83 -174.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.6 121.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 109.611 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.75 152.76 46.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.351 1.86 . . . . 0.0 109.622 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.03 -3.13 62.45 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -55.52 130.6 70.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 118.714 1.257 . . . . 0.0 110.276 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.41 138.4 65.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.792 2.995 . . . . 0.0 113.194 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.15 -6.88 50.34 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.936 0.894 . . . . 0.0 113.234 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.48 -18.82 62.28 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.569 -0.707 . . . . 0.0 112.473 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -90.69 129.94 36.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.634 1.174 . . . . 0.0 110.915 170.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.6 117.47 14.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.351 0.66 . . . . 0.0 110.891 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.05 -37.94 84.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.122 0.569 . . . . 0.0 111.382 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.4 -32.67 72.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.59 1.156 . . . . 0.0 113.202 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -71.0 -38.1 72.67 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.07 0.85 . . . . 0.0 111.402 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.951 0.796 . . . . 0.0 109.086 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.94 -49.6 70.94 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.929 0.786 . . . . 0.0 111.55 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -61.13 -43.66 98.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 112.576 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.66 -44.2 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.494 0.588 . . . . 0.0 111.371 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.0 mt -70.77 -31.49 68.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.79 -33.64 66.38 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.836 -1.165 . . . . 0.0 112.894 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.68 -58.53 3.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.24 1.016 . . . . 0.0 113.292 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.18 -42.38 13.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 0.0 113.449 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -90.31 -12.37 37.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.185 0.994 . . . . 0.0 112.818 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.49 30.14 17.16 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.226 1.81 . . . . 0.0 112.912 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.7 m -81.29 -172.2 3.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 111.442 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -147.47 150.64 34.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.731 1.212 . . . . 0.0 109.241 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.0 172.52 44.72 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 115.836 1.095 . . . . 0.0 115.836 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -153.39 158.13 41.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.425 1.89 . . . . 0.0 111.83 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.4 mt -91.86 130.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.676 1.19 . . . . 0.0 108.452 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -142.38 140.29 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.762 1.225 . . . . 0.0 109.399 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -92.27 115.36 28.02 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.788 -0.57 . . . . 0.0 110.528 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.98 142.73 65.0 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.29 1.036 . . . . 0.0 110.819 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.81 -31.27 61.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.835 3.024 . . . . 0.0 114.971 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.36 -44.98 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.361 1.064 . . . . 0.0 113.081 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.4 mtm -79.86 -12.24 59.76 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.68 -161.28 46.08 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.452 1.025 . . . . 0.0 112.956 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.9 121.4 17.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.552 0.741 . . . . 0.0 111.578 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 pt -141.66 154.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.071 1.748 . . . . 0.0 111.957 -173.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -92.68 129.98 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 166.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -97.56 130.79 44.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.073 1.349 . . . . 0.0 107.532 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -122.01 139.66 53.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.523 1.529 . . . . 0.0 108.578 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -78.12 136.14 37.81 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.339 -0.85 . . . . 0.0 111.17 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.54 -174.05 42.75 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.828 1.68 . . . . 0.0 113.27 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -97.83 88.69 4.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.42 1.888 . . . . 0.0 110.923 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -112.12 16.42 20.17 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.414 1.485 . . . . 0.0 113.358 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -58.89 -41.3 86.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.36 65.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.126 0.97 . . . . 0.0 112.319 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -66.07 -43.6 86.95 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.992 0.917 . . . . 0.0 111.911 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.47 -35.51 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.186 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.0 t -56.89 -48.85 77.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.454 1.024 . . . . 0.0 111.12 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.34 -38.78 81.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.708 0.803 . . . . 0.0 112.726 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.29 -47.3 86.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.713 1.142 . . . . 0.0 111.864 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.5 -42.33 96.12 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.117 0.967 . . . . 0.0 110.606 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.69 -47.33 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 111.471 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -77.48 -48.94 15.85 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -98.79 -34.53 10.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.4 -14.28 43.84 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.891 0.769 . . . . 0.0 112.24 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.86 15.72 80.87 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.957 1.265 . . . . 0.0 113.88 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.47 153.44 42.24 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.399 1.1 . . . . 0.0 111.805 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -82.72 140.39 33.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.759 -0.588 . . . . 0.0 110.004 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -54.5 -35.62 63.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.875 0.87 . . . . 0.0 113.275 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -56.65 -23.85 44.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.406 1.482 . . . . 0.0 114.323 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.64 -10.04 59.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.796 1.238 . . . . 0.0 113.031 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.2 mt -114.7 134.15 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.443 1.097 . . . . 0.0 110.76 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -110.75 126.94 55.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.574 1.949 . . . . 0.0 109.984 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.1 mt -100.93 125.98 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.464 1.105 . . . . 0.0 108.469 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -121.19 171.07 8.97 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.366 . . . . 0.0 112.729 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.66 -142.7 13.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.406 1.479 . . . . 0.0 112.41 174.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.051 2.14 . . . . 0.0 113.275 176.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.504 2.273 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 p -69.16 -29.45 67.47 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -80.65 -8.48 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.527 1.531 . . . . 0.0 113.426 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -83.9 146.81 27.86 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.781 1.632 . . . . 0.0 112.407 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -71.62 155.98 39.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.452 0.701 . . . . 0.0 112.156 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.63 -36.33 80.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 0.0 111.845 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -138.14 147.04 43.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.992 1.717 . . . . 0.0 111.073 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 m -147.96 155.65 41.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.87 1.268 . . . . 0.0 111.864 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -85.23 175.09 9.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.697 1.199 . . . . 0.0 111.412 169.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -105.64 109.02 62.76 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.607 1.163 . . . . 0.0 111.136 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.22 -23.98 71.98 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.066 3.177 . . . . 0.0 114.574 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -99.52 11.6 38.7 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.42 1.088 . . . . 0.0 113.009 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.24 67.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.59 1.156 . . . . 0.0 114.092 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -163.25 161.64 24.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 111.744 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.2 p -137.29 154.43 50.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.885 1.674 . . . . 0.0 111.161 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.07 16.45 8.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.731 1.634 . . . . 0.0 114.061 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -163.19 170.54 17.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.255 1.822 . . . . 0.0 112.378 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -138.11 142.84 40.19 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.807 1.643 . . . . 0.0 110.96 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -106.15 144.05 33.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.981 1.313 . . . . 0.0 112.175 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -135.06 166.1 23.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.059 1.744 . . . . 0.0 111.148 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.5 160.49 38.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.95 1.3 . . . . 0.0 112.0 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -80.22 -178.94 6.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.33 1.852 . . . . 0.0 111.624 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.9 57.43 0.32 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.804 2.041 . . . . 0.0 113.802 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -68.16 159.63 30.66 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.055 1.742 . . . . 0.0 112.659 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -68.28 137.96 55.12 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 107.46 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.32 126.12 37.27 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.561 0.745 . . . . 0.0 110.17 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.4 115.56 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -128.48 165.14 21.28 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.592 1.557 . . . . 0.0 110.575 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mt -109.71 142.13 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.258 1.023 . . . . 0.0 108.805 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -82.79 164.26 20.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.721 1.248 . . . . 0.0 113.897 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -75.71 154.07 36.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.331 1.853 . . . . 0.0 111.959 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -72.13 126.84 30.79 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.898 0.479 . . . . 0.0 109.966 175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -145.29 13.21 1.4 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.612 1.165 . . . . 0.0 113.97 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.67 22.0 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.994 1.759 . . . . 0.0 113.273 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -78.63 165.51 23.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.107 1.363 . . . . 0.0 111.273 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.09 170.12 6.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.266 1.027 . . . . 0.0 112.383 171.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.6 m -66.62 134.69 52.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.934 1.294 . . . . 0.0 109.865 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.79 138.72 51.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.545 1.138 . . . . 0.0 111.17 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.2 m -95.05 120.14 34.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.718 1.607 . . . . 0.0 108.11 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -99.09 123.91 43.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 110.499 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.21 128.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.957 1.303 . . . . 0.0 108.672 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -142.94 161.26 38.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.788 1.635 . . . . 0.0 110.9 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.48 -16.37 3.07 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 168.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -45.32 133.3 5.82 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 126.253 1.821 . . . . 0.0 112.777 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.15 142.44 55.26 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.982 3.122 . . . . 0.0 113.446 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.6 -13.87 62.54 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.09 -18.65 63.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.722 0.809 . . . . 0.0 113.098 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -93.59 112.64 24.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.846 1.258 . . . . 0.0 110.792 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -69.28 122.25 18.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.294 1.038 . . . . 0.0 112.002 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.42 -35.5 81.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.179 0.592 . . . . 0.0 112.116 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -63.07 -39.16 93.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 112.16 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.09 89.86 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.43 1.092 . . . . 0.0 111.099 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.11 -40.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.178 0.991 . . . . 0.0 110.395 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.32 -54.94 41.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.555 1.07 . . . . 0.0 110.84 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -56.9 -48.35 78.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.765 0.826 . . . . 0.0 112.623 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.47 -37.24 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.38 -33.62 65.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.141 0.882 . . . . 0.0 111.87 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.32 -33.3 74.07 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.908 -1.12 . . . . 0.0 112.572 170.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -79.39 -58.81 3.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.388 1.075 . . . . 0.0 113.314 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -85.1 -41.19 15.96 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.18 -12.64 32.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.938 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.15 31.59 17.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.165 1.786 . . . . 0.0 112.635 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.2 m -80.42 -172.8 3.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.615 1.166 . . . . 0.0 111.521 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -148.11 150.92 34.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.696 1.198 . . . . 0.0 109.266 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.57 171.19 42.29 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 115.642 1.017 . . . . 0.0 115.642 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -150.83 156.27 40.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.127 1.771 . . . . 0.0 111.627 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.34 131.53 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.669 1.188 . . . . 0.0 108.627 171.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.63 141.17 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.899 1.28 . . . . 0.0 109.396 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -104.24 124.45 49.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.99 0.916 . . . . 0.0 111.366 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.39 151.85 46.37 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.851 1.66 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -59.95 -37.76 83.19 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.587 2.858 . . . . 0.0 115.364 -169.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -36.4 4.94 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.573 1.549 . . . . 0.0 112.26 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.8 mtm -74.1 -18.98 60.73 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.45 -163.88 53.09 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.756 1.17 . . . . 0.0 112.913 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.46 121.31 22.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.22 1.008 . . . . 0.0 110.876 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.9 pt -139.2 152.52 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.251 1.821 . . . . 0.0 111.799 -171.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.3 mt -93.02 130.6 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -101.69 122.76 44.51 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -110.14 140.7 43.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.366 1.466 . . . . 0.0 108.733 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -69.21 135.66 50.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.42 0.688 . . . . 0.0 111.457 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.62 -164.4 41.39 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.08 1.324 . . . . 0.0 114.03 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -100.85 99.54 10.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.18 1.792 . . . . 0.0 109.918 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -121.76 18.09 11.08 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 113.081 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -63.03 -41.78 99.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -168.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.24 73.84 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 172.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -64.92 -45.2 86.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.693 0.797 . . . . 0.0 111.728 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.39 -36.77 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.477 0.711 . . . . 0.0 111.208 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -56.57 -49.41 74.95 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.719 1.145 . . . . 0.0 111.481 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.45 -39.62 84.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.532 0.733 . . . . 0.0 112.413 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.49 -48.11 83.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.099 0.863 . . . . 0.0 112.017 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.81 -42.94 94.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.441 1.096 . . . . 0.0 110.668 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.78 -47.1 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.1 t -75.79 -48.34 22.06 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -103.52 -29.73 10.96 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -168.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.25 -16.3 27.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.273 0.942 . . . . 0.0 112.416 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.38 19.02 75.0 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.41 1.005 . . . . 0.0 113.613 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.54 155.37 40.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.411 1.105 . . . . 0.0 110.716 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -83.38 148.74 27.14 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -53.98 -41.16 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.557 -0.714 . . . . 0.0 111.581 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -64.55 -14.08 55.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -75.93 -9.35 58.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 112.868 172.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.6 mt -115.91 136.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.115 . . . . 0.0 110.338 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -116.94 114.66 24.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.978 1.711 . . . . 0.0 109.96 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -92.53 118.45 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.88 -30.91 10.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.45 -150.22 44.84 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.945 0.783 . . . . 0.0 111.96 -173.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.637 1.175 . . . . 0.0 113.354 173.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.0 p -164.34 163.67 22.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.489 1.515 . . . . 0.0 111.45 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.2 150.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.355 1.062 . . . . 0.0 112.63 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.66 138.9 57.76 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.231 0.612 . . . . 0.0 110.439 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.15 154.38 27.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.45 1.1 . . . . 0.0 112.564 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.84 162.7 13.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.035 1.334 . . . . 0.0 112.197 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -63.32 143.86 57.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.461 1.105 . . . . 0.0 112.881 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -83.57 148.41 27.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.588 1.155 . . . . 0.0 112.653 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -137.99 156.83 47.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.572 1.549 . . . . 0.0 110.975 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.16 147.69 95.61 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.955 0.902 . . . . 0.0 112.347 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.52 -29.97 90.37 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.805 3.003 . . . . 0.0 114.126 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -170.91 156.16 4.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.507 2.323 . . . . 0.0 109.657 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.69 29.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.215 1.806 . . . . 0.0 111.605 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -80.66 154.64 27.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 112.421 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.53 -37.06 85.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.138 1.375 . . . . 0.0 112.244 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.5 176.44 51.37 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.986 1.279 . . . . 0.0 113.769 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -162.9 155.46 18.9 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.35 1.86 . . . . 0.0 110.886 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.73 -24.04 65.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.313 1.045 . . . . 0.0 113.758 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 75.44 -37.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.629 2.772 . . . . 0.0 113.908 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.9 t -164.21 178.5 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.427 1.891 . . . . 0.0 111.3 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.08 163.15 40.01 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.558 1.943 . . . . 0.0 111.614 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -163.09 176.69 9.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.123 1.769 . . . . 0.0 111.005 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -166.83 168.24 14.3 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.473 1.909 . . . . 0.0 111.98 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -155.02 150.69 27.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.889 1.275 . . . . 0.0 111.262 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -72.33 138.04 47.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.652 0.739 . . . . 0.0 112.827 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt -108.02 131.04 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.494 1.518 . . . . 0.0 108.66 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -112.47 114.63 27.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.452 1.101 . . . . 0.0 109.267 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.78 99.65 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -106.49 174.49 5.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.998 2.519 . . . . 0.0 110.72 -171.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -116.49 147.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.09 0.956 . . . . 0.0 108.868 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -129.79 115.73 17.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.758 1.623 . . . . 0.0 108.643 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -72.89 138.87 46.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.838 1.255 . . . . 0.0 111.67 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -124.78 168.31 13.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.507 1.923 . . . . 0.0 110.134 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.14 135.48 53.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.646 0.779 . . . . 0.0 111.873 171.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.66 -146.37 45.19 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.918 0.771 . . . . 0.0 112.674 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -83.14 3.13 32.07 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -77.35 21.39 0.26 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.941 1.696 . . . . 0.0 115.43 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -56.38 145.56 26.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.048 2.139 . . . . 0.0 111.72 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.6 149.94 43.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.088 1.355 . . . . 0.0 111.913 -170.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.98 131.32 38.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.575 1.55 . . . . 0.0 107.494 167.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -115.14 123.4 48.85 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.057 1.343 . . . . 0.0 110.548 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.58 123.64 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -131.49 143.96 50.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.038 1.735 . . . . 0.0 109.005 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.15 -0.44 83.72 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.27 130.56 51.85 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 118.905 1.352 . . . . 0.0 110.956 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -52.94 139.42 60.63 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.069 3.18 . . . . 0.0 113.324 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -74.32 -7.61 53.4 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.752 0.821 . . . . 0.0 112.652 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.86 126.25 35.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.646 1.178 . . . . 0.0 111.005 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.45 115.49 12.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.442 0.697 . . . . 0.0 111.157 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.58 -36.57 76.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.731 0.812 . . . . 0.0 111.624 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -63.65 -35.56 80.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.651 1.181 . . . . 0.0 112.421 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -67.93 -37.61 81.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 111.573 171.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.61 -40.86 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 0.0 110.023 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.94 -54.45 46.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.261 0.937 . . . . 0.0 110.714 169.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -57.43 -46.39 83.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 113.026 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.02 -36.88 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.43 -34.47 67.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.094 0.861 . . . . 0.0 111.751 176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.25 -34.11 76.75 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.986 -1.071 . . . . 0.0 112.554 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.8 -63.25 1.43 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.245 1.018 . . . . 0.0 113.119 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -81.9 -39.14 24.25 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.87 -3.41 51.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 112.767 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.12 27.99 17.13 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.17 1.788 . . . . 0.0 113.142 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -83.14 -179.94 7.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.524 1.13 . . . . 0.0 112.776 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -129.58 144.58 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.723 1.609 . . . . 0.0 107.898 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.71 171.24 44.33 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -158.4 161.68 37.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.464 1.506 . . . . 0.0 112.48 -174.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mt -94.93 129.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 108.219 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.87 139.49 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.071 0.948 . . . . 0.0 110.811 -176.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -88.22 109.56 20.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.162 0.985 . . . . 0.0 109.476 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.25 141.37 26.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.345 1.058 . . . . 0.0 111.657 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -57.81 -33.3 96.74 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.615 2.876 . . . . 0.0 114.468 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -108.15 -46.69 3.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.774 1.23 . . . . 0.0 112.071 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.0 mtt -80.91 -16.39 53.7 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -174.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.52 -159.2 49.74 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.048 0.832 . . . . 0.0 111.731 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -69.65 123.69 22.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.288 -1.125 . . . . 0.0 111.776 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.9 pt -144.5 153.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.133 1.773 . . . . 0.0 112.016 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.76 129.82 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 165.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -100.27 138.86 36.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.369 1.467 . . . . 0.0 108.801 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -128.96 142.7 50.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.23 1.812 . . . . 0.0 108.355 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -73.25 136.9 44.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.969 1.259 . . . . 0.0 112.027 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.33 -174.87 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.27 1.414 . . . . 0.0 113.702 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.82 73.73 3.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.719 2.007 . . . . 0.0 111.412 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -97.29 16.98 18.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.331 1.852 . . . . 0.0 113.526 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -58.22 -41.54 84.31 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.06 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.068 0.947 . . . . 0.0 112.105 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.57 -44.69 93.36 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.253 1.021 . . . . 0.0 111.853 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.77 -34.8 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.176 0.59 . . . . 0.0 111.199 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.0 t -58.44 -46.91 85.58 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.614 1.097 . . . . 0.0 111.243 171.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.46 -39.06 86.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.63 0.772 . . . . 0.0 112.39 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -60.12 -48.83 80.09 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.639 1.109 . . . . 0.0 111.753 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.4 mmt -60.63 -42.01 96.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.67 -45.92 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.677 0.791 . . . . 0.0 111.548 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -76.91 -47.81 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -101.13 -34.87 9.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -168.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.99 -14.2 48.2 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.166 0.894 . . . . 0.0 112.228 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.63 80.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.076 1.322 . . . . 0.0 113.757 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.83 144.48 52.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.539 1.169 . . . . 0.0 111.302 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -80.2 135.2 36.22 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.691 -0.631 . . . . 0.0 109.636 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -51.79 -34.43 39.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.964 1.305 . . . . 0.0 113.987 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.89 -22.25 9.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.838 1.655 . . . . 0.0 115.134 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -82.35 -9.23 59.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.684 1.194 . . . . 0.0 113.932 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 mt -116.99 128.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.61 1.095 . . . . 0.0 111.26 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.23 134.08 47.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.441 1.496 . . . . 0.0 110.682 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.08 126.27 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.983 1.313 . . . . 0.0 108.153 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -126.13 171.8 10.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.038 1.335 . . . . 0.0 113.265 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.88 -136.43 9.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.603 1.573 . . . . 0.0 111.896 170.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.807 2.043 . . . . 0.0 112.879 177.909 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -119.54 125.44 48.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.556 1.142 . . . . 0.0 110.31 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 51.8 mt -116.09 111.73 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.526 -1.286 . . . . 0.0 107.526 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -120.24 152.12 38.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.26 1.424 . . . . 0.0 110.342 -170.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.48 1.031 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 170.184 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.5 mt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -105.13 118.16 35.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.657 1.583 . . . . 0.0 108.8 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -98.36 126.71 43.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.429 1.492 . . . . 0.0 110.407 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.71 126.55 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.019 1.328 . . . . 0.0 109.485 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -136.66 146.78 46.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.617 1.567 . . . . 0.0 110.329 -169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.03 -6.17 82.03 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.9 p -52.44 133.65 43.79 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -52.94 138.09 61.48 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.802 3.002 . . . . 0.0 113.267 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.04 -16.18 63.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.842 0.857 . . . . 0.0 113.113 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.79 -18.3 64.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.129 0.972 . . . . 0.0 113.34 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -92.85 120.76 33.53 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.687 1.195 . . . . 0.0 110.511 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.51 124.05 22.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.329 0.652 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -60.85 -38.59 86.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.026 0.53 . . . . 0.0 111.266 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.19 -34.46 73.66 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 113.19 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -70.67 -37.76 73.68 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.408 -0.808 . . . . 0.0 111.441 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.3 mt -58.87 -47.87 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mt -54.82 -47.66 73.78 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.963 0.802 . . . . 0.0 111.561 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.26 -42.75 99.16 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 112.33 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.71 -46.42 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.127 0.571 . . . . 0.0 111.184 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.72 -27.71 65.2 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -78.76 -35.18 44.94 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.86 -1.15 . . . . 0.0 113.071 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -77.49 -59.35 2.82 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.988 0.915 . . . . 0.0 113.103 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.45 -39.78 14.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.326 1.051 . . . . 0.0 113.373 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.92 -13.11 34.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.855 0.862 . . . . 0.0 113.198 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.99 28.1 16.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.172 1.789 . . . . 0.0 113.332 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.33 -170.83 3.29 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.621 1.168 . . . . 0.0 111.1 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -144.62 150.9 38.19 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.233 1.013 . . . . 0.0 109.589 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.67 172.02 45.06 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.544 0.977 . . . . 0.0 115.544 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -154.22 158.53 40.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.355 1.862 . . . . 0.0 111.568 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.8 mt -89.49 128.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.7 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 124.877 1.271 . . . . 0.0 109.474 -173.485 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 pt . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.09 132.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.41 132.38 49.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.048 1.339 . . . . 0.0 108.13 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.26 143.02 47.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.926 1.69 . . . . 0.0 108.382 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.4 136.45 46.08 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.195 -0.941 . . . . 0.0 111.523 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.98 48.87 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.666 1.603 . . . . 0.0 113.63 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.93 87.46 4.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.53 1.932 . . . . 0.0 110.969 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -109.86 22.66 15.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.426 1.49 . . . . 0.0 112.985 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 43.1 ptt85 -57.37 -46.75 83.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 0.0 114.141 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.67 84.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.8 -47.24 78.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.178 0.991 . . . . 0.0 112.06 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.1 -36.24 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.978 -0.451 . . . . 0.0 111.35 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.45 -50.21 72.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.02 -38.11 81.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.929 . . . . 0.0 112.874 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -60.26 -49.37 77.86 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.003 1.274 . . . . 0.0 111.64 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.83 -38.27 87.55 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.236 1.015 . . . . 0.0 111.23 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.82 -47.11 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.64 0.776 . . . . 0.0 111.574 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -75.38 -48.22 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.198 0.999 . . . . 0.0 113.43 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -97.6 -32.68 11.66 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.93 -18.28 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.774 0.715 . . . . 0.0 112.719 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.54 10.32 85.4 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.618 1.104 . . . . 0.0 114.184 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.02 132.44 45.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.218 1.009 . . . . 0.0 110.014 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -76.23 136.29 39.69 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.477 -0.765 . . . . 0.0 110.95 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -48.99 -37.65 20.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.503 . . . . 0.0 114.841 -169.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -53.62 -23.14 10.2 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.535 1.534 . . . . 0.0 114.886 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -77.43 -14.33 59.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.99 1.316 . . . . 0.0 114.365 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.6 mt -105.58 119.3 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 119.454 1.024 . . . . 0.0 110.407 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -96.05 130.43 43.06 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.143 1.377 . . . . 0.0 109.922 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 108.919 174.549 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -118.47 117.62 29.5 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 109.748 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.6 mt -109.54 103.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -110.98 174.4 5.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.264 2.225 . . . . 0.0 110.594 -169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 124.169 0.988 . . . . 0.0 109.082 169.04 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 m -98.68 123.6 42.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.808 1.643 . . . . 0.0 108.778 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.82 115.81 30.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.289 1.836 . . . . 0.0 110.225 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.44 127.4 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.581 1.152 . . . . 0.0 109.845 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.41 152.5 51.47 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.343 1.857 . . . . 0.0 110.211 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.48 -3.79 71.64 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.61 132.55 71.62 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.676 1.238 . . . . 0.0 110.86 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -54.78 143.22 71.59 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.781 2.987 . . . . 0.0 113.169 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.86 -18.2 64.11 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.47 -19.51 65.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.974 0.91 . . . . 0.0 113.37 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -91.5 109.57 20.86 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.681 1.192 . . . . 0.0 110.285 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.89 118.83 10.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.203 1.001 . . . . 0.0 112.144 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -60.65 -38.2 84.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.462 0.705 . . . . 0.0 111.847 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.61 -38.14 89.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.208 1.003 . . . . 0.0 112.332 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -64.35 -38.06 89.7 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.201 -0.937 . . . . 0.0 111.928 170.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.64 -40.2 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.618 0.767 . . . . 0.0 110.1 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.6 -55.28 37.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.185 0.902 . . . . 0.0 110.749 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.35 -49.27 72.7 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.8 p -70.11 -36.87 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.37 -34.44 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.974 0.806 . . . . 0.0 112.034 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.28 -32.69 74.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.671 -1.268 . . . . 0.0 112.511 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -78.16 -67.63 0.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 112.889 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.22 -34.52 25.86 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -93.68 -4.15 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 112.65 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.43 28.42 16.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.157 1.783 . . . . 0.0 113.158 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.8 m -82.92 -174.9 5.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.551 1.14 . . . . 0.0 112.499 -174.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.41 145.29 35.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.474 1.51 . . . . 0.0 108.712 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.92 172.59 45.54 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.33 163.62 37.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.591 1.556 . . . . 0.0 112.866 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.36 134.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.883 1.273 . . . . 0.0 109.467 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 125.482 1.513 . . . . 0.0 109.463 178.867 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.198 0.523 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -95.34 133.63 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -104.45 128.07 52.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.15 1.38 . . . . 0.0 107.815 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.73 141.41 48.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.983 1.713 . . . . 0.0 108.483 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -72.75 137.48 45.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.858 1.208 . . . . 0.0 111.799 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.77 -175.78 47.25 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.692 1.615 . . . . 0.0 113.693 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.7 84.53 5.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.355 1.862 . . . . 0.0 111.098 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.79 14.62 26.52 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 112.919 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -59.32 -41.54 89.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.53 63.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.089 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -63.74 -44.81 92.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.936 0.894 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.7 -35.39 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.399 0.68 . . . . 0.0 111.246 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.8 t -56.47 -47.8 78.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.541 1.064 . . . . 0.0 111.156 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.81 -39.74 90.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.576 0.751 . . . . 0.0 112.438 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 28.4 t80 -60.09 -48.39 81.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.725 1.148 . . . . 0.0 111.792 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mmt -59.57 -43.27 93.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.582 1.153 . . . . 0.0 110.604 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.23 -45.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.693 0.797 . . . . 0.0 111.711 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -75.71 -47.15 27.3 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -102.24 -37.43 8.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.0 mt -89.36 -17.02 29.68 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.894 0.77 . . . . 0.0 112.723 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.97 15.99 80.44 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.461 1.029 . . . . 0.0 113.639 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.64 136.22 52.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.213 1.007 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -76.8 139.09 40.24 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.615 -0.678 . . . . 0.0 109.909 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -53.8 -37.55 63.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -56.69 -24.7 50.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.392 1.477 . . . . 0.0 114.981 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -76.86 -16.09 59.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.32 0.964 . . . . 0.0 113.277 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.86 126.24 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.294 1.407 . . . . 0.0 112.123 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -103.15 134.6 46.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.016 1.726 . . . . 0.0 110.27 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 124.98 1.312 . . . . 0.0 108.428 174.472 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -103.6 121.08 42.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.842 0.857 . . . . 0.0 110.076 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.28 103.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -113.16 171.23 7.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.971 2.108 . . . . 0.0 110.21 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.322 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -89.95 116.98 28.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.614 1.566 . . . . 0.0 108.26 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.57 117.19 32.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.952 1.701 . . . . 0.0 110.005 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.93 126.66 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 108.922 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -138.02 159.11 42.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.871 2.068 . . . . 0.0 109.233 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.23 -14.97 2.74 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.289 -1.507 . . . . 0.0 116.103 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.02 130.57 7.22 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 126.207 1.803 . . . . 0.0 112.151 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.43 139.41 65.23 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.241 3.294 . . . . 0.0 113.413 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.96 -11.14 60.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.15 -18.97 61.84 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.114 0.966 . . . . 0.0 113.018 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -90.8 119.72 31.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.561 1.144 . . . . 0.0 110.961 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.79 119.86 16.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 111.568 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -62.75 -38.39 90.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.297 0.639 . . . . 0.0 111.901 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.93 -39.51 89.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.936 0.895 . . . . 0.0 112.225 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -63.49 -39.62 94.92 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.227 -0.921 . . . . 0.0 111.943 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.48 -47.38 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.919 0.781 . . . . 0.0 109.103 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.72 -48.09 75.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.155 0.889 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -62.38 -39.71 94.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.438 -0.789 . . . . 0.0 112.443 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.97 -46.67 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.869 0.759 . . . . 0.0 111.147 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.42 -30.52 67.4 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.05 -31.86 63.06 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.837 -1.164 . . . . 0.0 112.974 171.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -80.01 -61.93 1.84 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.237 1.015 . . . . 0.0 113.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.14 -37.32 20.35 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -92.98 -13.13 29.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.876 0.871 . . . . 0.0 113.002 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.05 29.47 17.66 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.175 1.79 . . . . 0.0 113.012 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.7 m -82.43 -172.1 3.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.697 1.199 . . . . 0.0 111.284 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -146.34 152.76 39.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 109.944 168.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.9 176.23 47.92 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 115.451 0.94 . . . . 0.0 115.451 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -158.33 162.12 37.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.328 1.851 . . . . 0.0 111.64 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 143.79 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 108.985 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 124.436 1.094 . . . . 0.0 109.259 169.789 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.017 0.437 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.33 134.79 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.05 126.01 51.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.887 1.675 . . . . 0.0 107.491 168.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -113.27 140.46 47.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.231 1.412 . . . . 0.0 108.376 170.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -71.41 135.19 47.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.135 -0.978 . . . . 0.0 111.705 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 -169.86 45.88 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.453 1.501 . . . . 0.0 113.539 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.13 87.54 3.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.706 2.002 . . . . 0.0 111.205 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -112.35 20.25 16.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.584 1.553 . . . . 0.0 112.939 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.75 -42.03 92.3 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.38 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.056 0.942 . . . . 0.0 112.154 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.71 -45.15 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.868 0.867 . . . . 0.0 111.811 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.14 -34.81 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.09 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.0 -49.07 78.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.338 0.972 . . . . 0.0 111.162 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.13 -37.81 78.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.83 0.852 . . . . 0.0 112.652 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.36 -48.54 80.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.867 1.212 . . . . 0.0 111.664 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.6 mmt -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.051 0.94 . . . . 0.0 110.734 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.03 -47.89 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.954 0.902 . . . . 0.0 111.417 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -97.94 -33.21 11.3 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.98 -14.22 39.69 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.83 0.741 . . . . 0.0 112.107 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.81 79.75 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.865 1.221 . . . . 0.0 113.899 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.3 mt -71.41 144.07 49.92 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.434 1.117 . . . . 0.0 111.783 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -75.21 138.25 41.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -54.32 -34.86 61.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -55.65 -21.71 19.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.524 1.93 . . . . 0.0 115.311 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -76.68 -10.56 59.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.1 mt -112.86 133.17 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.049 0.94 . . . . 0.0 111.153 -169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.34 128.25 54.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.535 1.934 . . . . 0.0 110.153 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.4 mt . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 124.83 1.252 . . . . 0.0 109.077 175.75 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -118.12 111.43 18.86 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 111.005 -169.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -104.89 110.28 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -118.06 164.89 14.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.512 1.925 . . . . 0.0 109.696 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.646 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.3 m -93.62 118.02 30.84 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.481 1.513 . . . . 0.0 108.304 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.61 115.36 29.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.646 1.578 . . . . 0.0 110.001 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.66 126.89 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 109.288 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -137.62 161.01 37.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.717 2.007 . . . . 0.0 109.412 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 -13.43 8.14 Favored Glycine 0 N--CA 1.477 1.387 0 O-C-N 120.092 -1.63 . . . . 0.0 116.056 169.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -49.97 132.23 22.41 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.974 1.309 . . . . 0.0 111.061 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.83 136.73 51.62 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.086 3.19 . . . . 0.0 113.001 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.83 -3.04 29.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 -17.2 61.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 167.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.4 126.6 40.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.166 1.386 . . . . 0.0 110.247 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -77.64 131.25 37.68 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.608 -0.682 . . . . 0.0 110.84 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.4 -37.57 83.92 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.336 0.654 . . . . 0.0 111.678 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -61.15 -33.31 73.21 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.868 0.867 . . . . 0.0 112.601 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.6 -39.49 84.77 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.261 0.937 . . . . 0.0 111.516 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.04 -47.02 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 0.0 109.196 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.27 -47.08 76.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.766 0.712 . . . . 0.0 111.872 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -62.48 -39.3 93.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.725 0.693 . . . . 0.0 112.351 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.13 -48.17 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 118.985 0.811 . . . . 0.0 111.13 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.46 -29.76 67.5 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.22 -26.87 56.5 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.691 -1.256 . . . . 0.0 113.56 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.56 -49.58 5.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.96 -40.9 17.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.973 0.909 . . . . 0.0 112.953 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.71 -9.75 36.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.651 1.18 . . . . 0.0 112.606 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.32 30.84 20.12 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.934 1.694 . . . . 0.0 112.659 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.08 -165.07 1.27 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.558 1.143 . . . . 0.0 111.335 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.17 146.42 26.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.78 0.832 . . . . 0.0 110.971 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.47 176.17 46.13 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -155.71 164.46 38.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.131 1.773 . . . . 0.0 111.086 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mt -103.08 139.7 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.39 1.476 . . . . 0.0 110.055 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 125.124 1.37 . . . . 0.0 109.182 173.739 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.109 0.48 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.15 133.23 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -103.78 117.4 34.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.823 1.649 . . . . 0.0 107.005 167.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.45 145.14 30.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.894 1.278 . . . . 0.0 108.898 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.83 131.0 44.42 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.538 -0.726 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -167.05 47.82 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.707 1.146 . . . . 0.0 113.662 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -97.69 93.0 6.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.585 1.954 . . . . 0.0 111.25 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -116.87 22.4 12.66 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.417 1.487 . . . . 0.0 113.072 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -58.52 -45.47 88.73 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.26 77.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.991 0.916 . . . . 0.0 112.198 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -65.89 -45.59 81.44 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 111.954 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.99 -35.41 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.254 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.3 t -57.37 -48.22 79.61 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.106 0.866 . . . . 0.0 111.09 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.49 -37.86 87.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.475 0.71 . . . . 0.0 112.766 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.49 -49.93 75.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.792 1.178 . . . . 0.0 111.383 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -58.92 -43.89 91.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 110.672 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.42 -44.29 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.578 0.751 . . . . 0.0 111.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.9 t -76.36 -48.09 21.15 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -99.46 -35.48 9.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.44 -14.25 30.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.878 0.763 . . . . 0.0 112.834 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.58 15.16 81.26 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.583 1.087 . . . . 0.0 113.784 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.33 148.64 49.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.316 1.058 . . . . 0.0 110.109 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -86.58 144.83 27.01 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.376 -0.828 . . . . 0.0 110.031 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -52.93 -39.63 62.98 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.653 -0.655 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -59.5 -21.03 59.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.543 1.537 . . . . 0.0 114.983 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -77.46 -14.29 59.72 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.075 0.852 . . . . 0.0 113.204 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.5 mt -108.05 122.67 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 120.317 1.417 . . . . 0.0 111.607 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.94 123.79 43.45 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.374 1.87 . . . . 0.0 109.627 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.808 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -118.53 122.78 43.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.32 1.048 . . . . 0.0 110.494 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -116.58 111.09 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -120.55 174.21 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.411 1.484 . . . . 0.0 110.952 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 168.79 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.402 0.144 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -93.81 119.48 32.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 108.547 169.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -101.43 123.53 45.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.207 1.403 . . . . 0.0 110.608 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.27 123.88 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.584 1.154 . . . . 0.0 109.114 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.61 152.52 48.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.301 1.84 . . . . 0.0 109.33 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 -5.14 63.95 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.914 -1.116 . . . . 0.0 115.879 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.31 129.45 51.36 Favored Pre-proline 0 N--CA 1.477 0.918 0 CA-C-N 119.475 1.638 . . . . 0.0 109.89 170.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -51.32 140.7 42.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.842 3.028 . . . . 0.0 113.679 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.83 -3.47 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.87 -18.41 62.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 0.0 111.912 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -92.41 133.1 36.21 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.048 1.339 . . . . 0.0 111.319 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.79 117.63 17.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.224 1.009 . . . . 0.0 111.192 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.53 -39.99 89.87 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 111.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -56.91 -35.99 69.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 113.812 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -71.51 -35.81 70.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.949 0.9 . . . . 0.0 111.847 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.47 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.796 0.839 . . . . 0.0 109.717 173.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.25 -55.77 30.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.26 0.936 . . . . 0.0 110.443 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -54.15 -48.73 70.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.378 1.071 . . . . 0.0 113.217 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.4 p -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.57 -31.97 65.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.102 0.865 . . . . 0.0 112.261 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.54 -34.85 72.72 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.773 -1.205 . . . . 0.0 112.426 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -75.27 -59.28 2.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.475 1.11 . . . . 0.0 113.34 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.61 -38.83 15.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.192 0.997 . . . . 0.0 113.675 -169.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.4 -4.79 50.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.985 0.914 . . . . 0.0 113.013 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.13 24.5 13.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.087 1.755 . . . . 0.0 113.3 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.2 m -81.96 -171.96 3.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.849 1.26 . . . . 0.0 112.012 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -144.81 153.83 42.04 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.888 1.275 . . . . 0.0 109.256 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.01 176.46 46.85 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 -169.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.14 164.73 30.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.232 1.813 . . . . 0.0 112.067 -171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.15 146.37 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 125.593 1.557 . . . . 0.0 108.704 169.582 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 pt . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.279 0.562 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.9 mt -100.16 134.69 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 166.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -103.84 129.2 51.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.535 1.534 . . . . 0.0 107.501 168.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.24 142.53 46.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.335 1.454 . . . . 0.0 108.29 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -77.99 135.1 37.74 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.036 -1.04 . . . . 0.0 111.296 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.68 -172.1 44.05 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.713 1.625 . . . . 0.0 113.22 -174.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -97.8 88.44 4.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.465 1.906 . . . . 0.0 111.22 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -112.56 17.58 19.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.798 1.639 . . . . 0.0 113.014 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -59.21 -42.94 92.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -169.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.46 -38.59 74.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.964 0.905 . . . . 0.0 112.153 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.9 -44.77 84.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.75 -33.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.235 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -49.47 77.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.402 1.001 . . . . 0.0 111.042 170.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.0 -36.59 75.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.696 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.4 t80 -62.35 -49.36 75.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.781 1.173 . . . . 0.0 111.854 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.4 mmt -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.241 1.016 . . . . 0.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.53 -49.72 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.305 1.042 . . . . 0.0 111.782 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -75.62 -46.33 32.26 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -101.83 -36.66 8.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 mt -89.55 -18.49 26.51 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.953 0.797 . . . . 0.0 112.915 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.05 14.57 81.75 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.572 1.082 . . . . 0.0 113.618 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.16 134.55 49.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.292 1.046 . . . . 0.0 108.93 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -75.19 148.1 39.85 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.52 -0.738 . . . . 0.0 110.136 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -56.99 -36.63 70.59 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.704 -0.623 . . . . 0.0 112.338 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -64.42 -17.66 63.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.099 1.76 . . . . 0.0 115.199 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -79.69 -10.04 59.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.349 0.977 . . . . 0.0 113.202 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 42.3 mt -113.64 131.74 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.03 -1.044 . . . . 0.0 111.074 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -106.46 135.72 47.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.453 1.501 . . . . 0.0 110.628 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 124.63 1.172 . . . . 0.0 108.851 173.166 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -116.58 119.52 35.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 110.754 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mt -109.39 109.27 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -117.92 176.35 5.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.443 2.297 . . . . 0.0 110.892 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.477 0.897 0 O-C-N 121.126 -0.984 . . . . 0.0 110.117 168.068 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.662 0.267 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.7 m -96.91 130.4 44.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.441 1.497 . . . . 0.0 107.548 168.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.34 122.54 46.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 110.569 -176.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.43 124.16 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.594 1.158 . . . . 0.0 109.525 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -130.22 150.85 51.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.567 1.947 . . . . 0.0 109.673 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.88 58.5 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.53 129.22 69.65 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 119.107 1.454 . . . . 0.0 110.407 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.64 141.84 51.99 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.036 3.157 . . . . 0.0 112.616 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -11.99 60.06 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.72 -22.58 66.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.574 0.75 . . . . 0.0 112.314 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -91.1 104.33 16.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.852 1.261 . . . . 0.0 109.44 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.02 125.32 24.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.73 0.812 . . . . 0.0 112.554 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.9 -40.08 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.428 0.691 . . . . 0.0 112.343 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -63.9 -39.13 93.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.581 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -64.64 -36.45 84.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.041 0.936 . . . . 0.0 112.328 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.8 -48.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.951 0.796 . . . . 0.0 109.326 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.45 -42.63 82.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.2 0.909 . . . . 0.0 112.174 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -58.72 -41.79 87.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.082 0.855 . . . . 0.0 112.255 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.94 -46.27 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.708 0.685 . . . . 0.0 111.534 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.9 -31.62 68.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HE2' ' H ' ' A' ' 66' ' ' GLY . 87.5 mttt -75.42 -29.76 59.85 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.952 -1.092 . . . . 0.0 113.117 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -83.35 -61.66 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.11 0.964 . . . . 0.0 113.278 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.83 -39.24 24.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.151 0.98 . . . . 0.0 113.239 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -93.31 -7.8 43.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.565 1.146 . . . . 0.0 113.082 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.21 27.38 15.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.713 . . . . 0.0 113.287 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.4 m -83.86 -174.4 5.26 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.591 1.157 . . . . 0.0 111.736 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -138.85 144.95 39.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.209 1.004 . . . . 0.0 109.439 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' H ' ' HE2' ' A' ' 59' ' ' LYS . . . -169.03 171.57 43.01 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 115.431 0.933 . . . . 0.0 115.431 -169.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -162.73 158.93 23.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.947 1.699 . . . . 0.0 112.128 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.16 137.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.712 1.205 . . . . 0.0 109.556 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.173 1.389 . . . . 0.0 110.199 -178.481 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.81 134.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -101.87 140.67 35.84 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.488 1.515 . . . . 0.0 108.551 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.41 141.94 50.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.97 1.708 . . . . 0.0 108.433 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.41 138.03 44.98 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.016 -1.052 . . . . 0.0 111.923 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.7 -172.47 44.44 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.21 1.386 . . . . 0.0 113.412 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -94.04 99.01 11.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.719 1.207 . . . . 0.0 110.04 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.23 18.54 14.46 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.536 1.534 . . . . 0.0 112.544 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -52.45 -55.23 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.618 1.167 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.01 88.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.264 1.026 . . . . 0.0 112.49 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -66.46 -45.35 80.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.497 0.719 . . . . 0.0 112.041 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.82 -36.14 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.227 0.611 . . . . 0.0 110.961 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.78 -48.47 75.26 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.317 0.962 . . . . 0.0 111.193 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.9 -39.55 89.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.592 0.757 . . . . 0.0 112.767 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -59.91 -49.58 77.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.807 1.185 . . . . 0.0 111.465 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.9 mmt -58.32 -41.32 84.25 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.233 1.013 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.36 -50.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.505 -0.747 . . . . 0.0 111.491 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.2 m -89.46 -14.16 35.96 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.27 -39.94 3.33 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.087 1.312 . . . . 0.0 113.324 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.12 -15.08 39.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.495 1.043 . . . . 0.0 113.09 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.72 14.74 79.26 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.471 1.034 . . . . 0.0 113.709 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 mt -68.94 151.59 46.35 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.541 1.171 . . . . 0.0 109.956 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -88.03 145.28 26.06 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -55.4 -37.64 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -61.28 -18.07 56.68 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.55 -14.22 60.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.403 1.002 . . . . 0.0 112.974 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.2 mt -111.52 128.64 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.218 0.917 . . . . 0.0 111.233 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.2 133.26 48.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.463 1.905 . . . . 0.0 109.79 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 124.074 0.949 . . . . 0.0 108.912 172.915 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -110.36 125.99 53.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.942 0.897 . . . . 0.0 110.981 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.482 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.0 mt -116.61 117.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 108.258 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 mtt85 -129.59 174.59 9.53 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.79 1.636 . . . . 0.0 110.564 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 mt . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 110.371 175.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.7 m -89.34 115.76 27.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.661 1.184 . . . . 0.0 108.391 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -97.26 126.41 42.45 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.482 1.513 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.77 129.13 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.179 1.392 . . . . 0.0 109.586 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -139.97 157.68 45.29 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.453 1.901 . . . . 0.0 109.723 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.06 62.71 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.89 131.84 66.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 118.663 1.231 . . . . 0.0 110.143 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -53.01 140.75 58.87 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.678 2.919 . . . . 0.0 113.196 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.41 -15.05 62.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.33 -20.21 66.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.937 0.895 . . . . 0.0 113.228 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -90.89 115.78 28.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 110.63 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -68.41 121.17 15.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.071 0.949 . . . . 0.0 111.415 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 mt -59.81 -37.8 80.16 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.18 0.992 . . . . 0.0 111.936 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.36 -31.86 71.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.315 1.046 . . . . 0.0 112.488 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -37.34 69.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.872 0.869 . . . . 0.0 112.311 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.88 -47.26 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.88 -48.3 75.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.845 0.748 . . . . 0.0 111.637 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.28 -45.52 93.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.71 0.804 . . . . 0.0 112.148 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.51 -47.75 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.976 0.51 . . . . 0.0 111.329 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.46 -26.98 65.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.22 -37.1 38.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.616 -1.302 . . . . 0.0 113.308 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.03 -48.46 9.2 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.24 -38.77 12.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.958 0.903 . . . . 0.0 113.148 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -93.07 -8.44 42.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.952 0.901 . . . . 0.0 113.335 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.06 27.83 17.31 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.812 1.645 . . . . 0.0 113.57 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.5 m -87.84 -173.29 4.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.672 1.189 . . . . 0.0 111.282 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.74 145.75 38.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.388 1.075 . . . . 0.0 109.757 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -172.04 173.12 45.1 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.16 163.16 37.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 112.684 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.4 mt -98.4 134.98 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.927 1.291 . . . . 0.0 109.499 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 125.196 1.398 . . . . 0.0 109.278 176.348 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.23 0.538 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.73 136.96 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.93 133.22 51.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.569 . . . . 0.0 107.866 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.81 141.17 48.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 108.283 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.44 134.13 47.51 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.888 -1.133 . . . . 0.0 111.575 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.49 39.32 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.81 1.195 . . . . 0.0 113.621 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -101.8 100.78 11.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.68 1.592 . . . . 0.0 110.378 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -123.37 22.09 9.36 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.304 1.441 . . . . 0.0 113.173 -170.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.482 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.0 ptt180 -60.54 -43.88 96.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.11 89.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.455 0.702 . . . . 0.0 111.847 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.17 -47.28 80.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.05 0.94 . . . . 0.0 111.871 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.99 -34.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.882 -0.511 . . . . 0.0 111.534 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.93 -49.75 75.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.378 0.99 . . . . 0.0 111.083 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.49 -38.64 81.41 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.634 0.774 . . . . 0.0 112.65 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.32 -49.6 76.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.49 1.041 . . . . 0.0 111.633 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.13 -38.97 80.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.024 0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.99 -50.76 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.375 0.67 . . . . 0.0 111.374 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.5 m -84.93 -28.92 25.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -169.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -103.52 -44.0 5.24 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.264 0.938 . . . . 0.0 112.559 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.82 -19.77 28.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.071 0.85 . . . . 0.0 113.178 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.56 14.93 77.21 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.425 1.012 . . . . 0.0 113.727 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.07 145.21 51.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.626 1.213 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -74.28 140.95 45.31 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.506 -0.746 . . . . 0.0 110.819 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -53.29 -44.73 68.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.58 0.752 . . . . 0.0 112.211 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -63.79 -24.52 67.79 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.28 -6.27 54.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.548 1.139 . . . . 0.0 112.459 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.92 131.04 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.88 -1.137 . . . . 0.0 110.344 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -109.33 128.36 55.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 110.277 173.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 169.679 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -100.31 112.32 24.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.94 0.896 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.5 mt -102.3 101.8 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -107.6 174.47 5.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.101 2.16 . . . . 0.0 110.715 -171.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.168 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -89.53 124.41 34.49 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.689 1.596 . . . . 0.0 108.295 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 114.1 27.37 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.456 1.502 . . . . 0.0 110.118 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.76 122.55 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.118 0.967 . . . . 0.0 109.363 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -125.62 151.59 46.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.65 1.98 . . . . 0.0 109.681 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.86 4.45 82.45 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -57.5 131.13 81.64 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.698 1.249 . . . . 0.0 110.456 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.26 139.75 63.03 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.07 3.18 . . . . 0.0 113.149 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.47 -10.29 59.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.95 -19.8 62.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.993 0.917 . . . . 0.0 112.939 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -91.97 121.59 33.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.771 1.228 . . . . 0.0 110.917 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.71 118.16 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.701 0.8 . . . . 0.0 111.146 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.36 -37.15 77.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.686 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -63.17 -37.24 86.44 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.181 0.992 . . . . 0.0 112.121 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -66.69 -37.66 85.18 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.28 -0.887 . . . . 0.0 111.663 171.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.33 -40.96 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.536 0.734 . . . . 0.0 110.097 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.28 -54.26 48.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.302 0.955 . . . . 0.0 110.888 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -55.84 -48.27 75.79 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.942 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.99 -35.82 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.2 -30.72 62.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.025 0.829 . . . . 0.0 112.117 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -71.06 -30.43 66.58 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.768 -1.207 . . . . 0.0 112.769 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.15 -61.68 1.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 113.125 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.51 -40.55 23.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 -169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.87 -7.03 50.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.407 1.083 . . . . 0.0 112.554 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.65 28.98 17.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.11 1.764 . . . . 0.0 112.893 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -91.91 -162.13 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.635 1.174 . . . . 0.0 111.764 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -155.4 152.47 29.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.102 0.961 . . . . 0.0 111.421 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.7 176.4 48.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.03 165.03 36.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.862 1.665 . . . . 0.0 112.738 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -101.78 135.29 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.018 1.327 . . . . 0.0 109.876 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 125.24 1.416 . . . . 0.0 110.029 -178.509 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.01 132.51 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -100.22 133.18 45.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.001 1.32 . . . . 0.0 107.723 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tp -123.35 143.16 50.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.606 1.562 . . . . 0.0 108.756 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.158 -0.964 . . . . 0.0 112.093 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.93 -170.47 39.81 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.215 1.388 . . . . 0.0 113.669 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -97.55 77.56 2.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.895 2.078 . . . . 0.0 111.081 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -100.26 15.34 27.93 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.075 1.75 . . . . 0.0 113.54 -170.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -58.39 -40.18 81.66 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -41.3 64.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.001 0.921 . . . . 0.0 112.123 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -65.77 -41.8 91.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.847 0.859 . . . . 0.0 112.54 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.75 -35.31 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.809 -0.557 . . . . 0.0 111.204 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.56 -48.54 79.07 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.474 1.034 . . . . 0.0 111.014 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.13 -39.7 83.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.813 0.845 . . . . 0.0 112.551 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 40.3 t80 -60.17 -49.49 77.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.597 1.09 . . . . 0.0 111.778 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.4 mmt -61.02 -38.53 86.44 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.189 0.995 . . . . 0.0 110.893 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -74.02 -46.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.742 0.817 . . . . 0.0 111.002 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -82.4 -37.65 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -103.37 -39.65 6.7 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.472 0.709 . . . . 0.0 112.808 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.5 mt -83.61 -17.77 40.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.729 0.695 . . . . 0.0 112.273 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.65 76.31 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.662 1.125 . . . . 0.0 113.636 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.98 159.05 34.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.564 1.182 . . . . 0.0 111.24 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.2 146.96 25.8 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.608 -0.682 . . . . 0.0 109.435 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -55.95 -36.82 68.22 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.367 -0.833 . . . . 0.0 112.365 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -65.94 -10.47 39.37 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -78.79 -9.59 59.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.86 1.209 . . . . 0.0 113.078 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.7 mt -117.89 136.21 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.207 . . . . 0.0 110.995 -169.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -112.56 135.97 52.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.352 1.861 . . . . 0.0 109.968 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.421 1.089 . . . . 0.0 109.334 177.122 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -103.78 113.32 26.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.195 0.998 . . . . 0.0 109.655 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.72 98.75 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -106.41 174.5 5.86 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.886 2.074 . . . . 0.0 110.683 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 167.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.1 m -93.07 115.5 28.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.813 1.245 . . . . 0.0 108.945 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.49 112.07 24.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.715 1.606 . . . . 0.0 110.001 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.48 125.02 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 109.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -132.79 152.75 51.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.134 1.773 . . . . 0.0 110.186 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.33 77.19 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 168.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.16 131.43 60.16 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 118.717 1.259 . . . . 0.0 111.283 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -51.67 136.73 50.22 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 113.283 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.65 -13.44 62.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 113.906 -171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.69 -19.16 63.59 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.145 . . . . 0.0 113.11 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -94.56 125.34 39.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 111.0 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -74.57 124.75 27.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.504 0.722 . . . . 0.0 111.361 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.42 -38.75 85.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.075 0.55 . . . . 0.0 111.446 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -59.61 -37.18 77.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.497 1.119 . . . . 0.0 112.76 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -66.81 -39.52 87.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.191 0.905 . . . . 0.0 111.538 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.67 -47.26 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.222 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.868 0.758 . . . . 0.0 111.672 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.23 -42.43 99.31 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.428 -0.795 . . . . 0.0 112.512 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.14 -45.51 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.008 0.822 . . . . 0.0 111.346 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.15 -32.94 65.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.631 -1.293 . . . . 0.0 112.751 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -75.68 -63.72 1.23 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.72 1.208 . . . . 0.0 113.235 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -92.54 -32.69 14.74 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -167.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -90.91 -13.94 32.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 112.625 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 61.24 30.53 19.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.241 1.816 . . . . 0.0 112.86 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.32 -170.92 3.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.775 1.23 . . . . 0.0 111.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.94 152.75 36.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.869 1.268 . . . . 0.0 109.255 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.89 45.73 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 115.226 0.851 . . . . 0.0 115.226 -170.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -158.14 163.56 37.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.792 1.637 . . . . 0.0 112.32 -172.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.01 136.15 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.189 1.395 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 125.072 1.349 . . . . 0.0 109.573 177.614 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 121.294 0.568 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.84 134.28 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -105.96 116.8 32.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.643 1.577 . . . . 0.0 107.83 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tp -102.76 146.51 28.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.178 1.391 . . . . 0.0 109.185 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -69.37 133.4 47.76 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.547 0.739 . . . . 0.0 111.693 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 -170.12 54.78 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.11 1.338 . . . . 0.0 113.992 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -94.86 98.28 10.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.092 1.757 . . . . 0.0 111.326 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -120.45 20.75 11.82 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.057 1.743 . . . . 0.0 112.533 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -60.12 -40.91 91.4 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.57 70.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 112.355 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.98 -44.96 83.38 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.936 0.895 . . . . 0.0 111.691 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.61 -35.19 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.104 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.11 -49.54 75.58 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.51 1.05 . . . . 0.0 111.094 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.61 -39.11 79.54 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 0.0 112.68 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -60.43 -47.92 84.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.627 1.103 . . . . 0.0 112.02 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.4 mmt -61.27 -41.1 96.37 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.875 0.87 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.63 -47.97 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.732 0.813 . . . . 0.0 111.296 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -76.44 -48.09 20.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -100.48 -33.14 10.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.46 -15.85 38.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.145 0.884 . . . . 0.0 112.316 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.63 15.55 80.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.84 1.21 . . . . 0.0 113.685 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -71.1 157.89 37.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.547 1.174 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.48 147.14 24.81 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.642 -0.662 . . . . 0.0 109.586 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.56 -36.51 64.42 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.448 -0.782 . . . . 0.0 112.76 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -57.59 -21.7 40.6 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.884 1.674 . . . . 0.0 115.094 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -77.08 -7.69 56.17 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.279 0.945 . . . . 0.0 113.412 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.29 136.05 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.338 1.055 . . . . 0.0 110.791 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.53 134.22 54.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.755 2.022 . . . . 0.0 109.991 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 124.821 1.248 . . . . 0.0 108.996 177.443 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -114.94 120.68 40.76 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.624 1.169 . . . . 0.0 110.182 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 27.9 mt -114.27 116.37 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -128.99 174.57 9.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.253 1.821 . . . . 0.0 110.202 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.157 0.983 . . . . 0.0 108.483 169.481 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -89.7 132.37 35.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 107.663 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -112.94 124.5 52.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.246 1.419 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.36 126.57 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.973 1.309 . . . . 0.0 108.597 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -135.83 149.87 49.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.201 1.801 . . . . 0.0 109.502 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.12 -2.29 66.17 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 115.817 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.45 130.14 53.11 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.357 1.578 . . . . 0.0 111.08 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -52.29 139.7 53.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.397 3.398 . . . . 0.0 113.48 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.88 -16.19 63.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.85 0.86 . . . . 0.0 113.302 -172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.33 -20.2 66.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.026 0.931 . . . . 0.0 113.088 172.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -93.0 118.09 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.867 1.267 . . . . 0.0 110.693 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.12 120.3 14.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.966 0.906 . . . . 0.0 111.574 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.3 -39.05 89.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.729 0.811 . . . . 0.0 111.914 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.78 -35.59 78.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.001 0.921 . . . . 0.0 112.461 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.51 -40.39 96.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.206 0.912 . . . . 0.0 112.308 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.27 -40.15 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 109.915 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.97 -55.43 35.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.213 0.915 . . . . 0.0 110.848 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 0.0 112.788 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.06 -36.18 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.92 -32.81 65.56 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.974 0.807 . . . . 0.0 112.318 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -70.69 -33.8 71.28 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.082 . . . . 0.0 112.641 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -76.96 -58.6 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.495 1.118 . . . . 0.0 113.259 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.87 -41.32 15.08 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.31 -11.47 35.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.154 0.982 . . . . 0.0 113.127 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.25 26.92 15.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.242 1.817 . . . . 0.0 113.046 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.2 m -80.91 -171.99 3.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.717 1.207 . . . . 0.0 111.709 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -146.83 149.59 33.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.66 1.184 . . . . 0.0 109.83 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.62 46.62 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.436 0.934 . . . . 0.0 115.436 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.61 164.71 33.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.755 1.622 . . . . 0.0 112.872 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.4 mt -98.56 134.89 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.899 1.279 . . . . 0.0 109.663 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 125.167 1.387 . . . . 0.0 109.758 178.302 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.442 0.639 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.94 132.76 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 166.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -99.34 137.07 38.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.515 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tp -125.64 139.93 53.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.547 171.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -70.69 136.89 49.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.067 -1.021 . . . . 0.0 111.834 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.64 -163.09 36.62 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.893 1.235 . . . . 0.0 113.492 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.27 98.19 7.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.663 1.585 . . . . 0.0 110.146 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -120.8 18.23 11.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.146 1.379 . . . . 0.0 113.303 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 4.3 ptt180 -61.5 -42.75 99.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.36 82.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.534 0.734 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -66.25 -45.33 80.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.068 0.947 . . . . 0.0 111.958 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.67 -36.46 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.222 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.67 -49.34 75.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.388 0.994 . . . . 0.0 111.208 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.45 -39.8 84.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.928 0.891 . . . . 0.0 112.601 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 35.9 t80 -60.02 -49.61 76.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.746 1.157 . . . . 0.0 111.837 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.6 mmt -59.79 -37.22 78.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.23 1.012 . . . . 0.0 110.948 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -76.78 -44.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.911 0.884 . . . . 0.0 111.116 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.8 m -86.12 -21.99 27.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -169.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -119.03 -38.25 3.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 0.0 113.455 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.83 -14.88 50.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.401 1.0 . . . . 0.0 112.437 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.28 14.98 80.97 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.869 1.223 . . . . 0.0 113.798 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -70.94 158.43 36.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.405 1.102 . . . . 0.0 111.211 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -88.45 149.41 23.69 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -53.19 -39.69 63.84 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.501 -0.749 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -60.21 -18.52 49.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.738 1.615 . . . . 0.0 114.947 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -78.84 -8.97 59.3 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.352 0.978 . . . . 0.0 113.424 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.1 mt -118.03 130.34 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 119.353 0.978 . . . . 0.0 111.407 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -104.09 125.81 50.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.336 1.854 . . . . 0.0 110.082 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.9 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -112.38 117.14 31.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.302 1.041 . . . . 0.0 110.448 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 85' ' ' ARG . 44.5 mt -108.24 108.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.3 174.04 6.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.085 2.154 . . . . 0.0 109.949 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.472 0.667 0 O-C-N 120.983 -1.073 . . . . 0.0 108.725 169.106 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.52 0.2 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.1 m -89.11 118.7 29.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.584 1.954 . . . . 0.0 108.053 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.24 116.32 32.24 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.018 1.727 . . . . 0.0 110.126 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -101.39 126.63 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 109.557 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -135.93 158.21 44.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.741 2.016 . . . . 0.0 109.736 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.87 -6.39 48.32 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 120.438 -1.414 . . . . 0.0 116.183 168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.93 130.97 48.98 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 118.563 1.181 . . . . 0.0 110.529 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.24 137.1 55.43 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.931 3.087 . . . . 0.0 112.938 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.68 -14.33 62.85 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.5 -19.68 64.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.241 1.017 . . . . 0.0 113.165 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -89.86 123.87 34.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.548 1.139 . . . . 0.0 111.054 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -74.83 120.59 20.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.963 0.905 . . . . 0.0 111.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.3 -39.07 89.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.563 0.745 . . . . 0.0 111.765 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -60.22 -36.56 77.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.027 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -69.48 -36.88 76.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.875 0.87 . . . . 0.0 112.027 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.77 -47.67 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.917 0.781 . . . . 0.0 109.24 172.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.2 -46.61 79.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.178 0.899 . . . . 0.0 111.628 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -61.81 -33.76 74.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.135 0.974 . . . . 0.0 112.788 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.9 t -75.38 -50.57 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.064 0.545 . . . . 0.0 111.117 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.88 -33.37 74.59 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -72.28 -25.61 61.66 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.816 -1.178 . . . . 0.0 113.662 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.88 -48.92 5.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.132 0.973 . . . . 0.0 113.625 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -83.78 -38.85 20.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.065 0.946 . . . . 0.0 113.004 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 -10.93 23.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.856 1.263 . . . . 0.0 112.978 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.0 26.56 14.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.406 1.882 . . . . 0.0 113.145 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.39 -174.98 4.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.657 1.183 . . . . 0.0 112.241 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -143.7 150.81 39.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.488 1.115 . . . . 0.0 109.413 169.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.39 173.8 46.44 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.35 166.08 33.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.61 1.564 . . . . 0.0 112.372 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.4 134.98 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.948 1.299 . . . . 0.0 109.678 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.988 1.315 . . . . 0.0 109.533 177.783 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.397 0.617 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.2 mt -93.68 135.06 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.23 129.96 52.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.444 1.498 . . . . 0.0 107.548 168.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -120.75 140.15 52.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.338 1.455 . . . . 0.0 108.743 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.35 132.57 45.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.964 -1.085 . . . . 0.0 111.524 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.91 -156.12 21.32 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.923 1.725 . . . . 0.0 113.623 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.35 47.94 1.34 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.636 2.374 . . . . 0.0 111.605 -173.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -75.14 25.05 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.024 2.529 . . . . 0.0 116.29 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HA ' HG21 ' A' ' 28' ' ' ILE . 31.2 ptt-85 -57.7 -47.22 82.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.633 1.173 . . . . 0.0 114.082 -172.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.42 74.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.9 0.88 . . . . 0.0 111.932 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -64.52 -46.0 84.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.612 0.765 . . . . 0.0 111.868 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.92 -35.94 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.719 -0.613 . . . . 0.0 111.369 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -56.11 -49.02 75.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.209 0.913 . . . . 0.0 111.197 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.11 -38.36 86.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.788 0.835 . . . . 0.0 112.846 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.3 -48.56 81.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.934 1.243 . . . . 0.0 111.56 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.73 -44.68 93.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 110.581 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.34 -44.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.707 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.6 t -79.16 -49.15 13.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -98.11 -35.77 10.3 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -88.67 -13.88 38.7 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.753 0.706 . . . . 0.0 112.494 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.49 17.31 79.3 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.774 1.178 . . . . 0.0 113.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.7 mt -70.79 153.56 42.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.503 1.151 . . . . 0.0 111.74 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -79.42 137.69 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.675 -0.641 . . . . 0.0 110.39 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -55.23 -38.81 68.95 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 0.0 112.756 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -59.2 -21.16 59.05 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 114.605 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.58 -4.7 58.06 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.314 1.046 . . . . 0.0 112.942 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -112.01 126.59 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.51 -1.369 . . . . 0.0 110.89 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -105.89 120.16 41.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.585 1.954 . . . . 0.0 110.004 172.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 169.248 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -96.21 116.96 29.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.066 0.946 . . . . 0.0 110.049 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.41 102.52 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -108.09 174.11 6.02 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.92 2.088 . . . . 0.0 110.855 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.691 1.196 . . . . 0.0 108.217 169.15 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.359 0.123 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 m -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.529 1.932 . . . . 0.0 107.681 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.57 120.43 28.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 110.614 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.7 121.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.322 1.049 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -127.93 153.97 46.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.641 1.977 . . . . 0.0 110.02 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.98 -5.2 50.54 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.076 1.19 . . . . 0.0 116.076 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -49.36 129.86 17.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 0.0 111.001 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -52.01 137.45 53.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.944 3.096 . . . . 0.0 113.209 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.05 -8.67 55.01 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.25 -17.81 62.47 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.133 1.373 . . . . 0.0 113.0 169.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -94.13 129.76 40.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.081 1.353 . . . . 0.0 111.41 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.14 118.75 22.12 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.985 0.914 . . . . 0.0 111.936 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.76 -38.48 90.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.23 0.612 . . . . 0.0 112.254 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.43 -36.08 81.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.862 0.865 . . . . 0.0 112.584 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -64.03 -39.27 93.72 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.061 -1.024 . . . . 0.0 111.764 169.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -63.24 -39.71 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.93 0.892 . . . . 0.0 110.068 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.45 -55.83 30.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 110.976 170.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.4 -48.82 73.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.931 0.893 . . . . 0.0 112.8 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.6 p -70.86 -36.73 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.06 -34.68 64.13 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.193 0.906 . . . . 0.0 111.98 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -34.39 77.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.758 -1.214 . . . . 0.0 112.471 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.63 -60.44 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.32 1.048 . . . . 0.0 113.105 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.69 -39.16 18.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.89 -4.42 49.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.464 1.106 . . . . 0.0 112.638 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.39 28.85 18.32 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.161 1.785 . . . . 0.0 113.102 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.48 179.76 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.55 1.14 . . . . 0.0 112.74 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -133.27 140.92 47.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.356 1.462 . . . . 0.0 108.366 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.57 168.86 41.89 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 -169.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -159.41 165.05 34.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.661 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.4 135.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.681 1.192 . . . . 0.0 109.976 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.1 t . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 125.675 1.59 . . . . 0.0 109.052 175.402 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.29 131.92 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 166.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.5 139.11 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.318 1.447 . . . . 0.0 108.245 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.52 136.13 47.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.463 1.505 . . . . 0.0 108.419 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -72.56 138.95 47.21 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.102 -0.999 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.17 -174.95 39.2 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.985 1.755 . . . . 0.0 113.361 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.54 77.59 2.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.882 2.073 . . . . 0.0 110.828 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.65 15.52 27.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 113.652 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -58.6 -41.64 86.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.23 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.132 0.973 . . . . 0.0 112.279 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.03 -44.34 84.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 111.75 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.49 -33.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.173 0.589 . . . . 0.0 111.092 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 111.085 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.04 -39.65 78.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.52 0.728 . . . . 0.0 112.626 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 57' ' ' VAL . 53.7 t80 -59.92 -49.78 76.36 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.425 1.011 . . . . 0.0 111.733 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.0 mmt -59.76 -39.69 85.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 110.882 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.01 -52.7 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.611 0.765 . . . . 0.0 111.034 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -83.03 -31.18 27.55 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -103.58 -42.18 5.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.226 0.921 . . . . 0.0 112.938 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -82.39 -20.35 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.155 0.889 . . . . 0.0 112.577 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.19 18.7 66.39 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.318 0.961 . . . . 0.0 113.592 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.5 mt -69.59 157.05 37.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.642 1.221 . . . . 0.0 110.464 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -87.74 146.34 25.71 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.45 -0.781 . . . . 0.0 109.299 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -55.13 -36.69 66.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.317 -0.864 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.91 -19.54 43.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.892 1.677 . . . . 0.0 115.035 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -79.29 -9.46 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.05 132.3 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 120.957 -1.089 . . . . 0.0 110.926 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -106.31 124.87 50.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.548 1.539 . . . . 0.0 109.544 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 124.199 1.0 . . . . 0.0 108.415 174.102 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -118.67 120.18 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.222 1.009 . . . . 0.0 110.389 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.83 104.48 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -109.79 169.79 8.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.87 1.668 . . . . 0.0 110.568 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.462 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.0 m -89.18 138.93 30.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.595 1.558 . . . . 0.0 107.618 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -127.46 120.99 29.61 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.845 1.258 . . . . 0.0 110.335 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.84 126.52 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.671 1.188 . . . . 0.0 109.519 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.09 151.51 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.457 1.903 . . . . 0.0 109.751 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.91 -1.45 79.07 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.08 133.3 59.4 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.654 1.227 . . . . 0.0 111.101 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.52 144.19 64.08 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.039 3.159 . . . . 0.0 113.452 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.37 -16.66 63.57 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.053 0.941 . . . . 0.0 113.329 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.67 -17.8 63.52 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 113.481 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -93.23 122.12 35.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.666 1.187 . . . . 0.0 111.313 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -73.1 117.39 14.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.853 0.861 . . . . 0.0 111.331 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.2 mt -60.23 -36.5 77.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.598 0.759 . . . . 0.0 111.819 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -62.88 -38.46 90.97 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.325 1.05 . . . . 0.0 112.027 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -65.38 -37.43 86.98 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.431 -0.793 . . . . 0.0 111.697 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.28 -41.05 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 110.124 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.87 -53.24 60.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.262 0.937 . . . . 0.0 111.013 170.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -56.87 -50.06 73.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.554 0.742 . . . . 0.0 112.873 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.1 p -68.82 -37.43 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.97 -38.33 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.569 0.622 . . . . 0.0 111.712 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.23 -31.87 72.96 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.244 -1.535 . . . . 0.0 112.329 173.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -73.99 -65.43 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.142 1.377 . . . . 0.0 112.933 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -91.69 -29.32 16.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -167.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -93.98 -7.75 41.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.842 0.857 . . . . 0.0 112.488 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.38 26.05 15.59 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.402 1.881 . . . . 0.0 113.236 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -82.58 -169.24 2.36 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.558 1.143 . . . . 0.0 112.631 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -141.18 151.78 44.11 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.045 1.338 . . . . 0.0 109.339 167.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.61 172.32 44.09 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -158.01 162.03 38.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.717 1.607 . . . . 0.0 111.904 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.48 129.56 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.111 1.364 . . . . 0.0 108.329 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.601 1.16 . . . . 0.0 109.516 -178.083 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.398 0.618 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.7 mt -90.97 127.97 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -94.43 130.64 40.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.229 1.412 . . . . 0.0 107.713 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -119.09 136.21 54.26 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.655 1.582 . . . . 0.0 107.89 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -76.92 128.17 34.06 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.308 -0.87 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.56 -170.23 28.08 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.237 1.399 . . . . 0.0 113.363 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -97.76 83.95 3.28 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.68 1.992 . . . . 0.0 111.335 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -110.08 15.13 22.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.223 -169.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -59.18 -46.28 88.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.62 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.854 0.861 . . . . 0.0 111.912 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.25 -45.9 89.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.296 1.039 . . . . 0.0 111.913 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.52 -36.12 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.236 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.95 -47.36 80.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.521 1.055 . . . . 0.0 110.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.08 -39.14 91.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.456 0.702 . . . . 0.0 112.641 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 24.5 t80 -59.66 -49.13 78.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.65 1.114 . . . . 0.0 111.602 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.5 mmt -59.06 -44.34 91.83 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.625 1.17 . . . . 0.0 110.522 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt -72.18 -44.14 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.635 0.774 . . . . 0.0 111.68 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 t -75.3 -48.05 25.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -100.96 -37.09 8.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.0 mt -90.83 -13.39 33.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.723 0.692 . . . . 0.0 112.84 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.57 15.54 81.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.726 1.155 . . . . 0.0 113.687 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.2 145.01 53.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.239 1.019 . . . . 0.0 110.626 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -82.16 134.66 35.32 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.714 -0.617 . . . . 0.0 110.388 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -51.97 -44.43 63.99 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.75 0.82 . . . . 0.0 112.392 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -22.2 63.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -81.73 -10.96 59.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 112.982 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -106.73 124.55 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.644 1.111 . . . . 0.0 110.617 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -101.26 135.11 43.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.806 1.642 . . . . 0.0 110.457 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 108.845 173.888 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -96.53 118.82 33.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.62 0.768 . . . . 0.0 110.32 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mt -108.53 109.39 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -121.26 174.43 6.71 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.503 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 120.613 0.244 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -91.41 125.05 36.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.339 1.855 . . . . 0.0 108.441 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -106.69 128.9 54.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.539 1.536 . . . . 0.0 110.827 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.0 124.09 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.851 1.26 . . . . 0.0 109.734 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -127.67 155.21 44.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.452 1.901 . . . . 0.0 109.501 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 1.25 90.61 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 168.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -61.13 131.45 92.04 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 118.678 1.239 . . . . 0.0 110.661 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.49 142.36 59.44 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 124.124 3.216 . . . . 0.0 113.267 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.28 -17.25 62.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.164 0.985 . . . . 0.0 113.096 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.03 -18.64 65.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.876 0.87 . . . . 0.0 113.159 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.99 116.86 29.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.856 1.262 . . . . 0.0 110.79 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -69.79 120.78 16.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.074 0.95 . . . . 0.0 111.588 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.91 -39.27 88.74 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.208 1.003 . . . . 0.0 111.974 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.0 -31.38 71.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.926 0.891 . . . . 0.0 112.538 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -40.7 79.32 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 111.836 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.07 -47.65 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.654 0.782 . . . . 0.0 109.057 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.3 mt -55.65 -48.58 74.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.718 0.69 . . . . 0.0 111.674 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.58 -43.29 97.42 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.445 -0.785 . . . . 0.0 112.452 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.15 -46.61 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.118 0.872 . . . . 0.0 111.16 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.06 -27.65 64.81 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -76.81 -35.86 57.3 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.659 -1.276 . . . . 0.0 113.254 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -77.91 -62.32 1.71 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.95 -32.03 20.33 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.221 1.409 . . . . 0.0 113.988 -166.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.7 -8.88 27.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.13 0.972 . . . . 0.0 113.162 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.62 28.25 16.89 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.831 1.652 . . . . 0.0 113.444 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 92.9 m -87.32 -169.85 2.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.921 1.289 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -148.58 149.87 32.31 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.913 0.885 . . . . 0.0 110.082 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.14 177.38 47.15 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.7 161.41 29.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.912 1.685 . . . . 0.0 111.942 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.13 141.37 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.688 1.195 . . . . 0.0 109.226 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 124.971 1.308 . . . . 0.0 109.411 173.919 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.347 0.594 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.27 136.52 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.38 135.04 47.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.186 1.795 . . . . 0.0 108.212 168.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.93 140.62 52.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.749 1.62 . . . . 0.0 108.946 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -72.64 138.51 46.77 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.281 -0.887 . . . . 0.0 111.991 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.72 -169.69 43.1 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.558 1.551 . . . . 0.0 112.895 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.47 97.75 7.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.053 1.341 . . . . 0.0 109.998 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -115.07 27.45 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.885 1.274 . . . . 0.0 113.702 -167.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -51.94 -59.02 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.537 1.535 . . . . 0.0 112.639 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.46 -38.91 91.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.786 1.235 . . . . 0.0 112.195 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.72 -48.41 79.36 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 111.731 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.21 -34.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.828 -0.545 . . . . 0.0 111.344 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.95 -50.03 73.88 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.212 0.915 . . . . 0.0 111.182 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.79 -38.2 81.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.094 0.958 . . . . 0.0 112.647 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.68 -48.12 83.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.67 1.123 . . . . 0.0 111.791 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.5 mmt -61.86 -41.73 98.2 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 110.591 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.25 -48.18 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.049 0.94 . . . . 0.0 111.535 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -80.95 -48.34 12.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -98.51 -34.06 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -85.75 -15.61 41.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.897 0.771 . . . . 0.0 112.035 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.37 79.64 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.017 1.294 . . . . 0.0 113.777 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.48 151.71 42.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.562 1.181 . . . . 0.0 112.141 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -74.15 141.31 45.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.022 0.529 . . . . 0.0 109.929 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -57.36 -36.66 71.48 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.25 -21.1 47.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.961 . . . . 0.0 114.87 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.15 -9.76 58.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.105 0.962 . . . . 0.0 113.127 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.9 133.78 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.384 1.074 . . . . 0.0 110.692 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -110.65 133.84 52.96 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.148 1.779 . . . . 0.0 110.188 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 124.141 0.976 . . . . 0.0 109.346 173.158 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -107.45 115.08 29.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.559 1.144 . . . . 0.0 109.344 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.28 108.5 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -116.97 173.57 6.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.524 1.929 . . . . 0.0 110.865 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.755 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 m -89.43 132.37 35.03 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.878 1.671 . . . . 0.0 107.828 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -117.43 126.77 53.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 110.925 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.48 123.57 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.544 1.138 . . . . 0.0 108.943 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -129.9 149.51 51.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 109.388 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 4.85 89.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.58 131.71 64.01 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 118.567 1.184 . . . . 0.0 111.319 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.25 143.19 53.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.383 3.389 . . . . 0.0 113.615 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -67.49 -18.94 65.25 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 113.37 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.5 -16.91 62.95 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -96.23 124.27 40.17 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.718 1.207 . . . . 0.0 111.799 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.11 121.55 23.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.166 0.986 . . . . 0.0 111.852 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.24 -39.25 92.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.534 0.733 . . . . 0.0 112.395 -174.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -62.86 -34.71 77.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.285 -0.884 . . . . 0.0 112.172 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 tpt85 -64.95 -37.55 88.04 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.15 0.886 . . . . 0.0 111.929 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.9 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.373 1.069 . . . . 0.0 110.164 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.94 -52.78 64.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.199 0.909 . . . . 0.0 110.914 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -54.89 -50.52 68.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 112.638 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 p -70.11 -36.1 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -34.9 65.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.651 0.66 . . . . 0.0 112.145 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.45 -33.28 73.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.756 -1.215 . . . . 0.0 112.425 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -74.87 -66.23 0.78 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.122 1.369 . . . . 0.0 113.153 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -91.2 -29.82 17.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -167.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.33 -4.93 47.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.878 0.871 . . . . 0.0 112.561 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.34 28.1 16.26 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.193 1.797 . . . . 0.0 113.246 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.1 m -83.06 177.8 8.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.491 1.116 . . . . 0.0 112.771 -173.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -126.21 141.7 51.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.462 1.505 . . . . 0.0 107.93 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.26 166.96 39.57 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.84 158.34 40.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.236 1.815 . . . . 0.0 111.821 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.7 mt -93.69 136.24 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.741 1.216 . . . . 0.0 108.991 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.972 1.309 . . . . 0.0 109.448 177.249 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 121.338 0.589 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.0 mt -99.73 132.08 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 165.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -99.34 139.41 35.03 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.569 1.548 . . . . 0.0 108.682 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tp -129.02 138.44 51.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.783 1.633 . . . . 0.0 108.229 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -72.38 139.69 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.126 -0.984 . . . . 0.0 111.477 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.19 -172.39 43.42 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.419 1.485 . . . . 0.0 113.379 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -98.88 85.67 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.754 2.021 . . . . 0.0 110.954 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -109.45 16.21 22.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.596 1.559 . . . . 0.0 113.258 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -58.34 -42.96 88.03 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -39.31 66.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 112.089 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -63.81 -45.22 90.59 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.025 0.93 . . . . 0.0 111.826 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.44 -35.46 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.162 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.75 -48.81 76.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.494 1.043 . . . . 0.0 111.164 170.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.93 -40.15 83.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.784 0.834 . . . . 0.0 112.678 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.7 t80 -59.75 -49.94 75.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.767 1.167 . . . . 0.0 111.869 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.0 mmt -59.67 -37.82 79.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 110.903 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.52 -45.05 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.998 0.919 . . . . 0.0 111.084 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -85.42 -22.14 28.47 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.12 -38.0 2.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.386 0.993 . . . . 0.0 113.601 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.7 mt -82.74 -14.94 53.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.505 1.048 . . . . 0.0 112.48 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.81 14.95 80.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.841 1.21 . . . . 0.0 113.609 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.54 159.51 34.19 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.543 1.171 . . . . 0.0 111.514 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.13 151.29 22.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.378 0.671 . . . . 0.0 110.05 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -55.91 -38.92 70.88 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.255 -0.903 . . . . 0.0 111.657 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.19 -0.11 3.14 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.05 -1.86 56.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.967 1.258 . . . . 0.0 113.033 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt -128.06 132.44 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 120.738 -1.226 . . . . 0.0 111.597 -169.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.69 126.98 51.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.572 1.549 . . . . 0.0 109.829 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.058 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.1 127.62 55.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.919 . . . . 0.0 110.883 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.4 mt -117.71 99.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -103.53 174.61 5.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.715 2.406 . . . . 0.0 110.214 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.3 mt . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.058 0.943 . . . . 0.0 108.771 169.36 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -82.69 116.14 21.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.952 1.301 . . . . 0.0 107.919 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 113.31 24.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.502 1.521 . . . . 0.0 110.004 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.02 129.33 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.668 1.187 . . . . 0.0 108.479 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -144.75 161.45 39.2 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.992 1.717 . . . . 0.0 110.152 -167.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.62 -14.2 4.53 Favored Glycine 0 N--CA 1.475 1.251 0 O-C-N 120.463 -1.398 . . . . 0.0 116.541 168.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -47.99 130.93 12.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.224 1.41 . . . . 0.0 111.55 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -53.5 140.81 63.9 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.954 3.103 . . . . 0.0 113.112 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.76 -10.58 59.78 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.86 -19.57 63.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.85 0.86 . . . . 0.0 112.742 170.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.71 114.13 26.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.048 1.339 . . . . 0.0 110.394 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -66.99 123.15 19.39 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.32 -38.63 80.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.553 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.58 -32.9 74.51 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.118 0.967 . . . . 0.0 112.567 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -69.5 -38.4 77.61 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.277 -0.889 . . . . 0.0 111.517 171.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.2 mt -57.95 -47.05 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.041 0.837 . . . . 0.0 108.964 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.18 -48.73 73.37 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.005 0.82 . . . . 0.0 111.743 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -61.57 -43.67 98.44 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.665 -0.647 . . . . 0.0 112.301 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.23 -46.86 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.651 0.659 . . . . 0.0 111.137 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.63 -32.16 70.69 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.92 -34.36 64.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.674 -1.266 . . . . 0.0 113.208 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.83 -48.46 9.34 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.38 -41.36 12.88 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.704 0.802 . . . . 0.0 113.135 -171.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -94.38 -12.53 27.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.336 1.054 . . . . 0.0 113.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.82 31.17 16.56 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.146 1.778 . . . . 0.0 112.858 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.0 m -80.96 -177.67 6.52 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.476 1.11 . . . . 0.0 111.636 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -138.25 145.92 41.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.374 1.07 . . . . 0.0 109.332 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.63 172.09 45.13 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 116.158 1.223 . . . . 0.0 116.158 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.91 161.87 38.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.538 1.535 . . . . 0.0 112.583 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.0 mt -97.73 134.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.928 1.291 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t . . . . . 0 N--CA 1.477 0.884 0 C-N-CA 125.285 1.434 . . . . 0.0 109.773 179.095 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 121.345 0.593 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.91 133.47 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.17 123.2 45.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tp -108.97 136.36 48.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.174 1.39 . . . . 0.0 108.209 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.48 134.99 48.27 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.208 -0.933 . . . . 0.0 111.673 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.39 -168.95 40.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.378 1.466 . . . . 0.0 113.436 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -98.55 99.74 10.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.811 1.644 . . . . 0.0 109.899 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -122.0 20.72 10.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.863 1.265 . . . . 0.0 113.226 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.5 ptt180 -62.16 -44.28 96.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.07 -39.62 90.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.458 0.703 . . . . 0.0 111.772 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -64.76 -46.15 83.41 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.141 0.977 . . . . 0.0 111.988 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.47 -36.37 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.857 -0.527 . . . . 0.0 111.352 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.02 -48.24 82.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.313 0.96 . . . . 0.0 111.199 171.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.38 -37.72 78.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.817 0.847 . . . . 0.0 112.671 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.57 -48.72 79.69 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 111.693 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.7 mmt -59.99 -42.99 95.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.205 1.002 . . . . 0.0 110.578 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.75 -48.62 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.081 0.952 . . . . 0.0 111.608 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -79.17 -47.84 15.31 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -98.97 -35.82 9.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.21 -17.58 25.82 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.632 0.651 . . . . 0.0 112.728 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.84 17.29 80.0 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.372 0.987 . . . . 0.0 113.623 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.0 145.86 51.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.31 1.055 . . . . 0.0 110.785 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -74.29 143.85 44.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.725 0.774 . . . . 0.0 111.664 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.31 -42.07 99.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.509 0.724 . . . . 0.0 112.166 -168.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.04 -21.48 63.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.975 1.31 . . . . 0.0 113.999 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -82.3 -4.12 56.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.665 1.186 . . . . 0.0 112.326 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.32 136.12 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.669 1.588 . . . . 0.0 108.838 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.12 116.73 25.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.729 1.612 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.962 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.21 121.47 35.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.785 0.834 . . . . 0.0 110.098 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 85' ' ' ARG . 45.8 mt -113.71 104.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -111.89 166.0 11.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.267 1.827 . . . . 0.0 109.363 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.476 0.826 0 O-C-N 120.799 -1.188 . . . . 0.0 109.833 169.922 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.75 0.309 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.8 m -89.84 121.73 32.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.131 1.772 . . . . 0.0 107.999 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 p -106.64 121.42 44.3 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.451 1.5 . . . . 0.0 110.347 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.45 129.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.884 1.273 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.35 152.51 49.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.554 1.941 . . . . 0.0 109.878 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.34 2.31 78.83 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.12 132.76 68.61 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.234 1.413 . . . . 0.0 111.575 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.08 140.04 41.23 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.445 3.43 . . . . 0.0 113.664 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.48 -22.59 67.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.308 1.043 . . . . 0.0 113.564 -172.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.49 -19.08 65.7 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.21 103.95 15.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.042 1.337 . . . . 0.0 110.557 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.5 126.76 28.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.615 1.166 . . . . 0.0 112.2 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 mt -61.97 -40.04 94.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.24 0.616 . . . . 0.0 111.953 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.82 -36.37 83.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.809 0.844 . . . . 0.0 112.217 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -63.83 -38.9 92.8 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.044 -1.035 . . . . 0.0 111.936 169.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.88 -42.33 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.884 0.874 . . . . 0.0 109.931 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mt -58.12 -52.92 63.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.107 0.867 . . . . 0.0 111.025 171.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.56 -50.71 71.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.822 0.849 . . . . 0.0 112.975 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.66 -39.26 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.56 -37.43 71.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.727 0.694 . . . . 0.0 111.996 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -66.94 -29.67 69.6 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.101 -1.624 . . . . 0.0 112.729 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.19 -63.22 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.152 0.981 . . . . 0.0 113.094 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.06 -33.94 29.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.32 -8.31 36.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 112.8 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.41 26.82 16.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.219 1.807 . . . . 0.0 113.275 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.2 p -81.9 -169.93 2.6 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 112.851 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -139.48 149.22 43.71 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.931 1.292 . . . . 0.0 109.382 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -178.98 173.25 45.49 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -163.91 164.11 23.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.358 1.863 . . . . 0.0 111.717 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -100.06 140.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.554 1.141 . . . . 0.0 109.563 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.481 1.109 0 C-N-CA 125.259 1.423 . . . . 0.0 109.626 176.165 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.8 pt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.436 0.636 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.43 133.11 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -101.2 132.99 46.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.77 1.628 . . . . 0.0 107.987 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -122.6 135.14 54.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.935 1.694 . . . . 0.0 107.769 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -73.68 134.25 43.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.314 -0.866 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.54 -169.12 25.73 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.813 1.673 . . . . 0.0 113.279 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -105.09 52.37 0.74 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.015 2.126 . . . . 0.0 111.601 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -75.54 21.47 0.14 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.742 2.417 . . . . 0.0 116.267 -167.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HA ' HG21 ' A' ' 28' ' ' ILE . 30.1 ptt-85 -57.62 -47.55 81.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.5 74.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.872 0.869 . . . . 0.0 111.782 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -64.24 -45.34 88.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.29 -36.32 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.721 -0.612 . . . . 0.0 111.391 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.3 t -57.18 -48.6 78.33 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.34 0.973 . . . . 0.0 111.014 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.23 -39.0 85.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.095 0.958 . . . . 0.0 112.637 175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.37 -49.61 77.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.938 1.245 . . . . 0.0 111.632 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 mmt -62.97 -40.49 97.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.008 0.923 . . . . 0.0 110.734 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.02 -49.74 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.887 0.875 . . . . 0.0 111.605 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.8 t -79.47 -48.23 14.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -97.08 -33.31 11.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.35 -18.13 29.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.793 0.724 . . . . 0.0 112.369 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.91 17.22 77.57 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.546 1.07 . . . . 0.0 113.802 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.97 155.45 40.56 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.635 1.218 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.85 148.13 30.09 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.798 -0.564 . . . . 0.0 109.581 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -57.67 -35.75 70.99 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.466 -0.771 . . . . 0.0 112.212 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -63.86 -17.27 62.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.979 1.712 . . . . 0.0 115.131 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -73.66 -11.54 60.45 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.455 1.025 . . . . 0.0 113.132 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -117.34 138.97 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.975 1.31 . . . . 0.0 110.566 -169.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -120.25 115.58 23.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.51 1.924 . . . . 0.0 109.938 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.426 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.92 115.84 31.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.124 0.969 . . . . 0.0 109.887 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.56 104.52 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -110.22 173.93 6.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.163 2.185 . . . . 0.0 110.871 -170.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.747 1.219 . . . . 0.0 108.516 169.081 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -93.91 140.3 29.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.613 1.965 . . . . 0.0 108.027 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.33 119.02 24.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.75 1.22 . . . . 0.0 110.83 -174.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.6 121.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 109.611 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.75 152.76 46.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.351 1.86 . . . . 0.0 109.622 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.03 -3.13 62.45 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -55.52 130.6 70.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 118.714 1.257 . . . . 0.0 110.276 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.41 138.4 65.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.792 2.995 . . . . 0.0 113.194 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.15 -6.88 50.34 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.936 0.894 . . . . 0.0 113.234 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.48 -18.82 62.28 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.569 -0.707 . . . . 0.0 112.473 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -90.69 129.94 36.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.634 1.174 . . . . 0.0 110.915 170.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.6 117.47 14.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.351 0.66 . . . . 0.0 110.891 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.05 -37.94 84.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.122 0.569 . . . . 0.0 111.382 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.4 -32.67 72.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.59 1.156 . . . . 0.0 113.202 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -71.0 -38.1 72.67 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.07 0.85 . . . . 0.0 111.402 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.951 0.796 . . . . 0.0 109.086 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.94 -49.6 70.94 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.929 0.786 . . . . 0.0 111.55 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -61.13 -43.66 98.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 112.576 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.66 -44.2 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.494 0.588 . . . . 0.0 111.371 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.0 mt -70.77 -31.49 68.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.79 -33.64 66.38 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.836 -1.165 . . . . 0.0 112.894 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.68 -58.53 3.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.24 1.016 . . . . 0.0 113.292 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.18 -42.38 13.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 0.0 113.449 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -90.31 -12.37 37.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.185 0.994 . . . . 0.0 112.818 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.49 30.14 17.16 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.226 1.81 . . . . 0.0 112.912 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.7 m -81.29 -172.2 3.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 111.442 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -147.47 150.64 34.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.731 1.212 . . . . 0.0 109.241 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.0 172.52 44.72 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 115.836 1.095 . . . . 0.0 115.836 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -153.39 158.13 41.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.425 1.89 . . . . 0.0 111.83 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.4 mt -91.86 130.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.676 1.19 . . . . 0.0 108.452 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.762 1.225 . . . . 0.0 109.399 -176.894 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -92.68 129.98 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 166.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -97.56 130.79 44.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.073 1.349 . . . . 0.0 107.532 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -122.01 139.66 53.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.523 1.529 . . . . 0.0 108.578 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -78.12 136.14 37.81 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.339 -0.85 . . . . 0.0 111.17 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.54 -174.05 42.75 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.828 1.68 . . . . 0.0 113.27 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -97.83 88.69 4.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.42 1.888 . . . . 0.0 110.923 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -112.12 16.42 20.17 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.414 1.485 . . . . 0.0 113.358 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -58.89 -41.3 86.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.36 65.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.126 0.97 . . . . 0.0 112.319 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -66.07 -43.6 86.95 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.992 0.917 . . . . 0.0 111.911 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.47 -35.51 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.186 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.0 t -56.89 -48.85 77.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.454 1.024 . . . . 0.0 111.12 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.34 -38.78 81.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.708 0.803 . . . . 0.0 112.726 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.29 -47.3 86.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.713 1.142 . . . . 0.0 111.864 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.5 -42.33 96.12 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.117 0.967 . . . . 0.0 110.606 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.69 -47.33 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 111.471 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -77.48 -48.94 15.85 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -98.79 -34.53 10.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.4 -14.28 43.84 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.891 0.769 . . . . 0.0 112.24 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.86 15.72 80.87 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.957 1.265 . . . . 0.0 113.88 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.47 153.44 42.24 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.399 1.1 . . . . 0.0 111.805 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -82.72 140.39 33.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.759 -0.588 . . . . 0.0 110.004 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -54.5 -35.62 63.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.875 0.87 . . . . 0.0 113.275 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -56.65 -23.85 44.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.406 1.482 . . . . 0.0 114.323 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.64 -10.04 59.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.796 1.238 . . . . 0.0 113.031 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.2 mt -114.7 134.15 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.443 1.097 . . . . 0.0 110.76 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -110.75 126.94 55.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.574 1.949 . . . . 0.0 109.984 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.1 mt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 124.464 1.105 . . . . 0.0 108.469 173.915 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.32 126.12 37.27 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.561 0.745 . . . . 0.0 110.17 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 85' ' ' ARG . 13.0 mt -123.4 115.56 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -128.48 165.14 21.28 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.592 1.557 . . . . 0.0 110.575 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mt . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 124.258 1.023 . . . . 0.0 108.805 169.154 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.501 0.191 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.2 m -95.05 120.14 34.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.718 1.607 . . . . 0.0 108.11 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -99.09 123.91 43.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 110.499 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.21 128.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.957 1.303 . . . . 0.0 108.672 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -142.94 161.26 38.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.788 1.635 . . . . 0.0 110.9 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.48 -16.37 3.07 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 168.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -45.32 133.3 5.82 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 126.253 1.821 . . . . 0.0 112.777 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.15 142.44 55.26 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.982 3.122 . . . . 0.0 113.446 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.6 -13.87 62.54 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.09 -18.65 63.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.722 0.809 . . . . 0.0 113.098 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -93.59 112.64 24.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.846 1.258 . . . . 0.0 110.792 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -69.28 122.25 18.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.294 1.038 . . . . 0.0 112.002 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.42 -35.5 81.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.179 0.592 . . . . 0.0 112.116 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -63.07 -39.16 93.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 112.16 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.09 89.86 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.43 1.092 . . . . 0.0 111.099 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.11 -40.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.178 0.991 . . . . 0.0 110.395 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.32 -54.94 41.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.555 1.07 . . . . 0.0 110.84 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -56.9 -48.35 78.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.765 0.826 . . . . 0.0 112.623 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.5 p -70.47 -37.24 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.38 -33.62 65.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.141 0.882 . . . . 0.0 111.87 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.32 -33.3 74.07 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.908 -1.12 . . . . 0.0 112.572 170.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -79.39 -58.81 3.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.388 1.075 . . . . 0.0 113.314 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -85.1 -41.19 15.96 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.18 -12.64 32.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.938 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.15 31.59 17.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.165 1.786 . . . . 0.0 112.635 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.2 m -80.42 -172.8 3.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.615 1.166 . . . . 0.0 111.521 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -148.11 150.92 34.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.696 1.198 . . . . 0.0 109.266 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.57 171.19 42.29 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 115.642 1.017 . . . . 0.0 115.642 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -150.83 156.27 40.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.127 1.771 . . . . 0.0 111.627 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.34 131.53 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.669 1.188 . . . . 0.0 108.627 171.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 124.899 1.28 . . . . 0.0 109.396 179.334 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.197 0.522 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.3 mt -93.02 130.6 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -101.69 122.76 44.51 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -110.14 140.7 43.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.366 1.466 . . . . 0.0 108.733 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -69.21 135.66 50.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.42 0.688 . . . . 0.0 111.457 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.62 -164.4 41.39 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.08 1.324 . . . . 0.0 114.03 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -100.85 99.54 10.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.18 1.792 . . . . 0.0 109.918 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -121.76 18.09 11.08 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 113.081 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' ILE . 28.9 ptt-85 -63.03 -41.78 99.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -168.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.24 73.84 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 172.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -64.92 -45.2 86.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.693 0.797 . . . . 0.0 111.728 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.39 -36.77 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.477 0.711 . . . . 0.0 111.208 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -56.57 -49.41 74.95 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.719 1.145 . . . . 0.0 111.481 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.45 -39.62 84.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.532 0.733 . . . . 0.0 112.413 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.547 ' CE1' HG11 ' A' ' 57' ' ' VAL . 31.5 t80 -60.49 -48.11 83.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.099 0.863 . . . . 0.0 112.017 175.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.81 -42.94 94.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.441 1.096 . . . . 0.0 110.668 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.78 -47.1 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.1 t -75.79 -48.34 22.06 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -103.52 -29.73 10.96 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -168.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.25 -16.3 27.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.273 0.942 . . . . 0.0 112.416 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.38 19.02 75.0 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.41 1.005 . . . . 0.0 113.613 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.54 155.37 40.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.411 1.105 . . . . 0.0 110.716 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -83.38 148.74 27.14 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -53.98 -41.16 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.557 -0.714 . . . . 0.0 111.581 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -64.55 -14.08 55.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -75.93 -9.35 58.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 112.868 172.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.6 mt -115.91 136.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.115 . . . . 0.0 110.338 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -116.94 114.66 24.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.978 1.711 . . . . 0.0 109.96 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.753 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -112.47 114.63 27.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.452 1.101 . . . . 0.0 109.267 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.78 99.65 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -106.49 174.49 5.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.998 2.519 . . . . 0.0 110.72 -171.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 124.09 0.956 . . . . 0.0 108.868 169.62 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.98 131.32 38.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.575 1.55 . . . . 0.0 107.494 167.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -115.14 123.4 48.85 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.057 1.343 . . . . 0.0 110.548 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.58 123.64 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -131.49 143.96 50.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.038 1.735 . . . . 0.0 109.005 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.15 -0.44 83.72 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.27 130.56 51.85 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 118.905 1.352 . . . . 0.0 110.956 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -52.94 139.42 60.63 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.069 3.18 . . . . 0.0 113.324 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -74.32 -7.61 53.4 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.752 0.821 . . . . 0.0 112.652 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.86 126.25 35.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.646 1.178 . . . . 0.0 111.005 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.45 115.49 12.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.442 0.697 . . . . 0.0 111.157 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.58 -36.57 76.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.731 0.812 . . . . 0.0 111.624 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -63.65 -35.56 80.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.651 1.181 . . . . 0.0 112.421 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -67.93 -37.61 81.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 111.573 171.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.61 -40.86 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 0.0 110.023 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.94 -54.45 46.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.261 0.937 . . . . 0.0 110.714 169.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -57.43 -46.39 83.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 113.026 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 p -73.02 -36.88 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.43 -34.47 67.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.094 0.861 . . . . 0.0 111.751 176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.25 -34.11 76.75 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.986 -1.071 . . . . 0.0 112.554 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.8 -63.25 1.43 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.245 1.018 . . . . 0.0 113.119 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -81.9 -39.14 24.25 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.87 -3.41 51.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 112.767 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.12 27.99 17.13 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.17 1.788 . . . . 0.0 113.142 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -83.14 -179.94 7.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.524 1.13 . . . . 0.0 112.776 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -129.58 144.58 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.723 1.609 . . . . 0.0 107.898 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.71 171.24 44.33 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -158.4 161.68 37.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.464 1.506 . . . . 0.0 112.48 -174.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mt -94.93 129.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 108.219 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.071 0.948 . . . . 0.0 110.811 -176.001 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.76 129.82 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 165.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -100.27 138.86 36.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.369 1.467 . . . . 0.0 108.801 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -128.96 142.7 50.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.23 1.812 . . . . 0.0 108.355 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -73.25 136.9 44.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.969 1.259 . . . . 0.0 112.027 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.33 -174.87 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.27 1.414 . . . . 0.0 113.702 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.82 73.73 3.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.719 2.007 . . . . 0.0 111.412 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -97.29 16.98 18.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.331 1.852 . . . . 0.0 113.526 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -58.22 -41.54 84.31 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.06 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.068 0.947 . . . . 0.0 112.105 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.57 -44.69 93.36 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.253 1.021 . . . . 0.0 111.853 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.77 -34.8 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.176 0.59 . . . . 0.0 111.199 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.0 t -58.44 -46.91 85.58 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.614 1.097 . . . . 0.0 111.243 171.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.46 -39.06 86.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.63 0.772 . . . . 0.0 112.39 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 38.5 t80 -60.12 -48.83 80.09 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.639 1.109 . . . . 0.0 111.753 174.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.4 mmt -60.63 -42.01 96.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.67 -45.92 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.677 0.791 . . . . 0.0 111.548 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -76.91 -47.81 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -101.13 -34.87 9.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -168.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.99 -14.2 48.2 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.166 0.894 . . . . 0.0 112.228 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.63 80.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.076 1.322 . . . . 0.0 113.757 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.83 144.48 52.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.539 1.169 . . . . 0.0 111.302 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -80.2 135.2 36.22 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.691 -0.631 . . . . 0.0 109.636 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -51.79 -34.43 39.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.964 1.305 . . . . 0.0 113.987 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.89 -22.25 9.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.838 1.655 . . . . 0.0 115.134 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -82.35 -9.23 59.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.684 1.194 . . . . 0.0 113.932 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 mt -116.99 128.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.61 1.095 . . . . 0.0 111.26 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.23 134.08 47.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.441 1.496 . . . . 0.0 110.682 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 124.983 1.313 . . . . 0.0 108.153 171.466 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.504 2.273 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -163.65 -174.86 3.87 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.726 1.61 . . . . 0.0 110.871 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -154.67 146.87 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.786 1.634 . . . . 0.0 111.261 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.42 145.02 27.65 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.705 1.202 . . . . 0.0 111.683 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -153.26 146.43 24.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.298 1.439 . . . . 0.0 111.331 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.66 122.47 19.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.393 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -80.44 -36.95 32.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.9 t -173.31 177.73 2.57 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.002 2.121 . . . . 0.0 110.39 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.45 153.49 27.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.711 1.604 . . . . 0.0 111.834 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -79.91 147.76 66.86 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -89.26 -144.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 124.37 3.38 . . . . 0.0 110.152 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -104.05 -4.03 23.79 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.116 1.766 . . . . 0.0 114.071 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.05 144.4 56.74 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.626 1.17 . . . . 0.0 113.532 -171.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -165.2 162.17 19.82 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.768 2.027 . . . . 0.0 110.703 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.7 p -77.24 157.37 30.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.808 1.243 . . . . 0.0 112.374 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.88 154.41 26.7 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.839 1.209 . . . . 0.0 113.224 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -138.96 8.57 2.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.632 1.573 . . . . 0.0 113.889 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.92 158.0 36.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.47 1.508 . . . . 0.0 113.847 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.4 146.58 16.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.826 1.65 . . . . 0.0 110.276 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.3 m -61.88 132.0 51.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.732 1.613 . . . . 0.0 112.022 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.12 158.51 17.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.358 1.463 . . . . 0.0 112.5 171.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -65.37 141.5 58.54 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.482 1.913 . . . . 0.0 112.237 -172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.2 m -68.78 148.62 50.05 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 t30 174.49 126.45 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 130.21 3.404 . . . . 0.0 108.092 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -72.68 136.81 45.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.68 140.4 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.089 2.155 . . . . 0.0 108.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -119.54 125.44 48.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.556 1.142 . . . . 0.0 110.31 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 51.8 mt -116.09 111.73 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.526 -1.286 . . . . 0.0 107.526 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -120.24 152.12 38.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.26 1.424 . . . . 0.0 110.342 -170.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.6 143.26 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -108.02 150.39 27.2 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.84 1.656 . . . . 0.0 112.087 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.36 125.6 41.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.921 1.688 . . . . 0.0 107.852 168.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -140.82 158.23 44.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.547 1.139 . . . . 0.0 111.391 -171.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -63.44 -16.84 61.77 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.36 0.87 78.89 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.008 1.29 . . . . 0.0 114.613 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 78.54 -16.91 0.62 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.879 2.871 . . . . 0.0 114.356 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.37 142.01 55.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.232 0.924 . . . . 0.0 112.79 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.0 m -89.78 131.37 35.77 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 167.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.5 mt -128.94 152.31 48.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.989 0.916 . . . . 0.0 110.414 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -105.13 118.16 35.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.657 1.583 . . . . 0.0 108.8 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -98.36 126.71 43.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.429 1.492 . . . . 0.0 110.407 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.71 126.55 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.019 1.328 . . . . 0.0 109.485 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -136.66 146.78 46.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.617 1.567 . . . . 0.0 110.329 -169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.03 -6.17 82.03 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.9 p -52.44 133.65 43.79 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -52.94 138.09 61.48 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.802 3.002 . . . . 0.0 113.267 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.04 -16.18 63.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.842 0.857 . . . . 0.0 113.113 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.79 -18.3 64.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.129 0.972 . . . . 0.0 113.34 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -92.85 120.76 33.53 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.687 1.195 . . . . 0.0 110.511 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.51 124.05 22.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.329 0.652 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -60.85 -38.59 86.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.026 0.53 . . . . 0.0 111.266 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.19 -34.46 73.66 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 113.19 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -70.67 -37.76 73.68 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.408 -0.808 . . . . 0.0 111.441 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.3 mt -58.87 -47.87 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mt -54.82 -47.66 73.78 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.963 0.802 . . . . 0.0 111.561 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.26 -42.75 99.16 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 112.33 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.71 -46.42 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.127 0.571 . . . . 0.0 111.184 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.72 -27.71 65.2 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -78.76 -35.18 44.94 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.86 -1.15 . . . . 0.0 113.071 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -77.49 -59.35 2.82 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.988 0.915 . . . . 0.0 113.103 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.45 -39.78 14.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.326 1.051 . . . . 0.0 113.373 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.92 -13.11 34.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.855 0.862 . . . . 0.0 113.198 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.99 28.1 16.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.172 1.789 . . . . 0.0 113.332 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.33 -170.83 3.29 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.621 1.168 . . . . 0.0 111.1 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -144.62 150.9 38.19 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.233 1.013 . . . . 0.0 109.589 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.67 172.02 45.06 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.544 0.977 . . . . 0.0 115.544 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -154.22 158.53 40.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.355 1.862 . . . . 0.0 111.568 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.8 mt -89.49 128.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.7 t -140.41 142.09 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.877 1.271 . . . . 0.0 109.474 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -100.81 110.39 22.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.446 0.699 . . . . 0.0 111.187 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.98 143.81 46.57 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.981 1.312 . . . . 0.0 111.354 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -56.93 -33.51 95.32 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.537 2.825 . . . . 0.0 114.656 176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -106.96 -47.18 3.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.617 1.167 . . . . 0.0 112.019 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 57.9 mtt -84.17 -12.46 54.85 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.01 -159.96 47.86 Favored Glycine 0 N--CA 1.469 0.893 0 C-N-CA 124.45 1.024 . . . . 0.0 113.119 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -72.72 117.79 14.84 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.173 0.989 . . . . 0.0 111.258 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 pt -145.72 157.12 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.397 1.879 . . . . 0.0 111.668 -169.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.09 132.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.41 132.38 49.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.048 1.339 . . . . 0.0 108.13 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.26 143.02 47.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.926 1.69 . . . . 0.0 108.382 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.4 136.45 46.08 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.195 -0.941 . . . . 0.0 111.523 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.98 48.87 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.666 1.603 . . . . 0.0 113.63 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.93 87.46 4.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.53 1.932 . . . . 0.0 110.969 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -109.86 22.66 15.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.426 1.49 . . . . 0.0 112.985 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 43.1 ptt85 -57.37 -46.75 83.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 0.0 114.141 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.67 84.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.8 -47.24 78.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.178 0.991 . . . . 0.0 112.06 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.1 -36.24 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.978 -0.451 . . . . 0.0 111.35 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.45 -50.21 72.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.02 -38.11 81.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.929 . . . . 0.0 112.874 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -60.26 -49.37 77.86 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.003 1.274 . . . . 0.0 111.64 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.83 -38.27 87.55 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.236 1.015 . . . . 0.0 111.23 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.82 -47.11 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.64 0.776 . . . . 0.0 111.574 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -75.38 -48.22 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.198 0.999 . . . . 0.0 113.43 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -97.6 -32.68 11.66 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.93 -18.28 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.774 0.715 . . . . 0.0 112.719 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.54 10.32 85.4 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.618 1.104 . . . . 0.0 114.184 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.02 132.44 45.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.218 1.009 . . . . 0.0 110.014 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -76.23 136.29 39.69 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.477 -0.765 . . . . 0.0 110.95 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -48.99 -37.65 20.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.503 . . . . 0.0 114.841 -169.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -53.62 -23.14 10.2 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.535 1.534 . . . . 0.0 114.886 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -77.43 -14.33 59.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.99 1.316 . . . . 0.0 114.365 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.6 mt -105.58 119.3 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 119.454 1.024 . . . . 0.0 110.407 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -96.05 130.43 43.06 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.143 1.377 . . . . 0.0 109.922 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.17 129.35 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 108.919 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -125.31 141.9 51.81 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.151 1.38 . . . . 0.0 111.525 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.14 -144.29 6.94 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.807 1.194 . . . . 0.0 112.857 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 p90 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.588 1.955 . . . . 0.0 112.739 178.864 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 tpp . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 t 70.28 -171.57 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.234 1.813 . . . . 0.0 113.144 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.47 161.31 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.881 2.072 . . . . 0.0 111.427 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -75.41 131.16 40.0 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.436 0.694 . . . . 0.0 110.948 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.97 53.6 1.72 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.294 1.438 . . . . 0.0 113.238 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.87 -42.47 84.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.346 1.458 . . . . 0.0 113.335 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -168.67 151.96 5.4 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.97 1.708 . . . . 0.0 112.728 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 p -78.83 -52.49 8.26 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.673 1.189 . . . . 0.0 111.211 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 t80 74.09 164.52 0.28 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.421 2.688 . . . . 0.0 113.773 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -82.41 129.96 61.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.619 1.168 . . . . 0.0 111.801 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -86.14 -135.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.267 3.311 . . . . 0.0 109.638 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.95 -141.11 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.686 1.594 . . . . 0.0 111.732 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.99 -163.77 0.2 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.597 1.559 . . . . 0.0 112.941 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -148.0 48.82 1.06 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.394 1.478 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -71.96 168.24 18.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.203 1.801 . . . . 0.0 112.813 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.78 155.22 51.87 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.09 0.853 . . . . 0.0 113.587 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.55 150.65 48.04 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.157 1.383 . . . . 0.0 112.783 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -149.31 153.17 37.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.623 1.169 . . . . 0.0 112.138 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.61 125.09 28.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.369 1.068 . . . . 0.0 111.17 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.2 m 72.34 -39.33 0.44 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.194 2.598 . . . . 0.0 113.376 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.65 31.05 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.964 2.106 . . . . 0.0 115.538 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m 76.8 -34.42 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 128.116 2.566 . . . . 0.0 113.833 169.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 m -58.14 114.81 2.55 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.898 1.279 . . . . 0.0 113.303 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -177.16 141.58 0.33 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.54 2.336 . . . . 0.0 109.585 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -128.63 134.41 48.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.203 1.002 . . . . 0.0 113.012 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.3 mt -108.77 130.35 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 127.631 2.372 . . . . 0.0 106.827 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -118.47 117.62 29.5 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 109.748 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.6 mt -109.54 103.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -110.98 174.4 5.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.264 2.225 . . . . 0.0 110.594 -169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.84 147.84 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.169 0.988 . . . . 0.0 109.082 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -87.93 133.26 33.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.792 1.237 . . . . 0.0 109.079 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.05 152.21 41.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.961 0.904 . . . . 0.0 112.304 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -78.91 132.26 36.69 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.144 0.977 . . . . 0.0 111.899 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -168.02 69.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.043 2.137 . . . . 0.0 109.388 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.83 -37.32 2.31 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.571 1.558 . . . . 0.0 113.329 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -61.78 154.57 25.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 112.594 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.37 177.85 8.54 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.006 0.923 . . . . 0.0 110.29 166.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.6 m -68.78 129.99 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.233 -0.917 . . . . 0.0 109.182 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 mt -128.27 147.2 50.59 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.751 1.221 . . . . 0.0 109.856 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 m -98.68 123.6 42.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.808 1.643 . . . . 0.0 108.778 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.82 115.81 30.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.289 1.836 . . . . 0.0 110.225 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.44 127.4 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.581 1.152 . . . . 0.0 109.845 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.41 152.5 51.47 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.343 1.857 . . . . 0.0 110.211 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.48 -3.79 71.64 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.61 132.55 71.62 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.676 1.238 . . . . 0.0 110.86 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -54.78 143.22 71.59 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.781 2.987 . . . . 0.0 113.169 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.86 -18.2 64.11 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.47 -19.51 65.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.974 0.91 . . . . 0.0 113.37 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -91.5 109.57 20.86 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.681 1.192 . . . . 0.0 110.285 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.89 118.83 10.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.203 1.001 . . . . 0.0 112.144 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -60.65 -38.2 84.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.462 0.705 . . . . 0.0 111.847 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.61 -38.14 89.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.208 1.003 . . . . 0.0 112.332 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -64.35 -38.06 89.7 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.201 -0.937 . . . . 0.0 111.928 170.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.64 -40.2 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.618 0.767 . . . . 0.0 110.1 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.6 -55.28 37.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.185 0.902 . . . . 0.0 110.749 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.35 -49.27 72.7 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.8 p -70.11 -36.87 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.37 -34.44 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.974 0.806 . . . . 0.0 112.034 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.28 -32.69 74.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.671 -1.268 . . . . 0.0 112.511 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -78.16 -67.63 0.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 112.889 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.22 -34.52 25.86 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -93.68 -4.15 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 112.65 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.43 28.42 16.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.157 1.783 . . . . 0.0 113.158 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.8 m -82.92 -174.9 5.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.551 1.14 . . . . 0.0 112.499 -174.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.41 145.29 35.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.474 1.51 . . . . 0.0 108.712 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.92 172.59 45.54 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.33 163.62 37.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.591 1.556 . . . . 0.0 112.866 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.36 134.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.883 1.273 . . . . 0.0 109.467 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -132.95 140.64 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.482 1.513 . . . . 0.0 109.463 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -100.43 105.2 16.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.518 0.727 . . . . 0.0 109.241 169.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.16 144.78 39.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.993 1.317 . . . . 0.0 111.545 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.45 -33.92 98.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.373 2.715 . . . . 0.0 114.552 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -107.24 -48.22 3.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.873 1.269 . . . . 0.0 112.014 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.7 mtt -78.05 -19.05 55.02 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.09 -157.74 45.31 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.177 0.894 . . . . 0.0 112.522 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -70.67 118.72 13.83 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.75 0.82 . . . . 0.0 111.274 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt -139.74 151.39 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.457 1.903 . . . . 0.0 112.101 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -95.34 133.63 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -104.45 128.07 52.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.15 1.38 . . . . 0.0 107.815 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.73 141.41 48.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.983 1.713 . . . . 0.0 108.483 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -72.75 137.48 45.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.858 1.208 . . . . 0.0 111.799 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.77 -175.78 47.25 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.692 1.615 . . . . 0.0 113.693 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.7 84.53 5.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.355 1.862 . . . . 0.0 111.098 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.79 14.62 26.52 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 112.919 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -59.32 -41.54 89.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.53 63.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.089 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -63.74 -44.81 92.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.936 0.894 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.7 -35.39 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.399 0.68 . . . . 0.0 111.246 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.8 t -56.47 -47.8 78.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.541 1.064 . . . . 0.0 111.156 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.81 -39.74 90.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.576 0.751 . . . . 0.0 112.438 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 28.4 t80 -60.09 -48.39 81.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.725 1.148 . . . . 0.0 111.792 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mmt -59.57 -43.27 93.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.582 1.153 . . . . 0.0 110.604 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.23 -45.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.693 0.797 . . . . 0.0 111.711 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -75.71 -47.15 27.3 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -102.24 -37.43 8.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.0 mt -89.36 -17.02 29.68 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.894 0.77 . . . . 0.0 112.723 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.97 15.99 80.44 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.461 1.029 . . . . 0.0 113.639 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.64 136.22 52.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.213 1.007 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -76.8 139.09 40.24 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.615 -0.678 . . . . 0.0 109.909 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -53.8 -37.55 63.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -56.69 -24.7 50.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.392 1.477 . . . . 0.0 114.981 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -76.86 -16.09 59.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.32 0.964 . . . . 0.0 113.277 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.86 126.24 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.294 1.407 . . . . 0.0 112.123 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -103.15 134.6 46.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.016 1.726 . . . . 0.0 110.27 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.41 128.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.98 1.312 . . . . 0.0 108.428 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -125.06 169.57 12.02 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.763 1.225 . . . . 0.0 113.151 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.39 -139.33 9.8 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.543 1.544 . . . . 0.0 111.863 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 126.466 1.906 . . . . 0.0 113.283 177.619 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.502 2.175 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 p -160.07 -67.45 0.07 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.581 1.152 . . . . 0.0 111.066 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 tt -163.39 162.46 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 127.055 2.142 . . . . 0.0 110.024 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -63.78 123.36 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.466 0.706 . . . . 0.0 110.448 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -64.8 -16.58 63.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.78 -7.26 59.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.505 1.522 . . . . 0.0 113.551 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -59.25 138.06 57.75 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.457 1.026 . . . . 0.0 112.593 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.9 p -111.81 162.05 15.68 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.093 1.357 . . . . 0.0 113.374 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -164.12 151.78 12.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.657 1.983 . . . . 0.0 110.283 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -164.34 163.05 15.34 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.035 1.734 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.15 -14.72 35.3 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.736 2.957 . . . . 0.0 116.338 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -106.76 6.3 29.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.676 1.591 . . . . 0.0 112.01 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.57 -11.51 60.98 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.361 1.464 . . . . 0.0 114.131 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.35 140.29 58.86 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.073 1.349 . . . . 0.0 112.251 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.0 p -73.88 143.76 45.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.798 1.239 . . . . 0.0 112.84 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.41 -159.93 34.95 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.244 1.402 . . . . 0.0 113.018 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -71.26 -19.22 62.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.513 1.125 . . . . 0.0 113.437 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -153.81 154.57 34.21 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.428 1.891 . . . . 0.0 110.875 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -87.97 115.74 25.65 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 0.0 110.927 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.5 p -91.18 -18.78 23.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.394 1.478 . . . . 0.0 113.758 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.98 141.16 47.74 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.41 1.084 . . . . 0.0 112.93 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -81.49 -29.77 33.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.467 1.507 . . . . 0.0 112.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -63.46 140.73 58.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.936 1.294 . . . . 0.0 114.318 -172.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.92 144.54 48.93 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.897 0.879 . . . . 0.0 112.001 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -137.61 148.95 46.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.422 1.489 . . . . 0.0 110.95 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.98 119.54 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -103.6 121.08 42.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.842 0.857 . . . . 0.0 110.076 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.28 103.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -113.16 171.23 7.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.971 2.108 . . . . 0.0 110.21 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.58 145.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -80.25 152.99 28.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.816 0.846 . . . . 0.0 111.539 -177.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.51 154.92 40.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.278 1.431 . . . . 0.0 112.345 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -80.06 110.26 15.29 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.857 0.863 . . . . 0.0 110.729 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -136.52 25.75 3.14 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.832 1.653 . . . . 0.0 112.034 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.91 -4.99 83.53 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.613 1.578 . . . . 0.0 114.555 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -90.19 165.49 13.92 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.652 1.581 . . . . 0.0 111.46 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -65.86 161.42 21.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.913 0.885 . . . . 0.0 112.345 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.8 m -68.3 133.83 49.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.81 1.244 . . . . 0.0 109.85 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.8 mt -133.47 134.98 44.2 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.82 1.248 . . . . 0.0 110.234 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -89.95 116.98 28.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.614 1.566 . . . . 0.0 108.26 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.57 117.19 32.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.952 1.701 . . . . 0.0 110.005 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.93 126.66 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 108.922 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -138.02 159.11 42.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.871 2.068 . . . . 0.0 109.233 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.23 -14.97 2.74 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.289 -1.507 . . . . 0.0 116.103 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.02 130.57 7.22 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 126.207 1.803 . . . . 0.0 112.151 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.43 139.41 65.23 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.241 3.294 . . . . 0.0 113.413 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.96 -11.14 60.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.15 -18.97 61.84 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.114 0.966 . . . . 0.0 113.018 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -90.8 119.72 31.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.561 1.144 . . . . 0.0 110.961 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.79 119.86 16.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 111.568 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -62.75 -38.39 90.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.297 0.639 . . . . 0.0 111.901 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.93 -39.51 89.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.936 0.895 . . . . 0.0 112.225 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -63.49 -39.62 94.92 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.227 -0.921 . . . . 0.0 111.943 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.48 -47.38 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.919 0.781 . . . . 0.0 109.103 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.72 -48.09 75.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.155 0.889 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -62.38 -39.71 94.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.438 -0.789 . . . . 0.0 112.443 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.97 -46.67 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.869 0.759 . . . . 0.0 111.147 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.42 -30.52 67.4 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.05 -31.86 63.06 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.837 -1.164 . . . . 0.0 112.974 171.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -80.01 -61.93 1.84 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.237 1.015 . . . . 0.0 113.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.14 -37.32 20.35 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -92.98 -13.13 29.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.876 0.871 . . . . 0.0 113.002 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.05 29.47 17.66 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.175 1.79 . . . . 0.0 113.012 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.7 m -82.43 -172.1 3.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.697 1.199 . . . . 0.0 111.284 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -146.34 152.76 39.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 109.944 168.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.9 176.23 47.92 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 115.451 0.94 . . . . 0.0 115.451 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -158.33 162.12 37.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.328 1.851 . . . . 0.0 111.64 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 143.79 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 108.985 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.44 132.53 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.436 1.094 . . . . 0.0 109.259 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -94.07 89.31 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.725 1.21 . . . . 0.0 109.273 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.06 142.41 64.21 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.91 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -57.8 -33.03 96.35 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.496 2.797 . . . . 0.0 114.67 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -107.76 -47.63 3.56 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 112.042 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.6 mtt -80.26 -17.82 51.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.56 -158.81 52.77 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.25 0.932 . . . . 0.0 112.289 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -77.17 116.77 18.08 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.691 0.796 . . . . 0.0 112.317 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -134.92 151.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.985 2.114 . . . . 0.0 111.642 -174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.33 134.79 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.05 126.01 51.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.887 1.675 . . . . 0.0 107.491 168.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -113.27 140.46 47.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.231 1.412 . . . . 0.0 108.376 170.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -71.41 135.19 47.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.135 -0.978 . . . . 0.0 111.705 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 -169.86 45.88 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.453 1.501 . . . . 0.0 113.539 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.13 87.54 3.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.706 2.002 . . . . 0.0 111.205 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -112.35 20.25 16.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.584 1.553 . . . . 0.0 112.939 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.75 -42.03 92.3 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.38 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.056 0.942 . . . . 0.0 112.154 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.71 -45.15 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.868 0.867 . . . . 0.0 111.811 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.14 -34.81 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.09 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.0 -49.07 78.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.338 0.972 . . . . 0.0 111.162 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.13 -37.81 78.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.83 0.852 . . . . 0.0 112.652 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.36 -48.54 80.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.867 1.212 . . . . 0.0 111.664 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.6 mmt -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.051 0.94 . . . . 0.0 110.734 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.03 -47.89 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.954 0.902 . . . . 0.0 111.417 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -97.94 -33.21 11.3 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.98 -14.22 39.69 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.83 0.741 . . . . 0.0 112.107 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.81 79.75 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.865 1.221 . . . . 0.0 113.899 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.3 mt -71.41 144.07 49.92 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.434 1.117 . . . . 0.0 111.783 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -75.21 138.25 41.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -54.32 -34.86 61.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -55.65 -21.71 19.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.524 1.93 . . . . 0.0 115.311 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -76.68 -10.56 59.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.1 mt -112.86 133.17 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.049 0.94 . . . . 0.0 111.153 -169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.34 128.25 54.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.535 1.934 . . . . 0.0 110.153 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.81 129.65 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.83 1.252 . . . . 0.0 109.077 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -126.36 173.9 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.893 1.277 . . . . 0.0 113.138 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.41 -141.25 12.02 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.481 1.515 . . . . 0.0 112.115 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.931 2.092 . . . . 0.0 112.891 175.659 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -76.17 -38.37 56.73 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.231 -0.918 . . . . 0.0 112.761 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm -81.01 77.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -158.08 -18.56 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.737 1.215 . . . . 0.0 114.024 -168.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.163 -0.961 . . . . 0.0 112.137 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 pp -100.94 163.86 12.1 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.121 1.368 . . . . 0.0 112.952 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -165.4 149.36 8.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.847 2.059 . . . . 0.0 110.119 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -60.06 153.59 21.26 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.334 1.054 . . . . 0.0 113.763 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.645 1.578 . . . . 0.0 111.504 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.39 136.14 96.2 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.999 0.92 . . . . 0.0 112.547 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.18 -12.05 33.07 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.581 2.854 . . . . 0.0 115.128 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -135.36 -155.63 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.548 1.539 . . . . 0.0 110.695 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.89 -176.01 4.7 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.925 2.09 . . . . 0.0 111.185 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -143.27 146.95 34.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.408 1.483 . . . . 0.0 111.417 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -152.53 141.06 20.75 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.5 -145.86 18.42 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.41 1.481 . . . . 0.0 113.52 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -131.59 160.82 34.21 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.217 1.807 . . . . 0.0 110.852 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 152.56 45.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.877 0.871 . . . . 0.0 113.326 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -154.32 149.28 26.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.96 1.304 . . . . 0.0 111.025 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.9 m -76.26 78.44 3.04 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.789 1.236 . . . . 0.0 110.772 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.68 161.73 37.15 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.704 2.001 . . . . 0.0 111.311 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -151.82 170.6 19.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.885 1.274 . . . . 0.0 112.565 -169.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.3 m -139.93 143.13 36.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.747 2.019 . . . . 0.0 110.244 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -68.93 -32.75 72.58 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 61.4 m-85 -120.53 139.73 52.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.543 1.137 . . . . 0.0 113.724 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mt -113.98 134.36 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 128.084 2.554 . . . . 0.0 107.122 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -118.12 111.43 18.86 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 111.005 -169.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -104.89 110.28 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -118.06 164.89 14.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.512 1.925 . . . . 0.0 109.696 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -116.94 143.19 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -101.01 155.16 18.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.886 1.274 . . . . 0.0 110.769 -171.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -68.04 142.47 55.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.355 0.662 . . . . 0.0 109.691 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -80.04 80.26 6.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.733 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -82.39 -31.14 29.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.469 1.107 . . . . 0.0 111.959 171.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.9 -165.62 41.5 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.008 1.29 . . . . 0.0 111.924 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -67.5 -29.08 68.4 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -141.41 154.89 45.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.242 1.417 . . . . 0.0 112.245 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.3 m -68.19 147.56 52.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 110.782 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.26 147.28 50.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.653 1.181 . . . . 0.0 111.729 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.3 m -93.62 118.02 30.84 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.481 1.513 . . . . 0.0 108.304 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.61 115.36 29.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.646 1.578 . . . . 0.0 110.001 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.66 126.89 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 109.288 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -137.62 161.01 37.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.717 2.007 . . . . 0.0 109.412 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 -13.43 8.14 Favored Glycine 0 N--CA 1.477 1.387 0 O-C-N 120.092 -1.63 . . . . 0.0 116.056 169.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -49.97 132.23 22.41 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.974 1.309 . . . . 0.0 111.061 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.83 136.73 51.62 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.086 3.19 . . . . 0.0 113.001 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.83 -3.04 29.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 -17.2 61.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 167.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.4 126.6 40.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.166 1.386 . . . . 0.0 110.247 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -77.64 131.25 37.68 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.608 -0.682 . . . . 0.0 110.84 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.4 -37.57 83.92 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.336 0.654 . . . . 0.0 111.678 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -61.15 -33.31 73.21 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.868 0.867 . . . . 0.0 112.601 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.6 -39.49 84.77 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.261 0.937 . . . . 0.0 111.516 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.04 -47.02 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 0.0 109.196 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.27 -47.08 76.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.766 0.712 . . . . 0.0 111.872 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -62.48 -39.3 93.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.725 0.693 . . . . 0.0 112.351 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.13 -48.17 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 118.985 0.811 . . . . 0.0 111.13 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.46 -29.76 67.5 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.22 -26.87 56.5 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.691 -1.256 . . . . 0.0 113.56 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.56 -49.58 5.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.96 -40.9 17.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.973 0.909 . . . . 0.0 112.953 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.71 -9.75 36.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.651 1.18 . . . . 0.0 112.606 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.32 30.84 20.12 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.934 1.694 . . . . 0.0 112.659 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.08 -165.07 1.27 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.558 1.143 . . . . 0.0 111.335 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.17 146.42 26.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.78 0.832 . . . . 0.0 110.971 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.47 176.17 46.13 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -155.71 164.46 38.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.131 1.773 . . . . 0.0 111.086 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mt -103.08 139.7 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.39 1.476 . . . . 0.0 110.055 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -136.22 143.05 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.124 1.37 . . . . 0.0 109.182 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.59 103.49 15.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.022 0.929 . . . . 0.0 110.618 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -86.14 144.66 39.03 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.203 1.401 . . . . 0.0 111.487 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.77 -31.37 92.08 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.536 2.824 . . . . 0.0 114.711 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -111.17 -46.37 3.32 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.706 1.202 . . . . 0.0 112.437 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.5 mtt -78.02 -18.21 56.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.53 -157.3 47.56 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.77 1.176 . . . . 0.0 112.746 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.76 109.25 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.859 0.864 . . . . 0.0 110.322 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.64 148.84 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.547 1.939 . . . . 0.0 111.829 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.15 133.23 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -103.78 117.4 34.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.823 1.649 . . . . 0.0 107.005 167.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.45 145.14 30.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.894 1.278 . . . . 0.0 108.898 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.83 131.0 44.42 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.538 -0.726 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -167.05 47.82 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.707 1.146 . . . . 0.0 113.662 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -97.69 93.0 6.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.585 1.954 . . . . 0.0 111.25 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -116.87 22.4 12.66 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.417 1.487 . . . . 0.0 113.072 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -58.52 -45.47 88.73 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.26 77.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.991 0.916 . . . . 0.0 112.198 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -65.89 -45.59 81.44 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 111.954 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.99 -35.41 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.254 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.3 t -57.37 -48.22 79.61 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.106 0.866 . . . . 0.0 111.09 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.49 -37.86 87.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.475 0.71 . . . . 0.0 112.766 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.49 -49.93 75.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.792 1.178 . . . . 0.0 111.383 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -58.92 -43.89 91.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 110.672 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.42 -44.29 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.578 0.751 . . . . 0.0 111.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.9 t -76.36 -48.09 21.15 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -99.46 -35.48 9.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.44 -14.25 30.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.878 0.763 . . . . 0.0 112.834 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.58 15.16 81.26 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.583 1.087 . . . . 0.0 113.784 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.33 148.64 49.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.316 1.058 . . . . 0.0 110.109 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -86.58 144.83 27.01 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.376 -0.828 . . . . 0.0 110.031 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -52.93 -39.63 62.98 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.653 -0.655 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -59.5 -21.03 59.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.543 1.537 . . . . 0.0 114.983 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -77.46 -14.29 59.72 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.075 0.852 . . . . 0.0 113.204 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.5 mt -108.05 122.67 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 120.317 1.417 . . . . 0.0 111.607 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 73.0 mmtt -98.94 123.79 43.45 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.374 1.87 . . . . 0.0 109.627 169.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -101.99 120.92 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -103.96 -32.49 9.22 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.31 -139.21 35.32 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 p90 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.078 1.751 . . . . 0.0 113.234 176.874 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -68.8 148.83 49.73 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.118 0.967 . . . . 0.0 112.514 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 mt -86.69 85.93 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.355 -0.841 . . . . 0.0 109.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -161.42 134.35 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.779 1.632 . . . . 0.0 110.068 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -164.28 132.8 3.57 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.375 1.47 . . . . 0.0 111.231 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -119.03 137.54 53.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.241 1.416 . . . . 0.0 109.644 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -170.82 166.06 7.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.576 1.951 . . . . 0.0 112.048 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -86.66 136.09 33.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.874 0.87 . . . . 0.0 111.201 171.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -165.37 171.63 13.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.99 1.716 . . . . 0.0 111.472 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.48 151.91 19.05 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.524 1.529 . . . . 0.0 111.783 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.481 2.787 . . . . 0.0 112.662 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -171.42 145.09 2.05 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.423 2.289 . . . . 0.0 110.008 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.89 -20.96 29.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.081 0.952 . . . . 0.0 113.428 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -162.75 156.61 20.56 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.516 1.926 . . . . 0.0 111.023 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -106.98 163.36 13.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.746 1.618 . . . . 0.0 112.525 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.31 179.71 51.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.844 1.211 . . . . 0.0 114.779 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -160.65 -153.33 0.32 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.996 2.119 . . . . 0.0 110.421 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.15 147.82 46.27 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.679 -1.263 . . . . 0.0 113.386 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.23 -10.46 42.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.571 1.548 . . . . 0.0 114.539 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 t -56.42 -25.42 50.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.28 1.432 . . . . 0.0 113.695 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.29 83.38 1.89 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 110.903 170.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.4 t -157.62 172.28 18.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.084 2.153 . . . . 0.0 110.904 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m 69.74 -11.32 0.53 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.892 2.477 . . . . 0.0 114.66 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.34 174.23 9.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.211 1.804 . . . . 0.0 113.356 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -72.38 141.1 48.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.62 133.57 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.632 1.573 . . . . 0.0 107.63 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -118.53 122.78 43.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.32 1.048 . . . . 0.0 110.494 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -116.58 111.09 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -120.55 174.21 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.411 1.484 . . . . 0.0 110.952 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -113.01 133.59 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -108.14 128.96 55.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.634 1.974 . . . . 0.0 108.683 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -74.91 153.25 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.655 0.782 . . . . 0.0 111.735 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 121.0 13.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.535 1.134 . . . . 0.0 109.924 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -63.82 109.43 1.74 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.619 0.767 . . . . 0.0 112.201 -172.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 15.55 70.41 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.606 1.098 . . . . 0.0 114.794 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -136.96 178.2 7.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.799 1.639 . . . . 0.0 112.002 -169.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -53.9 140.05 31.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 114.118 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -68.53 142.01 55.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.487 1.515 . . . . 0.0 108.908 168.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.6 mt -127.07 138.4 53.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.874 0.87 . . . . 0.0 111.087 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -93.81 119.48 32.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 108.547 169.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -101.43 123.53 45.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.207 1.403 . . . . 0.0 110.608 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.27 123.88 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.584 1.154 . . . . 0.0 109.114 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.61 152.52 48.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.301 1.84 . . . . 0.0 109.33 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 -5.14 63.95 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.914 -1.116 . . . . 0.0 115.879 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.31 129.45 51.36 Favored Pre-proline 0 N--CA 1.477 0.918 0 CA-C-N 119.475 1.638 . . . . 0.0 109.89 170.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -51.32 140.7 42.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.842 3.028 . . . . 0.0 113.679 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.83 -3.47 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.87 -18.41 62.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 0.0 111.912 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -92.41 133.1 36.21 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.048 1.339 . . . . 0.0 111.319 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.79 117.63 17.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.224 1.009 . . . . 0.0 111.192 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.53 -39.99 89.87 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 111.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -56.91 -35.99 69.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 113.812 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -71.51 -35.81 70.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.949 0.9 . . . . 0.0 111.847 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.47 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.796 0.839 . . . . 0.0 109.717 173.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.25 -55.77 30.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.26 0.936 . . . . 0.0 110.443 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -54.15 -48.73 70.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.378 1.071 . . . . 0.0 113.217 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.4 p -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.57 -31.97 65.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.102 0.865 . . . . 0.0 112.261 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.54 -34.85 72.72 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.773 -1.205 . . . . 0.0 112.426 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -75.27 -59.28 2.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.475 1.11 . . . . 0.0 113.34 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.61 -38.83 15.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.192 0.997 . . . . 0.0 113.675 -169.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.4 -4.79 50.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.985 0.914 . . . . 0.0 113.013 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.13 24.5 13.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.087 1.755 . . . . 0.0 113.3 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.2 m -81.96 -171.96 3.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.849 1.26 . . . . 0.0 112.012 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -144.81 153.83 42.04 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.888 1.275 . . . . 0.0 109.256 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.01 176.46 46.85 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 -169.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.14 164.73 30.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.232 1.813 . . . . 0.0 112.067 -171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.15 146.37 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -136.17 142.19 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.593 1.557 . . . . 0.0 108.704 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -110.74 93.62 4.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.77 0.828 . . . . 0.0 110.008 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.02 145.87 37.29 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.452 1.501 . . . . 0.0 112.153 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.77 -33.83 97.39 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.501 2.801 . . . . 0.0 114.633 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -106.9 -47.4 3.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.777 1.231 . . . . 0.0 111.95 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.5 mtt -79.69 -16.5 55.58 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.97 -161.1 51.98 Favored Glycine 0 N--CA 1.47 0.958 0 C-N-CA 124.531 1.062 . . . . 0.0 113.219 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.43 112.18 8.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.447 1.099 . . . . 0.0 110.213 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 pt -136.63 153.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.669 1.988 . . . . 0.0 112.227 -171.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.9 mt -100.16 134.69 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 166.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -103.84 129.2 51.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.535 1.534 . . . . 0.0 107.501 168.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.24 142.53 46.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.335 1.454 . . . . 0.0 108.29 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -77.99 135.1 37.74 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.036 -1.04 . . . . 0.0 111.296 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.68 -172.1 44.05 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.713 1.625 . . . . 0.0 113.22 -174.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -97.8 88.44 4.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.465 1.906 . . . . 0.0 111.22 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -112.56 17.58 19.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.798 1.639 . . . . 0.0 113.014 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -59.21 -42.94 92.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -169.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.46 -38.59 74.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.964 0.905 . . . . 0.0 112.153 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.9 -44.77 84.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.75 -33.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.235 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -49.47 77.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.402 1.001 . . . . 0.0 111.042 170.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.0 -36.59 75.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.696 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.4 t80 -62.35 -49.36 75.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.781 1.173 . . . . 0.0 111.854 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.4 mmt -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.241 1.016 . . . . 0.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.53 -49.72 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.305 1.042 . . . . 0.0 111.782 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -75.62 -46.33 32.26 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -101.83 -36.66 8.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 mt -89.55 -18.49 26.51 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.953 0.797 . . . . 0.0 112.915 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.05 14.57 81.75 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.572 1.082 . . . . 0.0 113.618 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.16 134.55 49.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.292 1.046 . . . . 0.0 108.93 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -75.19 148.1 39.85 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.52 -0.738 . . . . 0.0 110.136 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -56.99 -36.63 70.59 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.704 -0.623 . . . . 0.0 112.338 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -64.42 -17.66 63.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.099 1.76 . . . . 0.0 115.199 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -79.69 -10.04 59.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.349 0.977 . . . . 0.0 113.202 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 42.3 mt -113.64 131.74 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.03 -1.044 . . . . 0.0 111.074 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -106.46 135.72 47.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.453 1.501 . . . . 0.0 110.628 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.05 126.94 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.63 1.172 . . . . 0.0 108.851 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -126.45 -161.54 1.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.583 1.553 . . . . 0.0 111.753 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.73 -151.12 18.91 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 125.182 1.372 . . . . 0.0 113.418 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.376 1.47 . . . . 0.0 114.151 -173.928 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 p -86.77 162.5 17.8 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.058 1.343 . . . . 0.0 113.085 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.288 39.6 pt 46.84 -142.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.92 2.088 . . . . 0.0 113.843 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.09 162.19 25.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.444 1.898 . . . . 0.0 111.216 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -74.18 156.41 37.34 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.189 0.995 . . . . 0.0 112.074 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -144.21 134.05 23.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.224 1.41 . . . . 0.0 110.795 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -79.17 153.73 29.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.831 1.252 . . . . 0.0 112.656 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -145.0 159.27 43.2 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.417 1.487 . . . . 0.0 110.68 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.91 132.58 49.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.212 1.005 . . . . 0.0 110.702 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -64.71 123.44 83.35 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.863 0.865 . . . . 0.0 111.598 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.96 46.86 2.33 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.957 3.105 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -169.99 140.82 2.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.705 2.402 . . . . 0.0 109.742 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -172.64 161.28 4.83 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.564 1.945 . . . . 0.0 111.157 -171.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -78.34 137.58 38.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.184 0.994 . . . . 0.0 112.065 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.2 p -147.97 155.25 41.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.304 1.841 . . . . 0.0 110.86 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.37 147.61 23.44 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.444 1.021 . . . . 0.0 112.551 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -85.18 125.36 32.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.542 1.137 . . . . 0.0 111.685 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -168.87 166.45 11.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.571 1.948 . . . . 0.0 111.01 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.27 133.11 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.736 1.614 . . . . 0.0 111.524 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.2 m -98.66 120.47 39.15 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.932 1.293 . . . . 0.0 109.383 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.74 -25.0 44.48 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -77.27 135.03 38.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 110.673 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -71.31 150.26 45.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.807 0.843 . . . . 0.0 113.061 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -158.04 163.26 37.88 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.045 1.338 . . . . 0.0 112.129 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.425 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 63.4 m-85 -75.53 142.32 42.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.43 131.49 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.141 1.776 . . . . 0.0 107.147 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -116.58 119.52 35.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 110.754 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mt -109.39 109.27 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -117.92 176.35 5.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.443 2.297 . . . . 0.0 110.892 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.91 147.63 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.126 -0.984 . . . . 0.0 110.117 168.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -126.88 143.13 51.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.707 2.003 . . . . 0.0 108.753 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -94.55 152.18 18.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.99 0.916 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -137.61 167.21 22.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.417 1.887 . . . . 0.0 110.235 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.68 143.32 42.04 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.982 0.913 . . . . 0.0 112.889 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -139.75 27.48 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.11 0.862 . . . . 0.0 112.042 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -83.59 -0.85 52.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.927 1.291 . . . . 0.0 113.681 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.36 131.26 43.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.415 1.086 . . . . 0.0 113.223 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 m -129.72 141.04 50.96 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.402 1.881 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt -123.48 148.73 45.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.875 1.27 . . . . 0.0 111.245 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.7 m -96.91 130.4 44.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.441 1.497 . . . . 0.0 107.548 168.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.34 122.54 46.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 110.569 -176.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.43 124.16 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.594 1.158 . . . . 0.0 109.525 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -130.22 150.85 51.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.567 1.947 . . . . 0.0 109.673 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.88 58.5 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.53 129.22 69.65 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 119.107 1.454 . . . . 0.0 110.407 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.64 141.84 51.99 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.036 3.157 . . . . 0.0 112.616 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -11.99 60.06 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.72 -22.58 66.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.574 0.75 . . . . 0.0 112.314 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -91.1 104.33 16.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.852 1.261 . . . . 0.0 109.44 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.02 125.32 24.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.73 0.812 . . . . 0.0 112.554 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.9 -40.08 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.428 0.691 . . . . 0.0 112.343 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -63.9 -39.13 93.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.581 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -64.64 -36.45 84.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.041 0.936 . . . . 0.0 112.328 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.8 -48.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.951 0.796 . . . . 0.0 109.326 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.45 -42.63 82.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.2 0.909 . . . . 0.0 112.174 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -58.72 -41.79 87.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.082 0.855 . . . . 0.0 112.255 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.94 -46.27 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.708 0.685 . . . . 0.0 111.534 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.9 -31.62 68.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HE2' ' H ' ' A' ' 66' ' ' GLY . 87.5 mttt -75.42 -29.76 59.85 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.952 -1.092 . . . . 0.0 113.117 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -83.35 -61.66 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.11 0.964 . . . . 0.0 113.278 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.83 -39.24 24.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.151 0.98 . . . . 0.0 113.239 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -93.31 -7.8 43.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.565 1.146 . . . . 0.0 113.082 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.21 27.38 15.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.713 . . . . 0.0 113.287 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.4 m -83.86 -174.4 5.26 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.591 1.157 . . . . 0.0 111.736 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -138.85 144.95 39.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.209 1.004 . . . . 0.0 109.439 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' H ' ' HE2' ' A' ' 59' ' ' LYS . . . -169.03 171.57 43.01 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 115.431 0.933 . . . . 0.0 115.431 -169.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -162.73 158.93 23.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.947 1.699 . . . . 0.0 112.128 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.16 137.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.712 1.205 . . . . 0.0 109.556 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.91 143.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.173 1.389 . . . . 0.0 110.199 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -102.94 104.28 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.46 146.16 41.32 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.37 1.468 . . . . 0.0 111.696 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.03 -32.17 97.01 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.395 2.73 . . . . 0.0 114.718 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.25 -47.64 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.712 1.205 . . . . 0.0 112.291 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -77.29 -18.23 57.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.95 -158.24 46.17 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.774 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.05 118.58 13.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.934 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt -144.87 154.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.947 1.699 . . . . 0.0 113.075 -169.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.81 134.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -101.87 140.67 35.84 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.488 1.515 . . . . 0.0 108.551 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.41 141.94 50.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.97 1.708 . . . . 0.0 108.433 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.41 138.03 44.98 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.016 -1.052 . . . . 0.0 111.923 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.7 -172.47 44.44 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.21 1.386 . . . . 0.0 113.412 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -94.04 99.01 11.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.719 1.207 . . . . 0.0 110.04 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.23 18.54 14.46 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.536 1.534 . . . . 0.0 112.544 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -52.45 -55.23 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.618 1.167 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.01 88.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.264 1.026 . . . . 0.0 112.49 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -66.46 -45.35 80.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.497 0.719 . . . . 0.0 112.041 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.82 -36.14 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.227 0.611 . . . . 0.0 110.961 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.78 -48.47 75.26 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.317 0.962 . . . . 0.0 111.193 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.9 -39.55 89.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.592 0.757 . . . . 0.0 112.767 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -59.91 -49.58 77.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.807 1.185 . . . . 0.0 111.465 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.9 mmt -58.32 -41.32 84.25 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.233 1.013 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.36 -50.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.505 -0.747 . . . . 0.0 111.491 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.2 m -89.46 -14.16 35.96 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.27 -39.94 3.33 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.087 1.312 . . . . 0.0 113.324 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.12 -15.08 39.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.495 1.043 . . . . 0.0 113.09 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.72 14.74 79.26 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.471 1.034 . . . . 0.0 113.709 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 mt -68.94 151.59 46.35 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.541 1.171 . . . . 0.0 109.956 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -88.03 145.28 26.06 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -55.4 -37.64 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -61.28 -18.07 56.68 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.55 -14.22 60.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.403 1.002 . . . . 0.0 112.974 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.2 mt -111.52 128.64 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.218 0.917 . . . . 0.0 111.233 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 71.5 mmtt -103.2 133.26 48.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.463 1.905 . . . . 0.0 109.79 169.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.55 129.89 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.074 0.949 . . . . 0.0 108.912 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -120.51 177.93 4.86 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.253 1.421 . . . . 0.0 112.246 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.84 -153.84 28.47 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.686 1.136 . . . . 0.0 113.628 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.988 2.115 . . . . 0.0 113.606 177.612 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.0 m -139.95 154.81 47.3 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.954 1.302 . . . . 0.0 111.767 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -86.22 151.67 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.465 1.106 . . . . 0.0 111.54 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.76 155.37 27.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.739 1.616 . . . . 0.0 110.844 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -76.1 155.9 34.32 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.95 171.53 14.98 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.552 1.141 . . . . 0.0 111.824 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -76.62 -176.0 3.6 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.9 p -69.53 155.6 40.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.723 1.209 . . . . 0.0 113.476 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -72.11 156.62 38.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.766 1.226 . . . . 0.0 112.56 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -112.23 85.68 7.11 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.571 1.548 . . . . 0.0 110.874 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.75 -25.35 39.86 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.202 2.601 . . . . 0.0 113.391 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -94.21 4.92 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.015 0.926 . . . . 0.0 113.066 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.2 -18.43 60.76 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.646 1.178 . . . . 0.0 113.529 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -69.18 128.92 38.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.497 1.119 . . . . 0.0 111.836 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 p -85.52 -17.0 37.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.494 1.518 . . . . 0.0 113.318 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -146.44 36.63 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.556 1.074 . . . . 0.0 113.191 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -139.43 156.21 47.11 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.001 1.72 . . . . 0.0 111.277 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.66 -17.35 61.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.367 1.067 . . . . 0.0 113.594 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.86 156.99 23.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.599 1.96 . . . . 0.0 110.915 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.4 p -77.77 133.72 38.19 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.58 1.152 . . . . 0.0 110.999 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.82 -20.42 60.46 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -138.54 160.15 40.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.117 2.167 . . . . 0.0 110.462 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.2 p -74.08 91.32 2.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.125 0.97 . . . . 0.0 111.526 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -66.64 136.77 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.76 0.824 . . . . 0.0 112.336 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 81.1 m-85 -80.42 140.88 35.78 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.77 124.98 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -110.36 125.99 53.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.942 0.897 . . . . 0.0 110.981 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.482 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.0 mt -116.61 117.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 108.258 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 mtt85 -129.59 174.59 9.53 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.79 1.636 . . . . 0.0 110.564 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.76 137.91 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 110.371 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -89.42 128.94 35.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.627 1.971 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -72.89 136.21 45.23 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.195 0.998 . . . . 0.0 111.683 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -82.98 153.35 25.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -167.95 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.066 2.546 . . . . 0.0 107.141 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.15 -28.91 55.24 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -84.71 155.8 21.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.568 1.947 . . . . 0.0 111.759 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -74.78 170.59 15.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.173 1.389 . . . . 0.0 113.034 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 m -79.62 119.13 22.15 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 167.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.8 mt -131.39 146.68 52.38 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.821 1.248 . . . . 0.0 110.26 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.7 m -89.34 115.76 27.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.661 1.184 . . . . 0.0 108.391 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -97.26 126.41 42.45 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.482 1.513 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.77 129.13 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.179 1.392 . . . . 0.0 109.586 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -139.97 157.68 45.29 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.453 1.901 . . . . 0.0 109.723 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.06 62.71 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.89 131.84 66.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 118.663 1.231 . . . . 0.0 110.143 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -53.01 140.75 58.87 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.678 2.919 . . . . 0.0 113.196 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.41 -15.05 62.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.33 -20.21 66.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.937 0.895 . . . . 0.0 113.228 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -90.89 115.78 28.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 110.63 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -68.41 121.17 15.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.071 0.949 . . . . 0.0 111.415 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 mt -59.81 -37.8 80.16 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.18 0.992 . . . . 0.0 111.936 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.36 -31.86 71.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.315 1.046 . . . . 0.0 112.488 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -37.34 69.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.872 0.869 . . . . 0.0 112.311 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.88 -47.26 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.88 -48.3 75.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.845 0.748 . . . . 0.0 111.637 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.28 -45.52 93.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.71 0.804 . . . . 0.0 112.148 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.51 -47.75 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.976 0.51 . . . . 0.0 111.329 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.46 -26.98 65.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.22 -37.1 38.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.616 -1.302 . . . . 0.0 113.308 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.03 -48.46 9.2 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.24 -38.77 12.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.958 0.903 . . . . 0.0 113.148 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -93.07 -8.44 42.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.952 0.901 . . . . 0.0 113.335 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.06 27.83 17.31 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.812 1.645 . . . . 0.0 113.57 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.5 m -87.84 -173.29 4.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.672 1.189 . . . . 0.0 111.282 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.74 145.75 38.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.388 1.075 . . . . 0.0 109.757 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -172.04 173.12 45.1 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.16 163.16 37.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 112.684 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.4 mt -98.4 134.98 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.927 1.291 . . . . 0.0 109.499 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.0 t -131.29 139.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.196 1.398 . . . . 0.0 109.278 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -103.89 99.24 9.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.865 0.866 . . . . 0.0 109.937 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.41 145.68 40.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.341 1.457 . . . . 0.0 111.784 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.0 -31.63 93.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.575 2.85 . . . . 0.0 114.735 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.34 -46.99 3.23 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.735 1.214 . . . . 0.0 112.426 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.2 mtt -78.68 -15.35 58.59 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.96 -158.62 52.26 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 124.37 0.986 . . . . 0.0 112.559 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -72.33 116.58 12.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.906 0.883 . . . . 0.0 110.893 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 pt -139.51 151.37 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.473 1.909 . . . . 0.0 112.173 -172.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.73 136.96 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.93 133.22 51.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.569 . . . . 0.0 107.866 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.81 141.17 48.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 108.283 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.44 134.13 47.51 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.888 -1.133 . . . . 0.0 111.575 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.49 39.32 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.81 1.195 . . . . 0.0 113.621 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -101.8 100.78 11.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.68 1.592 . . . . 0.0 110.378 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -123.37 22.09 9.36 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.304 1.441 . . . . 0.0 113.173 -170.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.482 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.0 ptt180 -60.54 -43.88 96.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.11 89.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.455 0.702 . . . . 0.0 111.847 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.17 -47.28 80.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.05 0.94 . . . . 0.0 111.871 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.99 -34.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.882 -0.511 . . . . 0.0 111.534 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.93 -49.75 75.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.378 0.99 . . . . 0.0 111.083 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.49 -38.64 81.41 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.634 0.774 . . . . 0.0 112.65 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.32 -49.6 76.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.49 1.041 . . . . 0.0 111.633 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.13 -38.97 80.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.024 0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.99 -50.76 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.375 0.67 . . . . 0.0 111.374 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.5 m -84.93 -28.92 25.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -169.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -103.52 -44.0 5.24 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.264 0.938 . . . . 0.0 112.559 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.82 -19.77 28.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.071 0.85 . . . . 0.0 113.178 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.56 14.93 77.21 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.425 1.012 . . . . 0.0 113.727 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.07 145.21 51.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.626 1.213 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -74.28 140.95 45.31 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.506 -0.746 . . . . 0.0 110.819 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -53.29 -44.73 68.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.58 0.752 . . . . 0.0 112.211 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -63.79 -24.52 67.79 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.28 -6.27 54.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.548 1.139 . . . . 0.0 112.459 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.92 131.04 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.88 -1.137 . . . . 0.0 110.344 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.2 mmtt -109.33 128.36 55.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 110.277 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 77.0 mt -107.49 119.53 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -104.59 -26.53 12.3 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.19 -150.46 43.96 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 123.783 0.833 . . . . 0.0 113.074 170.874 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 tpp . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -79.18 177.55 8.74 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 112.864 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.38 159.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.406 1.882 . . . . 0.0 111.967 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.47 163.03 27.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.283 1.033 . . . . 0.0 112.397 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -61.28 138.25 58.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.783 0.833 . . . . 0.0 112.544 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.7 tp -155.72 150.15 25.93 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.519 1.528 . . . . 0.0 110.708 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -155.37 167.09 31.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 0.0 112.24 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 t -161.91 170.96 18.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.777 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -85.91 174.66 9.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.869 1.668 . . . . 0.0 112.602 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.83 145.09 96.35 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.649 1.18 . . . . 0.0 113.316 -176.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.06 -21.97 17.57 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.4 2.733 . . . . 0.0 113.631 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -173.34 163.27 4.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.526 2.331 . . . . 0.0 109.928 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.28 155.61 35.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.535 1.934 . . . . 0.0 111.176 175.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.0 170.99 11.53 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.173 1.789 . . . . 0.0 112.041 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.4 t -160.09 158.44 30.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.905 1.682 . . . . 0.0 111.068 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.21 -172.07 22.37 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.702 1.62 . . . . 0.0 113.895 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -157.55 131.61 8.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.779 1.632 . . . . 0.0 110.896 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.61 165.39 10.21 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.646 1.978 . . . . 0.0 110.551 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.22 -26.48 58.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.7 p 65.37 -19.48 0.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 129.395 3.078 . . . . 0.0 116.973 170.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.89 6.47 2.58 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.56 1.544 . . . . 0.0 114.744 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -75.43 -11.11 59.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.922 2.089 . . . . 0.0 114.923 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 m -56.49 138.82 51.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.708 1.203 . . . . 0.0 114.108 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -74.31 -17.85 60.79 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -118.56 152.23 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.637 1.575 . . . . 0.0 112.44 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.4 mt -86.55 116.23 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 167.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -100.31 112.32 24.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.94 0.896 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.5 mt -102.3 101.8 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -107.6 174.47 5.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.101 2.16 . . . . 0.0 110.715 -171.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.7 mt -122.17 138.67 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.9 143.22 37.9 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.417 1.487 . . . . 0.0 110.02 -172.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -73.39 103.19 3.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.774 0.83 . . . . 0.0 110.035 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.68 126.71 31.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.739 0.816 . . . . 0.0 111.486 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -106.66 63.03 0.64 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.376 1.47 . . . . 0.0 109.816 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.27 7.43 88.48 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.82 1.2 . . . . 0.0 114.202 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -98.1 171.46 8.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.17 1.788 . . . . 0.0 111.963 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.59 153.0 44.18 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.553 0.741 . . . . 0.0 111.921 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -68.66 138.9 55.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.26 1.424 . . . . 0.0 110.791 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -128.62 135.42 49.29 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.604 1.162 . . . . 0.0 110.36 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -89.53 124.41 34.49 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.689 1.596 . . . . 0.0 108.295 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 114.1 27.37 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.456 1.502 . . . . 0.0 110.118 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.76 122.55 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.118 0.967 . . . . 0.0 109.363 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -125.62 151.59 46.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.65 1.98 . . . . 0.0 109.681 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.86 4.45 82.45 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -57.5 131.13 81.64 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.698 1.249 . . . . 0.0 110.456 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.26 139.75 63.03 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.07 3.18 . . . . 0.0 113.149 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.47 -10.29 59.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.95 -19.8 62.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.993 0.917 . . . . 0.0 112.939 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -91.97 121.59 33.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.771 1.228 . . . . 0.0 110.917 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.71 118.16 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.701 0.8 . . . . 0.0 111.146 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.36 -37.15 77.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.686 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -63.17 -37.24 86.44 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.181 0.992 . . . . 0.0 112.121 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -66.69 -37.66 85.18 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.28 -0.887 . . . . 0.0 111.663 171.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.33 -40.96 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.536 0.734 . . . . 0.0 110.097 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.28 -54.26 48.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.302 0.955 . . . . 0.0 110.888 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -55.84 -48.27 75.79 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.942 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.99 -35.82 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.2 -30.72 62.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.025 0.829 . . . . 0.0 112.117 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -71.06 -30.43 66.58 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.768 -1.207 . . . . 0.0 112.769 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.15 -61.68 1.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 113.125 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.51 -40.55 23.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 -169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.87 -7.03 50.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.407 1.083 . . . . 0.0 112.554 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.65 28.98 17.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.11 1.764 . . . . 0.0 112.893 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -91.91 -162.13 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.635 1.174 . . . . 0.0 111.764 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -155.4 152.47 29.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.102 0.961 . . . . 0.0 111.421 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.7 176.4 48.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.03 165.03 36.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.862 1.665 . . . . 0.0 112.738 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -101.78 135.29 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.018 1.327 . . . . 0.0 109.876 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.44 143.76 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.24 1.416 . . . . 0.0 110.029 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -105.75 100.6 10.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.548 0.739 . . . . 0.0 109.511 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -84.58 144.67 43.18 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.452 1.501 . . . . 0.0 111.781 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.52 -32.25 93.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.611 2.874 . . . . 0.0 114.871 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.76 -47.42 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.616 1.166 . . . . 0.0 112.19 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.1 mtm -80.26 -17.24 52.76 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 -157.55 44.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.221 0.915 . . . . 0.0 113.201 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -70.12 114.53 8.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.827 1.251 . . . . 0.0 110.634 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -142.4 152.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.714 1.606 . . . . 0.0 113.093 -169.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.01 132.51 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -100.22 133.18 45.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.001 1.32 . . . . 0.0 107.723 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tp -123.35 143.16 50.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.606 1.562 . . . . 0.0 108.756 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.158 -0.964 . . . . 0.0 112.093 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.93 -170.47 39.81 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.215 1.388 . . . . 0.0 113.669 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -97.55 77.56 2.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.895 2.078 . . . . 0.0 111.081 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -100.26 15.34 27.93 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.075 1.75 . . . . 0.0 113.54 -170.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -58.39 -40.18 81.66 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -41.3 64.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.001 0.921 . . . . 0.0 112.123 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -65.77 -41.8 91.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.847 0.859 . . . . 0.0 112.54 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.75 -35.31 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.809 -0.557 . . . . 0.0 111.204 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.56 -48.54 79.07 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.474 1.034 . . . . 0.0 111.014 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.13 -39.7 83.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.813 0.845 . . . . 0.0 112.551 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 40.3 t80 -60.17 -49.49 77.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.597 1.09 . . . . 0.0 111.778 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.4 mmt -61.02 -38.53 86.44 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.189 0.995 . . . . 0.0 110.893 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -74.02 -46.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.742 0.817 . . . . 0.0 111.002 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -82.4 -37.65 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -103.37 -39.65 6.7 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.472 0.709 . . . . 0.0 112.808 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.5 mt -83.61 -17.77 40.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.729 0.695 . . . . 0.0 112.273 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.65 76.31 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.662 1.125 . . . . 0.0 113.636 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.98 159.05 34.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.564 1.182 . . . . 0.0 111.24 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.2 146.96 25.8 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.608 -0.682 . . . . 0.0 109.435 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -55.95 -36.82 68.22 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.367 -0.833 . . . . 0.0 112.365 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -65.94 -10.47 39.37 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -78.79 -9.59 59.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.86 1.209 . . . . 0.0 113.078 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.7 mt -117.89 136.21 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.207 . . . . 0.0 110.995 -169.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -112.56 135.97 52.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.352 1.861 . . . . 0.0 109.968 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.3 127.08 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.421 1.089 . . . . 0.0 109.334 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -126.84 -157.71 0.82 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.583 1.553 . . . . 0.0 111.714 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.45 -151.54 19.37 Favored Glycine 0 N--CA 1.472 1.067 0 C-N-CA 125.03 1.3 . . . . 0.0 113.579 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.635 1.574 . . . . 0.0 114.299 -174.13 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p -78.9 -34.7 44.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.456 1.102 . . . . 0.0 113.056 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 3' ' ' ILE . 3.8 mp -65.5 135.56 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.446 1.099 . . . . 0.0 109.649 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 76.55 -8.4 1.67 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 128.036 2.535 . . . . 0.0 114.116 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -70.03 139.89 52.76 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.912 -1.118 . . . . 0.0 112.372 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 pp -162.19 170.46 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.204 1.802 . . . . 0.0 111.784 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -100.89 133.1 45.86 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.704 1.202 . . . . 0.0 111.368 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -105.56 9.99 33.22 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 114.197 -173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -0.95 9.51 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -146.12 145.2 23.64 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.289 1.435 . . . . 0.0 111.582 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.26 -34.37 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.138 2.559 . . . . 0.0 112.685 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.6 p90 177.87 168.9 0.72 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.23 3.012 . . . . 0.0 109.337 -174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.8 150.88 39.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.945 1.698 . . . . 0.0 111.319 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.21 29.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.023 1.329 . . . . 0.0 113.199 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.3 p -96.06 149.53 21.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 111.611 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.35 -4.13 59.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.754 1.169 . . . . 0.0 114.777 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -164.25 153.89 14.1 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.265 1.826 . . . . 0.0 111.278 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -158.34 158.09 33.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.902 1.681 . . . . 0.0 111.265 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.3 138.56 43.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.452 1.101 . . . . 0.0 112.137 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.2 p -100.45 -27.66 13.33 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.591 1.557 . . . . 0.0 113.602 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.1 59.08 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.5 p -84.09 172.97 11.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.157 1.783 . . . . 0.0 111.939 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.8 p -149.85 155.92 40.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.748 1.219 . . . . 0.0 111.938 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -77.52 150.21 34.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.974 0.91 . . . . 0.0 112.582 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -72.16 137.79 47.21 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.69 -0.631 . . . . 0.0 112.411 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mt -89.89 119.69 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -103.78 113.32 26.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.195 0.998 . . . . 0.0 109.655 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.72 98.75 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -106.41 174.5 5.86 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.886 2.074 . . . . 0.0 110.683 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -116.1 146.78 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -92.82 139.17 30.82 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.036 0.934 . . . . 0.0 109.596 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -70.33 147.49 49.56 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.212 1.005 . . . . 0.0 112.964 -172.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -79.41 138.58 37.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.536 1.134 . . . . 0.0 111.7 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -162.37 -127.72 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.138 1.775 . . . . 0.0 108.841 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.98 -22.64 78.72 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 119.863 1.21 . . . . 0.0 112.642 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -88.14 152.46 21.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.389 1.476 . . . . 0.0 111.155 170.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -72.79 -175.9 1.85 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.163 1.385 . . . . 0.0 112.688 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 m -67.96 129.93 41.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.279 1.032 . . . . 0.0 108.288 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.8 mt -136.4 141.37 43.64 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.671 1.188 . . . . 0.0 109.986 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.1 m -93.07 115.5 28.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.813 1.245 . . . . 0.0 108.945 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.49 112.07 24.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.715 1.606 . . . . 0.0 110.001 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.48 125.02 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 109.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -132.79 152.75 51.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.134 1.773 . . . . 0.0 110.186 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.33 77.19 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 168.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.16 131.43 60.16 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 118.717 1.259 . . . . 0.0 111.283 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -51.67 136.73 50.22 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 113.283 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.65 -13.44 62.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 113.906 -171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.69 -19.16 63.59 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.145 . . . . 0.0 113.11 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -94.56 125.34 39.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 111.0 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -74.57 124.75 27.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.504 0.722 . . . . 0.0 111.361 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.42 -38.75 85.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.075 0.55 . . . . 0.0 111.446 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -59.61 -37.18 77.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.497 1.119 . . . . 0.0 112.76 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -66.81 -39.52 87.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.191 0.905 . . . . 0.0 111.538 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.67 -47.26 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.222 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.868 0.758 . . . . 0.0 111.672 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.23 -42.43 99.31 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.428 -0.795 . . . . 0.0 112.512 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.14 -45.51 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.008 0.822 . . . . 0.0 111.346 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.15 -32.94 65.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.631 -1.293 . . . . 0.0 112.751 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -75.68 -63.72 1.23 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.72 1.208 . . . . 0.0 113.235 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -92.54 -32.69 14.74 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -167.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -90.91 -13.94 32.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 112.625 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 61.24 30.53 19.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.241 1.816 . . . . 0.0 112.86 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.32 -170.92 3.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.775 1.23 . . . . 0.0 111.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.94 152.75 36.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.869 1.268 . . . . 0.0 109.255 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.89 45.73 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 115.226 0.851 . . . . 0.0 115.226 -170.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -158.14 163.56 37.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.792 1.637 . . . . 0.0 112.32 -172.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.01 136.15 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.189 1.395 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.5 t -137.21 140.59 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.072 1.349 . . . . 0.0 109.573 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -100.47 105.27 16.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.436 0.694 . . . . 0.0 110.068 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -87.84 144.54 35.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 111.684 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.24 -31.49 93.71 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 114.803 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -110.65 -47.23 3.28 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.773 1.229 . . . . 0.0 112.377 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.5 mtt -78.47 -17.77 55.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.02 -159.88 47.78 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.541 1.067 . . . . 0.0 112.69 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -71.98 118.88 15.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.779 0.832 . . . . 0.0 111.134 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -142.0 152.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.122 1.769 . . . . 0.0 112.309 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.84 134.28 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -105.96 116.8 32.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.643 1.577 . . . . 0.0 107.83 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tp -102.76 146.51 28.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.178 1.391 . . . . 0.0 109.185 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -69.37 133.4 47.76 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.547 0.739 . . . . 0.0 111.693 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 -170.12 54.78 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.11 1.338 . . . . 0.0 113.992 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -94.86 98.28 10.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.092 1.757 . . . . 0.0 111.326 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -120.45 20.75 11.82 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.057 1.743 . . . . 0.0 112.533 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -60.12 -40.91 91.4 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.57 70.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 112.355 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.98 -44.96 83.38 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.936 0.895 . . . . 0.0 111.691 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.61 -35.19 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.104 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.11 -49.54 75.58 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.51 1.05 . . . . 0.0 111.094 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.61 -39.11 79.54 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 0.0 112.68 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -60.43 -47.92 84.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.627 1.103 . . . . 0.0 112.02 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.4 mmt -61.27 -41.1 96.37 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.875 0.87 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.63 -47.97 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.732 0.813 . . . . 0.0 111.296 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -76.44 -48.09 20.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -100.48 -33.14 10.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.46 -15.85 38.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.145 0.884 . . . . 0.0 112.316 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.63 15.55 80.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.84 1.21 . . . . 0.0 113.685 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -71.1 157.89 37.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.547 1.174 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.48 147.14 24.81 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.642 -0.662 . . . . 0.0 109.586 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.56 -36.51 64.42 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.448 -0.782 . . . . 0.0 112.76 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -57.59 -21.7 40.6 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.884 1.674 . . . . 0.0 115.094 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -77.08 -7.69 56.17 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.279 0.945 . . . . 0.0 113.412 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.29 136.05 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.338 1.055 . . . . 0.0 110.791 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.53 134.22 54.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.755 2.022 . . . . 0.0 109.991 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt -110.91 127.76 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.821 1.248 . . . . 0.0 108.996 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.56 171.36 11.16 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.863 1.265 . . . . 0.0 113.153 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.01 -140.52 11.51 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.615 1.579 . . . . 0.0 112.098 173.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.5 p90 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 126.483 1.913 . . . . 0.0 113.173 174.615 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 tpp . . . . . 0 N--CA 1.501 2.082 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 p -102.62 -16.29 16.1 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.83 -29.02 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -165.89 137.58 3.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.372 1.869 . . . . 0.0 109.843 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -91.13 112.03 23.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.043 0.937 . . . . 0.0 110.752 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.1 144.38 31.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 110.786 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -102.16 172.33 6.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.897 1.279 . . . . 0.0 112.322 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -76.32 136.63 39.58 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.185 -0.947 . . . . 0.0 111.501 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -144.19 166.29 25.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.358 1.463 . . . . 0.0 111.649 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -151.69 145.02 17.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.86 1.664 . . . . 0.0 111.215 174.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -93.66 -145.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.104 3.203 . . . . 0.0 110.437 -173.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.34 27.24 2.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.583 1.953 . . . . 0.0 111.662 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.69 153.57 41.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.168 1.387 . . . . 0.0 113.661 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.02 152.23 16.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.421 1.888 . . . . 0.0 110.791 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 t -161.97 165.72 27.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.459 1.503 . . . . 0.0 111.543 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.86 163.75 45.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.348 1.452 . . . . 0.0 114.006 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.08 163.15 26.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.43 1.492 . . . . 0.0 113.447 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -158.59 159.82 35.9 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.112 1.765 . . . . 0.0 111.037 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.77 144.53 45.85 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.197 1.399 . . . . 0.0 111.579 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 t -169.22 159.63 9.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.718 2.007 . . . . 0.0 110.639 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.75 -16.87 58.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.682 1.193 . . . . 0.0 113.172 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 m -72.01 145.12 48.54 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.728 1.611 . . . . 0.0 110.769 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.8 p -149.31 153.87 38.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.28 1.032 . . . . 0.0 112.647 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.91 171.92 8.8 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 112.898 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 72.5 m-85 -72.46 143.09 48.56 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 mt -94.02 132.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -114.94 120.68 40.76 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.624 1.169 . . . . 0.0 110.182 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 27.9 mt -114.27 116.37 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -128.99 174.57 9.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.253 1.821 . . . . 0.0 110.202 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -115.47 142.06 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.157 0.983 . . . . 0.0 108.483 169.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -87.29 135.76 33.19 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.454 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.96 124.57 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.24 0.616 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -141.16 146.32 36.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.726 1.61 . . . . 0.0 111.115 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -77.06 -27.84 54.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 113.22 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.24 162.14 26.94 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.516 1.532 . . . . 0.0 112.638 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.81 -6.21 30.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -74.33 55.82 0.62 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 113.591 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.1 m -68.66 143.19 54.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.919 2.088 . . . . 0.0 111.399 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -128.35 145.69 51.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.16 1.384 . . . . 0.0 111.945 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -89.7 132.37 35.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 107.663 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -112.94 124.5 52.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.246 1.419 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.36 126.57 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.973 1.309 . . . . 0.0 108.597 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -135.83 149.87 49.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.201 1.801 . . . . 0.0 109.502 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.12 -2.29 66.17 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 115.817 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.45 130.14 53.11 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.357 1.578 . . . . 0.0 111.08 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -52.29 139.7 53.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.397 3.398 . . . . 0.0 113.48 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.88 -16.19 63.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.85 0.86 . . . . 0.0 113.302 -172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.33 -20.2 66.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.026 0.931 . . . . 0.0 113.088 172.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -93.0 118.09 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.867 1.267 . . . . 0.0 110.693 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.12 120.3 14.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.966 0.906 . . . . 0.0 111.574 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.3 -39.05 89.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.729 0.811 . . . . 0.0 111.914 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.78 -35.59 78.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.001 0.921 . . . . 0.0 112.461 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.51 -40.39 96.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.206 0.912 . . . . 0.0 112.308 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.27 -40.15 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 109.915 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.97 -55.43 35.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.213 0.915 . . . . 0.0 110.848 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 0.0 112.788 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.06 -36.18 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.92 -32.81 65.56 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.974 0.807 . . . . 0.0 112.318 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -70.69 -33.8 71.28 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.082 . . . . 0.0 112.641 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -76.96 -58.6 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.495 1.118 . . . . 0.0 113.259 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.87 -41.32 15.08 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.31 -11.47 35.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.154 0.982 . . . . 0.0 113.127 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.25 26.92 15.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.242 1.817 . . . . 0.0 113.046 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.2 m -80.91 -171.99 3.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.717 1.207 . . . . 0.0 111.709 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -146.83 149.59 33.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.66 1.184 . . . . 0.0 109.83 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.62 46.62 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.436 0.934 . . . . 0.0 115.436 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.61 164.71 33.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.755 1.622 . . . . 0.0 112.872 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.4 mt -98.56 134.89 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.899 1.279 . . . . 0.0 109.663 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.0 t -136.22 141.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.167 1.387 . . . . 0.0 109.758 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -102.31 107.72 18.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.692 0.797 . . . . 0.0 109.201 168.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -88.57 145.49 35.41 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.987 1.315 . . . . 0.0 111.635 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.3 -32.4 95.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.495 2.797 . . . . 0.0 114.614 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -111.46 -46.75 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.429 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.4 mtt -77.58 -16.74 58.43 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.23 -161.19 48.62 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.623 1.106 . . . . 0.0 112.982 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.65 119.52 14.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.931 0.892 . . . . 0.0 110.941 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -141.4 150.23 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.281 1.832 . . . . 0.0 112.251 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.94 132.76 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 166.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -99.34 137.07 38.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.515 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tp -125.64 139.93 53.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.547 171.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -70.69 136.89 49.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.067 -1.021 . . . . 0.0 111.834 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.64 -163.09 36.62 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.893 1.235 . . . . 0.0 113.492 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.27 98.19 7.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.663 1.585 . . . . 0.0 110.146 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -120.8 18.23 11.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.146 1.379 . . . . 0.0 113.303 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 4.3 ptt180 -61.5 -42.75 99.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.36 82.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.534 0.734 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -66.25 -45.33 80.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.068 0.947 . . . . 0.0 111.958 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.67 -36.46 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.222 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.67 -49.34 75.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.388 0.994 . . . . 0.0 111.208 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.45 -39.8 84.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.928 0.891 . . . . 0.0 112.601 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 35.9 t80 -60.02 -49.61 76.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.746 1.157 . . . . 0.0 111.837 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.6 mmt -59.79 -37.22 78.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.23 1.012 . . . . 0.0 110.948 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -76.78 -44.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.911 0.884 . . . . 0.0 111.116 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.8 m -86.12 -21.99 27.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -169.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -119.03 -38.25 3.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 0.0 113.455 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.83 -14.88 50.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.401 1.0 . . . . 0.0 112.437 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.28 14.98 80.97 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.869 1.223 . . . . 0.0 113.798 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -70.94 158.43 36.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.405 1.102 . . . . 0.0 111.211 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -88.45 149.41 23.69 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -53.19 -39.69 63.84 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.501 -0.749 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -60.21 -18.52 49.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.738 1.615 . . . . 0.0 114.947 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -78.84 -8.97 59.3 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.352 0.978 . . . . 0.0 113.424 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.1 mt -118.03 130.34 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 119.353 0.978 . . . . 0.0 111.407 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.6 mmtt -104.09 125.81 50.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.336 1.854 . . . . 0.0 110.082 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.0 120.9 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -104.75 -33.98 8.26 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.74 -136.19 38.5 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -170.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 127.043 2.137 . . . . 0.0 113.438 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.502 2.158 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.9 m -126.96 148.94 50.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.97 1.308 . . . . 0.0 110.851 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -138.65 162.5 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.441 1.497 . . . . 0.0 111.678 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.49 158.72 26.99 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.953 1.701 . . . . 0.0 110.769 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.07 156.58 12.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.587 1.555 . . . . 0.0 112.25 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.3 mt 72.23 -52.78 0.7 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 129.034 2.934 . . . . 0.0 113.537 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -70.6 152.7 43.64 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.277 1.031 . . . . 0.0 113.305 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -169.44 170.65 8.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.207 1.803 . . . . 0.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -80.53 152.28 28.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.541 1.136 . . . . 0.0 112.075 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.13 145.96 16.94 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.736 1.614 . . . . 0.0 110.879 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.09 3.84 7.5 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.599 2.866 . . . . 0.0 115.18 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.25 66.72 9.34 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.98 1.312 . . . . 0.0 111.027 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 160.2 14.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.246 1.418 . . . . 0.0 113.028 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -62.65 136.61 57.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.637 1.175 . . . . 0.0 112.601 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 p -72.39 -39.01 68.31 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 175.17 45.15 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.787 1.661 . . . . 0.0 114.262 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.33 165.3 27.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.645 1.978 . . . . 0.0 110.787 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -147.25 147.91 30.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.837 1.255 . . . . 0.0 111.901 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.19 -41.25 0.15 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.122 1.769 . . . . 0.0 111.738 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 t -168.52 174.93 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.99 2.116 . . . . 0.0 110.336 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.54 171.85 16.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.111 1.764 . . . . 0.0 111.837 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 t -153.89 172.54 17.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.335 1.454 . . . . 0.0 111.946 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t 88.68 134.14 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 130.229 3.412 . . . . 0.0 111.648 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -94.14 -10.02 34.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.048 0.939 . . . . 0.0 113.485 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.503 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 32.5 m-85 -123.12 131.85 53.85 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt -100.28 128.1 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.051 2.14 . . . . 0.0 106.912 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -112.38 117.14 31.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.302 1.041 . . . . 0.0 110.448 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 85' ' ' ARG . 44.5 mt -108.24 108.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.3 174.04 6.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.085 2.154 . . . . 0.0 109.949 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.9 mt -125.92 142.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 120.983 -1.073 . . . . 0.0 108.725 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -88.31 130.48 35.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.143 1.377 . . . . 0.0 109.766 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 pm0 -72.56 145.39 47.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.907 0.883 . . . . 0.0 111.153 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.86 163.62 34.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -155.17 139.16 16.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.955 2.102 . . . . 0.0 109.58 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.98 14.65 80.11 Favored Glycine 0 CA--C 1.538 1.509 0 N-CA-C 115.266 0.867 . . . . 0.0 115.266 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.4 ptm85 -158.39 168.49 26.85 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.977 1.711 . . . . 0.0 112.087 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.07 148.72 51.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.158 0.983 . . . . 0.0 113.466 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.8 m -69.1 143.36 54.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.147 1.779 . . . . 0.0 110.027 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.08 133.93 47.02 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.244 1.018 . . . . 0.0 111.28 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.1 m -89.11 118.7 29.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.584 1.954 . . . . 0.0 108.053 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.24 116.32 32.24 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.018 1.727 . . . . 0.0 110.126 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -101.39 126.63 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 109.557 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -135.93 158.21 44.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.741 2.016 . . . . 0.0 109.736 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.87 -6.39 48.32 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 120.438 -1.414 . . . . 0.0 116.183 168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.93 130.97 48.98 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 118.563 1.181 . . . . 0.0 110.529 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.24 137.1 55.43 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.931 3.087 . . . . 0.0 112.938 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.68 -14.33 62.85 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.5 -19.68 64.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.241 1.017 . . . . 0.0 113.165 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -89.86 123.87 34.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.548 1.139 . . . . 0.0 111.054 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -74.83 120.59 20.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.963 0.905 . . . . 0.0 111.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.3 -39.07 89.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.563 0.745 . . . . 0.0 111.765 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -60.22 -36.56 77.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.027 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -69.48 -36.88 76.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.875 0.87 . . . . 0.0 112.027 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.77 -47.67 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.917 0.781 . . . . 0.0 109.24 172.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.2 -46.61 79.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.178 0.899 . . . . 0.0 111.628 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -61.81 -33.76 74.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.135 0.974 . . . . 0.0 112.788 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.9 t -75.38 -50.57 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.064 0.545 . . . . 0.0 111.117 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.88 -33.37 74.59 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -72.28 -25.61 61.66 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.816 -1.178 . . . . 0.0 113.662 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.88 -48.92 5.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.132 0.973 . . . . 0.0 113.625 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -83.78 -38.85 20.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.065 0.946 . . . . 0.0 113.004 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 -10.93 23.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.856 1.263 . . . . 0.0 112.978 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.0 26.56 14.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.406 1.882 . . . . 0.0 113.145 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.39 -174.98 4.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.657 1.183 . . . . 0.0 112.241 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -143.7 150.81 39.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.488 1.115 . . . . 0.0 109.413 169.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.39 173.8 46.44 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.35 166.08 33.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.61 1.564 . . . . 0.0 112.372 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.4 134.98 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.948 1.299 . . . . 0.0 109.678 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t -133.41 140.17 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.988 1.315 . . . . 0.0 109.533 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -99.8 102.6 14.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.582 0.753 . . . . 0.0 110.079 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -86.16 143.89 37.8 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.053 1.341 . . . . 0.0 111.666 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.36 -31.18 93.33 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.506 2.804 . . . . 0.0 114.776 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -110.4 -47.49 3.28 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.664 1.186 . . . . 0.0 112.323 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.5 mtt -78.52 -18.3 54.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.92 -158.88 46.99 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.308 0.956 . . . . 0.0 112.478 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -71.53 118.22 14.08 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.876 -0.779 . . . . 0.0 111.223 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.78 149.57 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.373 1.869 . . . . 0.0 112.202 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.2 mt -93.68 135.06 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.23 129.96 52.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.444 1.498 . . . . 0.0 107.548 168.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -120.75 140.15 52.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.338 1.455 . . . . 0.0 108.743 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.35 132.57 45.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.964 -1.085 . . . . 0.0 111.524 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.91 -156.12 21.32 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.923 1.725 . . . . 0.0 113.623 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.35 47.94 1.34 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.636 2.374 . . . . 0.0 111.605 -173.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -75.14 25.05 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.024 2.529 . . . . 0.0 116.29 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HA ' HG21 ' A' ' 28' ' ' ILE . 31.2 ptt-85 -57.7 -47.22 82.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.633 1.173 . . . . 0.0 114.082 -172.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.42 74.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.9 0.88 . . . . 0.0 111.932 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -64.52 -46.0 84.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.612 0.765 . . . . 0.0 111.868 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.92 -35.94 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.719 -0.613 . . . . 0.0 111.369 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -56.11 -49.02 75.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.209 0.913 . . . . 0.0 111.197 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.11 -38.36 86.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.788 0.835 . . . . 0.0 112.846 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.3 -48.56 81.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.934 1.243 . . . . 0.0 111.56 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.73 -44.68 93.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 110.581 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.34 -44.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.707 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.6 t -79.16 -49.15 13.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -98.11 -35.77 10.3 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -88.67 -13.88 38.7 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.753 0.706 . . . . 0.0 112.494 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.49 17.31 79.3 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.774 1.178 . . . . 0.0 113.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.7 mt -70.79 153.56 42.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.503 1.151 . . . . 0.0 111.74 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -79.42 137.69 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.675 -0.641 . . . . 0.0 110.39 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -55.23 -38.81 68.95 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 0.0 112.756 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -59.2 -21.16 59.05 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 114.605 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.58 -4.7 58.06 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.314 1.046 . . . . 0.0 112.942 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -112.01 126.59 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.51 -1.369 . . . . 0.0 110.89 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.6 mmtt -105.89 120.16 41.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.585 1.954 . . . . 0.0 110.004 172.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 73.8 mt -96.48 122.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -106.13 -35.08 7.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.117 0.967 . . . . 0.0 113.207 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -137.38 39.3 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.817 0.722 . . . . 0.0 111.593 -174.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.291 2.236 . . . . 0.0 113.46 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.3 p -75.72 161.55 28.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.367 1.067 . . . . 0.0 112.694 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.44 124.49 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.207 1.003 . . . . 0.0 109.814 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.26 162.97 16.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.802 1.241 . . . . 0.0 112.619 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -151.81 143.48 23.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.491 1.116 . . . . 0.0 112.007 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.2 tp -116.86 -17.56 10.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.814 1.646 . . . . 0.0 113.378 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -158.22 138.77 12.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.897 1.679 . . . . 0.0 111.188 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 t -123.93 151.31 43.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.021 0.928 . . . . 0.0 110.797 170.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -163.05 166.43 23.63 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.415 -173.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -101.64 113.32 65.86 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.894 0.878 . . . . 0.0 110.981 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.67 -35.37 3.54 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.594 2.196 . . . . 0.0 111.207 170.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -162.79 3.16 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.428 1.891 . . . . 0.0 113.564 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.54 147.39 37.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 113.563 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -161.27 -171.8 3.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.13 2.172 . . . . 0.0 109.962 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.1 m -65.15 129.22 38.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.742 1.217 . . . . 0.0 110.912 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.74 164.92 16.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.805 1.669 . . . . 0.0 113.227 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.82 -22.92 39.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.435 1.094 . . . . 0.0 113.279 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.98 159.98 24.73 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.191 1.396 . . . . 0.0 113.132 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.67 147.22 50.89 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 t -148.08 153.8 39.37 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.039 1.336 . . . . 0.0 111.804 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.69 151.68 1.92 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.433 2.693 . . . . 0.0 110.028 -175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -166.74 154.95 10.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.951 0.901 . . . . 0.0 113.284 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -94.08 7.57 44.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.734 1.614 . . . . 0.0 112.84 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -54.86 147.64 14.77 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.018 1.327 . . . . 0.0 114.238 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.01 139.7 57.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.63 113.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.513 1.125 . . . . 0.0 108.282 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -96.21 116.96 29.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.066 0.946 . . . . 0.0 110.049 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.41 102.52 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -108.09 174.11 6.02 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.92 2.088 . . . . 0.0 110.855 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -126.77 146.56 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.691 1.196 . . . . 0.0 108.217 169.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -93.53 167.74 11.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.519 1.128 . . . . 0.0 111.36 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -65.77 130.25 42.61 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.177 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -74.21 141.08 45.46 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -90.9 68.49 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.49 1.516 . . . . 0.0 109.284 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.6 -119.24 10.9 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -172.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -21.8 60.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 113.484 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -80.44 137.18 36.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.112 0.869 . . . . 0.0 112.381 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.8 m -129.14 150.36 50.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.191 2.196 . . . . 0.0 108.758 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.65 129.24 45.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.783 0.833 . . . . 0.0 111.129 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 m -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.529 1.932 . . . . 0.0 107.681 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.57 120.43 28.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 110.614 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.7 121.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.322 1.049 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -127.93 153.97 46.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.641 1.977 . . . . 0.0 110.02 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.98 -5.2 50.54 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.076 1.19 . . . . 0.0 116.076 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -49.36 129.86 17.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 0.0 111.001 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -52.01 137.45 53.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.944 3.096 . . . . 0.0 113.209 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.05 -8.67 55.01 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.25 -17.81 62.47 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.133 1.373 . . . . 0.0 113.0 169.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -94.13 129.76 40.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.081 1.353 . . . . 0.0 111.41 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.14 118.75 22.12 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.985 0.914 . . . . 0.0 111.936 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.76 -38.48 90.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.23 0.612 . . . . 0.0 112.254 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.43 -36.08 81.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.862 0.865 . . . . 0.0 112.584 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -64.03 -39.27 93.72 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.061 -1.024 . . . . 0.0 111.764 169.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -63.24 -39.71 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.93 0.892 . . . . 0.0 110.068 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.45 -55.83 30.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 110.976 170.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.4 -48.82 73.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.931 0.893 . . . . 0.0 112.8 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.6 p -70.86 -36.73 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.06 -34.68 64.13 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.193 0.906 . . . . 0.0 111.98 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -34.39 77.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.758 -1.214 . . . . 0.0 112.471 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.63 -60.44 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.32 1.048 . . . . 0.0 113.105 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.69 -39.16 18.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.89 -4.42 49.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.464 1.106 . . . . 0.0 112.638 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.39 28.85 18.32 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.161 1.785 . . . . 0.0 113.102 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.48 179.76 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.55 1.14 . . . . 0.0 112.74 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -133.27 140.92 47.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.356 1.462 . . . . 0.0 108.366 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.57 168.86 41.89 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 -169.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -159.41 165.05 34.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.661 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.4 135.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.681 1.192 . . . . 0.0 109.976 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.1 t -130.45 142.7 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.675 1.59 . . . . 0.0 109.052 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -111.49 103.36 11.7 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 0.0 110.979 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -98.36 144.77 28.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.417 1.487 . . . . 0.0 112.287 -171.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.85 -32.81 95.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.495 2.796 . . . . 0.0 114.897 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -106.51 -44.98 4.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.019 1.328 . . . . 0.0 112.511 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.7 mtt -82.86 -14.58 54.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.83 -167.16 54.36 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.133 1.349 . . . . 0.0 113.077 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.32 114.27 5.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt -134.64 151.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.108 1.763 . . . . 0.0 112.726 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.29 131.92 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 166.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.5 139.11 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.318 1.447 . . . . 0.0 108.245 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.52 136.13 47.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.463 1.505 . . . . 0.0 108.419 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -72.56 138.95 47.21 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.102 -0.999 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.17 -174.95 39.2 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.985 1.755 . . . . 0.0 113.361 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.54 77.59 2.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.882 2.073 . . . . 0.0 110.828 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.65 15.52 27.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 113.652 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -58.6 -41.64 86.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.23 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.132 0.973 . . . . 0.0 112.279 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.03 -44.34 84.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 111.75 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.49 -33.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.173 0.589 . . . . 0.0 111.092 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 111.085 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.04 -39.65 78.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.52 0.728 . . . . 0.0 112.626 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 57' ' ' VAL . 53.7 t80 -59.92 -49.78 76.36 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.425 1.011 . . . . 0.0 111.733 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.0 mmt -59.76 -39.69 85.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 110.882 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.01 -52.7 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.611 0.765 . . . . 0.0 111.034 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -83.03 -31.18 27.55 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -103.58 -42.18 5.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.226 0.921 . . . . 0.0 112.938 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -82.39 -20.35 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.155 0.889 . . . . 0.0 112.577 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.19 18.7 66.39 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.318 0.961 . . . . 0.0 113.592 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.5 mt -69.59 157.05 37.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.642 1.221 . . . . 0.0 110.464 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -87.74 146.34 25.71 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.45 -0.781 . . . . 0.0 109.299 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -55.13 -36.69 66.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.317 -0.864 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.91 -19.54 43.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.892 1.677 . . . . 0.0 115.035 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -79.29 -9.46 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.05 132.3 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 120.957 -1.089 . . . . 0.0 110.926 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -106.31 124.87 50.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.548 1.539 . . . . 0.0 109.544 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.8 mt -100.95 124.13 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.199 1.0 . . . . 0.0 108.415 174.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.38 171.33 8.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.954 1.302 . . . . 0.0 112.15 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.46 -144.65 14.71 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.114 1.34 . . . . 0.0 112.435 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.841 2.056 . . . . 0.0 113.313 175.739 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -137.92 154.63 49.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.011 1.324 . . . . 0.0 111.31 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 tt -158.81 149.77 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.589 1.555 . . . . 0.0 110.48 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -133.17 161.59 34.02 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.547 1.539 . . . . 0.0 111.291 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -156.48 154.63 30.69 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.779 1.632 . . . . 0.0 111.281 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -147.47 169.75 18.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.208 1.403 . . . . 0.0 112.478 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.88 97.9 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.049 0.94 . . . . 0.0 111.131 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 p -85.54 -16.2 40.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.699 1.2 . . . . 0.0 113.772 176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -90.74 153.34 20.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.892 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -143.12 146.98 39.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.103 1.761 . . . . 0.0 110.101 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.92 -28.36 5.11 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.193 2.595 . . . . 0.0 112.842 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -178.81 167.88 1.68 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.724 2.81 . . . . 0.0 109.293 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 146.79 27.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 111.157 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.69 -27.24 37.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.199 1.0 . . . . 0.0 113.068 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 p -86.71 150.48 24.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.827 1.651 . . . . 0.0 112.32 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.23 -161.08 37.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.998 1.285 . . . . 0.0 112.802 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.01 137.18 54.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.08 0.952 . . . . 0.0 111.901 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -80.49 135.38 36.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.036 . . . . 0.0 112.103 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -144.18 150.24 37.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.066 1.347 . . . . 0.0 111.197 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -148.0 12.75 0.98 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.089 1.356 . . . . 0.0 113.394 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.01 8.65 5.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.078 2.151 . . . . 0.0 115.55 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 152.5 41.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 112.147 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 p -79.1 -6.91 57.59 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.031 1.332 . . . . 0.0 113.358 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -74.94 -5.66 45.03 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 50.8 m-85 -72.88 134.63 44.9 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.067 -1.021 . . . . 0.0 112.554 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.9 mt -99.69 132.77 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.16 1.784 . . . . 0.0 107.425 170.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -118.67 120.18 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.222 1.009 . . . . 0.0 110.389 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.83 104.48 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -109.79 169.79 8.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.87 1.668 . . . . 0.0 110.568 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mt -126.11 140.4 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -74.84 156.77 36.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.892 0.877 . . . . 0.0 111.62 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -72.66 130.43 40.54 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.624 -0.673 . . . . 0.0 112.019 -169.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -80.05 100.8 8.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.33 1.052 . . . . 0.0 110.664 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -119.32 13.58 12.78 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.736 2.014 . . . . 0.0 113.212 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.21 53.13 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.506 1.527 . . . . 0.0 114.2 -172.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.96 171.6 7.31 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.016 1.727 . . . . 0.0 111.538 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -55.9 140.91 41.21 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.981 1.712 . . . . 0.0 113.857 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.4 m -70.71 124.55 24.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.463 1.105 . . . . 0.0 109.342 169.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.0 mt -129.58 136.35 49.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.48 1.512 . . . . 0.0 110.17 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.0 m -89.18 138.93 30.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.595 1.558 . . . . 0.0 107.618 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -127.46 120.99 29.61 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.845 1.258 . . . . 0.0 110.335 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.84 126.52 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.671 1.188 . . . . 0.0 109.519 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.09 151.51 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.457 1.903 . . . . 0.0 109.751 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.91 -1.45 79.07 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.08 133.3 59.4 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.654 1.227 . . . . 0.0 111.101 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.52 144.19 64.08 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.039 3.159 . . . . 0.0 113.452 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.37 -16.66 63.57 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.053 0.941 . . . . 0.0 113.329 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.67 -17.8 63.52 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 113.481 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -93.23 122.12 35.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.666 1.187 . . . . 0.0 111.313 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -73.1 117.39 14.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.853 0.861 . . . . 0.0 111.331 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.2 mt -60.23 -36.5 77.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.598 0.759 . . . . 0.0 111.819 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -62.88 -38.46 90.97 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.325 1.05 . . . . 0.0 112.027 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -65.38 -37.43 86.98 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.431 -0.793 . . . . 0.0 111.697 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.28 -41.05 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 110.124 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.87 -53.24 60.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.262 0.937 . . . . 0.0 111.013 170.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -56.87 -50.06 73.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.554 0.742 . . . . 0.0 112.873 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.1 p -68.82 -37.43 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.97 -38.33 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.569 0.622 . . . . 0.0 111.712 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.23 -31.87 72.96 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.244 -1.535 . . . . 0.0 112.329 173.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -73.99 -65.43 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.142 1.377 . . . . 0.0 112.933 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -91.69 -29.32 16.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -167.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -93.98 -7.75 41.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.842 0.857 . . . . 0.0 112.488 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.38 26.05 15.59 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.402 1.881 . . . . 0.0 113.236 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -82.58 -169.24 2.36 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.558 1.143 . . . . 0.0 112.631 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -141.18 151.78 44.11 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.045 1.338 . . . . 0.0 109.339 167.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.61 172.32 44.09 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -158.01 162.03 38.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.717 1.607 . . . . 0.0 111.904 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.48 129.56 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.111 1.364 . . . . 0.0 108.329 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.4 t -138.53 140.96 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.601 1.16 . . . . 0.0 109.516 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -101.93 111.64 23.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.671 0.788 . . . . 0.0 111.061 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.42 144.53 34.0 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.428 1.491 . . . . 0.0 111.234 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.11 -31.01 92.19 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.423 2.749 . . . . 0.0 114.775 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -111.64 -47.1 3.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.641 1.176 . . . . 0.0 112.348 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.6 mtt -78.04 -16.34 58.14 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.3 -160.71 48.05 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.599 1.095 . . . . 0.0 112.871 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -71.65 118.53 14.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.02 0.928 . . . . 0.0 111.015 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.51 152.22 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.304 1.841 . . . . 0.0 111.813 -170.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.7 mt -90.97 127.97 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -94.43 130.64 40.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.229 1.412 . . . . 0.0 107.713 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -119.09 136.21 54.26 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.655 1.582 . . . . 0.0 107.89 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -76.92 128.17 34.06 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.308 -0.87 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.56 -170.23 28.08 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.237 1.399 . . . . 0.0 113.363 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -97.76 83.95 3.28 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.68 1.992 . . . . 0.0 111.335 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -110.08 15.13 22.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.223 -169.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -59.18 -46.28 88.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.62 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.854 0.861 . . . . 0.0 111.912 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.25 -45.9 89.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.296 1.039 . . . . 0.0 111.913 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.52 -36.12 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.236 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.95 -47.36 80.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.521 1.055 . . . . 0.0 110.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.08 -39.14 91.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.456 0.702 . . . . 0.0 112.641 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 24.5 t80 -59.66 -49.13 78.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.65 1.114 . . . . 0.0 111.602 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.5 mmt -59.06 -44.34 91.83 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.625 1.17 . . . . 0.0 110.522 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt -72.18 -44.14 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.635 0.774 . . . . 0.0 111.68 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 t -75.3 -48.05 25.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -100.96 -37.09 8.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.0 mt -90.83 -13.39 33.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.723 0.692 . . . . 0.0 112.84 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.57 15.54 81.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.726 1.155 . . . . 0.0 113.687 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.2 145.01 53.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.239 1.019 . . . . 0.0 110.626 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -82.16 134.66 35.32 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.714 -0.617 . . . . 0.0 110.388 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -51.97 -44.43 63.99 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.75 0.82 . . . . 0.0 112.392 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -22.2 63.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -81.73 -10.96 59.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 112.982 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -106.73 124.55 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.644 1.111 . . . . 0.0 110.617 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 68.6 mmtt -101.26 135.11 43.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.806 1.642 . . . . 0.0 110.457 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.49 128.14 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 108.845 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -126.07 -159.24 0.9 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 111.296 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 -152.15 18.73 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.989 1.28 . . . . 0.0 113.079 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.384 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 N--CA 1.504 2.231 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -83.84 -9.83 58.47 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.6 pt -71.58 156.56 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.785 1.234 . . . . 0.0 113.168 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.06 157.23 31.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.97 1.308 . . . . 0.0 112.414 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.34 30.04 0.69 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.794 1.237 . . . . 0.0 112.412 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.74 118.56 10.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.312 1.445 . . . . 0.0 110.14 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -72.52 125.49 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.381 1.072 . . . . 0.0 112.497 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -84.06 147.34 27.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.892 0.877 . . . . 0.0 111.116 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.55 158.86 35.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.787 1.235 . . . . 0.0 112.078 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -158.31 143.6 12.1 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.326 1.85 . . . . 0.0 110.132 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.41 -47.31 26.54 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.608 2.872 . . . . 0.0 114.95 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -176.78 142.25 0.4 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.546 1.939 . . . . 0.0 111.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.83 27.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.186 1.394 . . . . 0.0 111.538 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.11 154.94 20.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.952 1.301 . . . . 0.0 112.974 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.2 m -136.23 135.9 39.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.81 1.644 . . . . 0.0 109.451 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 122.83 6.39 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.308 0.956 . . . . 0.0 111.466 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -165.73 159.48 16.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.398 1.879 . . . . 0.0 110.918 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.57 162.79 35.43 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.531 1.532 . . . . 0.0 112.605 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -155.15 150.76 27.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.063 1.345 . . . . 0.0 111.162 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 t -162.66 159.36 24.35 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.593 1.557 . . . . 0.0 111.427 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.68 64.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.62 1.168 . . . . 0.0 113.892 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -106.97 -100.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.38 1.472 . . . . 0.0 111.176 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 m -87.47 107.93 18.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 112.828 -169.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -154.76 160.69 41.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.559 1.543 . . . . 0.0 110.588 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -70.68 139.23 51.19 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.522 -0.736 . . . . 0.0 110.589 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mt -84.52 111.8 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -96.53 118.82 33.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.62 0.768 . . . . 0.0 110.32 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mt -108.53 109.39 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -121.26 174.43 6.71 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.7 mt -109.78 139.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -85.4 152.82 22.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.855 0.862 . . . . 0.0 111.042 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.49 150.06 49.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.774 1.229 . . . . 0.0 113.009 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -72.45 125.5 27.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.458 0.703 . . . . 0.0 110.931 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -168.27 -44.29 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.085 1.754 . . . . 0.0 111.514 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.79 173.83 55.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.664 1.126 . . . . 0.0 112.896 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -70.04 -22.21 63.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -132.67 158.32 42.61 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.898 1.679 . . . . 0.0 112.13 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 m -68.53 146.18 53.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.48 134.48 47.82 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.396 1.078 . . . . 0.0 111.252 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -91.41 125.05 36.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.339 1.855 . . . . 0.0 108.441 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -106.69 128.9 54.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.539 1.536 . . . . 0.0 110.827 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.0 124.09 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.851 1.26 . . . . 0.0 109.734 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -127.67 155.21 44.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.452 1.901 . . . . 0.0 109.501 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 1.25 90.61 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 168.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -61.13 131.45 92.04 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 118.678 1.239 . . . . 0.0 110.661 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.49 142.36 59.44 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 124.124 3.216 . . . . 0.0 113.267 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.28 -17.25 62.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.164 0.985 . . . . 0.0 113.096 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.03 -18.64 65.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.876 0.87 . . . . 0.0 113.159 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.99 116.86 29.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.856 1.262 . . . . 0.0 110.79 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -69.79 120.78 16.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.074 0.95 . . . . 0.0 111.588 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.91 -39.27 88.74 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.208 1.003 . . . . 0.0 111.974 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.0 -31.38 71.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.926 0.891 . . . . 0.0 112.538 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -40.7 79.32 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 111.836 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.07 -47.65 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.654 0.782 . . . . 0.0 109.057 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.3 mt -55.65 -48.58 74.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.718 0.69 . . . . 0.0 111.674 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.58 -43.29 97.42 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.445 -0.785 . . . . 0.0 112.452 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.15 -46.61 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.118 0.872 . . . . 0.0 111.16 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.06 -27.65 64.81 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -76.81 -35.86 57.3 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.659 -1.276 . . . . 0.0 113.254 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -77.91 -62.32 1.71 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.95 -32.03 20.33 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.221 1.409 . . . . 0.0 113.988 -166.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.7 -8.88 27.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.13 0.972 . . . . 0.0 113.162 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.62 28.25 16.89 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.831 1.652 . . . . 0.0 113.444 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 92.9 m -87.32 -169.85 2.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.921 1.289 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -148.58 149.87 32.31 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.913 0.885 . . . . 0.0 110.082 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.14 177.38 47.15 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.7 161.41 29.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.912 1.685 . . . . 0.0 111.942 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.13 141.37 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.688 1.195 . . . . 0.0 109.226 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.79 138.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.971 1.308 . . . . 0.0 109.411 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -100.14 97.97 8.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 109.579 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.49 146.3 50.02 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.42 1.488 . . . . 0.0 112.002 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.97 -32.84 87.35 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.793 2.995 . . . . 0.0 115.33 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -121.64 -36.68 3.0 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 mtt -77.52 -18.54 56.91 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.24 -157.76 50.13 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.264 0.935 . . . . 0.0 112.433 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.19 115.68 11.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.615 0.766 . . . . 0.0 111.004 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 pt -137.04 151.75 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.479 1.911 . . . . 0.0 112.173 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.27 136.52 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.38 135.04 47.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.186 1.795 . . . . 0.0 108.212 168.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.93 140.62 52.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.749 1.62 . . . . 0.0 108.946 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -72.64 138.51 46.77 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.281 -0.887 . . . . 0.0 111.991 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.72 -169.69 43.1 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.558 1.551 . . . . 0.0 112.895 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.47 97.75 7.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.053 1.341 . . . . 0.0 109.998 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -115.07 27.45 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.885 1.274 . . . . 0.0 113.702 -167.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -51.94 -59.02 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.537 1.535 . . . . 0.0 112.639 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.46 -38.91 91.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.786 1.235 . . . . 0.0 112.195 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.72 -48.41 79.36 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 111.731 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.21 -34.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.828 -0.545 . . . . 0.0 111.344 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.95 -50.03 73.88 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.212 0.915 . . . . 0.0 111.182 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.79 -38.2 81.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.094 0.958 . . . . 0.0 112.647 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.68 -48.12 83.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.67 1.123 . . . . 0.0 111.791 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.5 mmt -61.86 -41.73 98.2 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 110.591 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.25 -48.18 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.049 0.94 . . . . 0.0 111.535 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -80.95 -48.34 12.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -98.51 -34.06 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -85.75 -15.61 41.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.897 0.771 . . . . 0.0 112.035 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.37 79.64 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.017 1.294 . . . . 0.0 113.777 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.48 151.71 42.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.562 1.181 . . . . 0.0 112.141 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -74.15 141.31 45.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.022 0.529 . . . . 0.0 109.929 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -57.36 -36.66 71.48 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.25 -21.1 47.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.961 . . . . 0.0 114.87 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.15 -9.76 58.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.105 0.962 . . . . 0.0 113.127 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.9 133.78 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.384 1.074 . . . . 0.0 110.692 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -110.65 133.84 52.96 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.148 1.779 . . . . 0.0 110.188 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.6 mt -108.94 128.99 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.141 0.976 . . . . 0.0 109.346 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -126.74 161.37 28.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.647 1.579 . . . . 0.0 111.673 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.99 -143.19 7.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.406 1.003 . . . . 0.0 111.959 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 124.86 1.264 . . . . 0.0 112.886 169.828 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mtp . . . . . 0 N--CA 1.505 2.283 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -67.5 151.42 47.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 112.904 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp -160.06 151.56 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.501 1.52 . . . . 0.0 110.579 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -160.64 154.78 23.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.616 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -155.28 155.55 33.97 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.079 1.351 . . . . 0.0 111.639 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.31 135.23 53.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.256 1.422 . . . . 0.0 111.729 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -159.12 156.51 29.22 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.585 1.554 . . . . 0.0 112.394 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 t -167.82 152.14 6.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 110.036 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -143.28 139.99 30.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.683 1.193 . . . . 0.0 111.53 -171.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.08 146.15 47.87 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.963 1.305 . . . . 0.0 112.302 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.73 -37.96 64.15 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.392 2.728 . . . . 0.0 112.813 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -177.24 152.28 0.86 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.218 2.607 . . . . 0.0 109.913 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.65 53.53 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.196 0.998 . . . . 0.0 113.54 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -163.02 155.15 18.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.707 2.003 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -88.32 132.22 34.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.134 0.973 . . . . 0.0 109.943 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.8 7.64 76.23 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.825 1.202 . . . . 0.0 115.531 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -160.34 157.66 28.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.092 1.757 . . . . 0.0 111.527 -175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -144.45 6.49 1.28 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.322 1.849 . . . . 0.0 113.694 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.27 131.54 46.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.952 0.901 . . . . 0.0 111.78 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -84.76 131.81 34.51 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.375 1.47 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.26 144.32 28.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.097 0.959 . . . . 0.0 111.486 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -60.76 -42.74 98.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.099 1.36 . . . . 0.0 112.296 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -69.22 -16.3 63.57 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.61 1.164 . . . . 0.0 114.086 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -88.94 -15.71 33.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.263 1.025 . . . . 0.0 113.297 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -72.17 138.06 47.37 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.077 -1.014 . . . . 0.0 113.219 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.13 126.65 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.846 1.258 . . . . 0.0 107.943 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -107.45 115.08 29.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.559 1.144 . . . . 0.0 109.344 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.28 108.5 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -116.97 173.57 6.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.524 1.929 . . . . 0.0 110.865 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.0 141.64 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -84.17 162.3 20.27 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.455 0.645 . . . . 0.0 111.719 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -80.46 103.82 10.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -132.32 143.44 49.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.273 1.429 . . . . 0.0 111.317 -170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -85.22 130.96 34.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.285 1.034 . . . . 0.0 111.095 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.78 -147.18 50.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.86 0.743 . . . . 0.0 112.56 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.86 12.79 6.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.61 1.164 . . . . 0.0 113.715 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -73.47 32.12 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.097 -1.627 . . . . 0.0 113.133 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 m -68.34 142.94 55.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.988 2.915 . . . . 0.0 111.554 -168.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.97 128.86 39.31 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.762 1.225 . . . . 0.0 110.302 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 m -89.43 132.37 35.03 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.878 1.671 . . . . 0.0 107.828 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -117.43 126.77 53.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 110.925 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.48 123.57 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.544 1.138 . . . . 0.0 108.943 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -129.9 149.51 51.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 109.388 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 4.85 89.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.58 131.71 64.01 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 118.567 1.184 . . . . 0.0 111.319 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.25 143.19 53.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.383 3.389 . . . . 0.0 113.615 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -67.49 -18.94 65.25 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 113.37 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.5 -16.91 62.95 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -96.23 124.27 40.17 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.718 1.207 . . . . 0.0 111.799 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.11 121.55 23.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.166 0.986 . . . . 0.0 111.852 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.24 -39.25 92.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.534 0.733 . . . . 0.0 112.395 -174.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -62.86 -34.71 77.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.285 -0.884 . . . . 0.0 112.172 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 tpt85 -64.95 -37.55 88.04 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.15 0.886 . . . . 0.0 111.929 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.9 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.373 1.069 . . . . 0.0 110.164 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.94 -52.78 64.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.199 0.909 . . . . 0.0 110.914 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -54.89 -50.52 68.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 112.638 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 p -70.11 -36.1 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -34.9 65.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.651 0.66 . . . . 0.0 112.145 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.45 -33.28 73.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.756 -1.215 . . . . 0.0 112.425 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -74.87 -66.23 0.78 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.122 1.369 . . . . 0.0 113.153 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -91.2 -29.82 17.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -167.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.33 -4.93 47.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.878 0.871 . . . . 0.0 112.561 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.34 28.1 16.26 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.193 1.797 . . . . 0.0 113.246 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.1 m -83.06 177.8 8.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.491 1.116 . . . . 0.0 112.771 -173.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -126.21 141.7 51.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.462 1.505 . . . . 0.0 107.93 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.26 166.96 39.57 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.84 158.34 40.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.236 1.815 . . . . 0.0 111.821 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.7 mt -93.69 136.24 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.741 1.216 . . . . 0.0 108.991 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.36 142.25 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.972 1.309 . . . . 0.0 109.448 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.61 101.36 10.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.049 0.939 . . . . 0.0 109.844 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.52 144.96 32.82 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.154 1.382 . . . . 0.0 111.742 -172.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.43 -31.17 93.53 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.481 2.788 . . . . 0.0 114.744 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -111.15 -47.25 3.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.709 1.204 . . . . 0.0 112.4 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.4 mtt -77.76 -17.63 57.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.43 -161.02 49.87 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 124.599 1.095 . . . . 0.0 112.66 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.02 120.45 17.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.787 0.835 . . . . 0.0 111.023 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 pt -144.14 153.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.172 1.789 . . . . 0.0 112.557 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.0 mt -99.73 132.08 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 165.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -99.34 139.41 35.03 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.569 1.548 . . . . 0.0 108.682 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tp -129.02 138.44 51.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.783 1.633 . . . . 0.0 108.229 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -72.38 139.69 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.126 -0.984 . . . . 0.0 111.477 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.19 -172.39 43.42 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.419 1.485 . . . . 0.0 113.379 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -98.88 85.67 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.754 2.021 . . . . 0.0 110.954 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -109.45 16.21 22.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.596 1.559 . . . . 0.0 113.258 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -58.34 -42.96 88.03 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -39.31 66.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 112.089 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -63.81 -45.22 90.59 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.025 0.93 . . . . 0.0 111.826 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.44 -35.46 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.162 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.75 -48.81 76.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.494 1.043 . . . . 0.0 111.164 170.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.93 -40.15 83.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.784 0.834 . . . . 0.0 112.678 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.7 t80 -59.75 -49.94 75.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.767 1.167 . . . . 0.0 111.869 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.0 mmt -59.67 -37.82 79.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 110.903 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.52 -45.05 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.998 0.919 . . . . 0.0 111.084 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -85.42 -22.14 28.47 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.12 -38.0 2.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.386 0.993 . . . . 0.0 113.601 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.7 mt -82.74 -14.94 53.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.505 1.048 . . . . 0.0 112.48 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.81 14.95 80.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.841 1.21 . . . . 0.0 113.609 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.54 159.51 34.19 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.543 1.171 . . . . 0.0 111.514 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.13 151.29 22.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.378 0.671 . . . . 0.0 110.05 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -55.91 -38.92 70.88 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.255 -0.903 . . . . 0.0 111.657 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.19 -0.11 3.14 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.05 -1.86 56.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.967 1.258 . . . . 0.0 113.033 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt -128.06 132.44 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 120.738 -1.226 . . . . 0.0 111.597 -169.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.69 126.98 51.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.572 1.549 . . . . 0.0 109.829 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.87 122.73 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.78 172.24 7.16 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.242 1.417 . . . . 0.0 111.956 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.9 -154.38 27.77 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 124.819 1.199 . . . . 0.0 113.294 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.848 1.659 . . . . 0.0 112.888 169.716 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -75.04 35.33 0.11 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.419 1.887 . . . . 0.0 115.038 -171.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.25 159.7 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.272 1.429 . . . . 0.0 112.241 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -132.31 144.75 50.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.609 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -75.08 -21.02 59.22 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.946 0.899 . . . . 0.0 113.401 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.91 63.98 7.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.867 1.667 . . . . 0.0 110.381 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.9 -39.37 87.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.455 1.102 . . . . 0.0 113.37 -174.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.8 p -173.81 164.37 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.791 1.636 . . . . 0.0 112.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.45 162.79 34.86 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.108 1.763 . . . . 0.0 110.97 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -132.78 142.52 45.07 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.283 1.433 . . . . 0.0 111.085 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.62 -23.27 5.99 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.46 2.773 . . . . 0.0 113.261 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -176.47 157.23 1.64 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.629 2.372 . . . . 0.0 109.898 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.87 153.76 39.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.903 1.281 . . . . 0.0 112.621 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.92 142.63 47.87 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.571 1.148 . . . . 0.0 112.291 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.9 p -138.31 165.49 26.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.693 1.597 . . . . 0.0 111.865 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.52 141.6 5.88 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.822 1.677 . . . . 0.0 112.922 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -168.06 164.88 13.63 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.073 2.149 . . . . 0.0 110.528 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -153.48 139.61 18.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 112.622 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -170.51 169.94 7.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.468 2.307 . . . . 0.0 110.579 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 p -80.98 -71.69 0.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.94 1.296 . . . . 0.0 110.125 170.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.04 162.7 4.63 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.76 2.424 . . . . 0.0 111.303 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -164.38 161.85 21.86 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.223 1.809 . . . . 0.0 111.026 173.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -70.2 142.85 52.39 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.089 0.956 . . . . 0.0 112.118 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.52 159.84 25.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 112.91 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -136.77 163.5 30.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.755 1.622 . . . . 0.0 112.618 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mp -83.49 127.48 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.1 127.62 55.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.919 . . . . 0.0 110.883 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.4 mt -117.71 99.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -103.53 174.61 5.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.715 2.406 . . . . 0.0 110.214 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.3 mt -127.74 137.85 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.058 0.943 . . . . 0.0 108.771 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -95.88 126.87 41.44 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.63 1.172 . . . . 0.0 108.697 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -80.68 138.61 36.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.917 1.287 . . . . 0.0 108.961 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -155.46 144.88 21.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.486 0.715 . . . . 0.0 112.255 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -59.24 150.65 25.12 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.828 1.251 . . . . 0.0 112.582 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.28 13.55 79.65 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.471 1.034 . . . . 0.0 114.45 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 65.06 27.31 12.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.324 1.85 . . . . 0.0 112.457 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -79.06 62.3 3.44 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -65.7 137.17 57.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.124 1.77 . . . . 0.0 110.915 -171.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.6 mt -130.64 126.52 36.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.174 . . . . 0.0 110.202 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -82.69 116.14 21.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.952 1.301 . . . . 0.0 107.919 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 113.31 24.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.502 1.521 . . . . 0.0 110.004 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.02 129.33 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.668 1.187 . . . . 0.0 108.479 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -144.75 161.45 39.2 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.992 1.717 . . . . 0.0 110.152 -167.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.62 -14.2 4.53 Favored Glycine 0 N--CA 1.475 1.251 0 O-C-N 120.463 -1.398 . . . . 0.0 116.541 168.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -47.99 130.93 12.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.224 1.41 . . . . 0.0 111.55 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -53.5 140.81 63.9 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.954 3.103 . . . . 0.0 113.112 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.76 -10.58 59.78 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.86 -19.57 63.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.85 0.86 . . . . 0.0 112.742 170.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.71 114.13 26.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.048 1.339 . . . . 0.0 110.394 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -66.99 123.15 19.39 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.32 -38.63 80.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.553 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.58 -32.9 74.51 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.118 0.967 . . . . 0.0 112.567 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -69.5 -38.4 77.61 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.277 -0.889 . . . . 0.0 111.517 171.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.2 mt -57.95 -47.05 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.041 0.837 . . . . 0.0 108.964 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.18 -48.73 73.37 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.005 0.82 . . . . 0.0 111.743 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -61.57 -43.67 98.44 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.665 -0.647 . . . . 0.0 112.301 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.23 -46.86 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.651 0.659 . . . . 0.0 111.137 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.63 -32.16 70.69 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.92 -34.36 64.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.674 -1.266 . . . . 0.0 113.208 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.83 -48.46 9.34 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.38 -41.36 12.88 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.704 0.802 . . . . 0.0 113.135 -171.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -94.38 -12.53 27.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.336 1.054 . . . . 0.0 113.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.82 31.17 16.56 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.146 1.778 . . . . 0.0 112.858 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.0 m -80.96 -177.67 6.52 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.476 1.11 . . . . 0.0 111.636 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -138.25 145.92 41.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.374 1.07 . . . . 0.0 109.332 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.63 172.09 45.13 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 116.158 1.223 . . . . 0.0 116.158 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.91 161.87 38.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.538 1.535 . . . . 0.0 112.583 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.0 mt -97.73 134.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.928 1.291 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.35 140.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.285 1.434 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -95.54 103.97 15.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.27 143.8 39.84 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.942 1.297 . . . . 0.0 111.681 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.27 -31.38 93.52 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.541 2.827 . . . . 0.0 114.859 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -110.57 -47.13 3.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.583 1.153 . . . . 0.0 112.304 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 61.4 mtt -78.92 -18.88 53.09 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.88 -157.62 45.55 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.372 0.987 . . . . 0.0 112.476 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.83 117.79 11.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.814 -0.815 . . . . 0.0 111.322 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -140.62 152.93 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.26 1.824 . . . . 0.0 112.141 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.91 133.47 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.17 123.2 45.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tp -108.97 136.36 48.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.174 1.39 . . . . 0.0 108.209 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.48 134.99 48.27 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.208 -0.933 . . . . 0.0 111.673 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.39 -168.95 40.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.378 1.466 . . . . 0.0 113.436 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -98.55 99.74 10.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.811 1.644 . . . . 0.0 109.899 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -122.0 20.72 10.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.863 1.265 . . . . 0.0 113.226 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.5 ptt180 -62.16 -44.28 96.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.07 -39.62 90.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.458 0.703 . . . . 0.0 111.772 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -64.76 -46.15 83.41 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.141 0.977 . . . . 0.0 111.988 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.47 -36.37 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.857 -0.527 . . . . 0.0 111.352 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.02 -48.24 82.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.313 0.96 . . . . 0.0 111.199 171.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.38 -37.72 78.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.817 0.847 . . . . 0.0 112.671 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.57 -48.72 79.69 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 111.693 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.7 mmt -59.99 -42.99 95.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.205 1.002 . . . . 0.0 110.578 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.75 -48.62 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.081 0.952 . . . . 0.0 111.608 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -79.17 -47.84 15.31 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -98.97 -35.82 9.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.21 -17.58 25.82 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.632 0.651 . . . . 0.0 112.728 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.84 17.29 80.0 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.372 0.987 . . . . 0.0 113.623 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.0 145.86 51.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.31 1.055 . . . . 0.0 110.785 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -74.29 143.85 44.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.725 0.774 . . . . 0.0 111.664 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.31 -42.07 99.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.509 0.724 . . . . 0.0 112.166 -168.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.04 -21.48 63.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.975 1.31 . . . . 0.0 113.999 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -82.3 -4.12 56.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.665 1.186 . . . . 0.0 112.326 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.32 136.12 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.669 1.588 . . . . 0.0 108.838 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.12 116.73 25.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.729 1.612 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.97 124.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -111.28 -30.07 7.58 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.66 -155.41 49.79 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.328 0.966 . . . . 0.0 113.883 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.026 1.731 . . . . 0.0 114.59 179.176 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -71.96 -5.47 35.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pp -70.5 -3.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -153.75 139.45 17.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.51 1.524 . . . . 0.0 110.488 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.52 155.64 22.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.644 1.578 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.28 148.42 39.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 110.961 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -139.13 165.77 26.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.664 1.586 . . . . 0.0 111.819 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.1 p -161.16 162.82 31.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.178 1.391 . . . . 0.0 111.944 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -85.63 157.03 20.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 0.0 112.526 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.33 148.35 90.88 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.287 1.035 . . . . 0.0 112.07 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.06 -37.48 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.067 2.511 . . . . 0.0 112.142 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -159.6 152.29 21.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.457 2.303 . . . . 0.0 109.256 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.67 148.29 35.55 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.861 1.664 . . . . 0.0 111.405 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -88.14 169.37 11.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.321 1.448 . . . . 0.0 113.64 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -160.45 158.6 29.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.421 1.889 . . . . 0.0 110.509 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.92 -160.07 33.26 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.142 1.353 . . . . 0.0 113.452 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.49 167.94 20.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.236 1.415 . . . . 0.0 113.328 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -151.84 157.14 41.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.701 1.601 . . . . 0.0 111.524 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -29.21 69.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.457 1.103 . . . . 0.0 113.544 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.4 m 78.24 147.48 0.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.399 2.68 . . . . 0.0 111.83 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.48 152.91 43.18 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.584 1.554 . . . . 0.0 111.331 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -83.51 -63.25 1.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.427 1.491 . . . . 0.0 111.692 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -175.27 170.66 3.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.713 1.605 . . . . 0.0 112.923 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -159.6 -47.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.544 1.937 . . . . 0.0 109.497 169.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -147.79 148.03 30.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.715 2.406 . . . . 0.0 109.03 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.27 108.74 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.21 121.47 35.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.785 0.834 . . . . 0.0 110.098 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 85' ' ' ARG . 45.8 mt -113.71 104.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -111.89 166.0 11.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.267 1.827 . . . . 0.0 109.363 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -122.03 143.36 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.799 -1.188 . . . . 0.0 109.833 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -93.07 133.51 36.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.775 1.23 . . . . 0.0 108.864 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -73.86 143.78 45.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.826 0.85 . . . . 0.0 109.847 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -67.48 145.98 54.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.537 1.16 . . . . 0.0 114.126 -169.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -149.15 -41.58 0.15 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.331 2.252 . . . . 0.0 109.609 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.98 -172.87 48.59 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.393 1.473 . . . . 0.0 112.266 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -72.97 -13.03 61.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.16 157.73 45.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.018 1.327 . . . . 0.0 113.316 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.5 m -75.98 149.34 37.63 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.113 1.765 . . . . 0.0 108.974 169.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.2 127.36 44.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.435 0.694 . . . . 0.0 111.323 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.8 m -89.84 121.73 32.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.131 1.772 . . . . 0.0 107.999 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 p -106.64 121.42 44.3 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.451 1.5 . . . . 0.0 110.347 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.45 129.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.884 1.273 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.35 152.51 49.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.554 1.941 . . . . 0.0 109.878 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.34 2.31 78.83 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.12 132.76 68.61 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.234 1.413 . . . . 0.0 111.575 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.08 140.04 41.23 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.445 3.43 . . . . 0.0 113.664 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.48 -22.59 67.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.308 1.043 . . . . 0.0 113.564 -172.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.49 -19.08 65.7 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.21 103.95 15.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.042 1.337 . . . . 0.0 110.557 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.5 126.76 28.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.615 1.166 . . . . 0.0 112.2 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 mt -61.97 -40.04 94.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.24 0.616 . . . . 0.0 111.953 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.82 -36.37 83.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.809 0.844 . . . . 0.0 112.217 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -63.83 -38.9 92.8 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.044 -1.035 . . . . 0.0 111.936 169.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.88 -42.33 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.884 0.874 . . . . 0.0 109.931 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mt -58.12 -52.92 63.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.107 0.867 . . . . 0.0 111.025 171.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.56 -50.71 71.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.822 0.849 . . . . 0.0 112.975 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.66 -39.26 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.56 -37.43 71.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.727 0.694 . . . . 0.0 111.996 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -66.94 -29.67 69.6 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.101 -1.624 . . . . 0.0 112.729 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.19 -63.22 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.152 0.981 . . . . 0.0 113.094 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.06 -33.94 29.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.32 -8.31 36.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 112.8 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.41 26.82 16.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.219 1.807 . . . . 0.0 113.275 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.2 p -81.9 -169.93 2.6 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 112.851 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -139.48 149.22 43.71 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.931 1.292 . . . . 0.0 109.382 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -178.98 173.25 45.49 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -163.91 164.11 23.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.358 1.863 . . . . 0.0 111.717 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -100.06 140.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.554 1.141 . . . . 0.0 109.563 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -138.68 144.19 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.259 1.423 . . . . 0.0 109.626 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -102.98 103.36 13.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.806 0.842 . . . . 0.0 110.065 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.85 143.34 43.19 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.22 1.408 . . . . 0.0 111.687 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.49 -31.32 91.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.634 2.889 . . . . 0.0 114.78 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -109.63 -48.05 3.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.667 1.187 . . . . 0.0 112.301 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -80.5 -14.86 57.9 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.9 -159.09 49.13 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.288 0.946 . . . . 0.0 112.713 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.68 118.69 14.82 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.628 0.771 . . . . 0.0 111.245 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.8 pt -141.04 151.15 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.483 1.913 . . . . 0.0 112.172 -169.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.43 133.11 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -101.2 132.99 46.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.77 1.628 . . . . 0.0 107.987 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -122.6 135.14 54.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.935 1.694 . . . . 0.0 107.769 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -73.68 134.25 43.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.314 -0.866 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.54 -169.12 25.73 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.813 1.673 . . . . 0.0 113.279 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -105.09 52.37 0.74 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.015 2.126 . . . . 0.0 111.601 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -75.54 21.47 0.14 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.742 2.417 . . . . 0.0 116.267 -167.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HA ' HG21 ' A' ' 28' ' ' ILE . 30.1 ptt-85 -57.62 -47.55 81.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.5 74.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.872 0.869 . . . . 0.0 111.782 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -64.24 -45.34 88.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.29 -36.32 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.721 -0.612 . . . . 0.0 111.391 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.3 t -57.18 -48.6 78.33 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.34 0.973 . . . . 0.0 111.014 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.23 -39.0 85.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.095 0.958 . . . . 0.0 112.637 175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.37 -49.61 77.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.938 1.245 . . . . 0.0 111.632 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 mmt -62.97 -40.49 97.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.008 0.923 . . . . 0.0 110.734 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.02 -49.74 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.887 0.875 . . . . 0.0 111.605 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.8 t -79.47 -48.23 14.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -97.08 -33.31 11.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.35 -18.13 29.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.793 0.724 . . . . 0.0 112.369 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.91 17.22 77.57 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.546 1.07 . . . . 0.0 113.802 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.97 155.45 40.56 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.635 1.218 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.85 148.13 30.09 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.798 -0.564 . . . . 0.0 109.581 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -57.67 -35.75 70.99 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.466 -0.771 . . . . 0.0 112.212 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -63.86 -17.27 62.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.979 1.712 . . . . 0.0 115.131 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -73.66 -11.54 60.45 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.455 1.025 . . . . 0.0 113.132 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -117.34 138.97 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.975 1.31 . . . . 0.0 110.566 -169.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -120.25 115.58 23.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.51 1.924 . . . . 0.0 109.938 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.7 mt -90.61 123.25 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -106.06 -29.74 9.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.298 1.039 . . . . 0.0 112.951 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.05 -154.62 52.81 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.541 1.067 . . . . 0.0 113.462 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.909 1.684 . . . . 0.0 114.188 179.088 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -67.98 151.36 47.22 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.143 0.977 . . . . 0.0 112.75 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 70.5 mt -131.67 138.84 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.33 1.452 . . . . 0.0 109.003 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.88 141.3 49.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.182 1.393 . . . . 0.0 110.064 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -80.12 152.03 29.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.985 0.914 . . . . 0.0 112.658 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -78.01 60.86 2.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.852 1.261 . . . . 0.0 111.124 170.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -77.86 -22.95 49.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.867 1.267 . . . . 0.0 113.131 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 p -74.73 171.52 13.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.495 1.518 . . . . 0.0 113.193 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -149.8 163.64 37.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.268 1.427 . . . . 0.0 111.232 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -97.91 118.56 63.74 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.339 1.055 . . . . 0.0 111.122 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.83 -30.0 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.145 2.563 . . . . 0.0 112.677 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.9 p90 179.97 151.48 0.42 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.197 2.999 . . . . 0.0 108.866 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.77 12.26 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.38 170.63 15.25 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.673 2.389 . . . . 0.0 114.024 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -145.7 161.53 39.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.055 1.742 . . . . 0.0 110.562 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.13 136.01 16.61 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.577 1.084 . . . . 0.0 113.09 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.93 -23.87 24.99 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.764 1.226 . . . . 0.0 113.065 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.96 159.43 23.58 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.636 1.574 . . . . 0.0 113.679 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.54 14.02 16.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.419 1.488 . . . . 0.0 112.629 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -66.82 139.05 57.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.668 1.587 . . . . 0.0 111.276 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.62 57.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.239 1.016 . . . . 0.0 112.811 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.36 152.8 18.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.065 1.746 . . . . 0.0 112.385 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.2 p -159.3 128.73 5.44 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.611 1.165 . . . . 0.0 111.477 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -174.21 178.23 2.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.624 1.97 . . . . 0.0 110.862 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -72.6 145.96 46.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.304 -0.872 . . . . 0.0 110.889 168.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.61 118.33 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.92 115.84 31.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.124 0.969 . . . . 0.0 109.887 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.56 104.52 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -110.22 173.93 6.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.163 2.185 . . . . 0.0 110.871 -170.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt -121.95 148.19 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.747 1.219 . . . . 0.0 108.516 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -89.65 139.73 30.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.731 0.812 . . . . 0.0 110.948 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.484 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -97.62 127.28 43.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.291 1.437 . . . . 0.0 108.973 173.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -162.8 158.31 22.61 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.392 1.077 . . . . 0.0 112.698 -171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -79.73 -15.96 56.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.26 151.56 43.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.59 1.091 . . . . 0.0 112.605 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.6 -33.57 75.27 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -82.79 135.15 35.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.928 0.891 . . . . 0.0 112.309 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -82.46 151.02 26.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.028 1.731 . . . . 0.0 110.238 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt -127.8 135.41 50.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.412 1.085 . . . . 0.0 110.38 169.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -93.91 140.3 29.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.613 1.965 . . . . 0.0 108.027 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.33 119.02 24.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.75 1.22 . . . . 0.0 110.83 -174.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.6 121.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 109.611 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.75 152.76 46.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.351 1.86 . . . . 0.0 109.622 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.03 -3.13 62.45 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -55.52 130.6 70.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 118.714 1.257 . . . . 0.0 110.276 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.41 138.4 65.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.792 2.995 . . . . 0.0 113.194 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.15 -6.88 50.34 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.936 0.894 . . . . 0.0 113.234 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.48 -18.82 62.28 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.569 -0.707 . . . . 0.0 112.473 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -90.69 129.94 36.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.634 1.174 . . . . 0.0 110.915 170.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.6 117.47 14.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.351 0.66 . . . . 0.0 110.891 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.05 -37.94 84.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.122 0.569 . . . . 0.0 111.382 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.4 -32.67 72.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.59 1.156 . . . . 0.0 113.202 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -71.0 -38.1 72.67 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.07 0.85 . . . . 0.0 111.402 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.951 0.796 . . . . 0.0 109.086 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.94 -49.6 70.94 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.929 0.786 . . . . 0.0 111.55 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -61.13 -43.66 98.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 112.576 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.66 -44.2 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.494 0.588 . . . . 0.0 111.371 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.0 mt -70.77 -31.49 68.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.79 -33.64 66.38 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.836 -1.165 . . . . 0.0 112.894 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.68 -58.53 3.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.24 1.016 . . . . 0.0 113.292 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.18 -42.38 13.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 0.0 113.449 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -90.31 -12.37 37.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.185 0.994 . . . . 0.0 112.818 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.49 30.14 17.16 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.226 1.81 . . . . 0.0 112.912 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.7 m -81.29 -172.2 3.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 111.442 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -147.47 150.64 34.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.731 1.212 . . . . 0.0 109.241 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.0 172.52 44.72 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 115.836 1.095 . . . . 0.0 115.836 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -153.39 158.13 41.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.425 1.89 . . . . 0.0 111.83 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.4 mt -91.86 130.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.676 1.19 . . . . 0.0 108.452 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -142.38 140.29 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.762 1.225 . . . . 0.0 109.399 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -92.27 115.36 28.02 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.788 -0.57 . . . . 0.0 110.528 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.98 142.73 65.0 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.29 1.036 . . . . 0.0 110.819 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.81 -31.27 61.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.835 3.024 . . . . 0.0 114.971 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.36 -44.98 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.361 1.064 . . . . 0.0 113.081 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.4 mtm -79.86 -12.24 59.76 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.68 -161.28 46.08 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.452 1.025 . . . . 0.0 112.956 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.9 121.4 17.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.552 0.741 . . . . 0.0 111.578 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 pt -141.66 154.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.071 1.748 . . . . 0.0 111.957 -173.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -92.68 129.98 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 166.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -97.56 130.79 44.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.073 1.349 . . . . 0.0 107.532 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -122.01 139.66 53.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.523 1.529 . . . . 0.0 108.578 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -78.12 136.14 37.81 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.339 -0.85 . . . . 0.0 111.17 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.54 -174.05 42.75 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.828 1.68 . . . . 0.0 113.27 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -97.83 88.69 4.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.42 1.888 . . . . 0.0 110.923 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -112.12 16.42 20.17 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.414 1.485 . . . . 0.0 113.358 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -58.89 -41.3 86.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.36 65.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.126 0.97 . . . . 0.0 112.319 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -66.07 -43.6 86.95 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.992 0.917 . . . . 0.0 111.911 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.47 -35.51 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.186 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.0 t -56.89 -48.85 77.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.454 1.024 . . . . 0.0 111.12 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.34 -38.78 81.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.708 0.803 . . . . 0.0 112.726 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.29 -47.3 86.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.713 1.142 . . . . 0.0 111.864 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.5 -42.33 96.12 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.117 0.967 . . . . 0.0 110.606 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.69 -47.33 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 111.471 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -77.48 -48.94 15.85 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -98.79 -34.53 10.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.4 -14.28 43.84 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.891 0.769 . . . . 0.0 112.24 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.86 15.72 80.87 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.957 1.265 . . . . 0.0 113.88 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.47 153.44 42.24 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.399 1.1 . . . . 0.0 111.805 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -82.72 140.39 33.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.759 -0.588 . . . . 0.0 110.004 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -54.5 -35.62 63.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.875 0.87 . . . . 0.0 113.275 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -56.65 -23.85 44.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.406 1.482 . . . . 0.0 114.323 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.64 -10.04 59.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.796 1.238 . . . . 0.0 113.031 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.2 mt -114.7 134.15 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.443 1.097 . . . . 0.0 110.76 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -110.75 126.94 55.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.574 1.949 . . . . 0.0 109.984 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.1 mt -100.93 125.98 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.464 1.105 . . . . 0.0 108.469 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -121.19 171.07 8.97 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.366 . . . . 0.0 112.729 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.66 -142.7 13.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.406 1.479 . . . . 0.0 112.41 174.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.051 2.14 . . . . 0.0 113.275 176.942 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.504 2.273 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 p -69.16 -29.45 67.47 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -80.65 -8.48 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.527 1.531 . . . . 0.0 113.426 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -83.9 146.81 27.86 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.781 1.632 . . . . 0.0 112.407 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -71.62 155.98 39.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.452 0.701 . . . . 0.0 112.156 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.63 -36.33 80.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 0.0 111.845 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -138.14 147.04 43.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.992 1.717 . . . . 0.0 111.073 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 m -147.96 155.65 41.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.87 1.268 . . . . 0.0 111.864 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -85.23 175.09 9.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.697 1.199 . . . . 0.0 111.412 169.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -105.64 109.02 62.76 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.607 1.163 . . . . 0.0 111.136 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.22 -23.98 71.98 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.066 3.177 . . . . 0.0 114.574 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -99.52 11.6 38.7 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.42 1.088 . . . . 0.0 113.009 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.24 67.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.59 1.156 . . . . 0.0 114.092 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -163.25 161.64 24.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 111.744 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.2 p -137.29 154.43 50.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.885 1.674 . . . . 0.0 111.161 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.07 16.45 8.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.731 1.634 . . . . 0.0 114.061 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -163.19 170.54 17.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.255 1.822 . . . . 0.0 112.378 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -138.11 142.84 40.19 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.807 1.643 . . . . 0.0 110.96 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -106.15 144.05 33.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.981 1.313 . . . . 0.0 112.175 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -135.06 166.1 23.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.059 1.744 . . . . 0.0 111.148 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.5 160.49 38.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.95 1.3 . . . . 0.0 112.0 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -80.22 -178.94 6.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.33 1.852 . . . . 0.0 111.624 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.9 57.43 0.32 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.804 2.041 . . . . 0.0 113.802 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -68.16 159.63 30.66 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.055 1.742 . . . . 0.0 112.659 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -68.28 137.96 55.12 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 107.46 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.32 126.12 37.27 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.561 0.745 . . . . 0.0 110.17 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 85' ' ' ARG . 13.0 mt -123.4 115.56 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -128.48 165.14 21.28 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.592 1.557 . . . . 0.0 110.575 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mt -109.71 142.13 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.258 1.023 . . . . 0.0 108.805 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -82.79 164.26 20.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.721 1.248 . . . . 0.0 113.897 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -75.71 154.07 36.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.331 1.853 . . . . 0.0 111.959 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -72.13 126.84 30.79 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.898 0.479 . . . . 0.0 109.966 175.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -145.29 13.21 1.4 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.612 1.165 . . . . 0.0 113.97 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.67 22.0 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.994 1.759 . . . . 0.0 113.273 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -78.63 165.51 23.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.107 1.363 . . . . 0.0 111.273 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.09 170.12 6.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.266 1.027 . . . . 0.0 112.383 171.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.6 m -66.62 134.69 52.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.934 1.294 . . . . 0.0 109.865 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.79 138.72 51.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.545 1.138 . . . . 0.0 111.17 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.2 m -95.05 120.14 34.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.718 1.607 . . . . 0.0 108.11 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -99.09 123.91 43.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 110.499 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.21 128.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.957 1.303 . . . . 0.0 108.672 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -142.94 161.26 38.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.788 1.635 . . . . 0.0 110.9 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.48 -16.37 3.07 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 168.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -45.32 133.3 5.82 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 126.253 1.821 . . . . 0.0 112.777 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.15 142.44 55.26 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.982 3.122 . . . . 0.0 113.446 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.6 -13.87 62.54 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.09 -18.65 63.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.722 0.809 . . . . 0.0 113.098 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -93.59 112.64 24.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.846 1.258 . . . . 0.0 110.792 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -69.28 122.25 18.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.294 1.038 . . . . 0.0 112.002 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.42 -35.5 81.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.179 0.592 . . . . 0.0 112.116 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -63.07 -39.16 93.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 112.16 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.09 89.86 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.43 1.092 . . . . 0.0 111.099 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.11 -40.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.178 0.991 . . . . 0.0 110.395 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.32 -54.94 41.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.555 1.07 . . . . 0.0 110.84 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -56.9 -48.35 78.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.765 0.826 . . . . 0.0 112.623 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.5 p -70.47 -37.24 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.38 -33.62 65.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.141 0.882 . . . . 0.0 111.87 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.32 -33.3 74.07 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.908 -1.12 . . . . 0.0 112.572 170.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -79.39 -58.81 3.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.388 1.075 . . . . 0.0 113.314 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -85.1 -41.19 15.96 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.18 -12.64 32.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.938 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.15 31.59 17.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.165 1.786 . . . . 0.0 112.635 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.2 m -80.42 -172.8 3.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.615 1.166 . . . . 0.0 111.521 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -148.11 150.92 34.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.696 1.198 . . . . 0.0 109.266 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.57 171.19 42.29 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 115.642 1.017 . . . . 0.0 115.642 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -150.83 156.27 40.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.127 1.771 . . . . 0.0 111.627 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.34 131.53 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.669 1.188 . . . . 0.0 108.627 171.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.63 141.17 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.899 1.28 . . . . 0.0 109.396 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -104.24 124.45 49.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.99 0.916 . . . . 0.0 111.366 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.39 151.85 46.37 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.851 1.66 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -59.95 -37.76 83.19 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.587 2.858 . . . . 0.0 115.364 -169.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -36.4 4.94 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.573 1.549 . . . . 0.0 112.26 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.8 mtm -74.1 -18.98 60.73 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.45 -163.88 53.09 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.756 1.17 . . . . 0.0 112.913 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.46 121.31 22.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.22 1.008 . . . . 0.0 110.876 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.9 pt -139.2 152.52 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.251 1.821 . . . . 0.0 111.799 -171.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.3 mt -93.02 130.6 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -101.69 122.76 44.51 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -110.14 140.7 43.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.366 1.466 . . . . 0.0 108.733 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -69.21 135.66 50.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.42 0.688 . . . . 0.0 111.457 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.62 -164.4 41.39 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.08 1.324 . . . . 0.0 114.03 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -100.85 99.54 10.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.18 1.792 . . . . 0.0 109.918 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -121.76 18.09 11.08 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 113.081 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' ILE . 28.9 ptt-85 -63.03 -41.78 99.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -168.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.24 73.84 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 172.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -64.92 -45.2 86.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.693 0.797 . . . . 0.0 111.728 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.39 -36.77 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.477 0.711 . . . . 0.0 111.208 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -56.57 -49.41 74.95 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.719 1.145 . . . . 0.0 111.481 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.45 -39.62 84.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.532 0.733 . . . . 0.0 112.413 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.547 ' CE1' HG11 ' A' ' 57' ' ' VAL . 31.5 t80 -60.49 -48.11 83.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.099 0.863 . . . . 0.0 112.017 175.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.81 -42.94 94.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.441 1.096 . . . . 0.0 110.668 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.78 -47.1 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.1 t -75.79 -48.34 22.06 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -103.52 -29.73 10.96 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -168.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.25 -16.3 27.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.273 0.942 . . . . 0.0 112.416 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.38 19.02 75.0 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.41 1.005 . . . . 0.0 113.613 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.54 155.37 40.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.411 1.105 . . . . 0.0 110.716 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -83.38 148.74 27.14 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -53.98 -41.16 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.557 -0.714 . . . . 0.0 111.581 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -64.55 -14.08 55.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -75.93 -9.35 58.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 112.868 172.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.6 mt -115.91 136.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.115 . . . . 0.0 110.338 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -116.94 114.66 24.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.978 1.711 . . . . 0.0 109.96 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -92.53 118.45 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.88 -30.91 10.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.45 -150.22 44.84 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.945 0.783 . . . . 0.0 111.96 -173.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.637 1.175 . . . . 0.0 113.354 173.803 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.0 p -164.34 163.67 22.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.489 1.515 . . . . 0.0 111.45 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.2 150.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.355 1.062 . . . . 0.0 112.63 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.66 138.9 57.76 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.231 0.612 . . . . 0.0 110.439 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.15 154.38 27.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.45 1.1 . . . . 0.0 112.564 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.84 162.7 13.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.035 1.334 . . . . 0.0 112.197 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -63.32 143.86 57.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.461 1.105 . . . . 0.0 112.881 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -83.57 148.41 27.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.588 1.155 . . . . 0.0 112.653 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -137.99 156.83 47.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.572 1.549 . . . . 0.0 110.975 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.16 147.69 95.61 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.955 0.902 . . . . 0.0 112.347 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.52 -29.97 90.37 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.805 3.003 . . . . 0.0 114.126 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -170.91 156.16 4.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.507 2.323 . . . . 0.0 109.657 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.69 29.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.215 1.806 . . . . 0.0 111.605 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -80.66 154.64 27.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 112.421 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.53 -37.06 85.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.138 1.375 . . . . 0.0 112.244 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.5 176.44 51.37 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.986 1.279 . . . . 0.0 113.769 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -162.9 155.46 18.9 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.35 1.86 . . . . 0.0 110.886 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.73 -24.04 65.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.313 1.045 . . . . 0.0 113.758 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 75.44 -37.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.629 2.772 . . . . 0.0 113.908 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.9 t -164.21 178.5 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.427 1.891 . . . . 0.0 111.3 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.08 163.15 40.01 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.558 1.943 . . . . 0.0 111.614 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -163.09 176.69 9.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.123 1.769 . . . . 0.0 111.005 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -166.83 168.24 14.3 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.473 1.909 . . . . 0.0 111.98 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -155.02 150.69 27.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.889 1.275 . . . . 0.0 111.262 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -72.33 138.04 47.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.652 0.739 . . . . 0.0 112.827 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt -108.02 131.04 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.494 1.518 . . . . 0.0 108.66 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -112.47 114.63 27.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.452 1.101 . . . . 0.0 109.267 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.78 99.65 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -106.49 174.49 5.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.998 2.519 . . . . 0.0 110.72 -171.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -116.49 147.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.09 0.956 . . . . 0.0 108.868 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -129.79 115.73 17.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.758 1.623 . . . . 0.0 108.643 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -72.89 138.87 46.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.838 1.255 . . . . 0.0 111.67 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -124.78 168.31 13.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.507 1.923 . . . . 0.0 110.134 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.14 135.48 53.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.646 0.779 . . . . 0.0 111.873 171.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.66 -146.37 45.19 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.918 0.771 . . . . 0.0 112.674 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -83.14 3.13 32.07 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -77.35 21.39 0.26 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.941 1.696 . . . . 0.0 115.43 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -56.38 145.56 26.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.048 2.139 . . . . 0.0 111.72 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.6 149.94 43.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.088 1.355 . . . . 0.0 111.913 -170.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.98 131.32 38.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.575 1.55 . . . . 0.0 107.494 167.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -115.14 123.4 48.85 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.057 1.343 . . . . 0.0 110.548 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.58 123.64 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -131.49 143.96 50.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.038 1.735 . . . . 0.0 109.005 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.15 -0.44 83.72 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.27 130.56 51.85 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 118.905 1.352 . . . . 0.0 110.956 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -52.94 139.42 60.63 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.069 3.18 . . . . 0.0 113.324 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -74.32 -7.61 53.4 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.752 0.821 . . . . 0.0 112.652 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.86 126.25 35.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.646 1.178 . . . . 0.0 111.005 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.45 115.49 12.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.442 0.697 . . . . 0.0 111.157 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.58 -36.57 76.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.731 0.812 . . . . 0.0 111.624 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -63.65 -35.56 80.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.651 1.181 . . . . 0.0 112.421 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -67.93 -37.61 81.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 111.573 171.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.61 -40.86 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 0.0 110.023 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.94 -54.45 46.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.261 0.937 . . . . 0.0 110.714 169.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -57.43 -46.39 83.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 113.026 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 p -73.02 -36.88 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.43 -34.47 67.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.094 0.861 . . . . 0.0 111.751 176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.25 -34.11 76.75 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.986 -1.071 . . . . 0.0 112.554 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.8 -63.25 1.43 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.245 1.018 . . . . 0.0 113.119 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -81.9 -39.14 24.25 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.87 -3.41 51.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 112.767 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.12 27.99 17.13 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.17 1.788 . . . . 0.0 113.142 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -83.14 -179.94 7.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.524 1.13 . . . . 0.0 112.776 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -129.58 144.58 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.723 1.609 . . . . 0.0 107.898 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.71 171.24 44.33 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -158.4 161.68 37.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.464 1.506 . . . . 0.0 112.48 -174.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mt -94.93 129.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 108.219 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.87 139.49 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.071 0.948 . . . . 0.0 110.811 -176.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -88.22 109.56 20.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.162 0.985 . . . . 0.0 109.476 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.25 141.37 26.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.345 1.058 . . . . 0.0 111.657 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -57.81 -33.3 96.74 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.615 2.876 . . . . 0.0 114.468 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -108.15 -46.69 3.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.774 1.23 . . . . 0.0 112.071 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.0 mtt -80.91 -16.39 53.7 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.52 -159.2 49.74 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.048 0.832 . . . . 0.0 111.731 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -69.65 123.69 22.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.288 -1.125 . . . . 0.0 111.776 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.9 pt -144.5 153.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.133 1.773 . . . . 0.0 112.016 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.76 129.82 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 165.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -100.27 138.86 36.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.369 1.467 . . . . 0.0 108.801 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -128.96 142.7 50.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.23 1.812 . . . . 0.0 108.355 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -73.25 136.9 44.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.969 1.259 . . . . 0.0 112.027 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.33 -174.87 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.27 1.414 . . . . 0.0 113.702 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.82 73.73 3.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.719 2.007 . . . . 0.0 111.412 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -97.29 16.98 18.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.331 1.852 . . . . 0.0 113.526 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -58.22 -41.54 84.31 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.06 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.068 0.947 . . . . 0.0 112.105 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.57 -44.69 93.36 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.253 1.021 . . . . 0.0 111.853 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.77 -34.8 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.176 0.59 . . . . 0.0 111.199 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.0 t -58.44 -46.91 85.58 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.614 1.097 . . . . 0.0 111.243 171.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.46 -39.06 86.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.63 0.772 . . . . 0.0 112.39 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 38.5 t80 -60.12 -48.83 80.09 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.639 1.109 . . . . 0.0 111.753 174.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.4 mmt -60.63 -42.01 96.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.67 -45.92 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.677 0.791 . . . . 0.0 111.548 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -76.91 -47.81 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -101.13 -34.87 9.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -168.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.99 -14.2 48.2 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.166 0.894 . . . . 0.0 112.228 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.63 80.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.076 1.322 . . . . 0.0 113.757 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.83 144.48 52.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.539 1.169 . . . . 0.0 111.302 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -80.2 135.2 36.22 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.691 -0.631 . . . . 0.0 109.636 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -51.79 -34.43 39.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.964 1.305 . . . . 0.0 113.987 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.89 -22.25 9.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.838 1.655 . . . . 0.0 115.134 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -82.35 -9.23 59.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.684 1.194 . . . . 0.0 113.932 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 mt -116.99 128.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.61 1.095 . . . . 0.0 111.26 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.23 134.08 47.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.441 1.496 . . . . 0.0 110.682 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.08 126.27 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.983 1.313 . . . . 0.0 108.153 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -126.13 171.8 10.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.038 1.335 . . . . 0.0 113.265 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.88 -136.43 9.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.603 1.573 . . . . 0.0 111.896 170.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.807 2.043 . . . . 0.0 112.879 177.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -119.54 125.44 48.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.556 1.142 . . . . 0.0 110.31 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 51.8 mt -116.09 111.73 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.526 -1.286 . . . . 0.0 107.526 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -120.24 152.12 38.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.26 1.424 . . . . 0.0 110.342 -170.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.48 1.031 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 170.184 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.5 mt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -105.13 118.16 35.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.657 1.583 . . . . 0.0 108.8 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -98.36 126.71 43.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.429 1.492 . . . . 0.0 110.407 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.71 126.55 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.019 1.328 . . . . 0.0 109.485 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -136.66 146.78 46.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.617 1.567 . . . . 0.0 110.329 -169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.03 -6.17 82.03 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.9 p -52.44 133.65 43.79 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -52.94 138.09 61.48 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.802 3.002 . . . . 0.0 113.267 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.04 -16.18 63.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.842 0.857 . . . . 0.0 113.113 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.79 -18.3 64.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.129 0.972 . . . . 0.0 113.34 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -92.85 120.76 33.53 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.687 1.195 . . . . 0.0 110.511 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.51 124.05 22.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.329 0.652 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -60.85 -38.59 86.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.026 0.53 . . . . 0.0 111.266 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.19 -34.46 73.66 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 113.19 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -70.67 -37.76 73.68 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.408 -0.808 . . . . 0.0 111.441 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.3 mt -58.87 -47.87 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mt -54.82 -47.66 73.78 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.963 0.802 . . . . 0.0 111.561 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.26 -42.75 99.16 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 112.33 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.71 -46.42 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.127 0.571 . . . . 0.0 111.184 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.72 -27.71 65.2 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -78.76 -35.18 44.94 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.86 -1.15 . . . . 0.0 113.071 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -77.49 -59.35 2.82 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.988 0.915 . . . . 0.0 113.103 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.45 -39.78 14.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.326 1.051 . . . . 0.0 113.373 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.92 -13.11 34.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.855 0.862 . . . . 0.0 113.198 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.99 28.1 16.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.172 1.789 . . . . 0.0 113.332 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.33 -170.83 3.29 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.621 1.168 . . . . 0.0 111.1 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -144.62 150.9 38.19 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.233 1.013 . . . . 0.0 109.589 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.67 172.02 45.06 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.544 0.977 . . . . 0.0 115.544 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -154.22 158.53 40.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.355 1.862 . . . . 0.0 111.568 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.8 mt -89.49 128.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.7 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 124.877 1.271 . . . . 0.0 109.474 -173.485 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 pt . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.09 132.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.41 132.38 49.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.048 1.339 . . . . 0.0 108.13 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.26 143.02 47.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.926 1.69 . . . . 0.0 108.382 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.4 136.45 46.08 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.195 -0.941 . . . . 0.0 111.523 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.98 48.87 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.666 1.603 . . . . 0.0 113.63 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.93 87.46 4.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.53 1.932 . . . . 0.0 110.969 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -109.86 22.66 15.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.426 1.49 . . . . 0.0 112.985 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 43.1 ptt85 -57.37 -46.75 83.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 0.0 114.141 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.67 84.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.8 -47.24 78.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.178 0.991 . . . . 0.0 112.06 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.1 -36.24 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.978 -0.451 . . . . 0.0 111.35 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.45 -50.21 72.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.02 -38.11 81.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.929 . . . . 0.0 112.874 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -60.26 -49.37 77.86 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.003 1.274 . . . . 0.0 111.64 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.83 -38.27 87.55 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.236 1.015 . . . . 0.0 111.23 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.82 -47.11 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.64 0.776 . . . . 0.0 111.574 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -75.38 -48.22 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.198 0.999 . . . . 0.0 113.43 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -97.6 -32.68 11.66 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.93 -18.28 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.774 0.715 . . . . 0.0 112.719 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.54 10.32 85.4 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.618 1.104 . . . . 0.0 114.184 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.02 132.44 45.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.218 1.009 . . . . 0.0 110.014 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -76.23 136.29 39.69 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.477 -0.765 . . . . 0.0 110.95 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -48.99 -37.65 20.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.503 . . . . 0.0 114.841 -169.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -53.62 -23.14 10.2 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.535 1.534 . . . . 0.0 114.886 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -77.43 -14.33 59.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.99 1.316 . . . . 0.0 114.365 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.6 mt -105.58 119.3 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 119.454 1.024 . . . . 0.0 110.407 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -96.05 130.43 43.06 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.143 1.377 . . . . 0.0 109.922 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 108.919 174.549 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.3 mt . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -118.47 117.62 29.5 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 109.748 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.6 mt -109.54 103.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -110.98 174.4 5.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.264 2.225 . . . . 0.0 110.594 -169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 124.169 0.988 . . . . 0.0 109.082 169.04 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 m -98.68 123.6 42.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.808 1.643 . . . . 0.0 108.778 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.82 115.81 30.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.289 1.836 . . . . 0.0 110.225 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.44 127.4 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.581 1.152 . . . . 0.0 109.845 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.41 152.5 51.47 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.343 1.857 . . . . 0.0 110.211 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.48 -3.79 71.64 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.61 132.55 71.62 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.676 1.238 . . . . 0.0 110.86 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -54.78 143.22 71.59 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.781 2.987 . . . . 0.0 113.169 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.86 -18.2 64.11 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.47 -19.51 65.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.974 0.91 . . . . 0.0 113.37 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -91.5 109.57 20.86 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.681 1.192 . . . . 0.0 110.285 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.89 118.83 10.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.203 1.001 . . . . 0.0 112.144 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -60.65 -38.2 84.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.462 0.705 . . . . 0.0 111.847 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.61 -38.14 89.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.208 1.003 . . . . 0.0 112.332 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -64.35 -38.06 89.7 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.201 -0.937 . . . . 0.0 111.928 170.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.64 -40.2 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.618 0.767 . . . . 0.0 110.1 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.6 -55.28 37.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.185 0.902 . . . . 0.0 110.749 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.35 -49.27 72.7 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.8 p -70.11 -36.87 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.37 -34.44 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.974 0.806 . . . . 0.0 112.034 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.28 -32.69 74.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.671 -1.268 . . . . 0.0 112.511 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -78.16 -67.63 0.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 112.889 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.22 -34.52 25.86 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -93.68 -4.15 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 112.65 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.43 28.42 16.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.157 1.783 . . . . 0.0 113.158 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.8 m -82.92 -174.9 5.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.551 1.14 . . . . 0.0 112.499 -174.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.41 145.29 35.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.474 1.51 . . . . 0.0 108.712 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.92 172.59 45.54 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.33 163.62 37.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.591 1.556 . . . . 0.0 112.866 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.36 134.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.883 1.273 . . . . 0.0 109.467 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 125.482 1.513 . . . . 0.0 109.463 178.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 121.198 0.523 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -95.34 133.63 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -104.45 128.07 52.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.15 1.38 . . . . 0.0 107.815 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.73 141.41 48.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.983 1.713 . . . . 0.0 108.483 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -72.75 137.48 45.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.858 1.208 . . . . 0.0 111.799 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.77 -175.78 47.25 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.692 1.615 . . . . 0.0 113.693 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.7 84.53 5.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.355 1.862 . . . . 0.0 111.098 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.79 14.62 26.52 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 112.919 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -59.32 -41.54 89.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.53 63.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.089 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -63.74 -44.81 92.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.936 0.894 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.7 -35.39 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.399 0.68 . . . . 0.0 111.246 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.8 t -56.47 -47.8 78.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.541 1.064 . . . . 0.0 111.156 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.81 -39.74 90.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.576 0.751 . . . . 0.0 112.438 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 28.4 t80 -60.09 -48.39 81.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.725 1.148 . . . . 0.0 111.792 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mmt -59.57 -43.27 93.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.582 1.153 . . . . 0.0 110.604 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.23 -45.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.693 0.797 . . . . 0.0 111.711 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -75.71 -47.15 27.3 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -102.24 -37.43 8.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.0 mt -89.36 -17.02 29.68 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.894 0.77 . . . . 0.0 112.723 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.97 15.99 80.44 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.461 1.029 . . . . 0.0 113.639 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.64 136.22 52.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.213 1.007 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -76.8 139.09 40.24 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.615 -0.678 . . . . 0.0 109.909 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -53.8 -37.55 63.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -56.69 -24.7 50.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.392 1.477 . . . . 0.0 114.981 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -76.86 -16.09 59.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.32 0.964 . . . . 0.0 113.277 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.86 126.24 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.294 1.407 . . . . 0.0 112.123 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -103.15 134.6 46.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.016 1.726 . . . . 0.0 110.27 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 124.98 1.312 . . . . 0.0 108.428 174.472 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -103.6 121.08 42.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.842 0.857 . . . . 0.0 110.076 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.28 103.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -113.16 171.23 7.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.971 2.108 . . . . 0.0 110.21 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.322 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -89.95 116.98 28.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.614 1.566 . . . . 0.0 108.26 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.57 117.19 32.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.952 1.701 . . . . 0.0 110.005 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.93 126.66 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 108.922 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -138.02 159.11 42.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.871 2.068 . . . . 0.0 109.233 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.23 -14.97 2.74 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.289 -1.507 . . . . 0.0 116.103 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.02 130.57 7.22 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 126.207 1.803 . . . . 0.0 112.151 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.43 139.41 65.23 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.241 3.294 . . . . 0.0 113.413 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.96 -11.14 60.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.15 -18.97 61.84 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.114 0.966 . . . . 0.0 113.018 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -90.8 119.72 31.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.561 1.144 . . . . 0.0 110.961 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.79 119.86 16.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 111.568 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -62.75 -38.39 90.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.297 0.639 . . . . 0.0 111.901 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.93 -39.51 89.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.936 0.895 . . . . 0.0 112.225 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -63.49 -39.62 94.92 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.227 -0.921 . . . . 0.0 111.943 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.48 -47.38 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.919 0.781 . . . . 0.0 109.103 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.72 -48.09 75.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.155 0.889 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -62.38 -39.71 94.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.438 -0.789 . . . . 0.0 112.443 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.97 -46.67 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.869 0.759 . . . . 0.0 111.147 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.42 -30.52 67.4 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.05 -31.86 63.06 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.837 -1.164 . . . . 0.0 112.974 171.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -80.01 -61.93 1.84 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.237 1.015 . . . . 0.0 113.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.14 -37.32 20.35 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -92.98 -13.13 29.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.876 0.871 . . . . 0.0 113.002 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.05 29.47 17.66 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.175 1.79 . . . . 0.0 113.012 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.7 m -82.43 -172.1 3.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.697 1.199 . . . . 0.0 111.284 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -146.34 152.76 39.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 109.944 168.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.9 176.23 47.92 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 115.451 0.94 . . . . 0.0 115.451 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -158.33 162.12 37.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.328 1.851 . . . . 0.0 111.64 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 143.79 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 108.985 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 124.436 1.094 . . . . 0.0 109.259 169.789 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.017 0.437 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.33 134.79 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.05 126.01 51.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.887 1.675 . . . . 0.0 107.491 168.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -113.27 140.46 47.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.231 1.412 . . . . 0.0 108.376 170.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -71.41 135.19 47.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.135 -0.978 . . . . 0.0 111.705 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 -169.86 45.88 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.453 1.501 . . . . 0.0 113.539 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.13 87.54 3.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.706 2.002 . . . . 0.0 111.205 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -112.35 20.25 16.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.584 1.553 . . . . 0.0 112.939 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.75 -42.03 92.3 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.38 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.056 0.942 . . . . 0.0 112.154 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.71 -45.15 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.868 0.867 . . . . 0.0 111.811 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.14 -34.81 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.09 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.0 -49.07 78.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.338 0.972 . . . . 0.0 111.162 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.13 -37.81 78.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.83 0.852 . . . . 0.0 112.652 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.36 -48.54 80.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.867 1.212 . . . . 0.0 111.664 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.6 mmt -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.051 0.94 . . . . 0.0 110.734 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.03 -47.89 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.954 0.902 . . . . 0.0 111.417 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -97.94 -33.21 11.3 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.98 -14.22 39.69 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.83 0.741 . . . . 0.0 112.107 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.81 79.75 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.865 1.221 . . . . 0.0 113.899 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.3 mt -71.41 144.07 49.92 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.434 1.117 . . . . 0.0 111.783 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -75.21 138.25 41.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -54.32 -34.86 61.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -55.65 -21.71 19.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.524 1.93 . . . . 0.0 115.311 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -76.68 -10.56 59.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.1 mt -112.86 133.17 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.049 0.94 . . . . 0.0 111.153 -169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.34 128.25 54.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.535 1.934 . . . . 0.0 110.153 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.4 mt . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 124.83 1.252 . . . . 0.0 109.077 175.75 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -118.12 111.43 18.86 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 111.005 -169.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -104.89 110.28 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -118.06 164.89 14.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.512 1.925 . . . . 0.0 109.696 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.646 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.3 m -93.62 118.02 30.84 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.481 1.513 . . . . 0.0 108.304 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.61 115.36 29.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.646 1.578 . . . . 0.0 110.001 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.66 126.89 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 109.288 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -137.62 161.01 37.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.717 2.007 . . . . 0.0 109.412 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 -13.43 8.14 Favored Glycine 0 N--CA 1.477 1.387 0 O-C-N 120.092 -1.63 . . . . 0.0 116.056 169.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -49.97 132.23 22.41 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.974 1.309 . . . . 0.0 111.061 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.83 136.73 51.62 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.086 3.19 . . . . 0.0 113.001 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.83 -3.04 29.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 -17.2 61.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 167.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.4 126.6 40.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.166 1.386 . . . . 0.0 110.247 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -77.64 131.25 37.68 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.608 -0.682 . . . . 0.0 110.84 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.4 -37.57 83.92 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.336 0.654 . . . . 0.0 111.678 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -61.15 -33.31 73.21 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.868 0.867 . . . . 0.0 112.601 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.6 -39.49 84.77 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.261 0.937 . . . . 0.0 111.516 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.04 -47.02 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 0.0 109.196 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.27 -47.08 76.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.766 0.712 . . . . 0.0 111.872 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -62.48 -39.3 93.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.725 0.693 . . . . 0.0 112.351 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.13 -48.17 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 118.985 0.811 . . . . 0.0 111.13 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.46 -29.76 67.5 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.22 -26.87 56.5 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.691 -1.256 . . . . 0.0 113.56 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.56 -49.58 5.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.96 -40.9 17.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.973 0.909 . . . . 0.0 112.953 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.71 -9.75 36.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.651 1.18 . . . . 0.0 112.606 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.32 30.84 20.12 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.934 1.694 . . . . 0.0 112.659 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.08 -165.07 1.27 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.558 1.143 . . . . 0.0 111.335 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.17 146.42 26.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.78 0.832 . . . . 0.0 110.971 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.47 176.17 46.13 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -155.71 164.46 38.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.131 1.773 . . . . 0.0 111.086 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mt -103.08 139.7 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.39 1.476 . . . . 0.0 110.055 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 125.124 1.37 . . . . 0.0 109.182 173.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.109 0.48 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.15 133.23 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -103.78 117.4 34.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.823 1.649 . . . . 0.0 107.005 167.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.45 145.14 30.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.894 1.278 . . . . 0.0 108.898 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.83 131.0 44.42 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.538 -0.726 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -167.05 47.82 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.707 1.146 . . . . 0.0 113.662 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -97.69 93.0 6.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.585 1.954 . . . . 0.0 111.25 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -116.87 22.4 12.66 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.417 1.487 . . . . 0.0 113.072 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -58.52 -45.47 88.73 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.26 77.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.991 0.916 . . . . 0.0 112.198 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -65.89 -45.59 81.44 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 111.954 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.99 -35.41 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.254 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.3 t -57.37 -48.22 79.61 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.106 0.866 . . . . 0.0 111.09 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.49 -37.86 87.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.475 0.71 . . . . 0.0 112.766 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.49 -49.93 75.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.792 1.178 . . . . 0.0 111.383 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -58.92 -43.89 91.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 110.672 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.42 -44.29 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.578 0.751 . . . . 0.0 111.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.9 t -76.36 -48.09 21.15 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -99.46 -35.48 9.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.44 -14.25 30.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.878 0.763 . . . . 0.0 112.834 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.58 15.16 81.26 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.583 1.087 . . . . 0.0 113.784 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.33 148.64 49.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.316 1.058 . . . . 0.0 110.109 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -86.58 144.83 27.01 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.376 -0.828 . . . . 0.0 110.031 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -52.93 -39.63 62.98 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.653 -0.655 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -59.5 -21.03 59.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.543 1.537 . . . . 0.0 114.983 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -77.46 -14.29 59.72 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.075 0.852 . . . . 0.0 113.204 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.5 mt -108.05 122.67 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 120.317 1.417 . . . . 0.0 111.607 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.94 123.79 43.45 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.374 1.87 . . . . 0.0 109.627 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.808 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -118.53 122.78 43.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.32 1.048 . . . . 0.0 110.494 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -116.58 111.09 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -120.55 174.21 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.411 1.484 . . . . 0.0 110.952 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 168.79 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.402 0.144 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -93.81 119.48 32.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 108.547 169.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -101.43 123.53 45.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.207 1.403 . . . . 0.0 110.608 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.27 123.88 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.584 1.154 . . . . 0.0 109.114 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.61 152.52 48.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.301 1.84 . . . . 0.0 109.33 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 -5.14 63.95 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.914 -1.116 . . . . 0.0 115.879 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.31 129.45 51.36 Favored Pre-proline 0 N--CA 1.477 0.918 0 CA-C-N 119.475 1.638 . . . . 0.0 109.89 170.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -51.32 140.7 42.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.842 3.028 . . . . 0.0 113.679 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.83 -3.47 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.87 -18.41 62.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 0.0 111.912 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -92.41 133.1 36.21 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.048 1.339 . . . . 0.0 111.319 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.79 117.63 17.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.224 1.009 . . . . 0.0 111.192 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.53 -39.99 89.87 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 111.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -56.91 -35.99 69.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 113.812 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -71.51 -35.81 70.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.949 0.9 . . . . 0.0 111.847 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.47 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.796 0.839 . . . . 0.0 109.717 173.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.25 -55.77 30.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.26 0.936 . . . . 0.0 110.443 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -54.15 -48.73 70.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.378 1.071 . . . . 0.0 113.217 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.4 p -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.57 -31.97 65.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.102 0.865 . . . . 0.0 112.261 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.54 -34.85 72.72 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.773 -1.205 . . . . 0.0 112.426 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -75.27 -59.28 2.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.475 1.11 . . . . 0.0 113.34 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.61 -38.83 15.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.192 0.997 . . . . 0.0 113.675 -169.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.4 -4.79 50.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.985 0.914 . . . . 0.0 113.013 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.13 24.5 13.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.087 1.755 . . . . 0.0 113.3 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.2 m -81.96 -171.96 3.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.849 1.26 . . . . 0.0 112.012 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -144.81 153.83 42.04 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.888 1.275 . . . . 0.0 109.256 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.01 176.46 46.85 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 -169.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.14 164.73 30.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.232 1.813 . . . . 0.0 112.067 -171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.15 146.37 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 125.593 1.557 . . . . 0.0 108.704 169.582 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 pt . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.279 0.562 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.9 mt -100.16 134.69 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 166.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -103.84 129.2 51.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.535 1.534 . . . . 0.0 107.501 168.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.24 142.53 46.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.335 1.454 . . . . 0.0 108.29 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -77.99 135.1 37.74 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.036 -1.04 . . . . 0.0 111.296 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.68 -172.1 44.05 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.713 1.625 . . . . 0.0 113.22 -174.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -97.8 88.44 4.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.465 1.906 . . . . 0.0 111.22 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -112.56 17.58 19.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.798 1.639 . . . . 0.0 113.014 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -59.21 -42.94 92.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -169.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.46 -38.59 74.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.964 0.905 . . . . 0.0 112.153 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.9 -44.77 84.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.75 -33.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.235 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -49.47 77.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.402 1.001 . . . . 0.0 111.042 170.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.0 -36.59 75.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.696 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.4 t80 -62.35 -49.36 75.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.781 1.173 . . . . 0.0 111.854 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.4 mmt -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.241 1.016 . . . . 0.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.53 -49.72 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.305 1.042 . . . . 0.0 111.782 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -75.62 -46.33 32.26 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -101.83 -36.66 8.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 mt -89.55 -18.49 26.51 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.953 0.797 . . . . 0.0 112.915 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.05 14.57 81.75 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.572 1.082 . . . . 0.0 113.618 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.16 134.55 49.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.292 1.046 . . . . 0.0 108.93 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -75.19 148.1 39.85 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.52 -0.738 . . . . 0.0 110.136 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -56.99 -36.63 70.59 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.704 -0.623 . . . . 0.0 112.338 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -64.42 -17.66 63.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.099 1.76 . . . . 0.0 115.199 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -79.69 -10.04 59.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.349 0.977 . . . . 0.0 113.202 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 42.3 mt -113.64 131.74 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.03 -1.044 . . . . 0.0 111.074 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -106.46 135.72 47.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.453 1.501 . . . . 0.0 110.628 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 124.63 1.172 . . . . 0.0 108.851 173.166 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -116.58 119.52 35.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 110.754 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mt -109.39 109.27 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -117.92 176.35 5.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.443 2.297 . . . . 0.0 110.892 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.477 0.897 0 O-C-N 121.126 -0.984 . . . . 0.0 110.117 168.068 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.662 0.267 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.7 m -96.91 130.4 44.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.441 1.497 . . . . 0.0 107.548 168.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.34 122.54 46.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 110.569 -176.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.43 124.16 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.594 1.158 . . . . 0.0 109.525 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -130.22 150.85 51.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.567 1.947 . . . . 0.0 109.673 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.88 58.5 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.53 129.22 69.65 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 119.107 1.454 . . . . 0.0 110.407 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.64 141.84 51.99 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.036 3.157 . . . . 0.0 112.616 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -11.99 60.06 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.72 -22.58 66.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.574 0.75 . . . . 0.0 112.314 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -91.1 104.33 16.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.852 1.261 . . . . 0.0 109.44 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.02 125.32 24.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.73 0.812 . . . . 0.0 112.554 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.9 -40.08 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.428 0.691 . . . . 0.0 112.343 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -63.9 -39.13 93.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.581 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -64.64 -36.45 84.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.041 0.936 . . . . 0.0 112.328 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.8 -48.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.951 0.796 . . . . 0.0 109.326 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.45 -42.63 82.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.2 0.909 . . . . 0.0 112.174 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -58.72 -41.79 87.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.082 0.855 . . . . 0.0 112.255 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.94 -46.27 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.708 0.685 . . . . 0.0 111.534 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.9 -31.62 68.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HE2' ' H ' ' A' ' 66' ' ' GLY . 87.5 mttt -75.42 -29.76 59.85 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.952 -1.092 . . . . 0.0 113.117 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -83.35 -61.66 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.11 0.964 . . . . 0.0 113.278 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.83 -39.24 24.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.151 0.98 . . . . 0.0 113.239 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -93.31 -7.8 43.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.565 1.146 . . . . 0.0 113.082 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.21 27.38 15.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.713 . . . . 0.0 113.287 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.4 m -83.86 -174.4 5.26 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.591 1.157 . . . . 0.0 111.736 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -138.85 144.95 39.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.209 1.004 . . . . 0.0 109.439 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' H ' ' HE2' ' A' ' 59' ' ' LYS . . . -169.03 171.57 43.01 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 115.431 0.933 . . . . 0.0 115.431 -169.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -162.73 158.93 23.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.947 1.699 . . . . 0.0 112.128 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.16 137.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.712 1.205 . . . . 0.0 109.556 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.173 1.389 . . . . 0.0 110.199 -178.481 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.81 134.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -101.87 140.67 35.84 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.488 1.515 . . . . 0.0 108.551 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.41 141.94 50.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.97 1.708 . . . . 0.0 108.433 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.41 138.03 44.98 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.016 -1.052 . . . . 0.0 111.923 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.7 -172.47 44.44 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.21 1.386 . . . . 0.0 113.412 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -94.04 99.01 11.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.719 1.207 . . . . 0.0 110.04 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.23 18.54 14.46 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.536 1.534 . . . . 0.0 112.544 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -52.45 -55.23 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.618 1.167 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.01 88.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.264 1.026 . . . . 0.0 112.49 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -66.46 -45.35 80.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.497 0.719 . . . . 0.0 112.041 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.82 -36.14 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.227 0.611 . . . . 0.0 110.961 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.78 -48.47 75.26 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.317 0.962 . . . . 0.0 111.193 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.9 -39.55 89.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.592 0.757 . . . . 0.0 112.767 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -59.91 -49.58 77.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.807 1.185 . . . . 0.0 111.465 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.9 mmt -58.32 -41.32 84.25 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.233 1.013 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.36 -50.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.505 -0.747 . . . . 0.0 111.491 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.2 m -89.46 -14.16 35.96 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.27 -39.94 3.33 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.087 1.312 . . . . 0.0 113.324 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.12 -15.08 39.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.495 1.043 . . . . 0.0 113.09 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.72 14.74 79.26 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.471 1.034 . . . . 0.0 113.709 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 mt -68.94 151.59 46.35 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.541 1.171 . . . . 0.0 109.956 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -88.03 145.28 26.06 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -55.4 -37.64 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -61.28 -18.07 56.68 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.55 -14.22 60.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.403 1.002 . . . . 0.0 112.974 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.2 mt -111.52 128.64 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.218 0.917 . . . . 0.0 111.233 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.2 133.26 48.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.463 1.905 . . . . 0.0 109.79 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 124.074 0.949 . . . . 0.0 108.912 172.915 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -110.36 125.99 53.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.942 0.897 . . . . 0.0 110.981 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.482 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.0 mt -116.61 117.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 108.258 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 mtt85 -129.59 174.59 9.53 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.79 1.636 . . . . 0.0 110.564 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 mt . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 110.371 175.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.7 m -89.34 115.76 27.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.661 1.184 . . . . 0.0 108.391 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -97.26 126.41 42.45 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.482 1.513 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.77 129.13 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.179 1.392 . . . . 0.0 109.586 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -139.97 157.68 45.29 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.453 1.901 . . . . 0.0 109.723 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.06 62.71 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.89 131.84 66.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 118.663 1.231 . . . . 0.0 110.143 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -53.01 140.75 58.87 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.678 2.919 . . . . 0.0 113.196 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.41 -15.05 62.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.33 -20.21 66.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.937 0.895 . . . . 0.0 113.228 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -90.89 115.78 28.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 110.63 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -68.41 121.17 15.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.071 0.949 . . . . 0.0 111.415 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 mt -59.81 -37.8 80.16 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.18 0.992 . . . . 0.0 111.936 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.36 -31.86 71.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.315 1.046 . . . . 0.0 112.488 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -37.34 69.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.872 0.869 . . . . 0.0 112.311 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.88 -47.26 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.88 -48.3 75.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.845 0.748 . . . . 0.0 111.637 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.28 -45.52 93.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.71 0.804 . . . . 0.0 112.148 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.51 -47.75 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.976 0.51 . . . . 0.0 111.329 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.46 -26.98 65.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.22 -37.1 38.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.616 -1.302 . . . . 0.0 113.308 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.03 -48.46 9.2 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.24 -38.77 12.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.958 0.903 . . . . 0.0 113.148 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -93.07 -8.44 42.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.952 0.901 . . . . 0.0 113.335 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.06 27.83 17.31 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.812 1.645 . . . . 0.0 113.57 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.5 m -87.84 -173.29 4.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.672 1.189 . . . . 0.0 111.282 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.74 145.75 38.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.388 1.075 . . . . 0.0 109.757 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -172.04 173.12 45.1 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.16 163.16 37.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 112.684 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.4 mt -98.4 134.98 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.927 1.291 . . . . 0.0 109.499 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 125.196 1.398 . . . . 0.0 109.278 176.348 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 pt . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.23 0.538 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.73 136.96 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.93 133.22 51.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.569 . . . . 0.0 107.866 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.81 141.17 48.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 108.283 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.44 134.13 47.51 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.888 -1.133 . . . . 0.0 111.575 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.49 39.32 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.81 1.195 . . . . 0.0 113.621 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -101.8 100.78 11.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.68 1.592 . . . . 0.0 110.378 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -123.37 22.09 9.36 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.304 1.441 . . . . 0.0 113.173 -170.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.482 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.0 ptt180 -60.54 -43.88 96.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.11 89.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.455 0.702 . . . . 0.0 111.847 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.17 -47.28 80.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.05 0.94 . . . . 0.0 111.871 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.99 -34.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.882 -0.511 . . . . 0.0 111.534 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.93 -49.75 75.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.378 0.99 . . . . 0.0 111.083 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.49 -38.64 81.41 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.634 0.774 . . . . 0.0 112.65 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.32 -49.6 76.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.49 1.041 . . . . 0.0 111.633 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.13 -38.97 80.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.024 0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.99 -50.76 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.375 0.67 . . . . 0.0 111.374 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.5 m -84.93 -28.92 25.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -169.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -103.52 -44.0 5.24 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.264 0.938 . . . . 0.0 112.559 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.82 -19.77 28.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.071 0.85 . . . . 0.0 113.178 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.56 14.93 77.21 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.425 1.012 . . . . 0.0 113.727 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.07 145.21 51.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.626 1.213 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -74.28 140.95 45.31 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.506 -0.746 . . . . 0.0 110.819 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -53.29 -44.73 68.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.58 0.752 . . . . 0.0 112.211 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -63.79 -24.52 67.79 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.28 -6.27 54.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.548 1.139 . . . . 0.0 112.459 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.92 131.04 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.88 -1.137 . . . . 0.0 110.344 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -109.33 128.36 55.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 110.277 173.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 169.679 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -100.31 112.32 24.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.94 0.896 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.5 mt -102.3 101.8 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -107.6 174.47 5.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.101 2.16 . . . . 0.0 110.715 -171.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.168 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -89.53 124.41 34.49 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.689 1.596 . . . . 0.0 108.295 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 114.1 27.37 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.456 1.502 . . . . 0.0 110.118 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.76 122.55 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.118 0.967 . . . . 0.0 109.363 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -125.62 151.59 46.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.65 1.98 . . . . 0.0 109.681 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.86 4.45 82.45 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -57.5 131.13 81.64 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.698 1.249 . . . . 0.0 110.456 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.26 139.75 63.03 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.07 3.18 . . . . 0.0 113.149 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.47 -10.29 59.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.95 -19.8 62.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.993 0.917 . . . . 0.0 112.939 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -91.97 121.59 33.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.771 1.228 . . . . 0.0 110.917 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.71 118.16 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.701 0.8 . . . . 0.0 111.146 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.36 -37.15 77.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.686 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -63.17 -37.24 86.44 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.181 0.992 . . . . 0.0 112.121 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -66.69 -37.66 85.18 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.28 -0.887 . . . . 0.0 111.663 171.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.33 -40.96 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.536 0.734 . . . . 0.0 110.097 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.28 -54.26 48.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.302 0.955 . . . . 0.0 110.888 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -55.84 -48.27 75.79 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.942 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.99 -35.82 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.2 -30.72 62.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.025 0.829 . . . . 0.0 112.117 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -71.06 -30.43 66.58 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.768 -1.207 . . . . 0.0 112.769 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.15 -61.68 1.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 113.125 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.51 -40.55 23.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 -169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.87 -7.03 50.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.407 1.083 . . . . 0.0 112.554 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.65 28.98 17.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.11 1.764 . . . . 0.0 112.893 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -91.91 -162.13 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.635 1.174 . . . . 0.0 111.764 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -155.4 152.47 29.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.102 0.961 . . . . 0.0 111.421 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.7 176.4 48.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.03 165.03 36.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.862 1.665 . . . . 0.0 112.738 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -101.78 135.29 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.018 1.327 . . . . 0.0 109.876 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 125.24 1.416 . . . . 0.0 110.029 -178.509 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.01 132.51 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -100.22 133.18 45.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.001 1.32 . . . . 0.0 107.723 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tp -123.35 143.16 50.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.606 1.562 . . . . 0.0 108.756 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.158 -0.964 . . . . 0.0 112.093 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.93 -170.47 39.81 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.215 1.388 . . . . 0.0 113.669 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -97.55 77.56 2.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.895 2.078 . . . . 0.0 111.081 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -100.26 15.34 27.93 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.075 1.75 . . . . 0.0 113.54 -170.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -58.39 -40.18 81.66 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -41.3 64.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.001 0.921 . . . . 0.0 112.123 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -65.77 -41.8 91.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.847 0.859 . . . . 0.0 112.54 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.75 -35.31 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.809 -0.557 . . . . 0.0 111.204 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.56 -48.54 79.07 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.474 1.034 . . . . 0.0 111.014 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.13 -39.7 83.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.813 0.845 . . . . 0.0 112.551 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 40.3 t80 -60.17 -49.49 77.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.597 1.09 . . . . 0.0 111.778 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.4 mmt -61.02 -38.53 86.44 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.189 0.995 . . . . 0.0 110.893 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -74.02 -46.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.742 0.817 . . . . 0.0 111.002 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -82.4 -37.65 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -103.37 -39.65 6.7 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.472 0.709 . . . . 0.0 112.808 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.5 mt -83.61 -17.77 40.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.729 0.695 . . . . 0.0 112.273 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.65 76.31 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.662 1.125 . . . . 0.0 113.636 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.98 159.05 34.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.564 1.182 . . . . 0.0 111.24 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.2 146.96 25.8 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.608 -0.682 . . . . 0.0 109.435 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -55.95 -36.82 68.22 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.367 -0.833 . . . . 0.0 112.365 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -65.94 -10.47 39.37 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -78.79 -9.59 59.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.86 1.209 . . . . 0.0 113.078 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.7 mt -117.89 136.21 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.207 . . . . 0.0 110.995 -169.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -112.56 135.97 52.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.352 1.861 . . . . 0.0 109.968 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.421 1.089 . . . . 0.0 109.334 177.122 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -103.78 113.32 26.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.195 0.998 . . . . 0.0 109.655 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.72 98.75 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -106.41 174.5 5.86 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.886 2.074 . . . . 0.0 110.683 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 167.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.1 m -93.07 115.5 28.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.813 1.245 . . . . 0.0 108.945 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.49 112.07 24.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.715 1.606 . . . . 0.0 110.001 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.48 125.02 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 109.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -132.79 152.75 51.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.134 1.773 . . . . 0.0 110.186 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.33 77.19 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 168.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.16 131.43 60.16 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 118.717 1.259 . . . . 0.0 111.283 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -51.67 136.73 50.22 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 113.283 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.65 -13.44 62.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 113.906 -171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.69 -19.16 63.59 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.145 . . . . 0.0 113.11 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -94.56 125.34 39.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 111.0 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -74.57 124.75 27.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.504 0.722 . . . . 0.0 111.361 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.42 -38.75 85.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.075 0.55 . . . . 0.0 111.446 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -59.61 -37.18 77.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.497 1.119 . . . . 0.0 112.76 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -66.81 -39.52 87.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.191 0.905 . . . . 0.0 111.538 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.67 -47.26 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.222 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.868 0.758 . . . . 0.0 111.672 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.23 -42.43 99.31 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.428 -0.795 . . . . 0.0 112.512 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.14 -45.51 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.008 0.822 . . . . 0.0 111.346 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.15 -32.94 65.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.631 -1.293 . . . . 0.0 112.751 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -75.68 -63.72 1.23 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.72 1.208 . . . . 0.0 113.235 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -92.54 -32.69 14.74 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -167.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -90.91 -13.94 32.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 112.625 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 61.24 30.53 19.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.241 1.816 . . . . 0.0 112.86 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.32 -170.92 3.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.775 1.23 . . . . 0.0 111.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.94 152.75 36.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.869 1.268 . . . . 0.0 109.255 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.89 45.73 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 115.226 0.851 . . . . 0.0 115.226 -170.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -158.14 163.56 37.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.792 1.637 . . . . 0.0 112.32 -172.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.01 136.15 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.189 1.395 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 125.072 1.349 . . . . 0.0 109.573 177.614 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 121.294 0.568 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.84 134.28 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -105.96 116.8 32.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.643 1.577 . . . . 0.0 107.83 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tp -102.76 146.51 28.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.178 1.391 . . . . 0.0 109.185 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -69.37 133.4 47.76 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.547 0.739 . . . . 0.0 111.693 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 -170.12 54.78 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.11 1.338 . . . . 0.0 113.992 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -94.86 98.28 10.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.092 1.757 . . . . 0.0 111.326 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -120.45 20.75 11.82 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.057 1.743 . . . . 0.0 112.533 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -60.12 -40.91 91.4 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.57 70.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 112.355 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.98 -44.96 83.38 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.936 0.895 . . . . 0.0 111.691 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.61 -35.19 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.104 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.11 -49.54 75.58 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.51 1.05 . . . . 0.0 111.094 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.61 -39.11 79.54 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 0.0 112.68 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -60.43 -47.92 84.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.627 1.103 . . . . 0.0 112.02 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.4 mmt -61.27 -41.1 96.37 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.875 0.87 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.63 -47.97 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.732 0.813 . . . . 0.0 111.296 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -76.44 -48.09 20.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -100.48 -33.14 10.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.46 -15.85 38.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.145 0.884 . . . . 0.0 112.316 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.63 15.55 80.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.84 1.21 . . . . 0.0 113.685 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -71.1 157.89 37.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.547 1.174 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.48 147.14 24.81 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.642 -0.662 . . . . 0.0 109.586 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.56 -36.51 64.42 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.448 -0.782 . . . . 0.0 112.76 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -57.59 -21.7 40.6 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.884 1.674 . . . . 0.0 115.094 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -77.08 -7.69 56.17 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.279 0.945 . . . . 0.0 113.412 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.29 136.05 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.338 1.055 . . . . 0.0 110.791 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.53 134.22 54.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.755 2.022 . . . . 0.0 109.991 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 124.821 1.248 . . . . 0.0 108.996 177.443 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -114.94 120.68 40.76 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.624 1.169 . . . . 0.0 110.182 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 27.9 mt -114.27 116.37 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -128.99 174.57 9.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.253 1.821 . . . . 0.0 110.202 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.157 0.983 . . . . 0.0 108.483 169.481 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -89.7 132.37 35.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 107.663 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -112.94 124.5 52.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.246 1.419 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.36 126.57 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.973 1.309 . . . . 0.0 108.597 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -135.83 149.87 49.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.201 1.801 . . . . 0.0 109.502 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.12 -2.29 66.17 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 115.817 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.45 130.14 53.11 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.357 1.578 . . . . 0.0 111.08 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -52.29 139.7 53.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.397 3.398 . . . . 0.0 113.48 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.88 -16.19 63.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.85 0.86 . . . . 0.0 113.302 -172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.33 -20.2 66.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.026 0.931 . . . . 0.0 113.088 172.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -93.0 118.09 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.867 1.267 . . . . 0.0 110.693 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.12 120.3 14.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.966 0.906 . . . . 0.0 111.574 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.3 -39.05 89.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.729 0.811 . . . . 0.0 111.914 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.78 -35.59 78.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.001 0.921 . . . . 0.0 112.461 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.51 -40.39 96.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.206 0.912 . . . . 0.0 112.308 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.27 -40.15 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 109.915 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.97 -55.43 35.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.213 0.915 . . . . 0.0 110.848 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 0.0 112.788 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.06 -36.18 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.92 -32.81 65.56 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.974 0.807 . . . . 0.0 112.318 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -70.69 -33.8 71.28 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.082 . . . . 0.0 112.641 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -76.96 -58.6 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.495 1.118 . . . . 0.0 113.259 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.87 -41.32 15.08 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.31 -11.47 35.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.154 0.982 . . . . 0.0 113.127 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.25 26.92 15.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.242 1.817 . . . . 0.0 113.046 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.2 m -80.91 -171.99 3.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.717 1.207 . . . . 0.0 111.709 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -146.83 149.59 33.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.66 1.184 . . . . 0.0 109.83 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.62 46.62 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.436 0.934 . . . . 0.0 115.436 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.61 164.71 33.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.755 1.622 . . . . 0.0 112.872 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.4 mt -98.56 134.89 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.899 1.279 . . . . 0.0 109.663 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 125.167 1.387 . . . . 0.0 109.758 178.302 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.442 0.639 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.94 132.76 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 166.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -99.34 137.07 38.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.515 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tp -125.64 139.93 53.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.547 171.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -70.69 136.89 49.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.067 -1.021 . . . . 0.0 111.834 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.64 -163.09 36.62 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.893 1.235 . . . . 0.0 113.492 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.27 98.19 7.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.663 1.585 . . . . 0.0 110.146 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -120.8 18.23 11.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.146 1.379 . . . . 0.0 113.303 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 4.3 ptt180 -61.5 -42.75 99.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.36 82.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.534 0.734 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -66.25 -45.33 80.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.068 0.947 . . . . 0.0 111.958 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.67 -36.46 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.222 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.67 -49.34 75.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.388 0.994 . . . . 0.0 111.208 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.45 -39.8 84.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.928 0.891 . . . . 0.0 112.601 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 35.9 t80 -60.02 -49.61 76.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.746 1.157 . . . . 0.0 111.837 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.6 mmt -59.79 -37.22 78.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.23 1.012 . . . . 0.0 110.948 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -76.78 -44.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.911 0.884 . . . . 0.0 111.116 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.8 m -86.12 -21.99 27.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -169.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -119.03 -38.25 3.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 0.0 113.455 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.83 -14.88 50.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.401 1.0 . . . . 0.0 112.437 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.28 14.98 80.97 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.869 1.223 . . . . 0.0 113.798 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -70.94 158.43 36.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.405 1.102 . . . . 0.0 111.211 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -88.45 149.41 23.69 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -53.19 -39.69 63.84 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.501 -0.749 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -60.21 -18.52 49.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.738 1.615 . . . . 0.0 114.947 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -78.84 -8.97 59.3 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.352 0.978 . . . . 0.0 113.424 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.1 mt -118.03 130.34 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 119.353 0.978 . . . . 0.0 111.407 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -104.09 125.81 50.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.336 1.854 . . . . 0.0 110.082 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -112.38 117.14 31.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.302 1.041 . . . . 0.0 110.448 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 85' ' ' ARG . 44.5 mt -108.24 108.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.3 174.04 6.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.085 2.154 . . . . 0.0 109.949 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.472 0.667 0 O-C-N 120.983 -1.073 . . . . 0.0 108.725 169.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.52 0.2 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.1 m -89.11 118.7 29.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.584 1.954 . . . . 0.0 108.053 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.24 116.32 32.24 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.018 1.727 . . . . 0.0 110.126 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -101.39 126.63 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 109.557 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -135.93 158.21 44.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.741 2.016 . . . . 0.0 109.736 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.87 -6.39 48.32 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 120.438 -1.414 . . . . 0.0 116.183 168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.93 130.97 48.98 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 118.563 1.181 . . . . 0.0 110.529 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.24 137.1 55.43 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.931 3.087 . . . . 0.0 112.938 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.68 -14.33 62.85 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.5 -19.68 64.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.241 1.017 . . . . 0.0 113.165 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -89.86 123.87 34.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.548 1.139 . . . . 0.0 111.054 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -74.83 120.59 20.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.963 0.905 . . . . 0.0 111.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.3 -39.07 89.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.563 0.745 . . . . 0.0 111.765 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -60.22 -36.56 77.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.027 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -69.48 -36.88 76.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.875 0.87 . . . . 0.0 112.027 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.77 -47.67 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.917 0.781 . . . . 0.0 109.24 172.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.2 -46.61 79.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.178 0.899 . . . . 0.0 111.628 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -61.81 -33.76 74.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.135 0.974 . . . . 0.0 112.788 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.9 t -75.38 -50.57 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.064 0.545 . . . . 0.0 111.117 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.88 -33.37 74.59 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -72.28 -25.61 61.66 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.816 -1.178 . . . . 0.0 113.662 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.88 -48.92 5.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.132 0.973 . . . . 0.0 113.625 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -83.78 -38.85 20.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.065 0.946 . . . . 0.0 113.004 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 -10.93 23.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.856 1.263 . . . . 0.0 112.978 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.0 26.56 14.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.406 1.882 . . . . 0.0 113.145 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.39 -174.98 4.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.657 1.183 . . . . 0.0 112.241 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -143.7 150.81 39.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.488 1.115 . . . . 0.0 109.413 169.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.39 173.8 46.44 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.35 166.08 33.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.61 1.564 . . . . 0.0 112.372 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.4 134.98 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.948 1.299 . . . . 0.0 109.678 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.988 1.315 . . . . 0.0 109.533 177.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.397 0.617 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.2 mt -93.68 135.06 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.23 129.96 52.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.444 1.498 . . . . 0.0 107.548 168.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -120.75 140.15 52.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.338 1.455 . . . . 0.0 108.743 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.35 132.57 45.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.964 -1.085 . . . . 0.0 111.524 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.91 -156.12 21.32 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.923 1.725 . . . . 0.0 113.623 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.35 47.94 1.34 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.636 2.374 . . . . 0.0 111.605 -173.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -75.14 25.05 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.024 2.529 . . . . 0.0 116.29 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HA ' HG21 ' A' ' 28' ' ' ILE . 31.2 ptt-85 -57.7 -47.22 82.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.633 1.173 . . . . 0.0 114.082 -172.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.42 74.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.9 0.88 . . . . 0.0 111.932 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -64.52 -46.0 84.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.612 0.765 . . . . 0.0 111.868 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.92 -35.94 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.719 -0.613 . . . . 0.0 111.369 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -56.11 -49.02 75.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.209 0.913 . . . . 0.0 111.197 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.11 -38.36 86.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.788 0.835 . . . . 0.0 112.846 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.3 -48.56 81.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.934 1.243 . . . . 0.0 111.56 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.73 -44.68 93.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 110.581 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.34 -44.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.707 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.6 t -79.16 -49.15 13.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -98.11 -35.77 10.3 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -88.67 -13.88 38.7 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.753 0.706 . . . . 0.0 112.494 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.49 17.31 79.3 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.774 1.178 . . . . 0.0 113.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.7 mt -70.79 153.56 42.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.503 1.151 . . . . 0.0 111.74 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -79.42 137.69 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.675 -0.641 . . . . 0.0 110.39 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -55.23 -38.81 68.95 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 0.0 112.756 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -59.2 -21.16 59.05 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 114.605 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.58 -4.7 58.06 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.314 1.046 . . . . 0.0 112.942 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -112.01 126.59 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.51 -1.369 . . . . 0.0 110.89 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -105.89 120.16 41.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.585 1.954 . . . . 0.0 110.004 172.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 169.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -96.21 116.96 29.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.066 0.946 . . . . 0.0 110.049 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.41 102.52 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -108.09 174.11 6.02 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.92 2.088 . . . . 0.0 110.855 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.691 1.196 . . . . 0.0 108.217 169.15 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.359 0.123 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 m -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.529 1.932 . . . . 0.0 107.681 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.57 120.43 28.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 110.614 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.7 121.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.322 1.049 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -127.93 153.97 46.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.641 1.977 . . . . 0.0 110.02 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.98 -5.2 50.54 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.076 1.19 . . . . 0.0 116.076 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -49.36 129.86 17.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 0.0 111.001 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -52.01 137.45 53.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.944 3.096 . . . . 0.0 113.209 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.05 -8.67 55.01 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.25 -17.81 62.47 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.133 1.373 . . . . 0.0 113.0 169.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -94.13 129.76 40.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.081 1.353 . . . . 0.0 111.41 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.14 118.75 22.12 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.985 0.914 . . . . 0.0 111.936 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.76 -38.48 90.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.23 0.612 . . . . 0.0 112.254 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.43 -36.08 81.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.862 0.865 . . . . 0.0 112.584 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -64.03 -39.27 93.72 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.061 -1.024 . . . . 0.0 111.764 169.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -63.24 -39.71 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.93 0.892 . . . . 0.0 110.068 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.45 -55.83 30.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 110.976 170.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.4 -48.82 73.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.931 0.893 . . . . 0.0 112.8 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.6 p -70.86 -36.73 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.06 -34.68 64.13 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.193 0.906 . . . . 0.0 111.98 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -34.39 77.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.758 -1.214 . . . . 0.0 112.471 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.63 -60.44 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.32 1.048 . . . . 0.0 113.105 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.69 -39.16 18.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.89 -4.42 49.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.464 1.106 . . . . 0.0 112.638 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.39 28.85 18.32 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.161 1.785 . . . . 0.0 113.102 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.48 179.76 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.55 1.14 . . . . 0.0 112.74 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -133.27 140.92 47.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.356 1.462 . . . . 0.0 108.366 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.57 168.86 41.89 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 -169.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -159.41 165.05 34.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.661 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.4 135.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.681 1.192 . . . . 0.0 109.976 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.1 t . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 125.675 1.59 . . . . 0.0 109.052 175.402 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.29 131.92 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 166.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.5 139.11 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.318 1.447 . . . . 0.0 108.245 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.52 136.13 47.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.463 1.505 . . . . 0.0 108.419 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -72.56 138.95 47.21 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.102 -0.999 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.17 -174.95 39.2 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.985 1.755 . . . . 0.0 113.361 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.54 77.59 2.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.882 2.073 . . . . 0.0 110.828 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.65 15.52 27.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 113.652 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -58.6 -41.64 86.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.23 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.132 0.973 . . . . 0.0 112.279 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.03 -44.34 84.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 111.75 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.49 -33.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.173 0.589 . . . . 0.0 111.092 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 111.085 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.04 -39.65 78.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.52 0.728 . . . . 0.0 112.626 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 57' ' ' VAL . 53.7 t80 -59.92 -49.78 76.36 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.425 1.011 . . . . 0.0 111.733 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.0 mmt -59.76 -39.69 85.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 110.882 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.01 -52.7 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.611 0.765 . . . . 0.0 111.034 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -83.03 -31.18 27.55 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -103.58 -42.18 5.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.226 0.921 . . . . 0.0 112.938 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -82.39 -20.35 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.155 0.889 . . . . 0.0 112.577 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.19 18.7 66.39 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.318 0.961 . . . . 0.0 113.592 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.5 mt -69.59 157.05 37.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.642 1.221 . . . . 0.0 110.464 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -87.74 146.34 25.71 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.45 -0.781 . . . . 0.0 109.299 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -55.13 -36.69 66.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.317 -0.864 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.91 -19.54 43.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.892 1.677 . . . . 0.0 115.035 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -79.29 -9.46 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.05 132.3 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 120.957 -1.089 . . . . 0.0 110.926 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -106.31 124.87 50.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.548 1.539 . . . . 0.0 109.544 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 124.199 1.0 . . . . 0.0 108.415 174.102 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -118.67 120.18 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.222 1.009 . . . . 0.0 110.389 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.83 104.48 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -109.79 169.79 8.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.87 1.668 . . . . 0.0 110.568 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.462 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.0 m -89.18 138.93 30.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.595 1.558 . . . . 0.0 107.618 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -127.46 120.99 29.61 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.845 1.258 . . . . 0.0 110.335 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.84 126.52 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.671 1.188 . . . . 0.0 109.519 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.09 151.51 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.457 1.903 . . . . 0.0 109.751 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.91 -1.45 79.07 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.08 133.3 59.4 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.654 1.227 . . . . 0.0 111.101 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.52 144.19 64.08 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.039 3.159 . . . . 0.0 113.452 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.37 -16.66 63.57 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.053 0.941 . . . . 0.0 113.329 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.67 -17.8 63.52 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 113.481 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -93.23 122.12 35.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.666 1.187 . . . . 0.0 111.313 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -73.1 117.39 14.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.853 0.861 . . . . 0.0 111.331 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.2 mt -60.23 -36.5 77.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.598 0.759 . . . . 0.0 111.819 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -62.88 -38.46 90.97 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.325 1.05 . . . . 0.0 112.027 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -65.38 -37.43 86.98 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.431 -0.793 . . . . 0.0 111.697 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.28 -41.05 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 110.124 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.87 -53.24 60.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.262 0.937 . . . . 0.0 111.013 170.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -56.87 -50.06 73.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.554 0.742 . . . . 0.0 112.873 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.1 p -68.82 -37.43 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.97 -38.33 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.569 0.622 . . . . 0.0 111.712 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.23 -31.87 72.96 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.244 -1.535 . . . . 0.0 112.329 173.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -73.99 -65.43 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.142 1.377 . . . . 0.0 112.933 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -91.69 -29.32 16.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -167.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -93.98 -7.75 41.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.842 0.857 . . . . 0.0 112.488 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.38 26.05 15.59 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.402 1.881 . . . . 0.0 113.236 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -82.58 -169.24 2.36 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.558 1.143 . . . . 0.0 112.631 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -141.18 151.78 44.11 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.045 1.338 . . . . 0.0 109.339 167.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.61 172.32 44.09 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -158.01 162.03 38.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.717 1.607 . . . . 0.0 111.904 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.48 129.56 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.111 1.364 . . . . 0.0 108.329 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.601 1.16 . . . . 0.0 109.516 -178.083 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.398 0.618 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.7 mt -90.97 127.97 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -94.43 130.64 40.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.229 1.412 . . . . 0.0 107.713 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -119.09 136.21 54.26 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.655 1.582 . . . . 0.0 107.89 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -76.92 128.17 34.06 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.308 -0.87 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.56 -170.23 28.08 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.237 1.399 . . . . 0.0 113.363 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -97.76 83.95 3.28 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.68 1.992 . . . . 0.0 111.335 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -110.08 15.13 22.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.223 -169.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -59.18 -46.28 88.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.62 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.854 0.861 . . . . 0.0 111.912 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.25 -45.9 89.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.296 1.039 . . . . 0.0 111.913 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.52 -36.12 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.236 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.95 -47.36 80.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.521 1.055 . . . . 0.0 110.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.08 -39.14 91.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.456 0.702 . . . . 0.0 112.641 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 24.5 t80 -59.66 -49.13 78.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.65 1.114 . . . . 0.0 111.602 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.5 mmt -59.06 -44.34 91.83 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.625 1.17 . . . . 0.0 110.522 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt -72.18 -44.14 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.635 0.774 . . . . 0.0 111.68 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 t -75.3 -48.05 25.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -100.96 -37.09 8.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.0 mt -90.83 -13.39 33.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.723 0.692 . . . . 0.0 112.84 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.57 15.54 81.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.726 1.155 . . . . 0.0 113.687 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.2 145.01 53.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.239 1.019 . . . . 0.0 110.626 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -82.16 134.66 35.32 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.714 -0.617 . . . . 0.0 110.388 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -51.97 -44.43 63.99 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.75 0.82 . . . . 0.0 112.392 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -22.2 63.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -81.73 -10.96 59.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 112.982 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -106.73 124.55 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.644 1.111 . . . . 0.0 110.617 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -101.26 135.11 43.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.806 1.642 . . . . 0.0 110.457 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 108.845 173.888 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mt . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -96.53 118.82 33.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.62 0.768 . . . . 0.0 110.32 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mt -108.53 109.39 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -121.26 174.43 6.71 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.503 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 120.613 0.244 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -91.41 125.05 36.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.339 1.855 . . . . 0.0 108.441 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -106.69 128.9 54.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.539 1.536 . . . . 0.0 110.827 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.0 124.09 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.851 1.26 . . . . 0.0 109.734 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -127.67 155.21 44.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.452 1.901 . . . . 0.0 109.501 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 1.25 90.61 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 168.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -61.13 131.45 92.04 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 118.678 1.239 . . . . 0.0 110.661 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.49 142.36 59.44 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 124.124 3.216 . . . . 0.0 113.267 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.28 -17.25 62.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.164 0.985 . . . . 0.0 113.096 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.03 -18.64 65.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.876 0.87 . . . . 0.0 113.159 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.99 116.86 29.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.856 1.262 . . . . 0.0 110.79 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -69.79 120.78 16.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.074 0.95 . . . . 0.0 111.588 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.91 -39.27 88.74 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.208 1.003 . . . . 0.0 111.974 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.0 -31.38 71.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.926 0.891 . . . . 0.0 112.538 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -40.7 79.32 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 111.836 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.07 -47.65 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.654 0.782 . . . . 0.0 109.057 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.3 mt -55.65 -48.58 74.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.718 0.69 . . . . 0.0 111.674 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.58 -43.29 97.42 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.445 -0.785 . . . . 0.0 112.452 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.15 -46.61 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.118 0.872 . . . . 0.0 111.16 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.06 -27.65 64.81 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -76.81 -35.86 57.3 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.659 -1.276 . . . . 0.0 113.254 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -77.91 -62.32 1.71 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.95 -32.03 20.33 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.221 1.409 . . . . 0.0 113.988 -166.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.7 -8.88 27.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.13 0.972 . . . . 0.0 113.162 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.62 28.25 16.89 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.831 1.652 . . . . 0.0 113.444 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 92.9 m -87.32 -169.85 2.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.921 1.289 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -148.58 149.87 32.31 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.913 0.885 . . . . 0.0 110.082 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.14 177.38 47.15 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.7 161.41 29.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.912 1.685 . . . . 0.0 111.942 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.13 141.37 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.688 1.195 . . . . 0.0 109.226 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 124.971 1.308 . . . . 0.0 109.411 173.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.347 0.594 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.27 136.52 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.38 135.04 47.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.186 1.795 . . . . 0.0 108.212 168.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.93 140.62 52.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.749 1.62 . . . . 0.0 108.946 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -72.64 138.51 46.77 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.281 -0.887 . . . . 0.0 111.991 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.72 -169.69 43.1 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.558 1.551 . . . . 0.0 112.895 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.47 97.75 7.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.053 1.341 . . . . 0.0 109.998 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -115.07 27.45 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.885 1.274 . . . . 0.0 113.702 -167.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -51.94 -59.02 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.537 1.535 . . . . 0.0 112.639 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.46 -38.91 91.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.786 1.235 . . . . 0.0 112.195 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.72 -48.41 79.36 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 111.731 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.21 -34.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.828 -0.545 . . . . 0.0 111.344 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.95 -50.03 73.88 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.212 0.915 . . . . 0.0 111.182 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.79 -38.2 81.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.094 0.958 . . . . 0.0 112.647 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.68 -48.12 83.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.67 1.123 . . . . 0.0 111.791 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.5 mmt -61.86 -41.73 98.2 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 110.591 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.25 -48.18 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.049 0.94 . . . . 0.0 111.535 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -80.95 -48.34 12.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -98.51 -34.06 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -85.75 -15.61 41.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.897 0.771 . . . . 0.0 112.035 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.37 79.64 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.017 1.294 . . . . 0.0 113.777 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.48 151.71 42.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.562 1.181 . . . . 0.0 112.141 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -74.15 141.31 45.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.022 0.529 . . . . 0.0 109.929 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -57.36 -36.66 71.48 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.25 -21.1 47.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.961 . . . . 0.0 114.87 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.15 -9.76 58.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.105 0.962 . . . . 0.0 113.127 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.9 133.78 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.384 1.074 . . . . 0.0 110.692 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -110.65 133.84 52.96 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.148 1.779 . . . . 0.0 110.188 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 124.141 0.976 . . . . 0.0 109.346 173.158 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -107.45 115.08 29.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.559 1.144 . . . . 0.0 109.344 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.28 108.5 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -116.97 173.57 6.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.524 1.929 . . . . 0.0 110.865 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.755 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 m -89.43 132.37 35.03 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.878 1.671 . . . . 0.0 107.828 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -117.43 126.77 53.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 110.925 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.48 123.57 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.544 1.138 . . . . 0.0 108.943 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -129.9 149.51 51.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 109.388 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 4.85 89.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.58 131.71 64.01 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 118.567 1.184 . . . . 0.0 111.319 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.25 143.19 53.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.383 3.389 . . . . 0.0 113.615 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -67.49 -18.94 65.25 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 113.37 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.5 -16.91 62.95 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -96.23 124.27 40.17 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.718 1.207 . . . . 0.0 111.799 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.11 121.55 23.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.166 0.986 . . . . 0.0 111.852 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.24 -39.25 92.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.534 0.733 . . . . 0.0 112.395 -174.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -62.86 -34.71 77.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.285 -0.884 . . . . 0.0 112.172 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 tpt85 -64.95 -37.55 88.04 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.15 0.886 . . . . 0.0 111.929 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.9 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.373 1.069 . . . . 0.0 110.164 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.94 -52.78 64.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.199 0.909 . . . . 0.0 110.914 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -54.89 -50.52 68.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 112.638 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 p -70.11 -36.1 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -34.9 65.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.651 0.66 . . . . 0.0 112.145 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.45 -33.28 73.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.756 -1.215 . . . . 0.0 112.425 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -74.87 -66.23 0.78 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.122 1.369 . . . . 0.0 113.153 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -91.2 -29.82 17.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -167.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.33 -4.93 47.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.878 0.871 . . . . 0.0 112.561 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.34 28.1 16.26 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.193 1.797 . . . . 0.0 113.246 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.1 m -83.06 177.8 8.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.491 1.116 . . . . 0.0 112.771 -173.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -126.21 141.7 51.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.462 1.505 . . . . 0.0 107.93 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.26 166.96 39.57 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.84 158.34 40.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.236 1.815 . . . . 0.0 111.821 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.7 mt -93.69 136.24 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.741 1.216 . . . . 0.0 108.991 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.972 1.309 . . . . 0.0 109.448 177.249 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 pt . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 121.338 0.589 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.0 mt -99.73 132.08 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 165.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -99.34 139.41 35.03 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.569 1.548 . . . . 0.0 108.682 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tp -129.02 138.44 51.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.783 1.633 . . . . 0.0 108.229 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -72.38 139.69 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.126 -0.984 . . . . 0.0 111.477 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.19 -172.39 43.42 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.419 1.485 . . . . 0.0 113.379 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -98.88 85.67 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.754 2.021 . . . . 0.0 110.954 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -109.45 16.21 22.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.596 1.559 . . . . 0.0 113.258 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -58.34 -42.96 88.03 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -39.31 66.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 112.089 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -63.81 -45.22 90.59 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.025 0.93 . . . . 0.0 111.826 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.44 -35.46 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.162 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.75 -48.81 76.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.494 1.043 . . . . 0.0 111.164 170.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.93 -40.15 83.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.784 0.834 . . . . 0.0 112.678 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.7 t80 -59.75 -49.94 75.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.767 1.167 . . . . 0.0 111.869 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.0 mmt -59.67 -37.82 79.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 110.903 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.52 -45.05 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.998 0.919 . . . . 0.0 111.084 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -85.42 -22.14 28.47 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.12 -38.0 2.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.386 0.993 . . . . 0.0 113.601 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.7 mt -82.74 -14.94 53.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.505 1.048 . . . . 0.0 112.48 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.81 14.95 80.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.841 1.21 . . . . 0.0 113.609 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.54 159.51 34.19 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.543 1.171 . . . . 0.0 111.514 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.13 151.29 22.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.378 0.671 . . . . 0.0 110.05 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -55.91 -38.92 70.88 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.255 -0.903 . . . . 0.0 111.657 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.19 -0.11 3.14 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.05 -1.86 56.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.967 1.258 . . . . 0.0 113.033 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt -128.06 132.44 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 120.738 -1.226 . . . . 0.0 111.597 -169.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.69 126.98 51.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.572 1.549 . . . . 0.0 109.829 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.058 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.1 127.62 55.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.919 . . . . 0.0 110.883 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.4 mt -117.71 99.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -103.53 174.61 5.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.715 2.406 . . . . 0.0 110.214 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.3 mt . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.058 0.943 . . . . 0.0 108.771 169.36 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -82.69 116.14 21.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.952 1.301 . . . . 0.0 107.919 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 113.31 24.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.502 1.521 . . . . 0.0 110.004 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.02 129.33 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.668 1.187 . . . . 0.0 108.479 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -144.75 161.45 39.2 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.992 1.717 . . . . 0.0 110.152 -167.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.62 -14.2 4.53 Favored Glycine 0 N--CA 1.475 1.251 0 O-C-N 120.463 -1.398 . . . . 0.0 116.541 168.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -47.99 130.93 12.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.224 1.41 . . . . 0.0 111.55 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -53.5 140.81 63.9 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.954 3.103 . . . . 0.0 113.112 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.76 -10.58 59.78 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.86 -19.57 63.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.85 0.86 . . . . 0.0 112.742 170.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.71 114.13 26.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.048 1.339 . . . . 0.0 110.394 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -66.99 123.15 19.39 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.32 -38.63 80.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.553 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.58 -32.9 74.51 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.118 0.967 . . . . 0.0 112.567 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -69.5 -38.4 77.61 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.277 -0.889 . . . . 0.0 111.517 171.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.2 mt -57.95 -47.05 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.041 0.837 . . . . 0.0 108.964 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.18 -48.73 73.37 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.005 0.82 . . . . 0.0 111.743 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -61.57 -43.67 98.44 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.665 -0.647 . . . . 0.0 112.301 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.23 -46.86 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.651 0.659 . . . . 0.0 111.137 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.63 -32.16 70.69 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.92 -34.36 64.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.674 -1.266 . . . . 0.0 113.208 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.83 -48.46 9.34 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.38 -41.36 12.88 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.704 0.802 . . . . 0.0 113.135 -171.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -94.38 -12.53 27.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.336 1.054 . . . . 0.0 113.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.82 31.17 16.56 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.146 1.778 . . . . 0.0 112.858 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.0 m -80.96 -177.67 6.52 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.476 1.11 . . . . 0.0 111.636 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -138.25 145.92 41.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.374 1.07 . . . . 0.0 109.332 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.63 172.09 45.13 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 116.158 1.223 . . . . 0.0 116.158 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.91 161.87 38.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.538 1.535 . . . . 0.0 112.583 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.0 mt -97.73 134.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.928 1.291 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t . . . . . 0 N--CA 1.477 0.884 0 C-N-CA 125.285 1.434 . . . . 0.0 109.773 179.095 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 121.345 0.593 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.91 133.47 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.17 123.2 45.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tp -108.97 136.36 48.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.174 1.39 . . . . 0.0 108.209 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.48 134.99 48.27 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.208 -0.933 . . . . 0.0 111.673 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.39 -168.95 40.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.378 1.466 . . . . 0.0 113.436 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -98.55 99.74 10.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.811 1.644 . . . . 0.0 109.899 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -122.0 20.72 10.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.863 1.265 . . . . 0.0 113.226 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.5 ptt180 -62.16 -44.28 96.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.07 -39.62 90.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.458 0.703 . . . . 0.0 111.772 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -64.76 -46.15 83.41 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.141 0.977 . . . . 0.0 111.988 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.47 -36.37 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.857 -0.527 . . . . 0.0 111.352 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.02 -48.24 82.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.313 0.96 . . . . 0.0 111.199 171.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.38 -37.72 78.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.817 0.847 . . . . 0.0 112.671 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.57 -48.72 79.69 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 111.693 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.7 mmt -59.99 -42.99 95.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.205 1.002 . . . . 0.0 110.578 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.75 -48.62 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.081 0.952 . . . . 0.0 111.608 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -79.17 -47.84 15.31 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -98.97 -35.82 9.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.21 -17.58 25.82 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.632 0.651 . . . . 0.0 112.728 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.84 17.29 80.0 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.372 0.987 . . . . 0.0 113.623 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.0 145.86 51.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.31 1.055 . . . . 0.0 110.785 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -74.29 143.85 44.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.725 0.774 . . . . 0.0 111.664 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.31 -42.07 99.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.509 0.724 . . . . 0.0 112.166 -168.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.04 -21.48 63.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.975 1.31 . . . . 0.0 113.999 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -82.3 -4.12 56.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.665 1.186 . . . . 0.0 112.326 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.32 136.12 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.669 1.588 . . . . 0.0 108.838 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.12 116.73 25.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.729 1.612 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.21 121.47 35.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.785 0.834 . . . . 0.0 110.098 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 85' ' ' ARG . 45.8 mt -113.71 104.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -111.89 166.0 11.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.267 1.827 . . . . 0.0 109.363 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.476 0.826 0 O-C-N 120.799 -1.188 . . . . 0.0 109.833 169.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.75 0.309 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.8 m -89.84 121.73 32.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.131 1.772 . . . . 0.0 107.999 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 p -106.64 121.42 44.3 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.451 1.5 . . . . 0.0 110.347 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.45 129.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.884 1.273 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.35 152.51 49.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.554 1.941 . . . . 0.0 109.878 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.34 2.31 78.83 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.12 132.76 68.61 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.234 1.413 . . . . 0.0 111.575 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.08 140.04 41.23 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.445 3.43 . . . . 0.0 113.664 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.48 -22.59 67.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.308 1.043 . . . . 0.0 113.564 -172.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.49 -19.08 65.7 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.21 103.95 15.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.042 1.337 . . . . 0.0 110.557 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.5 126.76 28.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.615 1.166 . . . . 0.0 112.2 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 mt -61.97 -40.04 94.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.24 0.616 . . . . 0.0 111.953 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.82 -36.37 83.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.809 0.844 . . . . 0.0 112.217 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -63.83 -38.9 92.8 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.044 -1.035 . . . . 0.0 111.936 169.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.88 -42.33 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.884 0.874 . . . . 0.0 109.931 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mt -58.12 -52.92 63.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.107 0.867 . . . . 0.0 111.025 171.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.56 -50.71 71.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.822 0.849 . . . . 0.0 112.975 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.66 -39.26 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.56 -37.43 71.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.727 0.694 . . . . 0.0 111.996 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -66.94 -29.67 69.6 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.101 -1.624 . . . . 0.0 112.729 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.19 -63.22 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.152 0.981 . . . . 0.0 113.094 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.06 -33.94 29.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.32 -8.31 36.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 112.8 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.41 26.82 16.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.219 1.807 . . . . 0.0 113.275 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.2 p -81.9 -169.93 2.6 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 112.851 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -139.48 149.22 43.71 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.931 1.292 . . . . 0.0 109.382 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -178.98 173.25 45.49 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -163.91 164.11 23.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.358 1.863 . . . . 0.0 111.717 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -100.06 140.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.554 1.141 . . . . 0.0 109.563 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.481 1.109 0 C-N-CA 125.259 1.423 . . . . 0.0 109.626 176.165 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.8 pt . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.436 0.636 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.43 133.11 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -101.2 132.99 46.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.77 1.628 . . . . 0.0 107.987 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -122.6 135.14 54.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.935 1.694 . . . . 0.0 107.769 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -73.68 134.25 43.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.314 -0.866 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.54 -169.12 25.73 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.813 1.673 . . . . 0.0 113.279 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -105.09 52.37 0.74 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.015 2.126 . . . . 0.0 111.601 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -75.54 21.47 0.14 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.742 2.417 . . . . 0.0 116.267 -167.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HA ' HG21 ' A' ' 28' ' ' ILE . 30.1 ptt-85 -57.62 -47.55 81.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.5 74.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.872 0.869 . . . . 0.0 111.782 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -64.24 -45.34 88.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.29 -36.32 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.721 -0.612 . . . . 0.0 111.391 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.3 t -57.18 -48.6 78.33 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.34 0.973 . . . . 0.0 111.014 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.23 -39.0 85.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.095 0.958 . . . . 0.0 112.637 175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.37 -49.61 77.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.938 1.245 . . . . 0.0 111.632 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 mmt -62.97 -40.49 97.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.008 0.923 . . . . 0.0 110.734 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.02 -49.74 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.887 0.875 . . . . 0.0 111.605 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.8 t -79.47 -48.23 14.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -97.08 -33.31 11.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.35 -18.13 29.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.793 0.724 . . . . 0.0 112.369 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.91 17.22 77.57 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.546 1.07 . . . . 0.0 113.802 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.97 155.45 40.56 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.635 1.218 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.85 148.13 30.09 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.798 -0.564 . . . . 0.0 109.581 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -57.67 -35.75 70.99 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.466 -0.771 . . . . 0.0 112.212 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -63.86 -17.27 62.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.979 1.712 . . . . 0.0 115.131 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -73.66 -11.54 60.45 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.455 1.025 . . . . 0.0 113.132 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -117.34 138.97 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.975 1.31 . . . . 0.0 110.566 -169.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -120.25 115.58 23.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.51 1.924 . . . . 0.0 109.938 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.92 115.84 31.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.124 0.969 . . . . 0.0 109.887 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.56 104.52 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -110.22 173.93 6.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.163 2.185 . . . . 0.0 110.871 -170.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.747 1.219 . . . . 0.0 108.516 169.081 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -93.91 140.3 29.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.613 1.965 . . . . 0.0 108.027 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.33 119.02 24.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.75 1.22 . . . . 0.0 110.83 -174.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.6 121.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 109.611 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.75 152.76 46.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.351 1.86 . . . . 0.0 109.622 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.03 -3.13 62.45 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -55.52 130.6 70.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 118.714 1.257 . . . . 0.0 110.276 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.41 138.4 65.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.792 2.995 . . . . 0.0 113.194 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.15 -6.88 50.34 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.936 0.894 . . . . 0.0 113.234 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.48 -18.82 62.28 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.569 -0.707 . . . . 0.0 112.473 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -90.69 129.94 36.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.634 1.174 . . . . 0.0 110.915 170.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.6 117.47 14.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.351 0.66 . . . . 0.0 110.891 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.05 -37.94 84.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.122 0.569 . . . . 0.0 111.382 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.4 -32.67 72.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.59 1.156 . . . . 0.0 113.202 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -71.0 -38.1 72.67 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.07 0.85 . . . . 0.0 111.402 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.951 0.796 . . . . 0.0 109.086 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.94 -49.6 70.94 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.929 0.786 . . . . 0.0 111.55 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -61.13 -43.66 98.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 112.576 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.66 -44.2 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.494 0.588 . . . . 0.0 111.371 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.0 mt -70.77 -31.49 68.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.79 -33.64 66.38 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.836 -1.165 . . . . 0.0 112.894 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.68 -58.53 3.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.24 1.016 . . . . 0.0 113.292 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.18 -42.38 13.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 0.0 113.449 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -90.31 -12.37 37.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.185 0.994 . . . . 0.0 112.818 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.49 30.14 17.16 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.226 1.81 . . . . 0.0 112.912 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.7 m -81.29 -172.2 3.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 111.442 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -147.47 150.64 34.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.731 1.212 . . . . 0.0 109.241 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.0 172.52 44.72 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 115.836 1.095 . . . . 0.0 115.836 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -153.39 158.13 41.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.425 1.89 . . . . 0.0 111.83 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.4 mt -91.86 130.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.676 1.19 . . . . 0.0 108.452 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.762 1.225 . . . . 0.0 109.399 -176.894 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.461 0.648 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -92.68 129.98 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 166.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -97.56 130.79 44.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.073 1.349 . . . . 0.0 107.532 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -122.01 139.66 53.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.523 1.529 . . . . 0.0 108.578 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -78.12 136.14 37.81 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.339 -0.85 . . . . 0.0 111.17 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.54 -174.05 42.75 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.828 1.68 . . . . 0.0 113.27 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -97.83 88.69 4.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.42 1.888 . . . . 0.0 110.923 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -112.12 16.42 20.17 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.414 1.485 . . . . 0.0 113.358 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -58.89 -41.3 86.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.36 65.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.126 0.97 . . . . 0.0 112.319 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -66.07 -43.6 86.95 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.992 0.917 . . . . 0.0 111.911 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.47 -35.51 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.186 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.0 t -56.89 -48.85 77.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.454 1.024 . . . . 0.0 111.12 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.34 -38.78 81.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.708 0.803 . . . . 0.0 112.726 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.29 -47.3 86.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.713 1.142 . . . . 0.0 111.864 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.5 -42.33 96.12 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.117 0.967 . . . . 0.0 110.606 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.69 -47.33 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 111.471 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -77.48 -48.94 15.85 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -98.79 -34.53 10.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.4 -14.28 43.84 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.891 0.769 . . . . 0.0 112.24 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.86 15.72 80.87 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.957 1.265 . . . . 0.0 113.88 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.47 153.44 42.24 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.399 1.1 . . . . 0.0 111.805 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -82.72 140.39 33.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.759 -0.588 . . . . 0.0 110.004 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -54.5 -35.62 63.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.875 0.87 . . . . 0.0 113.275 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -56.65 -23.85 44.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.406 1.482 . . . . 0.0 114.323 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.64 -10.04 59.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.796 1.238 . . . . 0.0 113.031 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.2 mt -114.7 134.15 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.443 1.097 . . . . 0.0 110.76 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -110.75 126.94 55.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.574 1.949 . . . . 0.0 109.984 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.1 mt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 124.464 1.105 . . . . 0.0 108.469 173.915 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.32 126.12 37.27 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.561 0.745 . . . . 0.0 110.17 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 85' ' ' ARG . 13.0 mt -123.4 115.56 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -128.48 165.14 21.28 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.592 1.557 . . . . 0.0 110.575 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mt . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 124.258 1.023 . . . . 0.0 108.805 169.154 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.501 0.191 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.2 m -95.05 120.14 34.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.718 1.607 . . . . 0.0 108.11 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -99.09 123.91 43.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 110.499 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.21 128.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.957 1.303 . . . . 0.0 108.672 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -142.94 161.26 38.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.788 1.635 . . . . 0.0 110.9 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.48 -16.37 3.07 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 168.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -45.32 133.3 5.82 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 126.253 1.821 . . . . 0.0 112.777 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.15 142.44 55.26 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.982 3.122 . . . . 0.0 113.446 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.6 -13.87 62.54 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.09 -18.65 63.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.722 0.809 . . . . 0.0 113.098 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -93.59 112.64 24.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.846 1.258 . . . . 0.0 110.792 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -69.28 122.25 18.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.294 1.038 . . . . 0.0 112.002 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.42 -35.5 81.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.179 0.592 . . . . 0.0 112.116 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -63.07 -39.16 93.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 112.16 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.09 89.86 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.43 1.092 . . . . 0.0 111.099 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.11 -40.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.178 0.991 . . . . 0.0 110.395 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.32 -54.94 41.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.555 1.07 . . . . 0.0 110.84 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -56.9 -48.35 78.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.765 0.826 . . . . 0.0 112.623 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.5 p -70.47 -37.24 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.38 -33.62 65.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.141 0.882 . . . . 0.0 111.87 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.32 -33.3 74.07 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.908 -1.12 . . . . 0.0 112.572 170.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -79.39 -58.81 3.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.388 1.075 . . . . 0.0 113.314 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -85.1 -41.19 15.96 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.18 -12.64 32.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.938 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.15 31.59 17.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.165 1.786 . . . . 0.0 112.635 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.2 m -80.42 -172.8 3.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.615 1.166 . . . . 0.0 111.521 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -148.11 150.92 34.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.696 1.198 . . . . 0.0 109.266 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.57 171.19 42.29 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 115.642 1.017 . . . . 0.0 115.642 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -150.83 156.27 40.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.127 1.771 . . . . 0.0 111.627 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.34 131.53 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.669 1.188 . . . . 0.0 108.627 171.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 124.899 1.28 . . . . 0.0 109.396 179.334 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.197 0.522 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.3 mt -93.02 130.6 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -101.69 122.76 44.51 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -110.14 140.7 43.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.366 1.466 . . . . 0.0 108.733 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -69.21 135.66 50.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.42 0.688 . . . . 0.0 111.457 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.62 -164.4 41.39 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.08 1.324 . . . . 0.0 114.03 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -100.85 99.54 10.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.18 1.792 . . . . 0.0 109.918 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -121.76 18.09 11.08 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 113.081 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' ILE . 28.9 ptt-85 -63.03 -41.78 99.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -168.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.24 73.84 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 172.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -64.92 -45.2 86.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.693 0.797 . . . . 0.0 111.728 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.39 -36.77 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.477 0.711 . . . . 0.0 111.208 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -56.57 -49.41 74.95 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.719 1.145 . . . . 0.0 111.481 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.45 -39.62 84.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.532 0.733 . . . . 0.0 112.413 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.547 ' CE1' HG11 ' A' ' 57' ' ' VAL . 31.5 t80 -60.49 -48.11 83.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.099 0.863 . . . . 0.0 112.017 175.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.81 -42.94 94.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.441 1.096 . . . . 0.0 110.668 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.78 -47.1 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.1 t -75.79 -48.34 22.06 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -103.52 -29.73 10.96 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -168.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.25 -16.3 27.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.273 0.942 . . . . 0.0 112.416 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.38 19.02 75.0 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.41 1.005 . . . . 0.0 113.613 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.54 155.37 40.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.411 1.105 . . . . 0.0 110.716 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -83.38 148.74 27.14 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -53.98 -41.16 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.557 -0.714 . . . . 0.0 111.581 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -64.55 -14.08 55.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -75.93 -9.35 58.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 112.868 172.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.6 mt -115.91 136.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.115 . . . . 0.0 110.338 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -116.94 114.66 24.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.978 1.711 . . . . 0.0 109.96 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.753 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -112.47 114.63 27.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.452 1.101 . . . . 0.0 109.267 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.78 99.65 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -106.49 174.49 5.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.998 2.519 . . . . 0.0 110.72 -171.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 124.09 0.956 . . . . 0.0 108.868 169.62 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.98 131.32 38.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.575 1.55 . . . . 0.0 107.494 167.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -115.14 123.4 48.85 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.057 1.343 . . . . 0.0 110.548 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.58 123.64 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -131.49 143.96 50.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.038 1.735 . . . . 0.0 109.005 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.15 -0.44 83.72 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.27 130.56 51.85 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 118.905 1.352 . . . . 0.0 110.956 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -52.94 139.42 60.63 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.069 3.18 . . . . 0.0 113.324 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -74.32 -7.61 53.4 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.752 0.821 . . . . 0.0 112.652 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.86 126.25 35.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.646 1.178 . . . . 0.0 111.005 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.45 115.49 12.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.442 0.697 . . . . 0.0 111.157 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.58 -36.57 76.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.731 0.812 . . . . 0.0 111.624 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -63.65 -35.56 80.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.651 1.181 . . . . 0.0 112.421 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -67.93 -37.61 81.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 111.573 171.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.61 -40.86 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 0.0 110.023 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.94 -54.45 46.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.261 0.937 . . . . 0.0 110.714 169.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -57.43 -46.39 83.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 113.026 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 p -73.02 -36.88 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.43 -34.47 67.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.094 0.861 . . . . 0.0 111.751 176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.25 -34.11 76.75 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.986 -1.071 . . . . 0.0 112.554 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.8 -63.25 1.43 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.245 1.018 . . . . 0.0 113.119 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -81.9 -39.14 24.25 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.87 -3.41 51.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 112.767 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.12 27.99 17.13 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.17 1.788 . . . . 0.0 113.142 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -83.14 -179.94 7.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.524 1.13 . . . . 0.0 112.776 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -129.58 144.58 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.723 1.609 . . . . 0.0 107.898 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.71 171.24 44.33 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -158.4 161.68 37.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.464 1.506 . . . . 0.0 112.48 -174.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mt -94.93 129.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 108.219 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.071 0.948 . . . . 0.0 110.811 -176.001 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.76 129.82 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 165.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -100.27 138.86 36.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.369 1.467 . . . . 0.0 108.801 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -128.96 142.7 50.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.23 1.812 . . . . 0.0 108.355 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -73.25 136.9 44.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.969 1.259 . . . . 0.0 112.027 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.33 -174.87 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.27 1.414 . . . . 0.0 113.702 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.82 73.73 3.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.719 2.007 . . . . 0.0 111.412 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -97.29 16.98 18.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.331 1.852 . . . . 0.0 113.526 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -58.22 -41.54 84.31 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.06 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.068 0.947 . . . . 0.0 112.105 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.57 -44.69 93.36 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.253 1.021 . . . . 0.0 111.853 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.77 -34.8 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.176 0.59 . . . . 0.0 111.199 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.0 t -58.44 -46.91 85.58 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.614 1.097 . . . . 0.0 111.243 171.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.46 -39.06 86.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.63 0.772 . . . . 0.0 112.39 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 38.5 t80 -60.12 -48.83 80.09 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.639 1.109 . . . . 0.0 111.753 174.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.4 mmt -60.63 -42.01 96.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.67 -45.92 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.677 0.791 . . . . 0.0 111.548 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -76.91 -47.81 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -101.13 -34.87 9.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -168.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.99 -14.2 48.2 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.166 0.894 . . . . 0.0 112.228 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.63 80.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.076 1.322 . . . . 0.0 113.757 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.83 144.48 52.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.539 1.169 . . . . 0.0 111.302 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -80.2 135.2 36.22 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.691 -0.631 . . . . 0.0 109.636 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -51.79 -34.43 39.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.964 1.305 . . . . 0.0 113.987 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.89 -22.25 9.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.838 1.655 . . . . 0.0 115.134 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -82.35 -9.23 59.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.684 1.194 . . . . 0.0 113.932 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 mt -116.99 128.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.61 1.095 . . . . 0.0 111.26 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.23 134.08 47.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.441 1.496 . . . . 0.0 110.682 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 124.983 1.313 . . . . 0.0 108.153 171.466 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.504 2.273 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -163.65 -174.86 3.87 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.726 1.61 . . . . 0.0 110.871 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -154.67 146.87 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.786 1.634 . . . . 0.0 111.261 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -85.42 145.02 27.65 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.705 1.202 . . . . 0.0 111.683 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -153.26 146.43 24.69 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.298 1.439 . . . . 0.0 111.331 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.66 122.47 19.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.393 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -80.44 -36.95 32.88 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.9 t -173.31 177.73 2.57 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.002 2.121 . . . . 0.0 110.39 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.45 153.49 27.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.711 1.604 . . . . 0.0 111.834 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -79.91 147.76 66.86 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -89.26 -144.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 124.37 3.38 . . . . 0.0 110.152 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -104.05 -4.03 23.79 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.116 1.766 . . . . 0.0 114.071 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.05 144.4 56.74 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.626 1.17 . . . . 0.0 113.532 -171.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -165.2 162.17 19.82 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.768 2.027 . . . . 0.0 110.703 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.7 p -77.24 157.37 30.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.808 1.243 . . . . 0.0 112.374 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.88 154.41 26.7 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.839 1.209 . . . . 0.0 113.224 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -138.96 8.57 2.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.632 1.573 . . . . 0.0 113.889 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.92 158.0 36.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.47 1.508 . . . . 0.0 113.847 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.4 146.58 16.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.826 1.65 . . . . 0.0 110.276 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.3 m -61.88 132.0 51.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.732 1.613 . . . . 0.0 112.022 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.12 158.51 17.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.358 1.463 . . . . 0.0 112.5 171.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -65.37 141.5 58.54 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.482 1.913 . . . . 0.0 112.237 -172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.2 m -68.78 148.62 50.05 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 t30 174.49 126.45 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 130.21 3.404 . . . . 0.0 108.092 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -72.68 136.81 45.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.68 140.4 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.089 2.155 . . . . 0.0 108.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -119.54 125.44 48.84 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.556 1.142 . . . . 0.0 110.31 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 51.8 mt -116.09 111.73 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.526 -1.286 . . . . 0.0 107.526 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -120.24 152.12 38.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.26 1.424 . . . . 0.0 110.342 -170.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.6 143.26 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -108.02 150.39 27.2 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.84 1.656 . . . . 0.0 112.087 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.36 125.6 41.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.921 1.688 . . . . 0.0 107.852 168.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -140.82 158.23 44.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.547 1.139 . . . . 0.0 111.391 -171.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -63.44 -16.84 61.77 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.36 0.87 78.89 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.008 1.29 . . . . 0.0 114.613 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 78.54 -16.91 0.62 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.879 2.871 . . . . 0.0 114.356 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.37 142.01 55.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.232 0.924 . . . . 0.0 112.79 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.0 m -89.78 131.37 35.77 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 167.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 49.5 mt -128.94 152.31 48.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.989 0.916 . . . . 0.0 110.414 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -105.13 118.16 35.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.657 1.583 . . . . 0.0 108.8 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -98.36 126.71 43.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.429 1.492 . . . . 0.0 110.407 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.71 126.55 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.019 1.328 . . . . 0.0 109.485 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -136.66 146.78 46.35 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.617 1.567 . . . . 0.0 110.329 -169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.03 -6.17 82.03 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.9 p -52.44 133.65 43.79 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -52.94 138.09 61.48 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.802 3.002 . . . . 0.0 113.267 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.04 -16.18 63.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.842 0.857 . . . . 0.0 113.113 -174.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.79 -18.3 64.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.129 0.972 . . . . 0.0 113.34 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -92.85 120.76 33.53 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.687 1.195 . . . . 0.0 110.511 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.51 124.05 22.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.329 0.652 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -60.85 -38.59 86.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.026 0.53 . . . . 0.0 111.266 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -60.19 -34.46 73.66 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 113.19 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -70.67 -37.76 73.68 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.408 -0.808 . . . . 0.0 111.441 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.3 mt -58.87 -47.87 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mt -54.82 -47.66 73.78 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.963 0.802 . . . . 0.0 111.561 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.26 -42.75 99.16 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 112.33 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.71 -46.42 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.127 0.571 . . . . 0.0 111.184 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.72 -27.71 65.2 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -78.76 -35.18 44.94 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.86 -1.15 . . . . 0.0 113.071 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -77.49 -59.35 2.82 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.988 0.915 . . . . 0.0 113.103 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.45 -39.78 14.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.326 1.051 . . . . 0.0 113.373 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.92 -13.11 34.16 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.855 0.862 . . . . 0.0 113.198 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.99 28.1 16.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.172 1.789 . . . . 0.0 113.332 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.33 -170.83 3.29 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.621 1.168 . . . . 0.0 111.1 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -144.62 150.9 38.19 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.233 1.013 . . . . 0.0 109.589 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.67 172.02 45.06 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.544 0.977 . . . . 0.0 115.544 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -154.22 158.53 40.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.355 1.862 . . . . 0.0 111.568 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.8 mt -89.49 128.04 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 63.7 t -140.41 142.09 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.877 1.271 . . . . 0.0 109.474 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -100.81 110.39 22.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.446 0.699 . . . . 0.0 111.187 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.98 143.81 46.57 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.981 1.312 . . . . 0.0 111.354 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -56.93 -33.51 95.32 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.537 2.825 . . . . 0.0 114.656 176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -106.96 -47.18 3.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.617 1.167 . . . . 0.0 112.019 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 57.9 mtt -84.17 -12.46 54.85 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.01 -159.96 47.86 Favored Glycine 0 N--CA 1.469 0.893 0 C-N-CA 124.45 1.024 . . . . 0.0 113.119 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -72.72 117.79 14.84 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.173 0.989 . . . . 0.0 111.258 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 pt -145.72 157.12 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.397 1.879 . . . . 0.0 111.668 -169.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.09 132.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.41 132.38 49.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.048 1.339 . . . . 0.0 108.13 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tp -119.26 143.02 47.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.926 1.69 . . . . 0.0 108.382 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.4 136.45 46.08 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.195 -0.941 . . . . 0.0 111.523 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.74 -172.98 48.87 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.666 1.603 . . . . 0.0 113.63 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -95.93 87.46 4.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.53 1.932 . . . . 0.0 110.969 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -109.86 22.66 15.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.426 1.49 . . . . 0.0 112.985 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 43.1 ptt85 -57.37 -46.75 83.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 0.0 114.141 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.67 84.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.8 -47.24 78.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.178 0.991 . . . . 0.0 112.06 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.1 -36.24 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.978 -0.451 . . . . 0.0 111.35 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -56.45 -50.21 72.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.02 -38.11 81.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.929 . . . . 0.0 112.874 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -60.26 -49.37 77.86 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.003 1.274 . . . . 0.0 111.64 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 mmt -61.83 -38.27 87.55 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.236 1.015 . . . . 0.0 111.23 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.82 -47.11 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.64 0.776 . . . . 0.0 111.574 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 t -75.38 -48.22 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.198 0.999 . . . . 0.0 113.43 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -97.6 -32.68 11.66 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.3 mt -94.93 -18.28 21.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.774 0.715 . . . . 0.0 112.719 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.54 10.32 85.4 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.618 1.104 . . . . 0.0 114.184 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.02 132.44 45.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.218 1.009 . . . . 0.0 110.014 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -76.23 136.29 39.69 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.477 -0.765 . . . . 0.0 110.95 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -48.99 -37.65 20.9 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.503 . . . . 0.0 114.841 -169.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -53.62 -23.14 10.2 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.535 1.534 . . . . 0.0 114.886 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -77.43 -14.33 59.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.99 1.316 . . . . 0.0 114.365 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.6 mt -105.58 119.3 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 119.454 1.024 . . . . 0.0 110.407 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -96.05 130.43 43.06 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.143 1.377 . . . . 0.0 109.922 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -110.17 129.35 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 108.919 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -125.31 141.9 51.81 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.151 1.38 . . . . 0.0 111.525 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.14 -144.29 6.94 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.807 1.194 . . . . 0.0 112.857 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 p90 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.588 1.955 . . . . 0.0 112.739 178.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 tpp . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 t 70.28 -171.57 0.17 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.234 1.813 . . . . 0.0 113.144 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.47 161.31 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.881 2.072 . . . . 0.0 111.427 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -75.41 131.16 40.0 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.436 0.694 . . . . 0.0 110.948 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.97 53.6 1.72 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.294 1.438 . . . . 0.0 113.238 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.87 -42.47 84.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.346 1.458 . . . . 0.0 113.335 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -168.67 151.96 5.4 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.97 1.708 . . . . 0.0 112.728 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 p -78.83 -52.49 8.26 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.673 1.189 . . . . 0.0 111.211 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 t80 74.09 164.52 0.28 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.421 2.688 . . . . 0.0 113.773 171.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -82.41 129.96 61.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.619 1.168 . . . . 0.0 111.801 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -86.14 -135.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.267 3.311 . . . . 0.0 109.638 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -87.95 -141.11 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.686 1.594 . . . . 0.0 111.732 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.99 -163.77 0.2 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.597 1.559 . . . . 0.0 112.941 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -148.0 48.82 1.06 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.394 1.478 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -71.96 168.24 18.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.203 1.801 . . . . 0.0 112.813 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.78 155.22 51.87 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.09 0.853 . . . . 0.0 113.587 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.55 150.65 48.04 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.157 1.383 . . . . 0.0 112.783 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -149.31 153.17 37.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.623 1.169 . . . . 0.0 112.138 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.61 125.09 28.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.369 1.068 . . . . 0.0 111.17 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.2 m 72.34 -39.33 0.44 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 128.194 2.598 . . . . 0.0 113.376 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.65 31.05 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.964 2.106 . . . . 0.0 115.538 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m 76.8 -34.42 0.22 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 128.116 2.566 . . . . 0.0 113.833 169.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 m -58.14 114.81 2.55 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.898 1.279 . . . . 0.0 113.303 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -177.16 141.58 0.33 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.54 2.336 . . . . 0.0 109.585 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -128.63 134.41 48.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.203 1.002 . . . . 0.0 113.012 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.3 mt -108.77 130.35 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 127.631 2.372 . . . . 0.0 106.827 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -118.47 117.62 29.5 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 109.748 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.6 mt -109.54 103.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -110.98 174.4 5.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.264 2.225 . . . . 0.0 110.594 -169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.84 147.84 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.169 0.988 . . . . 0.0 109.082 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -87.93 133.26 33.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.792 1.237 . . . . 0.0 109.079 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.05 152.21 41.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.961 0.904 . . . . 0.0 112.304 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -78.91 132.26 36.69 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.144 0.977 . . . . 0.0 111.899 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -168.02 69.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.043 2.137 . . . . 0.0 109.388 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.83 -37.32 2.31 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.571 1.558 . . . . 0.0 113.329 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -61.78 154.57 25.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 112.594 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.37 177.85 8.54 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.006 0.923 . . . . 0.0 110.29 166.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.6 m -68.78 129.99 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.233 -0.917 . . . . 0.0 109.182 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 mt -128.27 147.2 50.59 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.751 1.221 . . . . 0.0 109.856 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 m -98.68 123.6 42.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.808 1.643 . . . . 0.0 108.778 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.82 115.81 30.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.289 1.836 . . . . 0.0 110.225 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.44 127.4 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.581 1.152 . . . . 0.0 109.845 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.41 152.5 51.47 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.343 1.857 . . . . 0.0 110.211 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.48 -3.79 71.64 Favored Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.61 132.55 71.62 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.676 1.238 . . . . 0.0 110.86 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -54.78 143.22 71.59 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.781 2.987 . . . . 0.0 113.169 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.86 -18.2 64.11 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.47 -19.51 65.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.974 0.91 . . . . 0.0 113.37 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -91.5 109.57 20.86 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.681 1.192 . . . . 0.0 110.285 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -65.89 118.83 10.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.203 1.001 . . . . 0.0 112.144 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -60.65 -38.2 84.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.462 0.705 . . . . 0.0 111.847 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.61 -38.14 89.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.208 1.003 . . . . 0.0 112.332 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -64.35 -38.06 89.7 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.201 -0.937 . . . . 0.0 111.928 170.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.64 -40.2 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.618 0.767 . . . . 0.0 110.1 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.6 -55.28 37.1 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.185 0.902 . . . . 0.0 110.749 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.35 -49.27 72.7 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.8 p -70.11 -36.87 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.37 -34.44 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.974 0.806 . . . . 0.0 112.034 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.28 -32.69 74.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.671 -1.268 . . . . 0.0 112.511 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -78.16 -67.63 0.72 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 112.889 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -83.22 -34.52 25.86 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -93.68 -4.15 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 112.65 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.43 28.42 16.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.157 1.783 . . . . 0.0 113.158 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 65.8 m -82.92 -174.9 5.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.551 1.14 . . . . 0.0 112.499 -174.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.41 145.29 35.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.474 1.51 . . . . 0.0 108.712 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.92 172.59 45.54 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.33 163.62 37.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.591 1.556 . . . . 0.0 112.866 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.36 134.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.883 1.273 . . . . 0.0 109.467 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -132.95 140.64 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.482 1.513 . . . . 0.0 109.463 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -100.43 105.2 16.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.518 0.727 . . . . 0.0 109.241 169.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.16 144.78 39.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.993 1.317 . . . . 0.0 111.545 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.45 -33.92 98.32 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.373 2.715 . . . . 0.0 114.552 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -107.24 -48.22 3.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.873 1.269 . . . . 0.0 112.014 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.7 mtt -78.05 -19.05 55.02 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.09 -157.74 45.31 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.177 0.894 . . . . 0.0 112.522 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -70.67 118.72 13.83 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.75 0.82 . . . . 0.0 111.274 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt -139.74 151.39 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.457 1.903 . . . . 0.0 112.101 -171.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -95.34 133.63 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -104.45 128.07 52.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.15 1.38 . . . . 0.0 107.815 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -116.73 141.41 48.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.983 1.713 . . . . 0.0 108.483 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -72.75 137.48 45.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.858 1.208 . . . . 0.0 111.799 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.77 -175.78 47.25 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.692 1.615 . . . . 0.0 113.693 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.7 84.53 5.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.355 1.862 . . . . 0.0 111.098 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.79 14.62 26.52 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.971 1.708 . . . . 0.0 112.919 -173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -59.32 -41.54 89.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.53 63.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.089 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -63.74 -44.81 92.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.936 0.894 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.7 -35.39 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.399 0.68 . . . . 0.0 111.246 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.8 t -56.47 -47.8 78.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.541 1.064 . . . . 0.0 111.156 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.81 -39.74 90.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.576 0.751 . . . . 0.0 112.438 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.412 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 28.4 t80 -60.09 -48.39 81.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.725 1.148 . . . . 0.0 111.792 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mmt -59.57 -43.27 93.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.582 1.153 . . . . 0.0 110.604 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.23 -45.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.693 0.797 . . . . 0.0 111.711 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -75.71 -47.15 27.3 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -102.24 -37.43 8.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.0 mt -89.36 -17.02 29.68 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.894 0.77 . . . . 0.0 112.723 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.97 15.99 80.44 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.461 1.029 . . . . 0.0 113.639 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.64 136.22 52.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.213 1.007 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -76.8 139.09 40.24 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.615 -0.678 . . . . 0.0 109.909 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -53.8 -37.55 63.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -56.69 -24.7 50.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.392 1.477 . . . . 0.0 114.981 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -76.86 -16.09 59.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.32 0.964 . . . . 0.0 113.277 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.86 126.24 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 120.294 1.407 . . . . 0.0 112.123 -168.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -103.15 134.6 46.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.016 1.726 . . . . 0.0 110.27 169.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -108.41 128.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.98 1.312 . . . . 0.0 108.428 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -125.06 169.57 12.02 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.763 1.225 . . . . 0.0 113.151 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.39 -139.33 9.8 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.543 1.544 . . . . 0.0 111.863 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 126.466 1.906 . . . . 0.0 113.283 177.619 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.502 2.175 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 p -160.07 -67.45 0.07 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.581 1.152 . . . . 0.0 111.066 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 tt -163.39 162.46 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 127.055 2.142 . . . . 0.0 110.024 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -63.78 123.36 18.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.466 0.706 . . . . 0.0 110.448 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -64.8 -16.58 63.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.78 -7.26 59.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.505 1.522 . . . . 0.0 113.551 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -59.25 138.06 57.75 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.457 1.026 . . . . 0.0 112.593 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.9 p -111.81 162.05 15.68 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.093 1.357 . . . . 0.0 113.374 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -164.12 151.78 12.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.657 1.983 . . . . 0.0 110.283 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -164.34 163.05 15.34 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.035 1.734 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.15 -14.72 35.3 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.736 2.957 . . . . 0.0 116.338 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -106.76 6.3 29.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.676 1.591 . . . . 0.0 112.01 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.57 -11.51 60.98 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.361 1.464 . . . . 0.0 114.131 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.35 140.29 58.86 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.073 1.349 . . . . 0.0 112.251 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.0 p -73.88 143.76 45.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.798 1.239 . . . . 0.0 112.84 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.41 -159.93 34.95 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.244 1.402 . . . . 0.0 113.018 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -71.26 -19.22 62.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.513 1.125 . . . . 0.0 113.437 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -153.81 154.57 34.21 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.428 1.891 . . . . 0.0 110.875 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -87.97 115.74 25.65 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 0.0 110.927 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.5 p -91.18 -18.78 23.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.394 1.478 . . . . 0.0 113.758 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.98 141.16 47.74 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.41 1.084 . . . . 0.0 112.93 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 m -81.49 -29.77 33.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.467 1.507 . . . . 0.0 112.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -63.46 140.73 58.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.936 1.294 . . . . 0.0 114.318 -172.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.92 144.54 48.93 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.897 0.879 . . . . 0.0 112.001 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -137.61 148.95 46.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.422 1.489 . . . . 0.0 110.95 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.98 119.54 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -103.6 121.08 42.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.842 0.857 . . . . 0.0 110.076 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.28 103.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -113.16 171.23 7.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.971 2.108 . . . . 0.0 110.21 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.58 145.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -80.25 152.99 28.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.816 0.846 . . . . 0.0 111.539 -177.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.51 154.92 40.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.278 1.431 . . . . 0.0 112.345 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -80.06 110.26 15.29 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.857 0.863 . . . . 0.0 110.729 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -136.52 25.75 3.14 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.832 1.653 . . . . 0.0 112.034 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.91 -4.99 83.53 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.613 1.578 . . . . 0.0 114.555 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -90.19 165.49 13.92 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.652 1.581 . . . . 0.0 111.46 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -65.86 161.42 21.14 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.913 0.885 . . . . 0.0 112.345 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.8 m -68.3 133.83 49.38 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.81 1.244 . . . . 0.0 109.85 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.8 mt -133.47 134.98 44.2 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.82 1.248 . . . . 0.0 110.234 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.7 m -89.95 116.98 28.42 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.614 1.566 . . . . 0.0 108.26 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.57 117.19 32.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.952 1.701 . . . . 0.0 110.005 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.93 126.66 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 108.922 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -138.02 159.11 42.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.871 2.068 . . . . 0.0 109.233 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.23 -14.97 2.74 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.289 -1.507 . . . . 0.0 116.103 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.02 130.57 7.22 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 126.207 1.803 . . . . 0.0 112.151 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.43 139.41 65.23 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.241 3.294 . . . . 0.0 113.413 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.96 -11.14 60.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.15 -18.97 61.84 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.114 0.966 . . . . 0.0 113.018 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -90.8 119.72 31.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.561 1.144 . . . . 0.0 110.961 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.79 119.86 16.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 111.568 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -62.75 -38.39 90.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.297 0.639 . . . . 0.0 111.901 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -60.93 -39.51 89.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.936 0.895 . . . . 0.0 112.225 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -63.49 -39.62 94.92 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.227 -0.921 . . . . 0.0 111.943 171.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.48 -47.38 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.919 0.781 . . . . 0.0 109.103 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.72 -48.09 75.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.155 0.889 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -62.38 -39.71 94.11 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.438 -0.789 . . . . 0.0 112.443 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.97 -46.67 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.869 0.759 . . . . 0.0 111.147 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.42 -30.52 67.4 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.05 -31.86 63.06 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.837 -1.164 . . . . 0.0 112.974 171.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -80.01 -61.93 1.84 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.237 1.015 . . . . 0.0 113.15 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -85.14 -37.32 20.35 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -92.98 -13.13 29.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.876 0.871 . . . . 0.0 113.002 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.05 29.47 17.66 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.175 1.79 . . . . 0.0 113.012 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.7 m -82.43 -172.1 3.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.697 1.199 . . . . 0.0 111.284 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -146.34 152.76 39.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 109.944 168.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.9 176.23 47.92 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 115.451 0.94 . . . . 0.0 115.451 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -158.33 162.12 37.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.328 1.851 . . . . 0.0 111.64 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 143.79 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 108.985 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.44 132.53 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.436 1.094 . . . . 0.0 109.259 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -94.07 89.31 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.725 1.21 . . . . 0.0 109.273 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.06 142.41 64.21 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.91 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -57.8 -33.03 96.35 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.496 2.797 . . . . 0.0 114.67 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -107.76 -47.63 3.56 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 112.042 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.6 mtt -80.26 -17.82 51.15 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.56 -158.81 52.77 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.25 0.932 . . . . 0.0 112.289 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -77.17 116.77 18.08 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.691 0.796 . . . . 0.0 112.317 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -134.92 151.55 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 126.985 2.114 . . . . 0.0 111.642 -174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.33 134.79 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 167.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.05 126.01 51.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.887 1.675 . . . . 0.0 107.491 168.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -113.27 140.46 47.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.231 1.412 . . . . 0.0 108.376 170.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -71.41 135.19 47.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.135 -0.978 . . . . 0.0 111.705 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 -169.86 45.88 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.453 1.501 . . . . 0.0 113.539 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.13 87.54 3.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.706 2.002 . . . . 0.0 111.205 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -112.35 20.25 16.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.584 1.553 . . . . 0.0 112.939 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.75 -42.03 92.3 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.38 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.056 0.942 . . . . 0.0 112.154 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.71 -45.15 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.868 0.867 . . . . 0.0 111.811 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.8 t -68.14 -34.81 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.09 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.0 -49.07 78.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.338 0.972 . . . . 0.0 111.162 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.13 -37.81 78.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.83 0.852 . . . . 0.0 112.652 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.36 -48.54 80.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.867 1.212 . . . . 0.0 111.664 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.6 mmt -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.051 0.94 . . . . 0.0 110.734 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.03 -47.89 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.954 0.902 . . . . 0.0 111.417 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -97.94 -33.21 11.3 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.98 -14.22 39.69 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.83 0.741 . . . . 0.0 112.107 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.81 79.75 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.865 1.221 . . . . 0.0 113.899 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.3 mt -71.41 144.07 49.92 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.434 1.117 . . . . 0.0 111.783 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -75.21 138.25 41.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -54.32 -34.86 61.9 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -55.65 -21.71 19.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.524 1.93 . . . . 0.0 115.311 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -76.68 -10.56 59.47 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.1 mt -112.86 133.17 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.049 0.94 . . . . 0.0 111.153 -169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -109.34 128.25 54.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.535 1.934 . . . . 0.0 110.153 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.81 129.65 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.83 1.252 . . . . 0.0 109.077 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -126.36 173.9 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.893 1.277 . . . . 0.0 113.138 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.41 -141.25 12.02 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.481 1.515 . . . . 0.0 112.115 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.931 2.092 . . . . 0.0 112.891 175.659 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -76.17 -38.37 56.73 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.231 -0.918 . . . . 0.0 112.761 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm -81.01 77.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -158.08 -18.56 0.08 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.737 1.215 . . . . 0.0 114.024 -168.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.163 -0.961 . . . . 0.0 112.137 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 pp -100.94 163.86 12.1 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.121 1.368 . . . . 0.0 112.952 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -165.4 149.36 8.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.847 2.059 . . . . 0.0 110.119 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -60.06 153.59 21.26 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.334 1.054 . . . . 0.0 113.763 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.645 1.578 . . . . 0.0 111.504 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.39 136.14 96.2 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.999 0.92 . . . . 0.0 112.547 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.18 -12.05 33.07 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.581 2.854 . . . . 0.0 115.128 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -135.36 -155.63 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.548 1.539 . . . . 0.0 110.695 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.89 -176.01 4.7 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.925 2.09 . . . . 0.0 111.185 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -143.27 146.95 34.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.408 1.483 . . . . 0.0 111.417 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -152.53 141.06 20.75 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.5 -145.86 18.42 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.41 1.481 . . . . 0.0 113.52 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -131.59 160.82 34.21 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.217 1.807 . . . . 0.0 110.852 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 152.56 45.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.877 0.871 . . . . 0.0 113.326 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -154.32 149.28 26.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.96 1.304 . . . . 0.0 111.025 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.9 m -76.26 78.44 3.04 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.789 1.236 . . . . 0.0 110.772 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.68 161.73 37.15 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.704 2.001 . . . . 0.0 111.311 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -151.82 170.6 19.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.885 1.274 . . . . 0.0 112.565 -169.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.3 m -139.93 143.13 36.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.747 2.019 . . . . 0.0 110.244 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -68.93 -32.75 72.58 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 61.4 m-85 -120.53 139.73 52.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.543 1.137 . . . . 0.0 113.724 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mt -113.98 134.36 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 128.084 2.554 . . . . 0.0 107.122 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -118.12 111.43 18.86 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 111.005 -169.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -104.89 110.28 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -118.06 164.89 14.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.512 1.925 . . . . 0.0 109.696 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -116.94 143.19 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -101.01 155.16 18.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.886 1.274 . . . . 0.0 110.769 -171.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -68.04 142.47 55.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.355 0.662 . . . . 0.0 109.691 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -80.04 80.26 6.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.733 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -82.39 -31.14 29.82 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.469 1.107 . . . . 0.0 111.959 171.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.9 -165.62 41.5 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.008 1.29 . . . . 0.0 111.924 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -67.5 -29.08 68.4 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -141.41 154.89 45.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.242 1.417 . . . . 0.0 112.245 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.3 m -68.19 147.56 52.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 110.782 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.26 147.28 50.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.653 1.181 . . . . 0.0 111.729 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.3 m -93.62 118.02 30.84 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.481 1.513 . . . . 0.0 108.304 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.61 115.36 29.23 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.646 1.578 . . . . 0.0 110.001 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.3 t -97.66 126.89 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.207 1.003 . . . . 0.0 109.288 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -137.62 161.01 37.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.717 2.007 . . . . 0.0 109.412 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.49 -13.43 8.14 Favored Glycine 0 N--CA 1.477 1.387 0 O-C-N 120.092 -1.63 . . . . 0.0 116.056 169.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -49.97 132.23 22.41 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.974 1.309 . . . . 0.0 111.061 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.83 136.73 51.62 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.086 3.19 . . . . 0.0 113.001 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.83 -3.04 29.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 -17.2 61.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.714 0.806 . . . . 0.0 112.144 167.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.4 126.6 40.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.166 1.386 . . . . 0.0 110.247 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -77.64 131.25 37.68 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.608 -0.682 . . . . 0.0 110.84 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.4 -37.57 83.92 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.336 0.654 . . . . 0.0 111.678 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -61.15 -33.31 73.21 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.868 0.867 . . . . 0.0 112.601 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -67.6 -39.49 84.77 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.261 0.937 . . . . 0.0 111.516 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.04 -47.02 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 0.0 109.196 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.27 -47.08 76.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.766 0.712 . . . . 0.0 111.872 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -62.48 -39.3 93.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.725 0.693 . . . . 0.0 112.351 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.13 -48.17 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 118.985 0.811 . . . . 0.0 111.13 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.46 -29.76 67.5 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.22 -26.87 56.5 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.691 -1.256 . . . . 0.0 113.56 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.56 -49.58 5.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.96 -40.9 17.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.973 0.909 . . . . 0.0 112.953 -172.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.71 -9.75 36.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.651 1.18 . . . . 0.0 112.606 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.32 30.84 20.12 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.934 1.694 . . . . 0.0 112.659 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.08 -165.07 1.27 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.558 1.143 . . . . 0.0 111.335 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -150.17 146.42 26.85 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.78 0.832 . . . . 0.0 110.971 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.47 176.17 46.13 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -155.71 164.46 38.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.131 1.773 . . . . 0.0 111.086 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.5 mt -103.08 139.7 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.39 1.476 . . . . 0.0 110.055 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.0 t -136.22 143.05 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.124 1.37 . . . . 0.0 109.182 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -98.59 103.49 15.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.022 0.929 . . . . 0.0 110.618 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -86.14 144.66 39.03 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.203 1.401 . . . . 0.0 111.487 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.77 -31.37 92.08 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.536 2.824 . . . . 0.0 114.711 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -111.17 -46.37 3.32 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.706 1.202 . . . . 0.0 112.437 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.5 mtt -78.02 -18.21 56.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.53 -157.3 47.56 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.77 1.176 . . . . 0.0 112.746 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -68.76 109.25 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.859 0.864 . . . . 0.0 110.322 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.6 pt -124.64 148.84 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.547 1.939 . . . . 0.0 111.829 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.15 133.23 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -103.78 117.4 34.28 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.823 1.649 . . . . 0.0 107.005 167.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.45 145.14 30.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.894 1.278 . . . . 0.0 108.898 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.83 131.0 44.42 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.538 -0.726 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -167.05 47.82 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.707 1.146 . . . . 0.0 113.662 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -97.69 93.0 6.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.585 1.954 . . . . 0.0 111.25 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -116.87 22.4 12.66 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.417 1.487 . . . . 0.0 113.072 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -58.52 -45.47 88.73 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.26 77.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.991 0.916 . . . . 0.0 112.198 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -65.89 -45.59 81.44 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 111.954 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.99 -35.41 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.254 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.3 t -57.37 -48.22 79.61 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.106 0.866 . . . . 0.0 111.09 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -62.49 -37.86 87.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.475 0.71 . . . . 0.0 112.766 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.49 -49.93 75.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.792 1.178 . . . . 0.0 111.383 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -58.92 -43.89 91.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 110.672 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.42 -44.29 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.578 0.751 . . . . 0.0 111.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.9 t -76.36 -48.09 21.15 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -99.46 -35.48 9.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.44 -14.25 30.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.878 0.763 . . . . 0.0 112.834 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.58 15.16 81.26 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.583 1.087 . . . . 0.0 113.784 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.33 148.64 49.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.316 1.058 . . . . 0.0 110.109 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -86.58 144.83 27.01 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.376 -0.828 . . . . 0.0 110.031 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -52.93 -39.63 62.98 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.653 -0.655 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -59.5 -21.03 59.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.543 1.537 . . . . 0.0 114.983 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -77.46 -14.29 59.72 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.075 0.852 . . . . 0.0 113.204 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.5 mt -108.05 122.67 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 120.317 1.417 . . . . 0.0 111.607 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 73.0 mmtt -98.94 123.79 43.45 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.374 1.87 . . . . 0.0 109.627 169.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -101.99 120.92 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -103.96 -32.49 9.22 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.31 -139.21 35.32 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 p90 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 126.078 1.751 . . . . 0.0 113.234 176.874 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -68.8 148.83 49.73 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.118 0.967 . . . . 0.0 112.514 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 mt -86.69 85.93 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.355 -0.841 . . . . 0.0 109.163 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -161.42 134.35 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.779 1.632 . . . . 0.0 110.068 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -164.28 132.8 3.57 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.375 1.47 . . . . 0.0 111.231 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -119.03 137.54 53.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.241 1.416 . . . . 0.0 109.644 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -170.82 166.06 7.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.576 1.951 . . . . 0.0 112.048 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -86.66 136.09 33.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.874 0.87 . . . . 0.0 111.201 171.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -165.37 171.63 13.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.99 1.716 . . . . 0.0 111.472 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.48 151.91 19.05 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.524 1.529 . . . . 0.0 111.783 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.481 2.787 . . . . 0.0 112.662 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -171.42 145.09 2.05 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.423 2.289 . . . . 0.0 110.008 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.89 -20.96 29.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.081 0.952 . . . . 0.0 113.428 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -162.75 156.61 20.56 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.516 1.926 . . . . 0.0 111.023 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -106.98 163.36 13.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.746 1.618 . . . . 0.0 112.525 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.31 179.71 51.0 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.844 1.211 . . . . 0.0 114.779 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -160.65 -153.33 0.32 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.996 2.119 . . . . 0.0 110.421 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.15 147.82 46.27 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.679 -1.263 . . . . 0.0 113.386 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.23 -10.46 42.08 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.571 1.548 . . . . 0.0 114.539 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.8 t -56.42 -25.42 50.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.28 1.432 . . . . 0.0 113.695 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.29 83.38 1.89 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 110.903 170.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.4 t -157.62 172.28 18.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.084 2.153 . . . . 0.0 110.904 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.5 m 69.74 -11.32 0.53 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.892 2.477 . . . . 0.0 114.66 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.34 174.23 9.14 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.211 1.804 . . . . 0.0 113.356 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -72.38 141.1 48.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.62 133.57 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.632 1.573 . . . . 0.0 107.63 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -118.53 122.78 43.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.32 1.048 . . . . 0.0 110.494 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -116.58 111.09 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -120.55 174.21 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.411 1.484 . . . . 0.0 110.952 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -113.01 133.59 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -108.14 128.96 55.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.634 1.974 . . . . 0.0 108.683 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -74.91 153.25 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.655 0.782 . . . . 0.0 111.735 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 121.0 13.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.535 1.134 . . . . 0.0 109.924 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -63.82 109.43 1.74 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.619 0.767 . . . . 0.0 112.201 -172.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 15.55 70.41 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.606 1.098 . . . . 0.0 114.794 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -136.96 178.2 7.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.799 1.639 . . . . 0.0 112.002 -169.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -53.9 140.05 31.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 114.118 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -68.53 142.01 55.37 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.487 1.515 . . . . 0.0 108.908 168.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.6 mt -127.07 138.4 53.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.874 0.87 . . . . 0.0 111.087 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -93.81 119.48 32.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 108.547 169.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -101.43 123.53 45.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.207 1.403 . . . . 0.0 110.608 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.27 123.88 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.584 1.154 . . . . 0.0 109.114 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.61 152.52 48.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.301 1.84 . . . . 0.0 109.33 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 -5.14 63.95 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.914 -1.116 . . . . 0.0 115.879 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.31 129.45 51.36 Favored Pre-proline 0 N--CA 1.477 0.918 0 CA-C-N 119.475 1.638 . . . . 0.0 109.89 170.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -51.32 140.7 42.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.842 3.028 . . . . 0.0 113.679 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.83 -3.47 41.67 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.87 -18.41 62.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 0.0 111.912 167.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -92.41 133.1 36.21 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.048 1.339 . . . . 0.0 111.319 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.79 117.63 17.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.224 1.009 . . . . 0.0 111.192 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.53 -39.99 89.87 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 111.642 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -56.91 -35.99 69.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.039 1.336 . . . . 0.0 113.812 172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -71.51 -35.81 70.86 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.949 0.9 . . . . 0.0 111.847 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.47 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.796 0.839 . . . . 0.0 109.717 173.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.25 -55.77 30.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.26 0.936 . . . . 0.0 110.443 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -54.15 -48.73 70.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.378 1.071 . . . . 0.0 113.217 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.4 p -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.57 -31.97 65.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.102 0.865 . . . . 0.0 112.261 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.54 -34.85 72.72 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.773 -1.205 . . . . 0.0 112.426 169.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -75.27 -59.28 2.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.475 1.11 . . . . 0.0 113.34 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.61 -38.83 15.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.192 0.997 . . . . 0.0 113.675 -169.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -93.4 -4.79 50.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.985 0.914 . . . . 0.0 113.013 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.13 24.5 13.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.087 1.755 . . . . 0.0 113.3 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.2 m -81.96 -171.96 3.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.849 1.26 . . . . 0.0 112.012 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -144.81 153.83 42.04 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.888 1.275 . . . . 0.0 109.256 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.01 176.46 46.85 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.829 1.092 . . . . 0.0 115.829 -169.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.14 164.73 30.42 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.232 1.813 . . . . 0.0 112.067 -171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.15 146.37 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 172.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -136.17 142.19 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.593 1.557 . . . . 0.0 108.704 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -110.74 93.62 4.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.77 0.828 . . . . 0.0 110.008 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.02 145.87 37.29 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.452 1.501 . . . . 0.0 112.153 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -57.77 -33.83 97.39 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.501 2.801 . . . . 0.0 114.633 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -106.9 -47.4 3.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.777 1.231 . . . . 0.0 111.95 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.5 mtt -79.69 -16.5 55.58 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.97 -161.1 51.98 Favored Glycine 0 N--CA 1.47 0.958 0 C-N-CA 124.531 1.062 . . . . 0.0 113.219 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -72.43 112.18 8.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.447 1.099 . . . . 0.0 110.213 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 pt -136.63 153.82 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.669 1.988 . . . . 0.0 112.227 -171.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.9 mt -100.16 134.69 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 166.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -103.84 129.2 51.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.535 1.534 . . . . 0.0 107.501 168.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.24 142.53 46.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.335 1.454 . . . . 0.0 108.29 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -77.99 135.1 37.74 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.036 -1.04 . . . . 0.0 111.296 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.68 -172.1 44.05 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.713 1.625 . . . . 0.0 113.22 -174.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -97.8 88.44 4.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.465 1.906 . . . . 0.0 111.22 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -112.56 17.58 19.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.798 1.639 . . . . 0.0 113.014 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -59.21 -42.94 92.15 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -169.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.46 -38.59 74.47 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.964 0.905 . . . . 0.0 112.153 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -65.9 -44.77 84.28 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.75 -33.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.235 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -49.47 77.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.402 1.001 . . . . 0.0 111.042 170.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.0 -36.59 75.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.696 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.4 t80 -62.35 -49.36 75.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.781 1.173 . . . . 0.0 111.854 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.4 mmt -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.241 1.016 . . . . 0.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.53 -49.72 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.305 1.042 . . . . 0.0 111.782 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -75.62 -46.33 32.26 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -101.83 -36.66 8.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 mt -89.55 -18.49 26.51 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.953 0.797 . . . . 0.0 112.915 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.05 14.57 81.75 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.572 1.082 . . . . 0.0 113.618 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.16 134.55 49.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.292 1.046 . . . . 0.0 108.93 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -75.19 148.1 39.85 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.52 -0.738 . . . . 0.0 110.136 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -56.99 -36.63 70.59 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.704 -0.623 . . . . 0.0 112.338 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -64.42 -17.66 63.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.099 1.76 . . . . 0.0 115.199 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -79.69 -10.04 59.73 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.349 0.977 . . . . 0.0 113.202 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 42.3 mt -113.64 131.74 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.03 -1.044 . . . . 0.0 111.074 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -106.46 135.72 47.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.453 1.501 . . . . 0.0 110.628 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.05 126.94 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.63 1.172 . . . . 0.0 108.851 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -126.45 -161.54 1.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.583 1.553 . . . . 0.0 111.753 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.73 -151.12 18.91 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 125.182 1.372 . . . . 0.0 113.418 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 . . . . . 0 C--O 1.252 1.216 0 C-N-CA 125.376 1.47 . . . . 0.0 114.151 -173.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 p -86.77 162.5 17.8 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.058 1.343 . . . . 0.0 113.085 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.288 39.6 pt 46.84 -142.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.92 2.088 . . . . 0.0 113.843 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.09 162.19 25.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.444 1.898 . . . . 0.0 111.216 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -74.18 156.41 37.34 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.189 0.995 . . . . 0.0 112.074 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -144.21 134.05 23.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.224 1.41 . . . . 0.0 110.795 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -79.17 153.73 29.83 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.831 1.252 . . . . 0.0 112.656 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -145.0 159.27 43.2 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.417 1.487 . . . . 0.0 110.68 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.91 132.58 49.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.212 1.005 . . . . 0.0 110.702 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -64.71 123.44 83.35 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.863 0.865 . . . . 0.0 111.598 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.96 46.86 2.33 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.957 3.105 . . . . 0.0 111.447 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -169.99 140.82 2.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.705 2.402 . . . . 0.0 109.742 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -172.64 161.28 4.83 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.564 1.945 . . . . 0.0 111.157 -171.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -78.34 137.58 38.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.184 0.994 . . . . 0.0 112.065 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.2 p -147.97 155.25 41.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.304 1.841 . . . . 0.0 110.86 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.37 147.61 23.44 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.444 1.021 . . . . 0.0 112.551 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -85.18 125.36 32.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.542 1.137 . . . . 0.0 111.685 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -168.87 166.45 11.36 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.571 1.948 . . . . 0.0 111.01 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -162.27 133.11 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.736 1.614 . . . . 0.0 111.524 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.2 m -98.66 120.47 39.15 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.932 1.293 . . . . 0.0 109.383 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.74 -25.0 44.48 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -77.27 135.03 38.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 110.673 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 m -71.31 150.26 45.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.807 0.843 . . . . 0.0 113.061 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -158.04 163.26 37.88 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.045 1.338 . . . . 0.0 112.129 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.425 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 63.4 m-85 -75.53 142.32 42.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.43 131.49 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.141 1.776 . . . . 0.0 107.147 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -116.58 119.52 35.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 110.754 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mt -109.39 109.27 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -117.92 176.35 5.24 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.443 2.297 . . . . 0.0 110.892 -169.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.91 147.63 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.126 -0.984 . . . . 0.0 110.117 168.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -126.88 143.13 51.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.707 2.003 . . . . 0.0 108.753 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -94.55 152.18 18.74 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.99 0.916 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -137.61 167.21 22.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.417 1.887 . . . . 0.0 110.235 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.68 143.32 42.04 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.982 0.913 . . . . 0.0 112.889 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -139.75 27.48 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.11 0.862 . . . . 0.0 112.042 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -83.59 -0.85 52.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.927 1.291 . . . . 0.0 113.681 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.36 131.26 43.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.415 1.086 . . . . 0.0 113.223 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 m -129.72 141.04 50.96 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.402 1.881 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt -123.48 148.73 45.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.875 1.27 . . . . 0.0 111.245 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.7 m -96.91 130.4 44.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.441 1.497 . . . . 0.0 107.548 168.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.34 122.54 46.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.239 1.416 . . . . 0.0 110.569 -176.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.43 124.16 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.594 1.158 . . . . 0.0 109.525 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -130.22 150.85 51.29 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.567 1.947 . . . . 0.0 109.673 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.88 58.5 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.53 129.22 69.65 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 119.107 1.454 . . . . 0.0 110.407 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.64 141.84 51.99 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.036 3.157 . . . . 0.0 112.616 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -11.99 60.06 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.72 -22.58 66.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.574 0.75 . . . . 0.0 112.314 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -91.1 104.33 16.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.852 1.261 . . . . 0.0 109.44 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.02 125.32 24.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.73 0.812 . . . . 0.0 112.554 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.9 -40.08 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.428 0.691 . . . . 0.0 112.343 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -63.9 -39.13 93.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.581 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -64.64 -36.45 84.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.041 0.936 . . . . 0.0 112.328 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.8 -48.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 118.951 0.796 . . . . 0.0 109.326 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.45 -42.63 82.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.2 0.909 . . . . 0.0 112.174 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -58.72 -41.79 87.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.082 0.855 . . . . 0.0 112.255 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.94 -46.27 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.708 0.685 . . . . 0.0 111.534 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.9 -31.62 68.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HE2' ' H ' ' A' ' 66' ' ' GLY . 87.5 mttt -75.42 -29.76 59.85 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.952 -1.092 . . . . 0.0 113.117 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -83.35 -61.66 1.79 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.11 0.964 . . . . 0.0 113.278 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.83 -39.24 24.27 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.151 0.98 . . . . 0.0 113.239 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -93.31 -7.8 43.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.565 1.146 . . . . 0.0 113.082 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.21 27.38 15.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.713 . . . . 0.0 113.287 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 90.4 m -83.86 -174.4 5.26 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.591 1.157 . . . . 0.0 111.736 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -138.85 144.95 39.45 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.209 1.004 . . . . 0.0 109.439 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' H ' ' HE2' ' A' ' 59' ' ' LYS . . . -169.03 171.57 43.01 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 115.431 0.933 . . . . 0.0 115.431 -169.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -162.73 158.93 23.61 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.947 1.699 . . . . 0.0 112.128 -169.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.16 137.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.712 1.205 . . . . 0.0 109.556 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.91 143.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.173 1.389 . . . . 0.0 110.199 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -102.94 104.28 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.46 146.16 41.32 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.37 1.468 . . . . 0.0 111.696 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.03 -32.17 97.01 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.395 2.73 . . . . 0.0 114.718 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.25 -47.64 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.712 1.205 . . . . 0.0 112.291 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -77.29 -18.23 57.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.95 -158.24 46.17 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.346 0.974 . . . . 0.0 112.774 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.05 118.58 13.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.934 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 pt -144.87 154.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.947 1.699 . . . . 0.0 113.075 -169.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.81 134.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -101.87 140.67 35.84 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.488 1.515 . . . . 0.0 108.551 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.41 141.94 50.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.97 1.708 . . . . 0.0 108.433 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -73.41 138.03 44.98 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.016 -1.052 . . . . 0.0 111.923 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.7 -172.47 44.44 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.21 1.386 . . . . 0.0 113.412 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -94.04 99.01 11.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.719 1.207 . . . . 0.0 110.04 171.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -117.23 18.54 14.46 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.536 1.534 . . . . 0.0 112.544 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -52.45 -55.23 23.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.618 1.167 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.01 88.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.264 1.026 . . . . 0.0 112.49 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -66.46 -45.35 80.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.497 0.719 . . . . 0.0 112.041 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.82 -36.14 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.227 0.611 . . . . 0.0 110.961 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.78 -48.47 75.26 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.317 0.962 . . . . 0.0 111.193 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.9 -39.55 89.72 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.592 0.757 . . . . 0.0 112.767 175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -59.91 -49.58 77.12 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.807 1.185 . . . . 0.0 111.465 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.9 mmt -58.32 -41.32 84.25 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.233 1.013 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -75.36 -50.62 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.505 -0.747 . . . . 0.0 111.491 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.2 m -89.46 -14.16 35.96 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.27 -39.94 3.33 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.087 1.312 . . . . 0.0 113.324 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.0 mt -87.12 -15.08 39.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.495 1.043 . . . . 0.0 113.09 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.72 14.74 79.26 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.471 1.034 . . . . 0.0 113.709 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.0 mt -68.94 151.59 46.35 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.541 1.171 . . . . 0.0 109.956 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -88.03 145.28 26.06 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -55.4 -37.64 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -61.28 -18.07 56.68 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.55 -14.22 60.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.403 1.002 . . . . 0.0 112.974 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 39.2 mt -111.52 128.64 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.218 0.917 . . . . 0.0 111.233 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 71.5 mmtt -103.2 133.26 48.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.463 1.905 . . . . 0.0 109.79 169.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.55 129.89 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.074 0.949 . . . . 0.0 108.912 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -120.51 177.93 4.86 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.253 1.421 . . . . 0.0 112.246 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.84 -153.84 28.47 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.686 1.136 . . . . 0.0 113.628 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.988 2.115 . . . . 0.0 113.606 177.612 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.0 m -139.95 154.81 47.3 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.954 1.302 . . . . 0.0 111.767 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -86.22 151.67 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.465 1.106 . . . . 0.0 111.54 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.76 155.37 27.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.739 1.616 . . . . 0.0 110.844 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -76.1 155.9 34.32 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.95 171.53 14.98 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.552 1.141 . . . . 0.0 111.824 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -76.62 -176.0 3.6 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.9 p -69.53 155.6 40.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.723 1.209 . . . . 0.0 113.476 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -72.11 156.62 38.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.766 1.226 . . . . 0.0 112.56 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -112.23 85.68 7.11 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.571 1.548 . . . . 0.0 110.874 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.75 -25.35 39.86 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.202 2.601 . . . . 0.0 113.391 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -94.21 4.92 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.015 0.926 . . . . 0.0 113.066 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.2 -18.43 60.76 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.646 1.178 . . . . 0.0 113.529 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -69.18 128.92 38.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.497 1.119 . . . . 0.0 111.836 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 p -85.52 -17.0 37.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.494 1.518 . . . . 0.0 113.318 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.94 -146.44 36.63 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.556 1.074 . . . . 0.0 113.191 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -139.43 156.21 47.11 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.001 1.72 . . . . 0.0 111.277 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.66 -17.35 61.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.367 1.067 . . . . 0.0 113.594 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.86 156.99 23.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.599 1.96 . . . . 0.0 110.915 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.4 p -77.77 133.72 38.19 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.58 1.152 . . . . 0.0 110.999 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.82 -20.42 60.46 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.1 p -138.54 160.15 40.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.117 2.167 . . . . 0.0 110.462 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.2 p -74.08 91.32 2.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.125 0.97 . . . . 0.0 111.526 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -66.64 136.77 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.76 0.824 . . . . 0.0 112.336 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 81.1 m-85 -80.42 140.88 35.78 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.77 124.98 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 168.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -110.36 125.99 53.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.942 0.897 . . . . 0.0 110.981 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.482 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.0 mt -116.61 117.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 108.258 174.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 mtt85 -129.59 174.59 9.53 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.79 1.636 . . . . 0.0 110.564 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.76 137.91 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 110.371 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -89.42 128.94 35.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.627 1.971 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -72.89 136.21 45.23 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.195 0.998 . . . . 0.0 111.683 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -82.98 153.35 25.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -167.95 -101.68 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.066 2.546 . . . . 0.0 107.141 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.15 -28.91 55.24 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 167.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -84.71 155.8 21.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.568 1.947 . . . . 0.0 111.759 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -74.78 170.59 15.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.173 1.389 . . . . 0.0 113.034 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 m -79.62 119.13 22.15 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 167.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.8 mt -131.39 146.68 52.38 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.821 1.248 . . . . 0.0 110.26 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.7 m -89.34 115.76 27.05 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.661 1.184 . . . . 0.0 108.391 171.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -97.26 126.41 42.45 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.482 1.513 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.77 129.13 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.179 1.392 . . . . 0.0 109.586 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -139.97 157.68 45.29 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.453 1.901 . . . . 0.0 109.723 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.06 62.71 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 p -54.89 131.84 66.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 118.663 1.231 . . . . 0.0 110.143 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -53.01 140.75 58.87 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.678 2.919 . . . . 0.0 113.196 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.41 -15.05 62.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.33 -20.21 66.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.937 0.895 . . . . 0.0 113.228 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -90.89 115.78 28.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.593 1.157 . . . . 0.0 110.63 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -68.41 121.17 15.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.071 0.949 . . . . 0.0 111.415 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 mt -59.81 -37.8 80.16 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.18 0.992 . . . . 0.0 111.936 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.36 -31.86 71.76 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.315 1.046 . . . . 0.0 112.488 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -37.34 69.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.872 0.869 . . . . 0.0 112.311 171.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.88 -47.26 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.88 -48.3 75.84 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.845 0.748 . . . . 0.0 111.637 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -60.28 -45.52 93.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.71 0.804 . . . . 0.0 112.148 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.51 -47.75 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.976 0.51 . . . . 0.0 111.329 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.46 -26.98 65.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.22 -37.1 38.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.616 -1.302 . . . . 0.0 113.308 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.03 -48.46 9.2 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -91.24 -38.77 12.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.958 0.903 . . . . 0.0 113.148 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -93.07 -8.44 42.78 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.952 0.901 . . . . 0.0 113.335 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.06 27.83 17.31 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.812 1.645 . . . . 0.0 113.57 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.5 m -87.84 -173.29 4.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.672 1.189 . . . . 0.0 111.282 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.74 145.75 38.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.388 1.075 . . . . 0.0 109.757 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -172.04 173.12 45.1 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.16 163.16 37.83 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 112.684 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.4 mt -98.4 134.98 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.927 1.291 . . . . 0.0 109.499 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.0 t -131.29 139.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.196 1.398 . . . . 0.0 109.278 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -103.89 99.24 9.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.865 0.866 . . . . 0.0 109.937 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.41 145.68 40.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.341 1.457 . . . . 0.0 111.784 -173.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.0 -31.63 93.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.575 2.85 . . . . 0.0 114.735 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.34 -46.99 3.23 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.735 1.214 . . . . 0.0 112.426 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.2 mtt -78.68 -15.35 58.59 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.96 -158.62 52.26 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 124.37 0.986 . . . . 0.0 112.559 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -72.33 116.58 12.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.906 0.883 . . . . 0.0 110.893 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 pt -139.51 151.37 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.473 1.909 . . . . 0.0 112.173 -172.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.7 mt -96.73 136.96 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.93 133.22 51.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.569 . . . . 0.0 107.866 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.81 141.17 48.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.242 1.417 . . . . 0.0 108.283 170.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.44 134.13 47.51 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.888 -1.133 . . . . 0.0 111.575 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.49 39.32 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.81 1.195 . . . . 0.0 113.621 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -101.8 100.78 11.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.68 1.592 . . . . 0.0 110.378 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -123.37 22.09 9.36 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.304 1.441 . . . . 0.0 113.173 -170.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.482 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.0 ptt180 -60.54 -43.88 96.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.11 89.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.455 0.702 . . . . 0.0 111.847 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -64.17 -47.28 80.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.05 0.94 . . . . 0.0 111.871 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.99 -34.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.882 -0.511 . . . . 0.0 111.534 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.93 -49.75 75.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.378 0.99 . . . . 0.0 111.083 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.49 -38.64 81.41 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.634 0.774 . . . . 0.0 112.65 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -60.32 -49.6 76.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.49 1.041 . . . . 0.0 111.633 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.13 -38.97 80.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.024 0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.99 -50.76 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.375 0.67 . . . . 0.0 111.374 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.5 m -84.93 -28.92 25.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -169.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -103.52 -44.0 5.24 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.264 0.938 . . . . 0.0 112.559 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.82 -19.77 28.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.071 0.85 . . . . 0.0 113.178 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.56 14.93 77.21 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.425 1.012 . . . . 0.0 113.727 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.07 145.21 51.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.626 1.213 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -74.28 140.95 45.31 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.506 -0.746 . . . . 0.0 110.819 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -53.29 -44.73 68.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.58 0.752 . . . . 0.0 112.211 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -63.79 -24.52 67.79 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.28 -6.27 54.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.548 1.139 . . . . 0.0 112.459 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.92 131.04 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.88 -1.137 . . . . 0.0 110.344 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.2 mmtt -109.33 128.36 55.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 110.277 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 77.0 mt -107.49 119.53 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -104.59 -26.53 12.3 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.19 -150.46 43.96 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 123.783 0.833 . . . . 0.0 113.074 170.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 tpp . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -79.18 177.55 8.74 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 112.864 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.38 159.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.406 1.882 . . . . 0.0 111.967 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.47 163.03 27.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.283 1.033 . . . . 0.0 112.397 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -61.28 138.25 58.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.783 0.833 . . . . 0.0 112.544 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.7 tp -155.72 150.15 25.93 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.519 1.528 . . . . 0.0 110.708 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -155.37 167.09 31.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.936 1.694 . . . . 0.0 112.24 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 t -161.91 170.96 18.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.777 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -85.91 174.66 9.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.869 1.668 . . . . 0.0 112.602 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.83 145.09 96.35 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.649 1.18 . . . . 0.0 113.316 -176.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.06 -21.97 17.57 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.4 2.733 . . . . 0.0 113.631 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -173.34 163.27 4.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.526 2.331 . . . . 0.0 109.928 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.28 155.61 35.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.535 1.934 . . . . 0.0 111.176 175.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.0 170.99 11.53 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.173 1.789 . . . . 0.0 112.041 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.4 t -160.09 158.44 30.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.905 1.682 . . . . 0.0 111.068 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.21 -172.07 22.37 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.702 1.62 . . . . 0.0 113.895 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -157.55 131.61 8.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.779 1.632 . . . . 0.0 110.896 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.61 165.39 10.21 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.646 1.978 . . . . 0.0 110.551 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.22 -26.48 58.96 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.7 p 65.37 -19.48 0.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 129.395 3.078 . . . . 0.0 116.973 170.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.89 6.47 2.58 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.56 1.544 . . . . 0.0 114.744 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 p -75.43 -11.11 59.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.922 2.089 . . . . 0.0 114.923 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 m -56.49 138.82 51.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.708 1.203 . . . . 0.0 114.108 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -74.31 -17.85 60.79 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -118.56 152.23 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.637 1.575 . . . . 0.0 112.44 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.4 mt -86.55 116.23 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 167.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -100.31 112.32 24.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.94 0.896 . . . . 0.0 109.741 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.5 mt -102.3 101.8 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -107.6 174.47 5.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.101 2.16 . . . . 0.0 110.715 -171.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.7 mt -122.17 138.67 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.9 143.22 37.9 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.417 1.487 . . . . 0.0 110.02 -172.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -73.39 103.19 3.97 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.774 0.83 . . . . 0.0 110.035 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.68 126.71 31.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.739 0.816 . . . . 0.0 111.486 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -106.66 63.03 0.64 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.376 1.47 . . . . 0.0 109.816 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.27 7.43 88.48 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.82 1.2 . . . . 0.0 114.202 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -98.1 171.46 8.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.17 1.788 . . . . 0.0 111.963 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.59 153.0 44.18 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.553 0.741 . . . . 0.0 111.921 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -68.66 138.9 55.36 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.26 1.424 . . . . 0.0 110.791 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.4 mt -128.62 135.42 49.29 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.604 1.162 . . . . 0.0 110.36 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -89.53 124.41 34.49 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.689 1.596 . . . . 0.0 108.295 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 114.1 27.37 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.456 1.502 . . . . 0.0 110.118 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.76 122.55 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.118 0.967 . . . . 0.0 109.363 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -125.62 151.59 46.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.65 1.98 . . . . 0.0 109.681 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.86 4.45 82.45 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -57.5 131.13 81.64 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.698 1.249 . . . . 0.0 110.456 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.26 139.75 63.03 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.07 3.18 . . . . 0.0 113.149 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -71.47 -10.29 59.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.95 -19.8 62.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.993 0.917 . . . . 0.0 112.939 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -91.97 121.59 33.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.771 1.228 . . . . 0.0 110.917 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.71 118.16 14.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.701 0.8 . . . . 0.0 111.146 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.36 -37.15 77.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.686 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -63.17 -37.24 86.44 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.181 0.992 . . . . 0.0 112.121 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -66.69 -37.66 85.18 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.28 -0.887 . . . . 0.0 111.663 171.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.33 -40.96 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.536 0.734 . . . . 0.0 110.097 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.28 -54.26 48.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.302 0.955 . . . . 0.0 110.888 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -55.84 -48.27 75.79 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.942 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.99 -35.82 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.2 -30.72 62.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.025 0.829 . . . . 0.0 112.117 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -71.06 -30.43 66.58 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.768 -1.207 . . . . 0.0 112.769 170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -83.15 -61.68 1.79 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 113.125 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -81.51 -40.55 23.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.232 1.013 . . . . 0.0 113.306 -169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.87 -7.03 50.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.407 1.083 . . . . 0.0 112.554 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.65 28.98 17.92 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.11 1.764 . . . . 0.0 112.893 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -91.91 -162.13 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.635 1.174 . . . . 0.0 111.764 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -155.4 152.47 29.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.102 0.961 . . . . 0.0 111.421 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.7 176.4 48.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.03 165.03 36.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.862 1.665 . . . . 0.0 112.738 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.7 mt -101.78 135.29 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.018 1.327 . . . . 0.0 109.876 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.44 143.76 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.24 1.416 . . . . 0.0 110.029 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -105.75 100.6 10.16 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.548 0.739 . . . . 0.0 109.511 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -84.58 144.67 43.18 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.452 1.501 . . . . 0.0 111.781 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.52 -32.25 93.72 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.611 2.874 . . . . 0.0 114.871 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.76 -47.42 3.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.616 1.166 . . . . 0.0 112.19 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.1 mtm -80.26 -17.24 52.76 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 -157.55 44.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.221 0.915 . . . . 0.0 113.201 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -70.12 114.53 8.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.827 1.251 . . . . 0.0 110.634 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -142.4 152.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.714 1.606 . . . . 0.0 113.093 -169.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.01 132.51 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -100.22 133.18 45.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.001 1.32 . . . . 0.0 107.723 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tp -123.35 143.16 50.28 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.606 1.562 . . . . 0.0 108.756 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.158 -0.964 . . . . 0.0 112.093 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.93 -170.47 39.81 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.215 1.388 . . . . 0.0 113.669 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -97.55 77.56 2.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.895 2.078 . . . . 0.0 111.081 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -100.26 15.34 27.93 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.075 1.75 . . . . 0.0 113.54 -170.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -58.39 -40.18 81.66 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -41.3 64.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.001 0.921 . . . . 0.0 112.123 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -65.77 -41.8 91.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.847 0.859 . . . . 0.0 112.54 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.75 -35.31 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.809 -0.557 . . . . 0.0 111.204 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.56 -48.54 79.07 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.474 1.034 . . . . 0.0 111.014 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.13 -39.7 83.18 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.813 0.845 . . . . 0.0 112.551 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 40.3 t80 -60.17 -49.49 77.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.597 1.09 . . . . 0.0 111.778 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.4 mmt -61.02 -38.53 86.44 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.189 0.995 . . . . 0.0 110.893 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -74.02 -46.28 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.742 0.817 . . . . 0.0 111.002 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -82.4 -37.65 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -103.37 -39.65 6.7 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.472 0.709 . . . . 0.0 112.808 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.5 mt -83.61 -17.77 40.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.729 0.695 . . . . 0.0 112.273 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.65 76.31 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.662 1.125 . . . . 0.0 113.636 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.98 159.05 34.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.564 1.182 . . . . 0.0 111.24 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.2 146.96 25.8 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.608 -0.682 . . . . 0.0 109.435 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -55.95 -36.82 68.22 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.367 -0.833 . . . . 0.0 112.365 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -65.94 -10.47 39.37 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -78.79 -9.59 59.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.86 1.209 . . . . 0.0 113.078 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.7 mt -117.89 136.21 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.207 . . . . 0.0 110.995 -169.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -112.56 135.97 52.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.352 1.861 . . . . 0.0 109.968 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.3 127.08 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.421 1.089 . . . . 0.0 109.334 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -126.84 -157.71 0.82 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.583 1.553 . . . . 0.0 111.714 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.45 -151.54 19.37 Favored Glycine 0 N--CA 1.472 1.067 0 C-N-CA 125.03 1.3 . . . . 0.0 113.579 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.635 1.574 . . . . 0.0 114.299 -174.13 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p -78.9 -34.7 44.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.456 1.102 . . . . 0.0 113.056 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 3' ' ' ILE . 3.8 mp -65.5 135.56 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.446 1.099 . . . . 0.0 109.649 172.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 76.55 -8.4 1.67 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 128.036 2.535 . . . . 0.0 114.116 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -70.03 139.89 52.76 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.912 -1.118 . . . . 0.0 112.372 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 pp -162.19 170.46 19.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.204 1.802 . . . . 0.0 111.784 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -100.89 133.1 45.86 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.704 1.202 . . . . 0.0 111.368 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -105.56 9.99 33.22 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 114.197 -173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -0.95 9.51 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -146.12 145.2 23.64 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.289 1.435 . . . . 0.0 111.582 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.26 -34.37 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.138 2.559 . . . . 0.0 112.685 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.6 p90 177.87 168.9 0.72 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.23 3.012 . . . . 0.0 109.337 -174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.8 150.88 39.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.945 1.698 . . . . 0.0 111.319 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.59 151.21 29.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.023 1.329 . . . . 0.0 113.199 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.3 p -96.06 149.53 21.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 111.611 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.35 -4.13 59.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.754 1.169 . . . . 0.0 114.777 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -164.25 153.89 14.1 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.265 1.826 . . . . 0.0 111.278 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -158.34 158.09 33.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.902 1.681 . . . . 0.0 111.265 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.3 138.56 43.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.452 1.101 . . . . 0.0 112.137 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.2 p -100.45 -27.66 13.33 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.591 1.557 . . . . 0.0 113.602 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.1 59.08 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.5 p -84.09 172.97 11.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.157 1.783 . . . . 0.0 111.939 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.8 p -149.85 155.92 40.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.748 1.219 . . . . 0.0 111.938 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -77.52 150.21 34.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.974 0.91 . . . . 0.0 112.582 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -72.16 137.79 47.21 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.69 -0.631 . . . . 0.0 112.411 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mt -89.89 119.69 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -103.78 113.32 26.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.195 0.998 . . . . 0.0 109.655 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.72 98.75 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -106.41 174.5 5.86 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.886 2.074 . . . . 0.0 110.683 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -116.1 146.78 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -92.82 139.17 30.82 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.036 0.934 . . . . 0.0 109.596 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -70.33 147.49 49.56 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.212 1.005 . . . . 0.0 112.964 -172.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -79.41 138.58 37.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.536 1.134 . . . . 0.0 111.7 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -162.37 -127.72 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.138 1.775 . . . . 0.0 108.841 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.98 -22.64 78.72 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 119.863 1.21 . . . . 0.0 112.642 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -88.14 152.46 21.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.389 1.476 . . . . 0.0 111.155 170.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -72.79 -175.9 1.85 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.163 1.385 . . . . 0.0 112.688 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 m -67.96 129.93 41.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.279 1.032 . . . . 0.0 108.288 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.8 mt -136.4 141.37 43.64 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.671 1.188 . . . . 0.0 109.986 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.1 m -93.07 115.5 28.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.813 1.245 . . . . 0.0 108.945 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.49 112.07 24.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.715 1.606 . . . . 0.0 110.001 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.48 125.02 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 109.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -132.79 152.75 51.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.134 1.773 . . . . 0.0 110.186 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -0.33 77.19 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 168.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -54.16 131.43 60.16 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 118.717 1.259 . . . . 0.0 111.283 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -51.67 136.73 50.22 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 113.283 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.65 -13.44 62.36 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.068 1.347 . . . . 0.0 113.906 -171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.69 -19.16 63.59 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.145 . . . . 0.0 113.11 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -94.56 125.34 39.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 111.0 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -74.57 124.75 27.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.504 0.722 . . . . 0.0 111.361 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.42 -38.75 85.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.075 0.55 . . . . 0.0 111.446 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -59.61 -37.18 77.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.497 1.119 . . . . 0.0 112.76 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -66.81 -39.52 87.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.191 0.905 . . . . 0.0 111.538 173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.67 -47.26 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.222 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.94 -48.79 75.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.868 0.758 . . . . 0.0 111.672 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.23 -42.43 99.31 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.428 -0.795 . . . . 0.0 112.512 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.14 -45.51 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.008 0.822 . . . . 0.0 111.346 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.23 -31.53 67.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.15 -32.94 65.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.631 -1.293 . . . . 0.0 112.751 171.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -75.68 -63.72 1.23 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.72 1.208 . . . . 0.0 113.235 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -92.54 -32.69 14.74 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -167.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -90.91 -13.94 32.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.637 0.775 . . . . 0.0 112.625 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 61.24 30.53 19.27 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.241 1.816 . . . . 0.0 112.86 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.6 m -82.32 -170.92 3.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.775 1.23 . . . . 0.0 111.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.94 152.75 36.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.869 1.268 . . . . 0.0 109.255 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.89 45.73 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 115.226 0.851 . . . . 0.0 115.226 -170.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -158.14 163.56 37.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.792 1.637 . . . . 0.0 112.32 -172.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.7 mt -102.01 136.15 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.189 1.395 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.5 t -137.21 140.59 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.072 1.349 . . . . 0.0 109.573 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -100.47 105.27 16.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.436 0.694 . . . . 0.0 110.068 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -87.84 144.54 35.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 111.684 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.24 -31.49 93.71 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 114.803 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -110.65 -47.23 3.28 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.773 1.229 . . . . 0.0 112.377 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.5 mtt -78.47 -17.77 55.81 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.02 -159.88 47.78 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.541 1.067 . . . . 0.0 112.69 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -71.98 118.88 15.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.779 0.832 . . . . 0.0 111.134 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -142.0 152.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.122 1.769 . . . . 0.0 112.309 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.84 134.28 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 167.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -105.96 116.8 32.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.643 1.577 . . . . 0.0 107.83 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tp -102.76 146.51 28.13 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.178 1.391 . . . . 0.0 109.185 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -69.37 133.4 47.76 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.547 0.739 . . . . 0.0 111.693 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 -170.12 54.78 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.11 1.338 . . . . 0.0 113.992 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -94.86 98.28 10.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.092 1.757 . . . . 0.0 111.326 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -120.45 20.75 11.82 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.057 1.743 . . . . 0.0 112.533 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -60.12 -40.91 91.4 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.88 -37.57 70.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 112.355 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.98 -44.96 83.38 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.936 0.895 . . . . 0.0 111.691 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.61 -35.19 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.104 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.11 -49.54 75.58 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.51 1.05 . . . . 0.0 111.094 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.61 -39.11 79.54 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 0.0 112.68 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -60.43 -47.92 84.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.627 1.103 . . . . 0.0 112.02 174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.4 mmt -61.27 -41.1 96.37 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.875 0.87 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.63 -47.97 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.732 0.813 . . . . 0.0 111.296 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -76.44 -48.09 20.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -100.48 -33.14 10.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.46 -15.85 38.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.145 0.884 . . . . 0.0 112.316 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.63 15.55 80.63 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.84 1.21 . . . . 0.0 113.685 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -71.1 157.89 37.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.547 1.174 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -88.48 147.14 24.81 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.642 -0.662 . . . . 0.0 109.586 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.56 -36.51 64.42 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.448 -0.782 . . . . 0.0 112.76 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -57.59 -21.7 40.6 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.884 1.674 . . . . 0.0 115.094 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -77.08 -7.69 56.17 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.279 0.945 . . . . 0.0 113.412 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.29 136.05 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.338 1.055 . . . . 0.0 110.791 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.53 134.22 54.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.755 2.022 . . . . 0.0 109.991 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt -110.91 127.76 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.821 1.248 . . . . 0.0 108.996 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.56 171.36 11.16 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.863 1.265 . . . . 0.0 113.153 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.01 -140.52 11.51 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.615 1.579 . . . . 0.0 112.098 173.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.5 p90 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 126.483 1.913 . . . . 0.0 113.173 174.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 tpp . . . . . 0 N--CA 1.501 2.082 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 p -102.62 -16.29 16.1 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.83 -29.02 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -165.89 137.58 3.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.372 1.869 . . . . 0.0 109.843 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -91.13 112.03 23.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.043 0.937 . . . . 0.0 110.752 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.1 144.38 31.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.238 1.015 . . . . 0.0 110.786 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -102.16 172.33 6.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.897 1.279 . . . . 0.0 112.322 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -76.32 136.63 39.58 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.185 -0.947 . . . . 0.0 111.501 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -144.19 166.29 25.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.358 1.463 . . . . 0.0 111.649 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -151.69 145.02 17.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.86 1.664 . . . . 0.0 111.215 174.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -93.66 -145.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.104 3.203 . . . . 0.0 110.437 -173.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -138.34 27.24 2.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.583 1.953 . . . . 0.0 111.662 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.69 153.57 41.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.168 1.387 . . . . 0.0 113.661 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.02 152.23 16.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.421 1.888 . . . . 0.0 110.791 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 t -161.97 165.72 27.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.459 1.503 . . . . 0.0 111.543 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.86 163.75 45.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.348 1.452 . . . . 0.0 114.006 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.08 163.15 26.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.43 1.492 . . . . 0.0 113.447 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -158.59 159.82 35.9 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.112 1.765 . . . . 0.0 111.037 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.77 144.53 45.85 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.197 1.399 . . . . 0.0 111.579 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 t -169.22 159.63 9.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.718 2.007 . . . . 0.0 110.639 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.75 -16.87 58.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.682 1.193 . . . . 0.0 113.172 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 m -72.01 145.12 48.54 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.728 1.611 . . . . 0.0 110.769 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.8 p -149.31 153.87 38.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.28 1.032 . . . . 0.0 112.647 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.91 171.92 8.8 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.396 1.478 . . . . 0.0 112.898 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 72.5 m-85 -72.46 143.09 48.56 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.2 mt -94.02 132.73 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 167.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -114.94 120.68 40.76 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.624 1.169 . . . . 0.0 110.182 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG21 ' HA ' ' A' ' 85' ' ' ARG . 27.9 mt -114.27 116.37 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -128.99 174.57 9.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.253 1.821 . . . . 0.0 110.202 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.4 mt -115.47 142.06 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.157 0.983 . . . . 0.0 108.483 169.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -87.29 135.76 33.19 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.454 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.96 124.57 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.24 0.616 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -141.16 146.32 36.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.726 1.61 . . . . 0.0 111.115 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -77.06 -27.84 54.47 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 113.22 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.24 162.14 26.94 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.516 1.532 . . . . 0.0 112.638 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.81 -6.21 30.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -74.33 55.82 0.62 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 113.591 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.1 m -68.66 143.19 54.86 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.919 2.088 . . . . 0.0 111.399 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -128.35 145.69 51.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.16 1.384 . . . . 0.0 111.945 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -89.7 132.37 35.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 107.663 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.0 p -112.94 124.5 52.77 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.246 1.419 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.36 126.57 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.973 1.309 . . . . 0.0 108.597 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -135.83 149.87 49.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.201 1.801 . . . . 0.0 109.502 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.12 -2.29 66.17 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 115.817 171.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.45 130.14 53.11 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.357 1.578 . . . . 0.0 111.08 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -52.29 139.7 53.77 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.397 3.398 . . . . 0.0 113.48 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -69.88 -16.19 63.2 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.85 0.86 . . . . 0.0 113.302 -172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -66.33 -20.2 66.02 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.026 0.931 . . . . 0.0 113.088 172.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -93.0 118.09 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.867 1.267 . . . . 0.0 110.693 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -69.12 120.3 14.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.966 0.906 . . . . 0.0 111.574 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.3 mt -61.3 -39.05 89.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.729 0.811 . . . . 0.0 111.914 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.78 -35.59 78.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.001 0.921 . . . . 0.0 112.461 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.51 -40.39 96.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.206 0.912 . . . . 0.0 112.308 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.27 -40.15 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 109.915 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.97 -55.43 35.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.213 0.915 . . . . 0.0 110.848 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 0.0 112.788 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 p -70.06 -36.18 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.92 -32.81 65.56 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.974 0.807 . . . . 0.0 112.318 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -70.69 -33.8 71.28 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.082 . . . . 0.0 112.641 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -76.96 -58.6 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.495 1.118 . . . . 0.0 113.259 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.87 -41.32 15.08 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.31 -11.47 35.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.154 0.982 . . . . 0.0 113.127 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.25 26.92 15.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.242 1.817 . . . . 0.0 113.046 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.2 m -80.91 -171.99 3.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.717 1.207 . . . . 0.0 111.709 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -146.83 149.59 33.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.66 1.184 . . . . 0.0 109.83 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.62 46.62 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 115.436 0.934 . . . . 0.0 115.436 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -159.61 164.71 33.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.755 1.622 . . . . 0.0 112.872 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.4 mt -98.56 134.89 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.899 1.279 . . . . 0.0 109.663 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.0 t -136.22 141.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.167 1.387 . . . . 0.0 109.758 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -102.31 107.72 18.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.692 0.797 . . . . 0.0 109.201 168.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -88.57 145.49 35.41 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.987 1.315 . . . . 0.0 111.635 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.3 -32.4 95.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.495 2.797 . . . . 0.0 114.614 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -111.46 -46.75 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.429 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.4 mtt -77.58 -16.74 58.43 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.23 -161.19 48.62 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.623 1.106 . . . . 0.0 112.982 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.65 119.52 14.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.931 0.892 . . . . 0.0 110.941 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -141.4 150.23 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.281 1.832 . . . . 0.0 112.251 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.94 132.76 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 166.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -99.34 137.07 38.36 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.183 1.393 . . . . 0.0 108.515 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tp -125.64 139.93 53.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.647 1.579 . . . . 0.0 108.547 171.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -70.69 136.89 49.33 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.067 -1.021 . . . . 0.0 111.834 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.64 -163.09 36.62 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.893 1.235 . . . . 0.0 113.492 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.27 98.19 7.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.663 1.585 . . . . 0.0 110.146 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -120.8 18.23 11.86 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.146 1.379 . . . . 0.0 113.303 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 28' ' ' ILE . 4.3 ptt180 -61.5 -42.75 99.27 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.05 -38.36 82.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.534 0.734 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -66.25 -45.33 80.94 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.068 0.947 . . . . 0.0 111.958 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.67 -36.46 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.222 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.67 -49.34 75.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.388 0.994 . . . . 0.0 111.208 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.45 -39.8 84.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.928 0.891 . . . . 0.0 112.601 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 35.9 t80 -60.02 -49.61 76.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.746 1.157 . . . . 0.0 111.837 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.6 mmt -59.79 -37.22 78.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.23 1.012 . . . . 0.0 110.948 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -76.78 -44.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.911 0.884 . . . . 0.0 111.116 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.8 m -86.12 -21.99 27.31 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -169.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -119.03 -38.25 3.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 0.0 113.455 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.83 -14.88 50.17 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.401 1.0 . . . . 0.0 112.437 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.28 14.98 80.97 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.869 1.223 . . . . 0.0 113.798 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.0 mt -70.94 158.43 36.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.405 1.102 . . . . 0.0 111.211 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -88.45 149.41 23.69 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -53.19 -39.69 63.84 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.501 -0.749 . . . . 0.0 112.227 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -60.21 -18.52 49.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.738 1.615 . . . . 0.0 114.947 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -78.84 -8.97 59.3 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.352 0.978 . . . . 0.0 113.424 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.1 mt -118.03 130.34 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 119.353 0.978 . . . . 0.0 111.407 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.6 mmtt -104.09 125.81 50.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.336 1.854 . . . . 0.0 110.082 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -102.0 120.9 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -104.75 -33.98 8.26 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.74 -136.19 38.5 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -170.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.145 0 C-N-CA 127.043 2.137 . . . . 0.0 113.438 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.502 2.158 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.9 m -126.96 148.94 50.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.97 1.308 . . . . 0.0 110.851 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -138.65 162.5 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.441 1.497 . . . . 0.0 111.678 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -161.49 158.72 26.99 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.953 1.701 . . . . 0.0 110.769 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.07 156.58 12.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.587 1.555 . . . . 0.0 112.25 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.3 mt 72.23 -52.78 0.7 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 129.034 2.934 . . . . 0.0 113.537 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -70.6 152.7 43.64 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.277 1.031 . . . . 0.0 113.305 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -169.44 170.65 8.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.207 1.803 . . . . 0.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -80.53 152.28 28.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.541 1.136 . . . . 0.0 112.075 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.13 145.96 16.94 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.736 1.614 . . . . 0.0 110.879 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.09 3.84 7.5 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.599 2.866 . . . . 0.0 115.18 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.25 66.72 9.34 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.98 1.312 . . . . 0.0 111.027 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 160.2 14.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.246 1.418 . . . . 0.0 113.028 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -62.65 136.61 57.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.637 1.175 . . . . 0.0 112.601 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.5 p -72.39 -39.01 68.31 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.15 175.17 45.15 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.787 1.661 . . . . 0.0 114.262 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.33 165.3 27.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.645 1.978 . . . . 0.0 110.787 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -147.25 147.91 30.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.837 1.255 . . . . 0.0 111.901 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.19 -41.25 0.15 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.122 1.769 . . . . 0.0 111.738 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 t -168.52 174.93 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.99 2.116 . . . . 0.0 110.336 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.54 171.85 16.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.111 1.764 . . . . 0.0 111.837 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.3 t -153.89 172.54 17.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.335 1.454 . . . . 0.0 111.946 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t 88.68 134.14 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 130.229 3.412 . . . . 0.0 111.648 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -94.14 -10.02 34.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.048 0.939 . . . . 0.0 113.485 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.503 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 32.5 m-85 -123.12 131.85 53.85 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt -100.28 128.1 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 127.051 2.14 . . . . 0.0 106.912 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -112.38 117.14 31.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.302 1.041 . . . . 0.0 110.448 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 85' ' ' ARG . 44.5 mt -108.24 108.12 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.3 174.04 6.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.085 2.154 . . . . 0.0 109.949 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.9 mt -125.92 142.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 120.983 -1.073 . . . . 0.0 108.725 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -88.31 130.48 35.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.143 1.377 . . . . 0.0 109.766 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 pm0 -72.56 145.39 47.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.907 0.883 . . . . 0.0 111.153 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.86 163.62 34.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -155.17 139.16 16.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.955 2.102 . . . . 0.0 109.58 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.98 14.65 80.11 Favored Glycine 0 CA--C 1.538 1.509 0 N-CA-C 115.266 0.867 . . . . 0.0 115.266 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.4 ptm85 -158.39 168.49 26.85 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.977 1.711 . . . . 0.0 112.087 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.07 148.72 51.38 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.158 0.983 . . . . 0.0 113.466 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.8 m -69.1 143.36 54.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.147 1.779 . . . . 0.0 110.027 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.5 mt -130.08 133.93 47.02 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.244 1.018 . . . . 0.0 111.28 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.1 m -89.11 118.7 29.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.584 1.954 . . . . 0.0 108.053 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.24 116.32 32.24 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.018 1.727 . . . . 0.0 110.126 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.5 t -101.39 126.63 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.743 1.217 . . . . 0.0 109.557 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -135.93 158.21 44.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.741 2.016 . . . . 0.0 109.736 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.87 -6.39 48.32 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 120.438 -1.414 . . . . 0.0 116.183 168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.93 130.97 48.98 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 118.563 1.181 . . . . 0.0 110.529 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -52.24 137.1 55.43 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.931 3.087 . . . . 0.0 112.938 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.68 -14.33 62.85 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.5 -19.68 64.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.241 1.017 . . . . 0.0 113.165 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -89.86 123.87 34.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.548 1.139 . . . . 0.0 111.054 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -74.83 120.59 20.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.963 0.905 . . . . 0.0 111.564 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.3 -39.07 89.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.563 0.745 . . . . 0.0 111.765 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -60.22 -36.56 77.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.601 1.16 . . . . 0.0 112.027 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -69.48 -36.88 76.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.875 0.87 . . . . 0.0 112.027 173.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.77 -47.67 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.917 0.781 . . . . 0.0 109.24 172.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.2 -46.61 79.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.178 0.899 . . . . 0.0 111.628 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -61.81 -33.76 74.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.135 0.974 . . . . 0.0 112.788 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.9 t -75.38 -50.57 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.064 0.545 . . . . 0.0 111.117 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.88 -33.37 74.59 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -72.28 -25.61 61.66 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.816 -1.178 . . . . 0.0 113.662 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -94.88 -48.92 5.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.132 0.973 . . . . 0.0 113.625 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -83.78 -38.85 20.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.065 0.946 . . . . 0.0 113.004 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 -10.93 23.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.856 1.263 . . . . 0.0 112.978 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.0 26.56 14.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.406 1.882 . . . . 0.0 113.145 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.8 m -79.39 -174.98 4.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.657 1.183 . . . . 0.0 112.241 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -143.7 150.81 39.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.488 1.115 . . . . 0.0 109.413 169.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.39 173.8 46.44 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.35 166.08 33.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.61 1.564 . . . . 0.0 112.372 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.4 134.98 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.948 1.299 . . . . 0.0 109.678 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t -133.41 140.17 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.988 1.315 . . . . 0.0 109.533 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -99.8 102.6 14.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.582 0.753 . . . . 0.0 110.079 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -86.16 143.89 37.8 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.053 1.341 . . . . 0.0 111.666 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.36 -31.18 93.33 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.506 2.804 . . . . 0.0 114.776 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -110.4 -47.49 3.28 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.664 1.186 . . . . 0.0 112.323 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.5 mtt -78.52 -18.3 54.93 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.92 -158.88 46.99 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.308 0.956 . . . . 0.0 112.478 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -71.53 118.22 14.08 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.876 -0.779 . . . . 0.0 111.223 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.78 149.57 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.373 1.869 . . . . 0.0 112.202 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.2 mt -93.68 135.06 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -104.23 129.96 52.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.444 1.498 . . . . 0.0 107.548 168.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tp -120.75 140.15 52.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.338 1.455 . . . . 0.0 108.743 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.35 132.57 45.85 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.964 -1.085 . . . . 0.0 111.524 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.91 -156.12 21.32 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.923 1.725 . . . . 0.0 113.623 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -116.35 47.94 1.34 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.636 2.374 . . . . 0.0 111.605 -173.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -75.14 25.05 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.024 2.529 . . . . 0.0 116.29 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HA ' HG21 ' A' ' 28' ' ' ILE . 31.2 ptt-85 -57.7 -47.22 82.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.633 1.173 . . . . 0.0 114.082 -172.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.42 74.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.9 0.88 . . . . 0.0 111.932 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -64.52 -46.0 84.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.612 0.765 . . . . 0.0 111.868 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.92 -35.94 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.719 -0.613 . . . . 0.0 111.369 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -56.11 -49.02 75.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.209 0.913 . . . . 0.0 111.197 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.11 -38.36 86.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.788 0.835 . . . . 0.0 112.846 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.3 -48.56 81.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.934 1.243 . . . . 0.0 111.56 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.6 mmt -59.73 -44.68 93.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 110.581 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -70.34 -44.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.707 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.6 t -79.16 -49.15 13.04 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -98.11 -35.77 10.3 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -88.67 -13.88 38.7 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.753 0.706 . . . . 0.0 112.494 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.49 17.31 79.3 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.774 1.178 . . . . 0.0 113.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.7 mt -70.79 153.56 42.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.503 1.151 . . . . 0.0 111.74 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -79.42 137.69 37.35 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.675 -0.641 . . . . 0.0 110.39 177.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -55.23 -38.81 68.95 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 0.0 112.756 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -59.2 -21.16 59.05 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.648 1.579 . . . . 0.0 114.605 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.58 -4.7 58.06 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.314 1.046 . . . . 0.0 112.942 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -112.01 126.59 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.51 -1.369 . . . . 0.0 110.89 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 72.6 mmtt -105.89 120.16 41.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.585 1.954 . . . . 0.0 110.004 172.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 73.8 mt -96.48 122.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -106.13 -35.08 7.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.117 0.967 . . . . 0.0 113.207 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -137.38 39.3 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.817 0.722 . . . . 0.0 111.593 -174.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.291 2.236 . . . . 0.0 113.46 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.3 p -75.72 161.55 28.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.367 1.067 . . . . 0.0 112.694 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.0 mm -93.44 124.49 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.207 1.003 . . . . 0.0 109.814 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -88.26 162.97 16.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.802 1.241 . . . . 0.0 112.619 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -151.81 143.48 23.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.491 1.116 . . . . 0.0 112.007 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.2 tp -116.86 -17.56 10.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.814 1.646 . . . . 0.0 113.378 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -158.22 138.77 12.76 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.897 1.679 . . . . 0.0 111.188 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 t -123.93 151.31 43.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.021 0.928 . . . . 0.0 110.797 170.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -163.05 166.43 23.63 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.27 1.428 . . . . 0.0 111.415 -173.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -101.64 113.32 65.86 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.894 0.878 . . . . 0.0 110.981 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.67 -35.37 3.54 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.594 2.196 . . . . 0.0 111.207 170.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -162.79 3.16 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.428 1.891 . . . . 0.0 113.564 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.54 147.39 37.76 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.505 1.122 . . . . 0.0 113.563 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -161.27 -171.8 3.15 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.13 2.172 . . . . 0.0 109.962 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.1 m -65.15 129.22 38.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.742 1.217 . . . . 0.0 110.912 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.74 164.92 16.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.805 1.669 . . . . 0.0 113.227 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.82 -22.92 39.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.435 1.094 . . . . 0.0 113.279 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.98 159.98 24.73 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.191 1.396 . . . . 0.0 113.132 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.67 147.22 50.89 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 t -148.08 153.8 39.37 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.039 1.336 . . . . 0.0 111.804 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.69 151.68 1.92 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.433 2.693 . . . . 0.0 110.028 -175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -166.74 154.95 10.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.951 0.901 . . . . 0.0 113.284 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -94.08 7.57 44.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.734 1.614 . . . . 0.0 112.84 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -54.86 147.64 14.77 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.018 1.327 . . . . 0.0 114.238 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.01 139.7 57.67 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.63 113.83 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.513 1.125 . . . . 0.0 108.282 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -96.21 116.96 29.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.066 0.946 . . . . 0.0 110.049 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.41 102.52 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -108.09 174.11 6.02 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.92 2.088 . . . . 0.0 110.855 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.0 mt -126.77 146.56 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.691 1.196 . . . . 0.0 108.217 169.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -93.53 167.74 11.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.519 1.128 . . . . 0.0 111.36 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -65.77 130.25 42.61 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.177 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -74.21 141.08 45.46 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -90.9 68.49 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.49 1.516 . . . . 0.0 109.284 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.6 -119.24 10.9 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -172.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -21.8 60.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 113.484 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -80.44 137.18 36.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.112 0.869 . . . . 0.0 112.381 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.8 m -129.14 150.36 50.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.191 2.196 . . . . 0.0 108.758 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.65 129.24 45.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.783 0.833 . . . . 0.0 111.129 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.4 m -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.529 1.932 . . . . 0.0 107.681 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.57 120.43 28.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 110.614 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.7 121.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.322 1.049 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -127.93 153.97 46.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.641 1.977 . . . . 0.0 110.02 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.98 -5.2 50.54 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 116.076 1.19 . . . . 0.0 116.076 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -49.36 129.86 17.71 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 0.0 111.001 172.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -52.01 137.45 53.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.944 3.096 . . . . 0.0 113.209 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.05 -8.67 55.01 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.25 -17.81 62.47 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.133 1.373 . . . . 0.0 113.0 169.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -94.13 129.76 40.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.081 1.353 . . . . 0.0 111.41 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.14 118.75 22.12 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.985 0.914 . . . . 0.0 111.936 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.1 mt -62.76 -38.48 90.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.23 0.612 . . . . 0.0 112.254 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.43 -36.08 81.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.862 0.865 . . . . 0.0 112.584 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -64.03 -39.27 93.72 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.061 -1.024 . . . . 0.0 111.764 169.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -63.24 -39.71 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.93 0.892 . . . . 0.0 110.068 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.45 -55.83 30.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 110.976 170.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.4 -48.82 73.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.931 0.893 . . . . 0.0 112.8 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.6 p -70.86 -36.73 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.06 -34.68 64.13 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.193 0.906 . . . . 0.0 111.98 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.58 -34.39 77.78 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.758 -1.214 . . . . 0.0 112.471 171.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.63 -60.44 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.32 1.048 . . . . 0.0 113.105 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.69 -39.16 18.88 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -93.89 -4.42 49.97 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.464 1.106 . . . . 0.0 112.638 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.39 28.85 18.32 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.161 1.785 . . . . 0.0 113.102 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.48 179.76 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.55 1.14 . . . . 0.0 112.74 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -133.27 140.92 47.74 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.356 1.462 . . . . 0.0 108.366 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.57 168.86 41.89 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 -169.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -159.41 165.05 34.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.568 1.547 . . . . 0.0 112.661 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.9 mt -99.4 135.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.681 1.192 . . . . 0.0 109.976 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.1 t -130.45 142.7 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.675 1.59 . . . . 0.0 109.052 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -111.49 103.36 11.7 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.647 0.779 . . . . 0.0 110.979 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -98.36 144.77 28.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.417 1.487 . . . . 0.0 112.287 -171.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.85 -32.81 95.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.495 2.796 . . . . 0.0 114.897 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -106.51 -44.98 4.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.019 1.328 . . . . 0.0 112.511 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.7 mtt -82.86 -14.58 54.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.83 -167.16 54.36 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.133 1.349 . . . . 0.0 113.077 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.32 114.27 5.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt -134.64 151.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.108 1.763 . . . . 0.0 112.726 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.29 131.92 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 166.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -99.5 139.11 35.63 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.318 1.447 . . . . 0.0 108.245 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.52 136.13 47.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.463 1.505 . . . . 0.0 108.419 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -72.56 138.95 47.21 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.102 -0.999 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.17 -174.95 39.2 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.985 1.755 . . . . 0.0 113.361 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.54 77.59 2.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.882 2.073 . . . . 0.0 110.828 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.65 15.52 27.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 113.652 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -58.6 -41.64 86.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.23 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.132 0.973 . . . . 0.0 112.279 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -66.03 -44.34 84.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.025 0.93 . . . . 0.0 111.75 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.6 t -69.49 -33.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.173 0.589 . . . . 0.0 111.092 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 111.085 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.04 -39.65 78.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.52 0.728 . . . . 0.0 112.626 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 57' ' ' VAL . 53.7 t80 -59.92 -49.78 76.36 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.425 1.011 . . . . 0.0 111.733 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.0 mmt -59.76 -39.69 85.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.166 0.986 . . . . 0.0 110.882 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.01 -52.7 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.611 0.765 . . . . 0.0 111.034 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -83.03 -31.18 27.55 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -103.58 -42.18 5.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.226 0.921 . . . . 0.0 112.938 -174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.1 mt -82.39 -20.35 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.155 0.889 . . . . 0.0 112.577 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.19 18.7 66.39 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.318 0.961 . . . . 0.0 113.592 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.5 mt -69.59 157.05 37.94 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.642 1.221 . . . . 0.0 110.464 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -87.74 146.34 25.71 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.45 -0.781 . . . . 0.0 109.299 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -55.13 -36.69 66.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.317 -0.864 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.91 -19.54 43.34 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.892 1.677 . . . . 0.0 115.035 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -79.29 -9.46 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.05 132.3 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 120.957 -1.089 . . . . 0.0 110.926 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -106.31 124.87 50.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.548 1.539 . . . . 0.0 109.544 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.8 mt -100.95 124.13 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.199 1.0 . . . . 0.0 108.415 174.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.38 171.33 8.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.954 1.302 . . . . 0.0 112.15 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.46 -144.65 14.71 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.114 1.34 . . . . 0.0 112.435 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.1 p90 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.841 2.056 . . . . 0.0 113.313 175.739 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -137.92 154.63 49.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.011 1.324 . . . . 0.0 111.31 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 tt -158.81 149.77 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.589 1.555 . . . . 0.0 110.48 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -133.17 161.59 34.02 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.547 1.539 . . . . 0.0 111.291 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -156.48 154.63 30.69 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.779 1.632 . . . . 0.0 111.281 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -147.47 169.75 18.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.208 1.403 . . . . 0.0 112.478 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.88 97.9 5.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.049 0.94 . . . . 0.0 111.131 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 p -85.54 -16.2 40.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.699 1.2 . . . . 0.0 113.772 176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -90.74 153.34 20.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.892 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -143.12 146.98 39.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.103 1.761 . . . . 0.0 110.101 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.92 -28.36 5.11 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.193 2.595 . . . . 0.0 112.842 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -178.81 167.88 1.68 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.724 2.81 . . . . 0.0 109.293 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.6 146.79 27.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 111.157 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.69 -27.24 37.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.199 1.0 . . . . 0.0 113.068 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 p -86.71 150.48 24.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.827 1.651 . . . . 0.0 112.32 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.23 -161.08 37.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.998 1.285 . . . . 0.0 112.802 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.01 137.18 54.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.08 0.952 . . . . 0.0 111.901 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -80.49 135.38 36.11 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.036 . . . . 0.0 112.103 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -144.18 150.24 37.71 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.066 1.347 . . . . 0.0 111.197 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -148.0 12.75 0.98 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.089 1.356 . . . . 0.0 113.394 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.01 8.65 5.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.078 2.151 . . . . 0.0 115.55 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 152.5 41.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 112.147 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 p -79.1 -6.91 57.59 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.031 1.332 . . . . 0.0 113.358 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -74.94 -5.66 45.03 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE1' ' HE2' ' A' ' 104' ' ' LYS . 50.8 m-85 -72.88 134.63 44.9 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.067 -1.021 . . . . 0.0 112.554 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.9 mt -99.69 132.77 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.16 1.784 . . . . 0.0 107.425 170.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -118.67 120.18 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.222 1.009 . . . . 0.0 110.389 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.83 104.48 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -109.79 169.79 8.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.87 1.668 . . . . 0.0 110.568 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mt -126.11 140.4 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -74.84 156.77 36.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.892 0.877 . . . . 0.0 111.62 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -72.66 130.43 40.54 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.624 -0.673 . . . . 0.0 112.019 -169.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -80.05 100.8 8.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.33 1.052 . . . . 0.0 110.664 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -119.32 13.58 12.78 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.736 2.014 . . . . 0.0 113.212 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.21 53.13 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.506 1.527 . . . . 0.0 114.2 -172.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -107.96 171.6 7.31 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.016 1.727 . . . . 0.0 111.538 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -55.9 140.91 41.21 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.981 1.712 . . . . 0.0 113.857 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.4 m -70.71 124.55 24.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.463 1.105 . . . . 0.0 109.342 169.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.0 mt -129.58 136.35 49.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.48 1.512 . . . . 0.0 110.17 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.0 m -89.18 138.93 30.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.595 1.558 . . . . 0.0 107.618 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -127.46 120.99 29.61 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.845 1.258 . . . . 0.0 110.335 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.84 126.52 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.671 1.188 . . . . 0.0 109.519 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.09 151.51 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.457 1.903 . . . . 0.0 109.751 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.91 -1.45 79.07 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.08 133.3 59.4 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.654 1.227 . . . . 0.0 111.101 173.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.52 144.19 64.08 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.039 3.159 . . . . 0.0 113.452 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.37 -16.66 63.57 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.053 0.941 . . . . 0.0 113.329 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.67 -17.8 63.52 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 113.481 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -93.23 122.12 35.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.666 1.187 . . . . 0.0 111.313 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -73.1 117.39 14.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.853 0.861 . . . . 0.0 111.331 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.2 mt -60.23 -36.5 77.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.598 0.759 . . . . 0.0 111.819 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -62.88 -38.46 90.97 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.325 1.05 . . . . 0.0 112.027 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -65.38 -37.43 86.98 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.431 -0.793 . . . . 0.0 111.697 171.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.28 -41.05 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.493 0.717 . . . . 0.0 110.124 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.87 -53.24 60.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.262 0.937 . . . . 0.0 111.013 170.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -56.87 -50.06 73.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.554 0.742 . . . . 0.0 112.873 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.1 p -68.82 -37.43 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.5 mt -72.97 -38.33 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.569 0.622 . . . . 0.0 111.712 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.23 -31.87 72.96 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.244 -1.535 . . . . 0.0 112.329 173.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -73.99 -65.43 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.142 1.377 . . . . 0.0 112.933 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -91.69 -29.32 16.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -167.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -93.98 -7.75 41.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.842 0.857 . . . . 0.0 112.488 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.38 26.05 15.59 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.402 1.881 . . . . 0.0 113.236 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -82.58 -169.24 2.36 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.558 1.143 . . . . 0.0 112.631 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -141.18 151.78 44.11 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.045 1.338 . . . . 0.0 109.339 167.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.61 172.32 44.09 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -158.01 162.03 38.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.717 1.607 . . . . 0.0 111.904 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.48 129.56 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.111 1.364 . . . . 0.0 108.329 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.4 t -138.53 140.96 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.601 1.16 . . . . 0.0 109.516 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -101.93 111.64 23.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.671 0.788 . . . . 0.0 111.061 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.42 144.53 34.0 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.428 1.491 . . . . 0.0 111.234 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.11 -31.01 92.19 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.423 2.749 . . . . 0.0 114.775 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -111.64 -47.1 3.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.641 1.176 . . . . 0.0 112.348 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.6 mtt -78.04 -16.34 58.14 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.3 -160.71 48.05 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.599 1.095 . . . . 0.0 112.871 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -71.65 118.53 14.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.02 0.928 . . . . 0.0 111.015 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.51 152.22 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.304 1.841 . . . . 0.0 111.813 -170.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.7 mt -90.97 127.97 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -94.43 130.64 40.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.229 1.412 . . . . 0.0 107.713 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -119.09 136.21 54.26 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.655 1.582 . . . . 0.0 107.89 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -76.92 128.17 34.06 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.308 -0.87 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.56 -170.23 28.08 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.237 1.399 . . . . 0.0 113.363 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -97.76 83.95 3.28 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.68 1.992 . . . . 0.0 111.335 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -110.08 15.13 22.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.235 1.414 . . . . 0.0 113.223 -169.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -59.18 -46.28 88.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -169.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.62 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.854 0.861 . . . . 0.0 111.912 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.25 -45.9 89.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.296 1.039 . . . . 0.0 111.913 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.52 -36.12 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.236 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.95 -47.36 80.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.521 1.055 . . . . 0.0 110.916 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.08 -39.14 91.44 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.456 0.702 . . . . 0.0 112.641 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 24.5 t80 -59.66 -49.13 78.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.65 1.114 . . . . 0.0 111.602 175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.5 mmt -59.06 -44.34 91.83 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.625 1.17 . . . . 0.0 110.522 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.0 mt -72.18 -44.14 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.635 0.774 . . . . 0.0 111.68 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.2 t -75.3 -48.05 25.0 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -100.96 -37.09 8.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.0 mt -90.83 -13.39 33.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.723 0.692 . . . . 0.0 112.84 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.57 15.54 81.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.726 1.155 . . . . 0.0 113.687 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.1 mt -69.2 145.01 53.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.239 1.019 . . . . 0.0 110.626 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -82.16 134.66 35.32 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.714 -0.617 . . . . 0.0 110.388 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -51.97 -44.43 63.99 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.75 0.82 . . . . 0.0 112.392 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -22.2 63.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -81.73 -10.96 59.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 112.982 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -106.73 124.55 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.644 1.111 . . . . 0.0 110.617 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HE2' ' CE1' ' A' ' 25' ' ' TYR . 68.6 mmtt -101.26 135.11 43.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.806 1.642 . . . . 0.0 110.457 171.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.49 128.14 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 108.845 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -126.07 -159.24 0.9 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 111.296 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 -152.15 18.73 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.989 1.28 . . . . 0.0 113.079 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -174.384 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 N--CA 1.504 2.231 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -83.84 -9.83 58.47 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.6 pt -71.58 156.56 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.785 1.234 . . . . 0.0 113.168 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.06 157.23 31.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.97 1.308 . . . . 0.0 112.414 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.34 30.04 0.69 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.794 1.237 . . . . 0.0 112.412 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.74 118.56 10.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.312 1.445 . . . . 0.0 110.14 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -72.52 125.49 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.381 1.072 . . . . 0.0 112.497 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -84.06 147.34 27.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.892 0.877 . . . . 0.0 111.116 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.55 158.86 35.1 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.787 1.235 . . . . 0.0 112.078 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -158.31 143.6 12.1 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.326 1.85 . . . . 0.0 110.132 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.41 -47.31 26.54 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.608 2.872 . . . . 0.0 114.95 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -176.78 142.25 0.4 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.546 1.939 . . . . 0.0 111.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.83 27.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.186 1.394 . . . . 0.0 111.538 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.11 154.94 20.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.952 1.301 . . . . 0.0 112.974 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.2 m -136.23 135.9 39.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.81 1.644 . . . . 0.0 109.451 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 122.83 6.39 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.308 0.956 . . . . 0.0 111.466 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -165.73 159.48 16.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.398 1.879 . . . . 0.0 110.918 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.57 162.79 35.43 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.531 1.532 . . . . 0.0 112.605 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -155.15 150.76 27.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.063 1.345 . . . . 0.0 111.162 -173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 t -162.66 159.36 24.35 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.593 1.557 . . . . 0.0 111.427 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.68 64.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.62 1.168 . . . . 0.0 113.892 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -106.97 -100.24 0.35 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.38 1.472 . . . . 0.0 111.176 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 m -87.47 107.93 18.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 112.828 -169.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -154.76 160.69 41.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.559 1.543 . . . . 0.0 110.588 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -70.68 139.23 51.19 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.522 -0.736 . . . . 0.0 110.589 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mt -84.52 111.8 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -96.53 118.82 33.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.62 0.768 . . . . 0.0 110.32 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.8 mt -108.53 109.39 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -121.26 174.43 6.71 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.777 1.631 . . . . 0.0 111.184 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.7 mt -109.78 139.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -85.4 152.82 22.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.855 0.862 . . . . 0.0 111.042 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.49 150.06 49.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.774 1.229 . . . . 0.0 113.009 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -72.45 125.5 27.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.458 0.703 . . . . 0.0 110.931 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -168.27 -44.29 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.085 1.754 . . . . 0.0 111.514 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.79 173.83 55.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.664 1.126 . . . . 0.0 112.896 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -70.04 -22.21 63.11 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -132.67 158.32 42.61 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.898 1.679 . . . . 0.0 112.13 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 m -68.53 146.18 53.34 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.708 1.603 . . . . 0.0 110.088 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.48 134.48 47.82 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.396 1.078 . . . . 0.0 111.252 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.0 m -91.41 125.05 36.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.339 1.855 . . . . 0.0 108.441 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -106.69 128.9 54.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.539 1.536 . . . . 0.0 110.827 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.0 124.09 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.851 1.26 . . . . 0.0 109.734 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -127.67 155.21 44.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.452 1.901 . . . . 0.0 109.501 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 1.25 90.61 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 168.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -61.13 131.45 92.04 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 118.678 1.239 . . . . 0.0 110.661 172.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -53.49 142.36 59.44 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 124.124 3.216 . . . . 0.0 113.267 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.28 -17.25 62.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.164 0.985 . . . . 0.0 113.096 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -66.03 -18.64 65.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.876 0.87 . . . . 0.0 113.159 172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.99 116.86 29.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.856 1.262 . . . . 0.0 110.79 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -69.79 120.78 16.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.074 0.95 . . . . 0.0 111.588 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.91 -39.27 88.74 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.208 1.003 . . . . 0.0 111.974 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.0 -31.38 71.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.926 0.891 . . . . 0.0 112.538 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -40.7 79.32 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.362 -0.836 . . . . 0.0 111.836 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.07 -47.65 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.654 0.782 . . . . 0.0 109.057 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.3 mt -55.65 -48.58 74.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.718 0.69 . . . . 0.0 111.674 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.58 -43.29 97.42 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.445 -0.785 . . . . 0.0 112.452 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.15 -46.61 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.118 0.872 . . . . 0.0 111.16 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.06 -27.65 64.81 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -76.81 -35.86 57.3 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.659 -1.276 . . . . 0.0 113.254 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -77.91 -62.32 1.71 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.95 -32.03 20.33 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.221 1.409 . . . . 0.0 113.988 -166.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -97.7 -8.88 27.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.13 0.972 . . . . 0.0 113.162 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.62 28.25 16.89 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.831 1.652 . . . . 0.0 113.444 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 92.9 m -87.32 -169.85 2.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.921 1.289 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -148.58 149.87 32.31 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.913 0.885 . . . . 0.0 110.082 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.14 177.38 47.15 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -161.7 161.41 29.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.912 1.685 . . . . 0.0 111.942 -170.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.13 141.37 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.688 1.195 . . . . 0.0 109.226 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.79 138.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.971 1.308 . . . . 0.0 109.411 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -100.14 97.97 8.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 109.579 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.49 146.3 50.02 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.42 1.488 . . . . 0.0 112.002 -172.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.97 -32.84 87.35 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.793 2.995 . . . . 0.0 115.33 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -121.64 -36.68 3.0 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 mtt -77.52 -18.54 56.91 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.24 -157.76 50.13 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.264 0.935 . . . . 0.0 112.433 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.19 115.68 11.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.615 0.766 . . . . 0.0 111.004 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 pt -137.04 151.75 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.479 1.911 . . . . 0.0 112.173 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.27 136.52 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -105.38 135.04 47.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.186 1.795 . . . . 0.0 108.212 168.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.93 140.62 52.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.749 1.62 . . . . 0.0 108.946 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -72.64 138.51 46.77 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.281 -0.887 . . . . 0.0 111.991 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.72 -169.69 43.1 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.558 1.551 . . . . 0.0 112.895 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.47 97.75 7.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.053 1.341 . . . . 0.0 109.998 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -115.07 27.45 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.885 1.274 . . . . 0.0 113.702 -167.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 47.8 mtm-85 -51.94 -59.02 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.537 1.535 . . . . 0.0 112.639 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.46 -38.91 91.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.786 1.235 . . . . 0.0 112.195 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.72 -48.41 79.36 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 111.731 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.21 -34.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.828 -0.545 . . . . 0.0 111.344 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.95 -50.03 73.88 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.212 0.915 . . . . 0.0 111.182 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -59.79 -38.2 81.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.094 0.958 . . . . 0.0 112.647 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.68 -48.12 83.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.67 1.123 . . . . 0.0 111.791 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.5 mmt -61.86 -41.73 98.2 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.888 0.875 . . . . 0.0 110.591 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.25 -48.18 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.049 0.94 . . . . 0.0 111.535 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -80.95 -48.34 12.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -98.51 -34.06 10.76 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -85.75 -15.61 41.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.897 0.771 . . . . 0.0 112.035 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.37 79.64 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.017 1.294 . . . . 0.0 113.777 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.48 151.71 42.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.562 1.181 . . . . 0.0 112.141 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -74.15 141.31 45.57 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.022 0.529 . . . . 0.0 109.929 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -57.36 -36.66 71.48 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -58.25 -21.1 47.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.961 . . . . 0.0 114.87 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -76.15 -9.76 58.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.105 0.962 . . . . 0.0 113.127 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.9 133.78 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.384 1.074 . . . . 0.0 110.692 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -110.65 133.84 52.96 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.148 1.779 . . . . 0.0 110.188 169.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 74.6 mt -108.94 128.99 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.141 0.976 . . . . 0.0 109.346 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -126.74 161.37 28.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.647 1.579 . . . . 0.0 111.673 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.99 -143.19 7.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.406 1.003 . . . . 0.0 111.959 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 124.86 1.264 . . . . 0.0 112.886 169.828 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mtp . . . . . 0 N--CA 1.505 2.283 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -67.5 151.42 47.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 112.904 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 tp -160.06 151.56 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.501 1.52 . . . . 0.0 110.579 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -160.64 154.78 23.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.616 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -155.28 155.55 33.97 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.079 1.351 . . . . 0.0 111.639 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.31 135.23 53.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.256 1.422 . . . . 0.0 111.729 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -159.12 156.51 29.22 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.585 1.554 . . . . 0.0 112.394 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 t -167.82 152.14 6.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.205 1.802 . . . . 0.0 110.036 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -143.28 139.99 30.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.683 1.193 . . . . 0.0 111.53 -171.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.08 146.15 47.87 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.963 1.305 . . . . 0.0 112.302 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -61.73 -37.96 64.15 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.392 2.728 . . . . 0.0 112.813 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -177.24 152.28 0.86 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.218 2.607 . . . . 0.0 109.913 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.65 53.53 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.196 0.998 . . . . 0.0 113.54 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -163.02 155.15 18.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.707 2.003 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -88.32 132.22 34.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.134 0.973 . . . . 0.0 109.943 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.8 7.64 76.23 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.825 1.202 . . . . 0.0 115.531 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -160.34 157.66 28.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.092 1.757 . . . . 0.0 111.527 -175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -144.45 6.49 1.28 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.322 1.849 . . . . 0.0 113.694 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.27 131.54 46.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.952 0.901 . . . . 0.0 111.78 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.8 p -84.76 131.81 34.51 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.375 1.47 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.26 144.32 28.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.097 0.959 . . . . 0.0 111.486 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -60.76 -42.74 98.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.099 1.36 . . . . 0.0 112.296 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -69.22 -16.3 63.57 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.61 1.164 . . . . 0.0 114.086 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -88.94 -15.71 33.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.263 1.025 . . . . 0.0 113.297 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -72.17 138.06 47.37 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.077 -1.014 . . . . 0.0 113.219 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.13 126.65 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.846 1.258 . . . . 0.0 107.943 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -107.45 115.08 29.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.559 1.144 . . . . 0.0 109.344 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.28 108.5 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -116.97 173.57 6.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.524 1.929 . . . . 0.0 110.865 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.0 141.64 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -84.17 162.3 20.27 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.455 0.645 . . . . 0.0 111.719 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -80.46 103.82 10.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -132.32 143.44 49.88 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.273 1.429 . . . . 0.0 111.317 -170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -85.22 130.96 34.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.285 1.034 . . . . 0.0 111.095 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.78 -147.18 50.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.86 0.743 . . . . 0.0 112.56 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.86 12.79 6.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.61 1.164 . . . . 0.0 113.715 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -73.47 32.12 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.097 -1.627 . . . . 0.0 113.133 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 m -68.34 142.94 55.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.988 2.915 . . . . 0.0 111.554 -168.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.97 128.86 39.31 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.762 1.225 . . . . 0.0 110.302 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 m -89.43 132.37 35.03 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.878 1.671 . . . . 0.0 107.828 169.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -117.43 126.77 53.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 110.925 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.48 123.57 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.544 1.138 . . . . 0.0 108.943 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -129.9 149.51 51.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.287 1.835 . . . . 0.0 109.388 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.77 4.85 89.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.58 131.71 64.01 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 118.567 1.184 . . . . 0.0 111.319 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.25 143.19 53.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.383 3.389 . . . . 0.0 113.615 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -67.49 -18.94 65.25 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 113.37 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.5 -16.91 62.95 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -96.23 124.27 40.17 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.718 1.207 . . . . 0.0 111.799 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.11 121.55 23.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.166 0.986 . . . . 0.0 111.852 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -65.24 -39.25 92.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.534 0.733 . . . . 0.0 112.395 -174.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -62.86 -34.71 77.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.285 -0.884 . . . . 0.0 112.172 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 tpt85 -64.95 -37.55 88.04 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.15 0.886 . . . . 0.0 111.929 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.9 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.373 1.069 . . . . 0.0 110.164 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.94 -52.78 64.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.199 0.909 . . . . 0.0 110.914 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -54.89 -50.52 68.54 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.533 0.733 . . . . 0.0 112.638 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 p -70.11 -36.1 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -34.9 65.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.651 0.66 . . . . 0.0 112.145 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.45 -33.28 73.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.756 -1.215 . . . . 0.0 112.425 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -74.87 -66.23 0.78 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.122 1.369 . . . . 0.0 113.153 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -91.2 -29.82 17.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -167.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.33 -4.93 47.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.878 0.871 . . . . 0.0 112.561 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.34 28.1 16.26 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.193 1.797 . . . . 0.0 113.246 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.1 m -83.06 177.8 8.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.491 1.116 . . . . 0.0 112.771 -173.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -126.21 141.7 51.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.462 1.505 . . . . 0.0 107.93 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.26 166.96 39.57 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.84 158.34 40.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.236 1.815 . . . . 0.0 111.821 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.7 mt -93.69 136.24 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.741 1.216 . . . . 0.0 108.991 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.36 142.25 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.972 1.309 . . . . 0.0 109.448 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.61 101.36 10.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.049 0.939 . . . . 0.0 109.844 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.52 144.96 32.82 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.154 1.382 . . . . 0.0 111.742 -172.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.43 -31.17 93.53 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.481 2.788 . . . . 0.0 114.744 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -111.15 -47.25 3.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.709 1.204 . . . . 0.0 112.4 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.4 mtt -77.76 -17.63 57.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.43 -161.02 49.87 Favored Glycine 0 N--CA 1.469 0.898 0 C-N-CA 124.599 1.095 . . . . 0.0 112.66 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -72.02 120.45 17.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.787 0.835 . . . . 0.0 111.023 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 pt -144.14 153.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.172 1.789 . . . . 0.0 112.557 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.0 mt -99.73 132.08 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 165.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -99.34 139.41 35.03 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.569 1.548 . . . . 0.0 108.682 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tp -129.02 138.44 51.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.783 1.633 . . . . 0.0 108.229 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -72.38 139.69 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.126 -0.984 . . . . 0.0 111.477 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.19 -172.39 43.42 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.419 1.485 . . . . 0.0 113.379 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -98.88 85.67 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.754 2.021 . . . . 0.0 110.954 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -109.45 16.21 22.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.596 1.559 . . . . 0.0 113.258 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -58.34 -42.96 88.03 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.85 -39.31 66.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 112.089 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -63.81 -45.22 90.59 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.025 0.93 . . . . 0.0 111.826 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.44 -35.46 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.162 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.7 t -56.75 -48.81 76.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.494 1.043 . . . . 0.0 111.164 170.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.93 -40.15 83.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.784 0.834 . . . . 0.0 112.678 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 31.7 t80 -59.75 -49.94 75.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.767 1.167 . . . . 0.0 111.869 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.0 mmt -59.67 -37.82 79.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 110.903 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.52 -45.05 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.998 0.919 . . . . 0.0 111.084 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -85.42 -22.14 28.47 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.12 -38.0 2.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.386 0.993 . . . . 0.0 113.601 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 31.7 mt -82.74 -14.94 53.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.505 1.048 . . . . 0.0 112.48 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.81 14.95 80.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.841 1.21 . . . . 0.0 113.609 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.54 159.51 34.19 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.543 1.171 . . . . 0.0 111.514 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.13 151.29 22.82 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.378 0.671 . . . . 0.0 110.05 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -55.91 -38.92 70.88 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.255 -0.903 . . . . 0.0 111.657 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.19 -0.11 3.14 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.05 -1.86 56.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.967 1.258 . . . . 0.0 113.033 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt -128.06 132.44 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 120.738 -1.226 . . . . 0.0 111.597 -169.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -103.69 126.98 51.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.572 1.549 . . . . 0.0 109.829 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.87 122.73 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.78 172.24 7.16 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.242 1.417 . . . . 0.0 111.956 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.9 -154.38 27.77 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 124.819 1.199 . . . . 0.0 113.294 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.848 1.659 . . . . 0.0 112.888 169.716 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 tpp . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -75.04 35.33 0.11 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.419 1.887 . . . . 0.0 115.038 -171.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.25 159.7 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.272 1.429 . . . . 0.0 112.241 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -132.31 144.75 50.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.609 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -75.08 -21.02 59.22 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.946 0.899 . . . . 0.0 113.401 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.91 63.98 7.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.867 1.667 . . . . 0.0 110.381 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.9 -39.37 87.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.455 1.102 . . . . 0.0 113.37 -174.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.8 p -173.81 164.37 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.791 1.636 . . . . 0.0 112.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.45 162.79 34.86 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.108 1.763 . . . . 0.0 110.97 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -132.78 142.52 45.07 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.283 1.433 . . . . 0.0 111.085 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.62 -23.27 5.99 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.46 2.773 . . . . 0.0 113.261 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -176.47 157.23 1.64 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.629 2.372 . . . . 0.0 109.898 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.87 153.76 39.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.903 1.281 . . . . 0.0 112.621 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -72.92 142.63 47.87 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.571 1.148 . . . . 0.0 112.291 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.9 p -138.31 165.49 26.6 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.693 1.597 . . . . 0.0 111.865 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.52 141.6 5.88 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.822 1.677 . . . . 0.0 112.922 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -168.06 164.88 13.63 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.073 2.149 . . . . 0.0 110.528 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -153.48 139.61 18.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 112.622 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -170.51 169.94 7.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.468 2.307 . . . . 0.0 110.579 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.8 p -80.98 -71.69 0.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.94 1.296 . . . . 0.0 110.125 170.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.04 162.7 4.63 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.76 2.424 . . . . 0.0 111.303 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -164.38 161.85 21.86 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.223 1.809 . . . . 0.0 111.026 173.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -70.2 142.85 52.39 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.089 0.956 . . . . 0.0 112.118 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.52 159.84 25.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 112.91 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -136.77 163.5 30.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.755 1.622 . . . . 0.0 112.618 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mp -83.49 127.48 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.1 127.62 55.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.999 0.919 . . . . 0.0 110.883 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.492 HG21 ' HA ' ' A' ' 85' ' ' ARG . 29.4 mt -117.71 99.61 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -103.53 174.61 5.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.715 2.406 . . . . 0.0 110.214 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.3 mt -127.74 137.85 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.058 0.943 . . . . 0.0 108.771 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -95.88 126.87 41.44 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.63 1.172 . . . . 0.0 108.697 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -80.68 138.61 36.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.917 1.287 . . . . 0.0 108.961 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -155.46 144.88 21.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.486 0.715 . . . . 0.0 112.255 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -59.24 150.65 25.12 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.828 1.251 . . . . 0.0 112.582 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.28 13.55 79.65 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.471 1.034 . . . . 0.0 114.45 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 65.06 27.31 12.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.324 1.85 . . . . 0.0 112.457 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -79.06 62.3 3.44 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.455 1.502 . . . . 0.0 111.485 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -65.7 137.17 57.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.124 1.77 . . . . 0.0 110.915 -171.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.6 mt -130.64 126.52 36.83 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.174 . . . . 0.0 110.202 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 45.2 m -82.69 116.14 21.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.952 1.301 . . . . 0.0 107.919 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 113.31 24.96 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.502 1.521 . . . . 0.0 110.004 -177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.02 129.33 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.668 1.187 . . . . 0.0 108.479 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -144.75 161.45 39.2 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.992 1.717 . . . . 0.0 110.152 -167.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.62 -14.2 4.53 Favored Glycine 0 N--CA 1.475 1.251 0 O-C-N 120.463 -1.398 . . . . 0.0 116.541 168.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 p -47.99 130.93 12.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.224 1.41 . . . . 0.0 111.55 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -53.5 140.81 63.9 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.954 3.103 . . . . 0.0 113.112 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.76 -10.58 59.78 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.86 -19.57 63.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.85 0.86 . . . . 0.0 112.742 170.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.71 114.13 26.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.048 1.339 . . . . 0.0 110.394 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -66.99 123.15 19.39 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.32 -38.63 80.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.372 0.669 . . . . 0.0 111.553 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.58 -32.9 74.51 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.118 0.967 . . . . 0.0 112.567 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -69.5 -38.4 77.61 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.277 -0.889 . . . . 0.0 111.517 171.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.2 mt -57.95 -47.05 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.041 0.837 . . . . 0.0 108.964 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.18 -48.73 73.37 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.005 0.82 . . . . 0.0 111.743 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -61.57 -43.67 98.44 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.665 -0.647 . . . . 0.0 112.301 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.23 -46.86 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.651 0.659 . . . . 0.0 111.137 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.63 -32.16 70.69 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.92 -34.36 64.33 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.674 -1.266 . . . . 0.0 113.208 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.83 -48.46 9.34 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.38 -41.36 12.88 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.704 0.802 . . . . 0.0 113.135 -171.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -94.38 -12.53 27.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.336 1.054 . . . . 0.0 113.023 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.82 31.17 16.56 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.146 1.778 . . . . 0.0 112.858 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 95.0 m -80.96 -177.67 6.52 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.476 1.11 . . . . 0.0 111.636 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -138.25 145.92 41.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.374 1.07 . . . . 0.0 109.332 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -174.63 172.09 45.13 Favored Glycine 0 N--CA 1.467 0.709 0 N-CA-C 116.158 1.223 . . . . 0.0 116.158 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.91 161.87 38.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.538 1.535 . . . . 0.0 112.583 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.0 mt -97.73 134.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.928 1.291 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.35 140.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.285 1.434 . . . . 0.0 109.773 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -95.54 103.97 15.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.27 143.8 39.84 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.942 1.297 . . . . 0.0 111.681 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.27 -31.38 93.52 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.541 2.827 . . . . 0.0 114.859 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -110.57 -47.13 3.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.583 1.153 . . . . 0.0 112.304 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 61.4 mtt -78.92 -18.88 53.09 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.88 -157.62 45.55 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.372 0.987 . . . . 0.0 112.476 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -69.83 117.79 11.86 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.814 -0.815 . . . . 0.0 111.322 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -140.62 152.93 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.26 1.824 . . . . 0.0 112.141 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.91 133.47 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.17 123.2 45.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tp -108.97 136.36 48.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.174 1.39 . . . . 0.0 108.209 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.48 134.99 48.27 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.208 -0.933 . . . . 0.0 111.673 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.39 -168.95 40.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.378 1.466 . . . . 0.0 113.436 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -98.55 99.74 10.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.811 1.644 . . . . 0.0 109.899 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -122.0 20.72 10.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.863 1.265 . . . . 0.0 113.226 -170.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.5 ptt180 -62.16 -44.28 96.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -169.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.07 -39.62 90.23 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.458 0.703 . . . . 0.0 111.772 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -64.76 -46.15 83.41 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.141 0.977 . . . . 0.0 111.988 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.47 -36.37 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.857 -0.527 . . . . 0.0 111.352 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.02 -48.24 82.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.313 0.96 . . . . 0.0 111.199 171.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.38 -37.72 78.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.817 0.847 . . . . 0.0 112.671 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.57 -48.72 79.69 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 111.693 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 14.7 mmt -59.99 -42.99 95.42 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.205 1.002 . . . . 0.0 110.578 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.75 -48.62 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.081 0.952 . . . . 0.0 111.608 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -79.17 -47.84 15.31 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -98.97 -35.82 9.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.21 -17.58 25.82 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.632 0.651 . . . . 0.0 112.728 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.84 17.29 80.0 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.372 0.987 . . . . 0.0 113.623 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -70.0 145.86 51.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.31 1.055 . . . . 0.0 110.785 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -74.29 143.85 44.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.725 0.774 . . . . 0.0 111.664 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -62.31 -42.07 99.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.509 0.724 . . . . 0.0 112.166 -168.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -70.04 -21.48 63.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.975 1.31 . . . . 0.0 113.999 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -82.3 -4.12 56.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.665 1.186 . . . . 0.0 112.326 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.1 mt -107.32 136.12 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.669 1.588 . . . . 0.0 108.838 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.12 116.73 25.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.729 1.612 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.97 124.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -111.28 -30.07 7.58 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.66 -155.41 49.79 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.328 0.966 . . . . 0.0 113.883 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.026 1.731 . . . . 0.0 114.59 179.176 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -71.96 -5.47 35.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 pp -70.5 -3.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -153.75 139.45 17.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.51 1.524 . . . . 0.0 110.488 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.52 155.64 22.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.644 1.578 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.28 148.42 39.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.715 1.206 . . . . 0.0 110.961 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -139.13 165.77 26.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.664 1.586 . . . . 0.0 111.819 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.1 p -161.16 162.82 31.49 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.178 1.391 . . . . 0.0 111.944 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -85.63 157.03 20.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.585 1.154 . . . . 0.0 112.526 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.33 148.35 90.88 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 124.287 1.035 . . . . 0.0 112.07 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.06 -37.48 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.067 2.511 . . . . 0.0 112.142 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -159.6 152.29 21.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.457 2.303 . . . . 0.0 109.256 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.67 148.29 35.55 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.861 1.664 . . . . 0.0 111.405 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -88.14 169.37 11.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.321 1.448 . . . . 0.0 113.64 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 t -160.45 158.6 29.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.421 1.889 . . . . 0.0 110.509 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.92 -160.07 33.26 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.142 1.353 . . . . 0.0 113.452 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.49 167.94 20.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.236 1.415 . . . . 0.0 113.328 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -151.84 157.14 41.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.701 1.601 . . . . 0.0 111.524 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -29.21 69.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.457 1.103 . . . . 0.0 113.544 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.4 m 78.24 147.48 0.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.399 2.68 . . . . 0.0 111.83 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.48 152.91 43.18 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.584 1.554 . . . . 0.0 111.331 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -83.51 -63.25 1.39 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.427 1.491 . . . . 0.0 111.692 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -175.27 170.66 3.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.713 1.605 . . . . 0.0 112.923 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -159.6 -47.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.544 1.937 . . . . 0.0 109.497 169.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -147.79 148.03 30.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.715 2.406 . . . . 0.0 109.03 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.1 mt -83.27 108.74 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.21 121.47 35.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.785 0.834 . . . . 0.0 110.098 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 85' ' ' ARG . 45.8 mt -113.71 104.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -111.89 166.0 11.59 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.267 1.827 . . . . 0.0 109.363 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -122.03 143.36 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.799 -1.188 . . . . 0.0 109.833 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -93.07 133.51 36.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.775 1.23 . . . . 0.0 108.864 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -73.86 143.78 45.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.826 0.85 . . . . 0.0 109.847 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -67.48 145.98 54.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.537 1.16 . . . . 0.0 114.126 -169.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -149.15 -41.58 0.15 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.331 2.252 . . . . 0.0 109.609 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.98 -172.87 48.59 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.393 1.473 . . . . 0.0 112.266 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -72.97 -13.03 61.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -171.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.16 157.73 45.46 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.018 1.327 . . . . 0.0 113.316 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.5 m -75.98 149.34 37.63 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.113 1.765 . . . . 0.0 108.974 169.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.2 127.36 44.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.435 0.694 . . . . 0.0 111.323 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.8 m -89.84 121.73 32.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.131 1.772 . . . . 0.0 107.999 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 p -106.64 121.42 44.3 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.451 1.5 . . . . 0.0 110.347 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.45 129.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.884 1.273 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -137.35 152.51 49.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.554 1.941 . . . . 0.0 109.878 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.34 2.31 78.83 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 169.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.12 132.76 68.61 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.234 1.413 . . . . 0.0 111.575 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.08 140.04 41.23 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.445 3.43 . . . . 0.0 113.664 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.48 -22.59 67.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.308 1.043 . . . . 0.0 113.564 -172.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.49 -19.08 65.7 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.21 103.95 15.88 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.042 1.337 . . . . 0.0 110.557 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.5 126.76 28.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.615 1.166 . . . . 0.0 112.2 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.0 mt -61.97 -40.04 94.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.24 0.616 . . . . 0.0 111.953 -175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.82 -36.37 83.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.809 0.844 . . . . 0.0 112.217 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -63.83 -38.9 92.8 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.044 -1.035 . . . . 0.0 111.936 169.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.88 -42.33 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.884 0.874 . . . . 0.0 109.931 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mt -58.12 -52.92 63.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.107 0.867 . . . . 0.0 111.025 171.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.56 -50.71 71.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.822 0.849 . . . . 0.0 112.975 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.66 -39.26 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.56 -37.43 71.08 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.727 0.694 . . . . 0.0 111.996 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -66.94 -29.67 69.6 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.101 -1.624 . . . . 0.0 112.729 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.19 -63.22 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.152 0.981 . . . . 0.0 113.094 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.06 -33.94 29.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.32 -8.31 36.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.035 0.934 . . . . 0.0 112.8 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 60.41 26.82 16.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.219 1.807 . . . . 0.0 113.275 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.2 p -81.9 -169.93 2.6 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 112.851 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -139.48 149.22 43.71 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.931 1.292 . . . . 0.0 109.382 168.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -178.98 173.25 45.49 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -163.91 164.11 23.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.358 1.863 . . . . 0.0 111.717 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -100.06 140.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.554 1.141 . . . . 0.0 109.563 175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -138.68 144.19 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.259 1.423 . . . . 0.0 109.626 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -102.98 103.36 13.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.806 0.842 . . . . 0.0 110.065 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.85 143.34 43.19 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.22 1.408 . . . . 0.0 111.687 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.49 -31.32 91.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.634 2.889 . . . . 0.0 114.78 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -109.63 -48.05 3.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.667 1.187 . . . . 0.0 112.301 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -80.5 -14.86 57.9 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.9 -159.09 49.13 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.288 0.946 . . . . 0.0 112.713 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.68 118.69 14.82 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.628 0.771 . . . . 0.0 111.245 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.8 pt -141.04 151.15 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.483 1.913 . . . . 0.0 112.172 -169.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.1 mt -92.43 133.11 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -101.2 132.99 46.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.77 1.628 . . . . 0.0 107.987 168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -122.6 135.14 54.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.935 1.694 . . . . 0.0 107.769 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -73.68 134.25 43.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.314 -0.866 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.54 -169.12 25.73 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.813 1.673 . . . . 0.0 113.279 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -105.09 52.37 0.74 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.015 2.126 . . . . 0.0 111.601 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -75.54 21.47 0.14 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.742 2.417 . . . . 0.0 116.267 -167.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HA ' HG21 ' A' ' 28' ' ' ILE . 30.1 ptt-85 -57.62 -47.55 81.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.5 74.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.872 0.869 . . . . 0.0 111.782 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -64.24 -45.34 88.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.29 -36.32 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.721 -0.612 . . . . 0.0 111.391 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.3 t -57.18 -48.6 78.33 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.34 0.973 . . . . 0.0 111.014 171.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.23 -39.0 85.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.095 0.958 . . . . 0.0 112.637 175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.37 -49.61 77.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.938 1.245 . . . . 0.0 111.632 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 mmt -62.97 -40.49 97.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.008 0.923 . . . . 0.0 110.734 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.02 -49.74 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.887 0.875 . . . . 0.0 111.605 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.8 t -79.47 -48.23 14.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -169.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -97.08 -33.31 11.57 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.2 mt -88.35 -18.13 29.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.793 0.724 . . . . 0.0 112.369 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.91 17.22 77.57 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.546 1.07 . . . . 0.0 113.802 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.97 155.45 40.56 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.635 1.218 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.85 148.13 30.09 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.798 -0.564 . . . . 0.0 109.581 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -57.67 -35.75 70.99 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.466 -0.771 . . . . 0.0 112.212 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -63.86 -17.27 62.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.979 1.712 . . . . 0.0 115.131 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -73.66 -11.54 60.45 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.455 1.025 . . . . 0.0 113.132 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.1 mt -117.34 138.97 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.975 1.31 . . . . 0.0 110.566 -169.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -120.25 115.58 23.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.51 1.924 . . . . 0.0 109.938 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.7 mt -90.61 123.25 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -106.06 -29.74 9.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.298 1.039 . . . . 0.0 112.951 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.05 -154.62 52.81 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.541 1.067 . . . . 0.0 113.462 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.909 1.684 . . . . 0.0 114.188 179.088 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -67.98 151.36 47.22 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.143 0.977 . . . . 0.0 112.75 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 70.5 mt -131.67 138.84 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.33 1.452 . . . . 0.0 109.003 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.88 141.3 49.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.182 1.393 . . . . 0.0 110.064 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -80.12 152.03 29.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.985 0.914 . . . . 0.0 112.658 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -78.01 60.86 2.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.852 1.261 . . . . 0.0 111.124 170.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -77.86 -22.95 49.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.867 1.267 . . . . 0.0 113.131 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 p -74.73 171.52 13.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.495 1.518 . . . . 0.0 113.193 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -149.8 163.64 37.45 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.268 1.427 . . . . 0.0 111.232 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -97.91 118.56 63.74 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.339 1.055 . . . . 0.0 111.122 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.83 -30.0 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.145 2.563 . . . . 0.0 112.677 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.9 p90 179.97 151.48 0.42 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.197 2.999 . . . . 0.0 108.866 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.77 12.26 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.38 170.63 15.25 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.673 2.389 . . . . 0.0 114.024 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -145.7 161.53 39.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.055 1.742 . . . . 0.0 110.562 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.13 136.01 16.61 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.577 1.084 . . . . 0.0 113.09 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.93 -23.87 24.99 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.764 1.226 . . . . 0.0 113.065 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -81.96 159.43 23.58 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.636 1.574 . . . . 0.0 113.679 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.54 14.02 16.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.419 1.488 . . . . 0.0 112.629 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -66.82 139.05 57.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.668 1.587 . . . . 0.0 111.276 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 141.62 57.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.239 1.016 . . . . 0.0 112.811 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.36 152.8 18.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.065 1.746 . . . . 0.0 112.385 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.2 p -159.3 128.73 5.44 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.611 1.165 . . . . 0.0 111.477 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -174.21 178.23 2.11 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.624 1.97 . . . . 0.0 110.862 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -72.6 145.96 46.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.304 -0.872 . . . . 0.0 110.889 168.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.6 mt -89.61 118.33 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.92 115.84 31.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.124 0.969 . . . . 0.0 109.887 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.56 104.52 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -110.22 173.93 6.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.163 2.185 . . . . 0.0 110.871 -170.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt -121.95 148.19 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.747 1.219 . . . . 0.0 108.516 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -89.65 139.73 30.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.731 0.812 . . . . 0.0 110.948 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.484 ' H ' ' CD ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -97.62 127.28 43.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.291 1.437 . . . . 0.0 108.973 173.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -162.8 158.31 22.61 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.392 1.077 . . . . 0.0 112.698 -171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -79.73 -15.96 56.53 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.26 151.56 43.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.59 1.091 . . . . 0.0 112.605 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -67.6 -33.57 75.27 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -82.79 135.15 35.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.928 0.891 . . . . 0.0 112.309 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.9 m -82.46 151.02 26.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.028 1.731 . . . . 0.0 110.238 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt -127.8 135.41 50.05 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.412 1.085 . . . . 0.0 110.38 169.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.7 m -93.91 140.3 29.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.613 1.965 . . . . 0.0 108.027 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.33 119.02 24.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.75 1.22 . . . . 0.0 110.83 -174.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.6 121.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 109.611 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.75 152.76 46.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.351 1.86 . . . . 0.0 109.622 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.03 -3.13 62.45 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.9 p -55.52 130.6 70.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 118.714 1.257 . . . . 0.0 110.276 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.41 138.4 65.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.792 2.995 . . . . 0.0 113.194 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.15 -6.88 50.34 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.936 0.894 . . . . 0.0 113.234 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.48 -18.82 62.28 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.569 -0.707 . . . . 0.0 112.473 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -90.69 129.94 36.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.634 1.174 . . . . 0.0 110.915 170.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.6 117.47 14.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.351 0.66 . . . . 0.0 110.891 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.5 mt -61.05 -37.94 84.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.122 0.569 . . . . 0.0 111.382 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.4 -32.67 72.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.59 1.156 . . . . 0.0 113.202 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -71.0 -38.1 72.67 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.07 0.85 . . . . 0.0 111.402 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.951 0.796 . . . . 0.0 109.086 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.94 -49.6 70.94 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.929 0.786 . . . . 0.0 111.55 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -61.13 -43.66 98.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 112.576 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.66 -44.2 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.494 0.588 . . . . 0.0 111.371 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.0 mt -70.77 -31.49 68.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.79 -33.64 66.38 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.836 -1.165 . . . . 0.0 112.894 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.68 -58.53 3.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.24 1.016 . . . . 0.0 113.292 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.18 -42.38 13.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 0.0 113.449 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -90.31 -12.37 37.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.185 0.994 . . . . 0.0 112.818 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.49 30.14 17.16 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.226 1.81 . . . . 0.0 112.912 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.7 m -81.29 -172.2 3.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.557 1.143 . . . . 0.0 111.442 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -147.47 150.64 34.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.731 1.212 . . . . 0.0 109.241 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.0 172.52 44.72 Favored Glycine 0 N--CA 1.466 0.636 0 N-CA-C 115.836 1.095 . . . . 0.0 115.836 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -153.39 158.13 41.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.425 1.89 . . . . 0.0 111.83 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.4 mt -91.86 130.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.676 1.19 . . . . 0.0 108.452 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -142.38 140.29 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.762 1.225 . . . . 0.0 109.399 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -92.27 115.36 28.02 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.788 -0.57 . . . . 0.0 110.528 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.98 142.73 65.0 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.29 1.036 . . . . 0.0 110.819 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.81 -31.27 61.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.835 3.024 . . . . 0.0 114.971 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -116.36 -44.98 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.361 1.064 . . . . 0.0 113.081 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.4 mtm -79.86 -12.24 59.76 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -174.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.68 -161.28 46.08 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.452 1.025 . . . . 0.0 112.956 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.9 121.4 17.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.552 0.741 . . . . 0.0 111.578 -176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 pt -141.66 154.47 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.071 1.748 . . . . 0.0 111.957 -173.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -92.68 129.98 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 166.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -97.56 130.79 44.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.073 1.349 . . . . 0.0 107.532 168.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -122.01 139.66 53.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.523 1.529 . . . . 0.0 108.578 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -78.12 136.14 37.81 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.339 -0.85 . . . . 0.0 111.17 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.54 -174.05 42.75 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.828 1.68 . . . . 0.0 113.27 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -97.83 88.69 4.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.42 1.888 . . . . 0.0 110.923 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -112.12 16.42 20.17 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.414 1.485 . . . . 0.0 113.358 -169.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -58.89 -41.3 86.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.76 -37.36 65.06 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.126 0.97 . . . . 0.0 112.319 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -66.07 -43.6 86.95 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.992 0.917 . . . . 0.0 111.911 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.47 -35.51 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.186 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.0 t -56.89 -48.85 77.23 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.454 1.024 . . . . 0.0 111.12 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.34 -38.78 81.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.708 0.803 . . . . 0.0 112.726 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -61.29 -47.3 86.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.713 1.142 . . . . 0.0 111.864 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.5 -42.33 96.12 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.117 0.967 . . . . 0.0 110.606 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -69.69 -47.33 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.79 0.836 . . . . 0.0 111.471 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -77.48 -48.94 15.85 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -98.79 -34.53 10.46 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.4 -14.28 43.84 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.891 0.769 . . . . 0.0 112.24 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.86 15.72 80.87 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.957 1.265 . . . . 0.0 113.88 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.47 153.44 42.24 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.399 1.1 . . . . 0.0 111.805 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -82.72 140.39 33.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.759 -0.588 . . . . 0.0 110.004 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -54.5 -35.62 63.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.875 0.87 . . . . 0.0 113.275 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -56.65 -23.85 44.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.406 1.482 . . . . 0.0 114.323 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.64 -10.04 59.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.796 1.238 . . . . 0.0 113.031 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 44.2 mt -114.7 134.15 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.443 1.097 . . . . 0.0 110.76 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -110.75 126.94 55.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.574 1.949 . . . . 0.0 109.984 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.1 mt -100.93 125.98 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.464 1.105 . . . . 0.0 108.469 173.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -121.19 171.07 8.97 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.366 . . . . 0.0 112.729 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.66 -142.7 13.61 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.406 1.479 . . . . 0.0 112.41 174.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.2 p90 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.051 2.14 . . . . 0.0 113.275 176.942 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.504 2.273 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 p -69.16 -29.45 67.47 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -80.65 -8.48 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.527 1.531 . . . . 0.0 113.426 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -83.9 146.81 27.86 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.781 1.632 . . . . 0.0 112.407 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -71.62 155.98 39.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.452 0.701 . . . . 0.0 112.156 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.63 -36.33 80.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 0.0 111.845 172.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -138.14 147.04 43.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.992 1.717 . . . . 0.0 111.073 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 m -147.96 155.65 41.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.87 1.268 . . . . 0.0 111.864 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -85.23 175.09 9.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.697 1.199 . . . . 0.0 111.412 169.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -105.64 109.02 62.76 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.607 1.163 . . . . 0.0 111.136 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.22 -23.98 71.98 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.066 3.177 . . . . 0.0 114.574 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -99.52 11.6 38.7 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.42 1.088 . . . . 0.0 113.009 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.24 67.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.59 1.156 . . . . 0.0 114.092 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -163.25 161.64 24.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 111.744 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.2 p -137.29 154.43 50.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.885 1.674 . . . . 0.0 111.161 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.07 16.45 8.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.731 1.634 . . . . 0.0 114.061 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -163.19 170.54 17.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.255 1.822 . . . . 0.0 112.378 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -138.11 142.84 40.19 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.807 1.643 . . . . 0.0 110.96 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -106.15 144.05 33.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.981 1.313 . . . . 0.0 112.175 -172.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -135.06 166.1 23.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.059 1.744 . . . . 0.0 111.148 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.5 160.49 38.31 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.95 1.3 . . . . 0.0 112.0 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -80.22 -178.94 6.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.33 1.852 . . . . 0.0 111.624 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.9 57.43 0.32 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.804 2.041 . . . . 0.0 113.802 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -68.16 159.63 30.66 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.055 1.742 . . . . 0.0 112.659 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -68.28 137.96 55.12 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.39 107.46 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.32 126.12 37.27 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.561 0.745 . . . . 0.0 110.17 176.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 85' ' ' ARG . 13.0 mt -123.4 115.56 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -128.48 165.14 21.28 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.592 1.557 . . . . 0.0 110.575 -171.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mt -109.71 142.13 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.258 1.023 . . . . 0.0 108.805 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -82.79 164.26 20.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.721 1.248 . . . . 0.0 113.897 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -75.71 154.07 36.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.331 1.853 . . . . 0.0 111.959 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -72.13 126.84 30.79 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.898 0.479 . . . . 0.0 109.966 175.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -145.29 13.21 1.4 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.612 1.165 . . . . 0.0 113.97 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.67 22.0 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.994 1.759 . . . . 0.0 113.273 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -78.63 165.51 23.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.107 1.363 . . . . 0.0 111.273 169.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.09 170.12 6.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.266 1.027 . . . . 0.0 112.383 171.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.6 m -66.62 134.69 52.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.934 1.294 . . . . 0.0 109.865 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.79 138.72 51.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.545 1.138 . . . . 0.0 111.17 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.2 m -95.05 120.14 34.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.718 1.607 . . . . 0.0 108.11 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -99.09 123.91 43.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 110.499 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.21 128.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.957 1.303 . . . . 0.0 108.672 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -142.94 161.26 38.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.788 1.635 . . . . 0.0 110.9 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.48 -16.37 3.07 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 168.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -45.32 133.3 5.82 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 126.253 1.821 . . . . 0.0 112.777 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.15 142.44 55.26 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.982 3.122 . . . . 0.0 113.446 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.6 -13.87 62.54 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.09 -18.65 63.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.722 0.809 . . . . 0.0 113.098 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -93.59 112.64 24.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.846 1.258 . . . . 0.0 110.792 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -69.28 122.25 18.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.294 1.038 . . . . 0.0 112.002 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.42 -35.5 81.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.179 0.592 . . . . 0.0 112.116 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -63.07 -39.16 93.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 112.16 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -42.09 89.86 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.43 1.092 . . . . 0.0 111.099 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -64.11 -40.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.178 0.991 . . . . 0.0 110.395 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.32 -54.94 41.01 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.555 1.07 . . . . 0.0 110.84 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -56.9 -48.35 78.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.765 0.826 . . . . 0.0 112.623 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' CE1' ' A' ' 91' ' ' PHE . 7.5 p -70.47 -37.24 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.38 -33.62 65.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.141 0.882 . . . . 0.0 111.87 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.32 -33.3 74.07 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.908 -1.12 . . . . 0.0 112.572 170.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -79.39 -58.81 3.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.388 1.075 . . . . 0.0 113.314 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -85.1 -41.19 15.96 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.18 -12.64 32.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.179 0.992 . . . . 0.0 112.938 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 62.15 31.59 17.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.165 1.786 . . . . 0.0 112.635 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 91.2 m -80.42 -172.8 3.73 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.615 1.166 . . . . 0.0 111.521 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -148.11 150.92 34.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.696 1.198 . . . . 0.0 109.266 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.57 171.19 42.29 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 115.642 1.017 . . . . 0.0 115.642 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -150.83 156.27 40.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.127 1.771 . . . . 0.0 111.627 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.34 131.53 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.669 1.188 . . . . 0.0 108.627 171.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.63 141.17 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.899 1.28 . . . . 0.0 109.396 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -104.24 124.45 49.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.99 0.916 . . . . 0.0 111.366 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.39 151.85 46.37 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.851 1.66 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -59.95 -37.76 83.19 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.587 2.858 . . . . 0.0 115.364 -169.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -36.4 4.94 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.573 1.549 . . . . 0.0 112.26 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.8 mtm -74.1 -18.98 60.73 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.45 -163.88 53.09 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.756 1.17 . . . . 0.0 112.913 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.46 121.31 22.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.22 1.008 . . . . 0.0 110.876 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.9 pt -139.2 152.52 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 126.251 1.821 . . . . 0.0 111.799 -171.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.3 mt -93.02 130.6 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -101.69 122.76 44.51 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -110.14 140.7 43.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.366 1.466 . . . . 0.0 108.733 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -69.21 135.66 50.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.42 0.688 . . . . 0.0 111.457 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.62 -164.4 41.39 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.08 1.324 . . . . 0.0 114.03 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -100.85 99.54 10.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.18 1.792 . . . . 0.0 109.918 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -121.76 18.09 11.08 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.603 1.161 . . . . 0.0 113.081 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' ILE . 28.9 ptt-85 -63.03 -41.78 99.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -168.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.24 73.84 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 172.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -64.92 -45.2 86.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.693 0.797 . . . . 0.0 111.728 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.39 -36.77 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.477 0.711 . . . . 0.0 111.208 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.7 t -56.57 -49.41 74.95 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.719 1.145 . . . . 0.0 111.481 171.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.45 -39.62 84.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.532 0.733 . . . . 0.0 112.413 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.547 ' CE1' HG11 ' A' ' 57' ' ' VAL . 31.5 t80 -60.49 -48.11 83.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.099 0.863 . . . . 0.0 112.017 175.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.81 -42.94 94.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.441 1.096 . . . . 0.0 110.668 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.78 -47.1 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.737 0.815 . . . . 0.0 111.175 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.1 t -75.79 -48.34 22.06 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -103.52 -29.73 10.96 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -168.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.25 -16.3 27.82 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.273 0.942 . . . . 0.0 112.416 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.38 19.02 75.0 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.41 1.005 . . . . 0.0 113.613 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.54 155.37 40.58 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.411 1.105 . . . . 0.0 110.716 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -83.38 148.74 27.14 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -53.98 -41.16 67.58 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.557 -0.714 . . . . 0.0 111.581 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -64.55 -14.08 55.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -75.93 -9.35 58.54 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 112.868 172.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 30.6 mt -115.91 136.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.115 . . . . 0.0 110.338 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -116.94 114.66 24.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.978 1.711 . . . . 0.0 109.96 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -92.53 118.45 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.88 -30.91 10.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.45 -150.22 44.84 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.945 0.783 . . . . 0.0 111.96 -173.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.637 1.175 . . . . 0.0 113.354 173.803 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.0 p -164.34 163.67 22.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.489 1.515 . . . . 0.0 111.45 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.2 150.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.355 1.062 . . . . 0.0 112.63 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.66 138.9 57.76 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.231 0.612 . . . . 0.0 110.439 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.15 154.38 27.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.45 1.1 . . . . 0.0 112.564 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.84 162.7 13.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.035 1.334 . . . . 0.0 112.197 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -63.32 143.86 57.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.461 1.105 . . . . 0.0 112.881 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -83.57 148.41 27.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.588 1.155 . . . . 0.0 112.653 172.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -137.99 156.83 47.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.572 1.549 . . . . 0.0 110.975 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.16 147.69 95.61 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.955 0.902 . . . . 0.0 112.347 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.52 -29.97 90.37 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.805 3.003 . . . . 0.0 114.126 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -170.91 156.16 4.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.507 2.323 . . . . 0.0 109.657 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.86 157.69 29.57 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.215 1.806 . . . . 0.0 111.605 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -80.66 154.64 27.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 112.421 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.53 -37.06 85.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.138 1.375 . . . . 0.0 112.244 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.5 176.44 51.37 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.986 1.279 . . . . 0.0 113.769 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -162.9 155.46 18.9 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.35 1.86 . . . . 0.0 110.886 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.73 -24.04 65.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.313 1.045 . . . . 0.0 113.758 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 75.44 -37.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.629 2.772 . . . . 0.0 113.908 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.9 t -164.21 178.5 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.427 1.891 . . . . 0.0 111.3 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -156.08 163.15 40.01 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.558 1.943 . . . . 0.0 111.614 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -163.09 176.69 9.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.123 1.769 . . . . 0.0 111.005 -177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -166.83 168.24 14.3 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.473 1.909 . . . . 0.0 111.98 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -155.02 150.69 27.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.889 1.275 . . . . 0.0 111.262 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -72.33 138.04 47.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.652 0.739 . . . . 0.0 112.827 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 mt -108.02 131.04 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.494 1.518 . . . . 0.0 108.66 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -112.47 114.63 27.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.452 1.101 . . . . 0.0 109.267 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.78 99.65 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -106.49 174.49 5.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.998 2.519 . . . . 0.0 110.72 -171.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -116.49 147.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.09 0.956 . . . . 0.0 108.868 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -129.79 115.73 17.71 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.758 1.623 . . . . 0.0 108.643 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -72.89 138.87 46.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.838 1.255 . . . . 0.0 111.67 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -124.78 168.31 13.39 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.507 1.923 . . . . 0.0 110.134 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.14 135.48 53.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.646 0.779 . . . . 0.0 111.873 171.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.66 -146.37 45.19 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.918 0.771 . . . . 0.0 112.674 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -83.14 3.13 32.07 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -77.35 21.39 0.26 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.941 1.696 . . . . 0.0 115.43 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -56.38 145.56 26.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.048 2.139 . . . . 0.0 111.72 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.6 149.94 43.31 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.088 1.355 . . . . 0.0 111.913 -170.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.98 131.32 38.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.575 1.55 . . . . 0.0 107.494 167.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -115.14 123.4 48.85 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.057 1.343 . . . . 0.0 110.548 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.58 123.64 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -131.49 143.96 50.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.038 1.735 . . . . 0.0 109.005 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.15 -0.44 83.72 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.27 130.56 51.85 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 118.905 1.352 . . . . 0.0 110.956 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -52.94 139.42 60.63 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.069 3.18 . . . . 0.0 113.324 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -74.32 -7.61 53.4 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.752 0.821 . . . . 0.0 112.652 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.86 126.25 35.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.646 1.178 . . . . 0.0 111.005 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.45 115.49 12.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.442 0.697 . . . . 0.0 111.157 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 mt -59.58 -36.57 76.49 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.731 0.812 . . . . 0.0 111.624 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -63.65 -35.56 80.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.651 1.181 . . . . 0.0 112.421 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -67.93 -37.61 81.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 111.573 171.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.61 -40.86 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 0.0 110.023 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.94 -54.45 46.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.261 0.937 . . . . 0.0 110.714 169.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -57.43 -46.39 83.62 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 113.026 -174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 p -73.02 -36.88 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.43 -34.47 67.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.094 0.861 . . . . 0.0 111.751 176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.25 -34.11 76.75 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.986 -1.071 . . . . 0.0 112.554 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.8 -63.25 1.43 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.245 1.018 . . . . 0.0 113.119 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -81.9 -39.14 24.25 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.87 -3.41 51.86 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 112.767 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 59.12 27.99 17.13 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.17 1.788 . . . . 0.0 113.142 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 64.6 m -83.14 -179.94 7.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.524 1.13 . . . . 0.0 112.776 -173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -129.58 144.58 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.723 1.609 . . . . 0.0 107.898 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.71 171.24 44.33 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 116.343 1.297 . . . . 0.0 116.343 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -158.4 161.68 37.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.464 1.506 . . . . 0.0 112.48 -174.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mt -94.93 129.66 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.429 1.492 . . . . 0.0 108.219 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.4 t -139.87 139.49 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.071 0.948 . . . . 0.0 110.811 -176.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -88.22 109.56 20.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.162 0.985 . . . . 0.0 109.476 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.25 141.37 26.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.345 1.058 . . . . 0.0 111.657 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -57.81 -33.3 96.74 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.615 2.876 . . . . 0.0 114.468 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -108.15 -46.69 3.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.774 1.23 . . . . 0.0 112.071 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.0 mtt -80.91 -16.39 53.7 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.52 -159.2 49.74 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.048 0.832 . . . . 0.0 111.731 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -69.65 123.69 22.01 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.288 -1.125 . . . . 0.0 111.776 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.9 pt -144.5 153.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.133 1.773 . . . . 0.0 112.016 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.76 129.82 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 165.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -100.27 138.86 36.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.369 1.467 . . . . 0.0 108.801 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.0 tp -128.96 142.7 50.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.23 1.812 . . . . 0.0 108.355 172.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -73.25 136.9 44.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.969 1.259 . . . . 0.0 112.027 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.33 -174.87 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.27 1.414 . . . . 0.0 113.702 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.82 73.73 3.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.719 2.007 . . . . 0.0 111.412 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -97.29 16.98 18.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.331 1.852 . . . . 0.0 113.526 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -58.22 -41.54 84.31 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -40.06 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.068 0.947 . . . . 0.0 112.105 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.57 -44.69 93.36 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.253 1.021 . . . . 0.0 111.853 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.77 -34.8 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.176 0.59 . . . . 0.0 111.199 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 33.0 t -58.44 -46.91 85.58 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.614 1.097 . . . . 0.0 111.243 171.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.46 -39.06 86.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.63 0.772 . . . . 0.0 112.39 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.428 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 38.5 t80 -60.12 -48.83 80.09 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.639 1.109 . . . . 0.0 111.753 174.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.4 mmt -60.63 -42.01 96.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 110.734 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.1 mt -70.67 -45.92 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.677 0.791 . . . . 0.0 111.548 177.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -76.91 -47.81 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -101.13 -34.87 9.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -168.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.99 -14.2 48.2 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.166 0.894 . . . . 0.0 112.228 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.63 80.7 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.076 1.322 . . . . 0.0 113.757 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.83 144.48 52.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.539 1.169 . . . . 0.0 111.302 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -80.2 135.2 36.22 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.691 -0.631 . . . . 0.0 109.636 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -51.79 -34.43 39.87 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.964 1.305 . . . . 0.0 113.987 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.89 -22.25 9.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.838 1.655 . . . . 0.0 115.134 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -82.35 -9.23 59.54 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.684 1.194 . . . . 0.0 113.932 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 mt -116.99 128.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.61 1.095 . . . . 0.0 111.26 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.23 134.08 47.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.441 1.496 . . . . 0.0 110.682 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.08 126.27 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.983 1.313 . . . . 0.0 108.153 171.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -126.13 171.8 10.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.038 1.335 . . . . 0.0 113.265 -174.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.88 -136.43 9.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.603 1.573 . . . . 0.0 111.896 170.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.807 2.043 . . . . 0.0 112.879 177.909 . . . . . . . . 0 0 . 1 stop_ save_